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TYPE 2 DIABETES MELLITUS IN SOUTH ASIANS
Type 2 diabetes mellitus is a chronic, multifactorial disease characterized by variable 
degrees of insulin resistance at the skeletal muscle, adipose tissue and hepatic level, and 
impaired insulin secretion.1-3 Type 2 diabetes is associated with reduced life expectancy, 
significant morbidity and mortality due to diabetes related complications affecting 
many organ systems, and diminished quality of life, imposing a tremendous burden on 
the individual with diabetes, but also on society and on the health care system.4
Epidemiology. Type 2 diabetes is one of the most common chronic diseases worldwide, 
and continues to increase in numbers and significance. The estimated prevalence of 
diabetes in 2011 was 366 million people worldwide, with an overall predicted increase 
in prevalence from 2011 to 2030 of 50.7%, leading to an estimated prevalence of 552 
million people in 2030. 48% of the anticipated absolute global increase of 186 million 
people with diabetes is projected to occur in India and China alone. According to the 
World Health Organization (WHO), diabetes caused 1.3 million deaths in 2008 (mortality 
rate 2.3%). Worldwide, the global cost of diabetes in 2010 was estimated at nearly 500 
billion US dollars, and it is estimated to rise to at least 745 billion US dollars in 2030, an 
increase of almost 50%, with developing countries, like India and China, increasingly 
taking on a much greater share of the expenses.4
There is a considerable geographic variation in the prevalence and incidence of 
type 2 diabetes, which is likely due to genetic, behavioural, and environmental factors, 
with a large impact of countries’ income status. Diabetes prevalence also varies among 
different ethnic populations within a given country.5 In this respect, people of South 
Asian descent stand out, since the rapid increase in the prevalence of type 2 diabetes 
is especially seen in this ethnic population (Table 1). South Asians originate from the 
Table 1. Burden of type 2 diabetes in South Asians compared to white Caucasians.
Burden of type 2 diabetes in South Asians compared to white Caucasians References
- 4-6 times higher prevalence rate 5-8
-  Highest global number of T2DM patients in India with an estimated prevalence of up to 16.8% in 
urban areas
6;9-11
-  Similar prevalence rates in South Asian migrants in the USA, Canada and various European countries 12-18
- Highest prevalence rate of all ethnic minorities in the Netherlands 19
- Age-standardized prevalence rate of T2DM is 26.7% vs. 5.5% in ethnic Dutch 8
- T2DM occurs at a younger age (approximately 10 years sooner) 8;14;20
- T2DM occurs at a lower BMI (22.6 kg/m2 vs. 30.0 kg/m2) 8;14;20-23
- Severity of T2DM is higher with an increased risk of complications  16;24-29
T2DM, type 2 diabetes mellitus
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Indian subcontinent – India, Pakistan, Bangladesh, Nepal and Sri Lanka – and represent 
one fifth of the total world’s population. Both native and migrant South Asians, such as 
the Surinamese South Asian population in the Netherlands, are at high risk of develop-
ing type 2 diabetes compared to white Caucasians.5-8 India has currently the highest 
global number of diabetes patients, with an estimated prevalence of up to 16.8% in 
urban areas.6;9-11 Similar prevalence rates have also been reported in migrants of South 
Asian descent in the United States of America (USA), Canada, and various European 
countries.12-18 For example, in the United Kingdom (UK), diabetes prevalence in 35-60 
year old South Asian males was 16% compared to only 4% among European whites.13 
In the Netherlands, South Asians (Dutch Hindostani – see Intermezzo) have the highest 
type 2 diabetes prevalence of all ethnic minorities living in the Netherlands.19 In 2008, 
an age-standardized prevalence rate of type 2 diabetes of 26.7% for this group has been 
reported, compared to 5.5% in ethnic Dutch,8 and to 10% globally (WHO).
Not only is the prevalence of type 2 diabetes four to six times higher in South Asians, 
it also occurs at a younger age8;14;20 – around 10 years sooner – and lower body mass 
index (BMI)8;14;20-23 compared to white Caucasians. In a recent study in 2011, BMI obesity 
cut-off points equivalent to 30.0 kg/m2 in white Caucasians were 22.6 kg/m2 for a gly-
caemia factor (combining fasting and 2 hour glucose and HbA1c) in South Asian males.22 
Moreover, the severity of the disease is higher with an increased risk of cardiovascular 
and renal complications.16;24-29
Pathophysiology. The rapid increase in type 2 diabetes prevalence worldwide has been 
associated with a Western, obesogenic lifestyle.30 South Asians, however, appear to have 
an exceptionally high susceptibility to develop type 2 diabetes in the context of the 
same environmental pressure when compared to other ethnicities.5;7;8;21 Hence, a gene-
environment interaction underlying this excess risk seems most likely: South Asians 
seem to have a high genetic susceptibility and enhanced interaction with environmental 
triggers such as an energy-rich diet and a sedentary lifestyle.
Risk factors to develop type 2 diabetes, such as visceral or abdominal fat distribu-
tion, a sedentary life style, and dietary factors, are highly present in South Asians. This is 
partly due to rapid nutrition, lifestyle, and socioeconomic transitions that are occurring 
in South Asians in the last decades. Unlike the gradual transitions in Western countries, 
these changes have happened rapidly in many lower-income countries, such as South 
Asian countries. However, although environmental factors such as urbanization are 
important, they cannot account for all the characteristics of the excess risk in South 
Asians, and genetic influences probably have an important role. For example, genetic 
makeup probably accounts for the disadvantageous body composition of South Asians 
with relatively thin extremities, i.e. low muscle mass, high proportion of total body fat, 
and prominent abdominal adiposity, i.e. increased visceral fat mass, the so called ‘thin-
15
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fat-phenotype’. Low lean body mass and abdominal adiposity are both associated with 
insulin resistance and the development of type 2 diabetes.31;32
Type 2 diabetes is characterized by insulin resistance and impaired insulin secretion. 
In South Asians, multiple studies have consistently shown higher insulin levels compared 
to other ethnic groups regardless of age, gender or BMI, suggesting a higher rate of 
insulin resistance in this population.20;33-42 Already in neonates fasting insulin levels are 
markedly higher compared to white Caucasian neonates.43;44 Hence, the predominant 
mechanism in this ethnicity seems to be insulin resistance rather than impaired insulin 
secretion. In Chapter 2 we describe several possible mechanisms that may underlie 
or contribute to the increased insulin resistance observed in South Asians. Here, I will 
describe our main topics that we have investigated in this thesis.
Insulin signalling. Skeletal muscle accounts for 75-80% of whole-body insulin-stimu-
lated glucose disposal.45 Non-oxidative glucose disposal (NOGD) or glycogen synthesis, 
and oxidative glucose metabolism through glycolysis are the major pathways for 
glucose metabolism in skeletal muscle. In type 2 diabetes patients, the primary defect 
at the skeletal muscle level seems to reside in NOGD.46-48 Surprisingly, in South Asians 
only two in-depth studies have been conducted so far, which obtained skeletal muscle 
biopsies to investigate mitochondrial function and the insulin signalling pathway.38;49 
In this thesis, we investigated insulin signalling in young adult and adult South Asians 
(Chapters 4 and 5). A depiction of the insulin signalling pathway aimed at increasing 
the rate of glucose transport is shown in Figure 1.
Energy/nutrient-sensing pathways. Given the high susceptibility of South Asians to 
develop type 2 diabetes despite a similar environmental pressure when compared to 
people of different origins, a possible explanation for this predisposition might be re-
lated to differences in the regulation of energy/nutrient-sensing pathways in metabolic 
tissues affecting whole-body substrate homeostasis. To date, however, these pathways 
have not been analysed in South Asians. Furthermore, in the context of energy/nutrient 
sensing, the effect of dietary intervention on insulin sensitivity has not been studied 
in this ethnicity. In this thesis, we investigated energy/nutrient-sensing pathways in 
adolescent and adult South Asians (Chapters 4 and 5).
mTOR. Among these pathways, the nutrient and energy-sensing protein kinase 
mammalian target of rapamycin (mTOR), which regulates cell growth according to nutri-
ent availability and cellular energy status,50 is of major importance. The mTOR kinase 
interacts with several proteins to form two distinct complexes named mTOR complex 
1 (mTORC1) and mTOR complex 2, which differ in their molecular composition, regula-
tion, sensitivity to rapamycin, and downstream targets.50 mTORC1 responds to insulin 
and other growth factors, stress, oxygen and nutrient levels and controls key cellular 
Chapter 1
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processes.50;51 When active, mTORC1 promotes protein synthesis, cell growth and dif-
ferentiation, and may inhibit insulin signalling by feedback regulation of the insulin 
receptor substrate 1 (IRS1). mTORC1 was also recently shown to play a crucial role in mi-
tochondrial biogenesis and oxidative metabolism.52-55 A simplified view of the mTORC1 
signalling pathway at the skeletal muscle level is shown in Figure 2.
Brown adipose tissue. Another major hypothesis that we have investigated in this 
thesis is related to brown adipose tissue (BAT). In Chapter 6 we give an overview of 
the anatomy, physiology and function of BAT. In short, BAT is a highly metabolically 
active tissue involved in facultative thermogenesis. In contrast to white adipose tissue, 
BAT takes up glucose and triglyceride-derived and free fatty acids from the plasma and 
subsequently burns fatty acids to generate heat through a process called mitochondrial 
uncoupling.56 Only in 2009, cold-induced 18F-fluorodeoxyglucose (FDG) positron emis-
sion tomography-computed tomography (PET-CT) studies in humans have shown that 
BAT is still present and functional in adults.57-59 It has been estimated that fully activated 
BAT in humans can contribute to up to 15-20% of total energy expenditure.56 Intrigu-
ingly, obese individuals appear to have lower BAT volume and activity supporting the 
metabolic importance of BAT.57-59 Therefore, stimulation of BAT is currently considered a 
potential preventive and therapeutic target in the combat against obesity and related 
diseases, such as dyslipidemia and type 2 diabetes. In this thesis, we hypothesize that a 
low BAT volume or activity might underlie the disadvantageous metabolic phenotype 
and susceptibility for type 2 diabetes in South Asians (Chapter 7). Figure 3 shows the 
localization and a simplified view of the activation of BAT in human adults.
CARDIOVASCULAR DISEASE IN SOUTH ASIANS
Cardiovascular disease is common in the general population, affecting the majority of 
adults past the age of 60 years. Cardiovascular disease includes coronary heart disease, 
cerebrovascular disease, and diseases of the aorta and arteries including hypertension 
and peripheral vascular disease. Coronary heart diseases account for approximately 
one-third to one-half of the total cases of cardiovascular disease (WHO).
Epidemiology. Cardiovascular disease currently accounts for nearly half of noncommu-
nicable diseases, principally cardiovascular disease, type 2 diabetes, cancer and chronic 
respiratory diseases, which have overtaken communicable diseases as the world’s major 
disease burden. A rough estimated prevalence of cardiovascular disease in 2011 was 450 
million people worldwide. Cardiovascular disease is the leading global cause of death, 
with an estimated number of 17.3 million deaths worldwide on an annual basis in 2012, 
17
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a number that is expected to grow to 23.5 million by 2030, especially in low- and middle-
income countries.60 In 2010, the global cost of cardiovascular disease was estimated at 
863 billion US dollars, and it is estimated to rise to 1.044 billion US dollars in 2030, an 
increase of 22%.4
People of South Asian origin have an increased risk of developing cardiovascular 
disease compared to white Caucasians (Table 2).12 The age-standardized mortality 
rate from cardiovascular disease is around 50% higher for South Asians than for Cau-
casians.26;61-64 Furthermore, the mean age of first acute myocardial infarction is approxi-
mately five years earlier in South Asians than in Caucasians.65;66 Moreover, cardiovascular 

























Figure 1. Insulin signalling pathway at the skeletal muscle level. Insulin binds at the cell membrane 
at the insulin receptor leading to phosphorylation of the receptor and insulin receptor substrate (IRS). 
Activated IRS-1 subsequently binds to phosphatidylinositol 3-kinase (PI3K), which is recruited to the cell 
membrane and converts phosphatidylinositols-4,5-biphosphate (PIP2) to phosphatidylinositols-3,4,5-tri-
phosphate (PIP3). PIP3 attracts phosphatidylinositol-dependent protein kinase (PDK) and protein kinase B 
(PKB)/Akt to the cell membrane where Akt is activated by PKD-mediated phosphorylation and dissociated 
from the cell membrane to affect several metabolic processes. First, activated Akt leads to phosphoryla-
tion of Akt substrate 160 (AS160) that allows glucose transporter 4 (GLUT4) storage vesicles to translocate 
to the cell membrane. Insulin-independent pathways involved in GLUT-4 translocation involve adenosine 
monophosphate-activated kinase (AMPK)-dependent (contraction, hypoxia) and –independent pathways. 
Second, activated Akt inactivates glycogen synthase kinase 3 (GSK3), relieving the inhibitory action of GSK3 
on glycogen synthase, and thus stimulating glycogen synthesis. Third, activated Akt phosphorylates the 
nuclear protein Proline-rich Akt substrate of 40 kDa (PRAS40), disrupting the interaction between mam-
malian target of rapamycin complex 1 (mTORC1) and PRAS40, thereby relieving the inhibitory action of 
PRAS40 on mTORC1 activity. A major mTORC1 substrate is S6 kinase 1 (S6K1). Activated S6K1 leads to en-










































Figure 2. Simplified view of the mTORC1 signalling pathway at the skeletal muscle level. mTORC1 
is composed of mTOR, mTOR-associated protein LST8 homologue (mLST8) and the regulatory-associated 
protein of mTOR (Raptor). mTORC1 responds to insulin and other growth factors, amino acids, stress, oxy-
gen, and energy status. It is stimulated by the active, GTP-bound form of RHEB. Immediately upstream of 
RHEB is the TSC1/2 tumour suppressor complex, which contains a GTPase-activating protein (GAP) domain 
that converts RHEB to its inactive, GDP-bound form. Multiple upstream signalling inputs from e.g. PI3K–
AKT, Ras–ERK–RSK, AMPK-GSK3β, LKB1–AMPK pathways either positively or negatively regulate mTORC1 
signalling by inhibiting or activating, respectively, the ability of TSC2 to act as a GAP for RHEB. Kinases that 
inhibit the function of TSC2 towards RHEB and thus activate mTORC1 are AKT, ERK, and RSK. Conversely, 
AMPK- and GSK3-mediated phosphorylation events positively regulate TSC2 activity towards RHEB, re-
sulting in inhibition of mTORC1. Furthermore, some of these kinases can modulate mTORC1 activity in a 
TSC2-independent manner. For example, AKT-mediated phosphorylation of the mTORC1 inhibitory factor 
PRAS40 and RSK-mediated phosphorylation of raptor contribute to mTORC1 activation, whereas AMPK-
mediated phosphorylation of raptor results in the inhibition of mTORC1 signalling. When active, mTORC1 
promotes protein synthesis, lipogenesis, and energy metabolism and inhibits autophagy and lysosome 
biogenesis. Furthermore, activated mTORC1 leads to enhanced phosphorylation of IRS-1, which serves as 
negative feedback to dampen the insulin response. Regarding protein synthesis, two major mTORC1 sub-
strates are S6 kinase 1 (S6K1) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1).
Table 2. Burden of cardiovascular disease in South Asians compared to white Caucasians.
Burden of cardiovascular disease in South Asians compared to white Caucasians References
- Risk of CVD is at least two fold higher 12;26;61-64
- South Asians are affected at a younger age:
  mean age of first acute myocardial infarct ~5 years earlier
65;66
- CVD is more aggressive and has higher mortality rate at younger ages:






Pathophysiology. The excess risk of cardiovascular disease in South Asians most likely 
refl ects interactions between genetic susceptibility and environmental factors, such as 
changes secondary to urbanization and migration. Indeed, the risk of cardiovascular dis-
ease appears to increase as South Asians move from rural India to urban India to other 
countries.67 With urbanization and migration to Western environments the consumption 
of energy rich diets markedly increases. In addition, energy expenditure decreases due 
to less physical activity, and exposure to stress increases. Acculturation is positively asso-
ciated with coronary artery disease and type 2 diabetes in South Asian immigrants in the 
USA.68 Thus, migration itself could be an aggravating factor in the high cardiovascular 
disease risk of migrant South Asians.
The major cause of cardiovascular disease is atherosclerosis, which is present many 
years before any clinical symptoms of cardiovascular disease become manifest, and which 
may be promoted by several risk factors. Several of these risk factors are highly present 
in South Asians.27;62;66;69 As already mentioned, South Asians are known for their disad-
vantageous metabolic phenotype, consisting of insulin resistance, central obesity and 
dyslipidemia. However, after correction for these ‘classical’ risk factors, ethnicity remains an 









Figure 3. Localization and simplifi ed view of activation of brown adipose tissue (BAT) in human 
adults. In adults, BAT is predominantly located in the supraclavicular and paravertebral regions (black areas 
on 18F-FDG-PET-CT image on left side = 18F-FDG uptake). In addition, individual brown fat cells lie scattered 
in other tissues, such as white adipose tissue and skeletal muscle, where they form a pool of ´peripheral 
brown adipocytes´, the so called ‘beige adipocytes´ (not shown in this fi gure). BAT takes up glucose and 
triglyceride-derived fatty acids (FA) from the plasma and subsequently burns FA to generate heat by means 
of mitochondrial uncoupling, a process called thermogenesis. For this purpose, BAT contains high numbers 
of mitochondria that express uncoupling protein 1 (UCP-1), which uncouples respiration from ATP, in order 
to provide high oxidative capacity and is densely innervated by the sympathetic nervous system (SNS). 
The latter makes sure that BAT is rapidly activated in case of a cold environment, resulting in generation of 
heat. The thermogenic capacity of BAT is also dependent on the thyroid hormone axis (T3/T4). For a more 
detailed view on the activation of BAT see Figure 2 in Chapter 6.
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gesting that additional ‘non-classical’ risk factors must play a role. This residual risk is most 
likely caused by genetic factors since it is present in both native and migrant South Asians. 
In Chapter 8, we review classical risk factors contributing to the increased cardiovascular 
risk of South Asians and discuss potential other non-classical factors that might elucidate 
the unexplained ‘excess’ risk for cardiovascular disease in this population.
RELEVANCE OF THIS THESIS
The high prevalence of type 2 diabetes and cardiovascular disease in South Asians, 
who comprise one fifth of the total world’s population, poses a major health and so-
cioeconomic burden worldwide. The underlying cause of this excess risk is still poorly 
understood. Remarkably, though, only few in-depth studies have been conducted to 
investigate the pathogenesis of type 2 diabetes and cardiovascular disease in South 
Asians. Therefore, this thesis aimed to gain more insight in the pathogenesis of, and to 
provide new leads for preventive strategies and treatment options for type 2 diabetes 
and cardiovascular disease in people of South Asian descent. For this purpose, sophis-
ticated techniques such as a hyperinsulinemic euglycemic clamp with stable isotopes, 
indirect calorimetry, skeletal muscle biopsies, and magnetic resonance (MR)- and PET-
CT-imaging were used, combined with short-term dietary interventions, in both young 
adult and adult subjects. A large cohort of South Asian immigrants, or Dutch Hindostani, 
lives in The Netherlands. The subjects who participated in the studies in this thesis are 
from this cohort, in addition to Dutch white Caucasian subjects who formed the control 
groups. See Intermezzo: Study population for more details on the study subjects.
INTERMEZZO: STUDY POPULATION
Caucasian subjects. The Caucasian subjects who participated in the studies described in this thesis are 
all of Dutch origin. Caucasian has multiple meanings. In this thesis Caucasian means of white or West-
ern European origin. White Caucasian and Caucasian are used interchangeably throughout this text.
South Asian subjects. The South Asian subjects who participated in the studies included in this thesis 
are all Dutch Hindostani.
Etymology. Hindostan or Hindustan is derived from the Persian word Hindu, which is derived from 
the old Sanskrit name for the Indus River: Sindhu. Hence, originally, Hindu were the people in the 
land beyond the Indus River and Hindustan meant “land of the Indus”. Hindostani or Hindustani 
are an ethnic group of South Asian origin in the Netherlands and Surinam. In Dutch they are called 
‘Hindostanen’ or ‘Hindoestanen’, although some people say that ‘Hindoestanen’ refers to the religion 
(Hindu) and ‘Hindostanen’ to the ethnic group.
21
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Migration history. Dutch Hindostani originally come from North India. After the abolition of slavery in 
1862 in Dutch colonies, such as Surinam, the Dutch were allowed by the British in 1873 to recruit la-
bourers in North India to Surinam. The recruitment of immigrants from North India was mainly done 
in one area: the United Provinces of Agra and Oudh, now known as the Indian states Uttar Pradesh 
and West Bihar. This area was known for its overpopulation, poverty and shortage of food and em-
ployment. The Dutch government chose this area hoping for more recruitment. South Asian migrants 
who were found physically fit after medical screening were selected. In total, around 34.000 South 
Asians migrated to Surinam, mainly to Nickerie and the districts Paramaribo, Wanica and Commewi-
jne, and worked on the plantations (agriculture and sugar cane). After five years, they had the option 
to return to India with a free passage; around one third of the immigrants returned. Just before and 
just after the independence of Surinam in 1975 many Hindostani emigrated to the Netherlands.70 The 
migration history of Dutch Hindostani is shown in Figure 4.
In 2010, around 123.000 – 147.000 Hindostani lived in the Netherlands (0.7-0.9% of the total pop-
ulation). The estimated number of Hindostani in Surinam was almost 147.000 in 2012 (27.4% of 
the total population); around 100.000 live elsewhere in the world. In the Netherlands, the largest 
group lives in The Hague with around 45.000 Hindostani; other cities are Almere (~7000), Rotterdam 
(~30.000), Amsterdam (~12.000) and Utrecht (~5000).71-73
1 
2 
Figure 4. Migration history of Dutch Hindostani. The South Asian subjects who participated in 
the studies included in this thesis are Dutch Hindostani. They originally come from North India. Af-
ter the abolition of slavery in 1862 in Dutch colonies, such as Surinam, the Dutch were allowed by 
the British in 1873 to recruit labourers in North India to Surinam (arrow 1). Just before and just after 
the independence of Surinam in 1975 many Hindostani emigrated to the Netherlands (arrow 2).
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OUTLINE OF THE THESIS
The first part of this thesis focuses on the high prevalence of type 2 diabetes in South 
Asians. In Chapter 2 we review the available literature on potential pathophysiological 
mechanisms responsible for the increased risk of type 2 diabetes in South Asians com-
pared to white Caucasians, and we suggest several other areas of interest that should 
be explored to further investigate the increased risk for insulin resistance and type 2 
diabetes.
Multiple studies have repeatedly shown that South Asians have higher insulin 
levels during an oral glucose test (OGTT) compared to white Caucasians. Therefore, in 
Chapter 3, we aimed to investigate if this increased insulin response causes reactive 
hypoglycemia, and if an increased glucagon-like-peptide-1 (GLP-1) response, which 
could contribute to the hyperinsulinemia, is present in young, healthy South Asian men, 
using a prolonged 6-hour 75-g OGTT.
In Chapter 4 we compare the metabolic adaptation to a 5-day high-fat-high-calorie 
diet (HFHCD) between young, healthy, lean South Asian and white Caucasian men. In 
particular, we were interested whether differences in the activity of mTOR in skeletal 
muscle exist between the two ethnicities. Furthermore, hepatic and peripheral insulin 
sensitivity, substrate oxidation, abdominal fat distribution and skeletal muscle insulin 
signalling and mitochondrial respiratory-chain content were assessed. In Chapter 5 we 
assessed the effect of caloric restriction through an 8-day very low calorie diet (VLCD) 
on skeletal muscle energy/nutrient-sensing pathways in middle-aged overweight South 
Asian and white Caucasian men. We hypothesized that differences in the regulation of 
energy/nutrient-sensing pathways in metabolic tissues may affect whole-body substrate 
metabolism, and ultimately contribute to the increased risk of type 2 diabetes in South 
Asians.
Recently, brown adipose tissue has emerged as a novel player in energy metabolism 
in humans by combusting fatty acids towards heat. In Chapter 6 we give an overview of 
the anatomy, physiology and function of BAT and describe how BAT could be manipu-
lated in order to increase energy expenditure and possibly induce weight loss. South 
Asians frequently exhibit a disadvantageous metabolic phenotype, consisting of central 
obesity, insulin resistance, and dyslipidemia. Since BAT is involved in total energy ex-
penditure and clearance of serum triglycerides and glucose, we hypothesized that a low 
BAT volume and/or activity might underlie this disadvantageous metabolic phenotype 
and high susceptibility for type 2 diabetes in South Asians. Therefore, in Chapter 7, we 
investigated resting energy expenditure as well as BAT volume and activity in young 
healthy lean South Asian and white Caucasian men, using ventilated hoods and cold-
induced 18F-FDG-PET-CT-scans. In addition, we examined the effect of cold exposure on 
non-shivering thermogenesis, thermoregulation, and plasma lipid levels.
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Part two of this thesis focuses on the high risk of developing cardiovascular disease in 
South Asians. In Chapter 8, we review potential factors, both classical ‘metabolic’ and 
non-classical ‘inflammatory’ factors, contributing to the increased cardiovascular risk of 
South Asians and propose a pathophysiological mechanism underlying the high preva-
lence of classical risk factors, i.e. the disadvantageous metabolic phenotype, in South 
Asians. Furthermore, we discuss novel therapeutic strategies based on recent insights. 
Chapter 9 aimed to assess whether cardiac dimensions, cardiovascular function and 
myocardial triglyceride content differ between young, healthy South Asian and white 
Caucasian men, possibly contributing to the increased cardiovascular disease risk in 
South Asians. In addition, we hypothesized that possible differences in cardiovascular 
function between both ethnicities can be attributed to alterations in energy metabo-
lism, including a differential fat distribution in South Asians. Therefore, we subjected 
the participants to a 5-day HFHCD. In Chapter 10 we assessed whether metabolic and 
functional cardiovascular flexibility to caloric restriction differs between middle-aged, 
overweight South Asian and white Caucasian men. 
Finally, numerous studies have consistently shown a strong inverse association 
between the level of high density lipoprotein (HDL)-cholesterol and cardiovascular 
risk. The cardiovascular protective effects of HDL have been attributed to several 
anti-atherogenic properties. Interestingly, multiple studies have repeatedly found lower 
HDL-cholesterol levels in South Asians compared to white Caucasians, even in South 
Asian neonates. Hence, a possible contributing factor to the high risk of developing 
cardiovascular disease in South Asians might be dysfunction of HDL. Therefore, Chapter 
11, aimed to compare HDL function in South Asian and white Caucasian subjects.
The findings of this thesis are discussed in Chapter 12. This chapter also offers a per-
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The risk of developing type 2 diabetes is exceptionally high among both native and 
migrant South Asians. Type 2 diabetes occurs more often and at a younger age and 
lower BMI, and the risk of coronary artery and cerebrovascular disease and renal com-
plications is higher for this ethnicity compared to people of white Caucasian descent. 
The high prevalence of diabetes and its related complications in South Asians, which 
comprise one fifth of the total world’s population, poses a major health and socioeco-
nomic burden. The underlying cause of this excess risk, however, is still not completely 
understood. Therefore, gaining insight in the pathogenesis of type 2 diabetes in South 
Asians is of great importance. The predominant mechanism in this ethnicity seems to be 
insulin resistance rather than impairment in β-cell function. In this systematic review we 
describe several possible mechanisms that may underlie or contribute to the increased 
insulin resistance observed in South Asians.
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INTRODUCTION
Worldwide the prevalence of type 2 diabetes increases, particularly in South Asian coun-
tries and especially in India, which currently has the highest global number of diabetes 
patients, with an estimated prevalence of up to 16.8% in urban areas.1-4 Similar preva-
lence rates have also been reported in migrants of South Asian descent (India, Pakistan, 
Bangladesh, Nepal and Sri Lanka) in the United States of America (USA), Canada and vari-
ous European countries.5-8 In the Netherlands, South Asians mostly consist of Hindustani 
Surinamese who migrated from Surinam, a former Dutch colony in South America, and 
whose ancestors came from the Indian subcontinent about a century ago. Hindustani 
Surinamese have the highest type 2 diabetes prevalence of all ethnic minorities living in 
the Netherlands.9 An age-standardized prevalence rate of type 2 diabetes of 26.7% for 
this group has been reported, compared to 5.5% in ethnic Dutch (Table 1).10
In addition to the increased prevalence, South Asians develop diabetes at a much 
younger age than white Caucasians and have an increased incidence of retinopathy, 
microalbuminuria and end-stage renal disease.11-13 Furthermore, South Asians have an 
increased risk of developing coronary artery and cerebrovascular disease, and a 50% 
higher age-adjusted mortality rate from coronary heart disease.8
Uncovering the underlying mechanisms involved in the higher prevalence of type 
2 diabetes in South Asians is very relevant, as they represent over 20% of the world’s 
population. In this review we discuss the available literature on potential pathophysi-
ological mechanisms responsible for the increased prevalence of type 2 diabetes in 
South Asians as compared to white Caucasians.
METHODS
The literature was searched using international databases: PubMed (1949 to July 2013), 
EMBASE (OVID-version, 1980 to July 2013), Web of Science (1945 to July 2013), and the 
Cochrane Library (1990 to July 2013). Terms used were ‘South Asian’ OR ‘Indo Asian’ com-
bined with several keywords related to diabetes and its risk factors (i.e. type 2 diabetes 
mellitus, obesity, metabolic syndrome, insulin resistance, insulin secretion, body fat, liver 
fat, skeletal muscle, mitochondrial dysfunction, endothelial dysfunction, adipokines, in-
Table 1. Prevalence of T2DM in South Asians and white Caucasians
Prevalence of T2DM References
Rural India 3.0 - 8.3 % 2
Urban India 10.9 - 14.2 % 2
South Asians (Dutch) 26.7% 10
white Caucasians (Dutch) 5.5% 10
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flammation). References were limited to studies in humans, written in English or Dutch. 
See the Supplementary Methods online for the complete literature search.
TYPE 2 DIABETES MELLITUS IN SOUTH ASIANS
Pathogenesis
Type 2 diabetes mellitus is a chronic, multifactorial disease characterized by a combina-
tion of insulin resistance and impaired insulin secretion (Figure 1).14 The predominant 
mechanism, however, appears to be different in various ethnic groups.
Multiple studies have repeatedly shown that South Asians have higher fasting insu-
lin concentrations compared to other ethnic groups regardless of age, gender or BMI, 
suggesting a higher rate of insulin resistance in this population.15-25 Already in neonates 
fasting insulin levels are markedly higher compared to white Caucasian neonates,26;27 and 
fasting insulin remains higher in school children28;29and teenagers.30 In addition, studies 
with an oral glucose or meal tolerance test each show a higher serum insulin level after 
two hours and/or a higher insulin area under the curve with a normal glucose response 
in South Asians compared to different ethnicities.16;17;19;20;23-25;28;31;32 The response to an 
insulin tolerance test is also worse in South Asians.31;32 Moreover, hyperinsulinemic eug-
lycemic clamp studies in men and women of all age groups and with a relatively normal 
BMI all show lower insulin sensitivity (up to almost 50%) in South Asians compared to 
different ethnic populations.16;18;21;23-25;33-36 Thus, South Asians seem to resemble Pima 
Indians, in whom insulin resistance and hyperinsulinemia are also predominant findings 










with -cell compensation 





Figure 1. The relation between insulin sensitivity and β-cell function in type 2 diabetes. β-cell func-
tion adapts to insulin resistance in order to maintain glucose tolerance normal (derived from thesis I.M. 
Jazet, 2006, chapter 1, page 25).
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Insulin secretion or β-cell function has been investigated in fewer studies and with 
more inferior techniques (e.g. no hyperglycemic clamp studies have been performed) 
compared to insulin sensitivity in South Asians. In a large study of the UK Prospective 
Diabetes Study (UKPDS) in 5098 newly diagnosed type 2 diabetes patients (82% white 
Caucasians, 10% South Asians and 8% Afro-Caribbeans), β-cell function, measured with 
HOMA %B, was best in South Asians and worse in Afro-Caribbeans, while for insulin 
sensitivity, measured with HOMA %S, the opposite was true.15 In another study, in which 
an intravenous glucose tolerance test (IVGTT) was performed in 17 healthy first degree 
relatives of patients with type 2 diabetes and 17 healthy controls with no family his-
tory of type 2 diabetes, insulin secretory defects prevailed in the European relatives 
(n=10), whereas insulin resistance was predominant in the South Asian relatives (n=7).39 
Similar results were found in a study in which an oral glucose tolerance test (OGTT) 
was performed in 260 middle-aged South Asians with different stages of glucose toler-
ance. They found that impaired glucose tolerance was not associated with a significant 
defect in insulin secretion, whereas insulin resistance was present already in an early 
stage of glucose intolerance, suggesting that insulin resistance might precede β-cell 
deficiency.40 Another study found that Asian Indian men (n=21) had a ~30% increase 
in basal β-cell responsivity, measured by the oral C-peptide minimal model, compared 
to Caucasian men (n=71).22 Although this increase in β-cell function was inadequate 
for their degree of insulin resistance as reflected by a lower disposition index, this com-
pensatory increase suggests that β-cell dysfunction is not the main problem. Hence, 
impairment in insulin secretion does not seem the primary defect in the development 
of type 2 diabetes in South Asians, in contrast to other ethnicities, such as Japanese and 
Afro-Caribbeans.15;41;42
In the next sections we will describe several possible mechanisms that may contrib-
ute to the increased risk of type 2 diabetes, and in particular insulin resistance, in South 
Asians.
Evolutionary and developmental hypotheses
The excess risk of type 2 diabetes among South Asians has been attributed to several 
hypotheses (Table 2).
The thrifty genotype hypothesis states that predisposition to diabetes must have 
evolved as an adaptive trait in certain environmental situations that later turned disad-
vantageous due to changes in life style. According to Neel, the thrifty genotype helped 
survival in the “feast-or-famine days of hunting and gathering cultures”, but has now 
turned detrimental in the modern era of “continuous feasting”.43 In line with the thrifty 
genotype hypothesis, other evolutionary theories, such as the adipose tissue overflow44 
(see “Body composition and fat distribution”), El Niño45 and the variable disease selec-
tion46 hypotheses, postulate that South Asians are particularly susceptible to central 
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Table 2. Evolutionary and developmental hypotheses explaining the excess risk of type 2 diabetes among 
South Asians.




Predisposition to T2DM must have evolved 
as an adaptive trait in certain environmental 
situations that later turned disadvantageous 
due to changes in lifestyle
Does not explain why South Asians, in 
particular, are susceptible to central 
rather than peripheral obesity, or why 
central obesity is more important than 




The primary adipose tissue compartment is 
less developed in South Asians due to climatic 
influences, resulting in early expansion of 
the secondary adipose tissue compartments, 
especially in the face of excess energy intake, 
eventually leading to metabolic disturbances 
such as dysglycemia and dyslipidemia.
Explains why South Asians are particularly 
susceptible to central obesity, and why 
white Caucasians appear to be relatively 




Susceptibility to central obesity and 
subsequently to insulin resistance and T2DM 
is due to nutritional influences. Chronic 
energy deficiency favours increased allocation 
to the visceral depot.
Explains why South Asians are particularly 
susceptible to central obesity.
For many generations, South Asians 
have endured fluctuations of energy 
supply, associated in turn with global 





Susceptibility to central obesity and 
subsequently to insulin resistance and T2DM 
is due to infectious influences. Exposures to 
varying burdens of infectious disease may 
have been a selective pressure accounting 
for genetic ethnic variability in adipose tissue 
distribution.
Explains why South Asians are particularly 
susceptible to central obesity.
Chronic exposures to endemic 
gastrointestinal diseases, including 






Energy producing efficiency of mitochondria 
enhanced the successful adaptation of South 
Asians to climatic (heat) and other nutritional 
exposures (periods of starvation). Instead of 
using energy to generate heat, South Asian’ 
mitochondria are more likely to produce and 
subsequently store energy. This mitochondrial 
efficiency might be disadvantageous when 
adopting a new lifestyle with low physical 
activity and a high caloric diet.
Explains the tendency of South Asians to 
obesity per se, central obesity and adverse 
metabolic outcomes in our current 
environment, where food is abundant and 
physical activity is low.
Integrates other hypotheses, and offers 




Hales & Barker, 
2001
An intrauterine disadvantageous environment 
induces thrifty mechanisms that sets the 
metabolism to cope with potential future 
food shortages, which is beneficial for early 
survival, but increases the risk of T2DM later in 
life in a nutrient rich environment. Based on 
strong association between low birth weight 
and increased risk of T2DM later in life, which 
is further increased by rapid weight gain in 
childhood.
Low birth weight and rapid weight gain 
are common in both native and migrant 
South Asian neonates.
Does not explain why South Asians 
are susceptible to central rather than 
peripheral obesity, or why central obesity 
is more important than generalized 
obesity in relation to T2DM.
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obesity and subsequently to insulin resistance and type 2 diabetes due to selective 
evolutionary pressures (e.g. climatic, nutritional, or infectious). Recently Bhopal and 
Rafnsson proposed the mitochondrial efficiency hypothesis: the energy producing ef-
ficiency of mitochondria enhanced the successful adaptation of South Asians to climatic 
(heat) and other nutritional exposures (periods of starvation). Instead of using energy 
to generate heat, South Asian mitochondria are therefore more likely to produce and 
subsequently store energy. This mitochondrial efficiency might be disadvantageous 
when adopting a new lifestyle with low physical activity and a high caloric diet, as 
is currently the case for South Asians.47 The study of Nair et al. (discussed in “Skeletal 
muscle”), supports this hypothesis in that they found higher mitochondrial capacity for 
oxidative phosphorylation in both non-diabetic and diabetic South Asians compared to 
non-diabetic white Caucasians.21
Finally, according to the thrifty phenotype hypothesis, a developmental theory, 
there is a mismatch between intrauterine and adult life environments. An intrauterine 
disadvantageous environment (due to maternal malnutrition, maternal hyperglyce-
mia, or other maternal/placental influences) induces thrifty mechanisms that sets the 
metabolism to cope with potential future food shortages, which is beneficial for early 
survival, but increases the risk of diabetes later in life in a nutrient rich environment.48;49 
This theory is based on the strong association between low birth weight and increased 
risk of type 2 diabetes later in life observed in a variety of ethnic populations.50 Low 
birth weight is common in both native and migrant South Asian neonates.27;51;52 The risk 
to develop type 2 diabetes is further increased by rapid weight gain (catch-up growth) 
in childhood. This applies particularly to countries going through a rapid nutritional 
transition or when migration takes place from less developed to developed countries, 
as is the case for both native and migrant South Asians. Interestingly, recent studies in 
rats showed that intrauterine growth restriction increases the susceptibility to high fat 
diet induced alterations of fat distribution, adipocyte size, lipid metabolism, and insulin-
signalling pathways, supporting the thrifty phenotype hypothesis,53 and resembling the 
problem in South Asians.
Although these hypotheses help explain better why South Asians are at an increased 
risk of developing insulin resistance and type 2 diabetes, they do not give an exact 
molecular mechanism, except the mitochondrial efficiency hypothesis.
Genetic factors
Type 2 diabetes is considered a polygenic disease that involves polymorphisms of sev-
eral genes with a high gene-environment interaction.54 Many loci associated with type 
2 diabetes have been found in white Caucasians, however all variants found up till now 
have a modest effect size, with approximately twofold the lifetime prevalence rate of 
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type 2 diabetes in persons carrying two copies of the risk allele as compared to persons 
with none.55
Most loci found in white Caucasians have been verified in studies with South Asian 
subjects,56-58 but few differences between the ethnic groups have been found and the 
differences are not all consistently shown. For example, Radha et al. found that in South 
Asians the Pro12Ala polymorphism of the peroxisome proliferator activator gamma 
(PPARγ) gene, which has a protective effect on type 2 diabetes development in white 
populations, is present at the same frequency in South Asians with and without diabetes 
and was not associated with a decreased risk of type 2 diabetes.59 However, in a study 
in Asian Indian Sikhs they did see a protective effect of the polymorphism, suggesting 
that there might be differences between specific South Asian groups.60 An interesting 
difference might lie in the fat-mass and obesity-associated (FTO) gene, which holds 
the strongest known obesity-susceptibility locus in Europeans. An association with 
type 2 diabetes has also been shown, but this seemed to be secondary to obesity. In 
South Asians however, the FTO polymorphism was found to be associated with type 2 
diabetes independently of BMI,61-63 implying that in South Asians there may be a differ-
ent relationship between BMI and type 2 diabetes. However, associations between FTO 
and type 2 diabetes that were mediated by obesity have been found in South Asians as 
well64 and in a study in North India none of the FTO variants was even associated with 
type 2 diabetes.65 Two other recent studies in South Asians found polymorphisms of 
genes related to skeletal muscle; one associated with abdominal obesity and low lean 
body mass (myostatin)66, and one contributing to type 2 diabetes susceptibility (SCGC)67, 
which merit further investigation.
Thus, so far no clear genetic differences between white Caucasians and South Asians 
have been found. Interestingly, most loci associated with type 2 diabetes are related 
to impaired β-cell function and insulin secretion, which is not considered the primary 
defect in the South Asian population, as discussed before. Therefore, differences be-
tween the two ethnic groups on these loci is unlikely. However, an exceptionally high 
percentage of South Asians have a positive family history of type 2 diabetes, making it 
likely that genetic differences are somehow involved in the increased prevalence of TDM 
and insulin resistance in this ethnic group.
Diet and exercise
An unhealthy diet is a known risk factor for type 2 diabetes. Various studies have 
reported a number of dietary imbalances in South Asian diets associated with insulin 
resistance, such as high intake of total fat, saturated fatty acids, long chain ω-6 poly-
unsaturated fatty acids (PUFA), transfatty acids, and carbohydrates, and low intake of 
monounsaturated fatty acids, long chain ω-3 PUFAs, fibre and several micronutrients 
(e.g. magnesium, calcium, vitamin D).68-73 Furthermore, children and adolescents already 
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have a high intake of ω-6 PUFA and a low intake of ω-3 PUFA, which is correlated with 
fasting hyperinsulinemia.74;75 However, supplementation of ω-3 PUFAs (fish oil) did not 
improve insulin sensitivity in South Asians.69;76 Moreover, other studies even reported 
that South Asian diets are healthier compared to Caucasian diets (lower intake of fat).73;77-
79 Furthermore, different regional and religious South Asian communities in the United 
Kingdom (UK) all had a similar, markedly higher prevalence of diabetes compared to 
white Europeans, despite the known dietary, cultural and socioeconomic differences 
between these different South Asian communities. In addition, there were no discern-
ible differences in the dietary customs of those with normal glucose tolerance, impaired 
glucose tolerance and newly diagnosed type 2 diabetes.80;81 Lack of exercise is another 
risk factor for type 2 diabetes. The 2004 Health Survey for England data reported lower 
levels of physical activity in South Asian groups compared to the general UK population 
and other ethnic minority groups,77 and other studies showed similar results in migrant 
and urban South Asians.6;15;82-87 This low level of physical activity is already present in 
children and adolescents.77;85;88-91
Hence, although lifestyle factors will certainly play a role in the etiology of insulin re-
sistance as they do in white Caucasians, there is no reason to assume that this role is any 
different between both ethnicities. This is strengthened by the fact that the excessive 
risk for type 2 diabetes applies to both native and migrant South Asians despite differ-
ences in lifestyle. Hence, South Asians seem to have an exceptionally high susceptibility 
to develop type 2 diabetes in the context of the same environmental pressure when 
compared to other ethnicities.
Body composition and fat distribution
South Asians develop insulin resistance and type 2 diabetes at lower ranges of BMI than 
white Caucasians. An equivalent incidence rate of type 2 diabetes is seen at a BMI of 24 
kg/m² in South Asians compared to 30 kg/m² in Caucasian subjects.92 Gray et al. even 
showed an equivalent level of dysglycemia at a BMI cut-off point of 22.6 kg/m2 in South 
Asian males as compared to 30.0 kg/m2 in white Caucasian males.93 In addition, a cross-
sectional study of 4633 9- to 10-year-old children of South Asian, black African-Caribbean 
and white European origin showed that South Asian children were more metabolically 
sensitive to adiposity as indicated by stronger positive associations between HOMA-IR 
and adiposity measures.94 It has been proposed that an increase in total fat mass and 
an adverse pattern of fat distribution contributes to the higher risk of type 2 diabetes in 
South Asians at similar BMI levels. Therefore, it has been suggested that ethnic-specific 
BMI cut off values should be used for assessing diabetes risk in different populations.
Several studies have shown that South Asians have a higher percentage of body fat 
for comparable levels of BMI compared with white Caucasians and are therefore referred 
to as ‘metabolically obese’ (Table 3).16;23;34;95-97 This is already apparent in children and 
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adolescents.98-100 Also the distribution of fat differs between ethnicities. South Asian 
neonates exhibit the ‘thin-fat phenotype’, described as low muscle mass with preserved 
subscapular (central) fat27;101;102 and this phenotype is retained in Surinam South Asian 
babies of the fourth to fifth generation after migration from India.103 Modi et al. showed 
that South Asian neonates have significantly increased abdominal adiposity as compared 
to European babies104 and this increase in abdominal adiposity has also been observed 
in adults in several other studies.16;23;34;95;96  The ‘thin-fat phenotype’ is also apparent in 
pre-pubertal Indian children who have greater adiposity than white UK children despite 
significantly lower BMIs.29
It is currently unclear which of the abdominal adipose tissue compartments, visceral 
adipose tissue (VAT) or subcutaneous adipose tissue (SAT), has the most detrimental 
effect on insulin sensitivity.44 Banerji et al. showed that South Asians have high amounts 
of VAT and that insulin resistance is correlated with total visceral and not subcutaneous 
abdominal adipose tissue volume.16 Other studies also showed an association of VAT 
with diabetes105 and cardiovascular risk factors in South Asians.106;107 However, in a study 
of Raji et al., insulin sensitivity measured with a hyperinsulinemic euglycemic clamp in 
healthy South Asians and white Caucasians was inversely related with VAT as well as 
abdominal SAT and total abdominal adipose tissue.23 This was however a small study 
including only 12 South Asian and 12 white Caucasian subjects. In another study in 171 
South Asians, abdominal SAT was a better predictor of the metabolic syndrome. Also, 
SAT (and not VAT) was significantly correlated with insulin resistance, however insulin re-
sistance was measured by HOMA and data were available for 46 patients only.108 Further-
more, Chandalia et al. showed that insulin resistance was present in South Asians who 
had higher percentages of total body fat and abdominal SAT, but similar amounts of VAT 
as compared to white Caucasians.34 However, these studies do not discriminate between 
superficial SAT (SSAT) and deep SAT (DSAT). It is believed that an increase in DSAT, similar 
to VAT, is associated with metabolic disturbances.44 Sniderman et al. theorized in their 
‘overflow hypothesis’ that SSAT is the primary adipose tissue compartment and DSAT 
and VAT are secondary compartments, which have adverse metabolic consequences. 
Table 3. Differences in body composition in South Asians vs. white Caucasians
South Asians vs. white Caucasians References
Higher percentage of body fat 16;23;34;95-97
Thin fat phenotype in neonates 27;101-103
Increased abdominal adiposity 16;23;34;95;96
Increased VAT 23;96
Increased deep SAT, lower or similar superficial SAT 109;110
Decreased skeletal muscle mass/lean body mass 16;95;109;146
VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue.
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They propose that South Asians have a less developed primary compartment, resulting 
in earlier expansion of the secondary compartment, thereby leading to the increased 
risk of type 2 diabetes and cardiovascular disease.44 Studies showing that South Asians 
have higher levels of DSAT and lower or similar amounts of abdominal SSAT as compared 
to white Caucasians support this hypothesis.109;110
Thus, South Asians have higher total fat mass than white Caucasians. This fat is pri-
marily stored in the visceral and deep subcutaneous compartments and correlates with 
insulin resistance. This might be due to different metabolic characteristics of adipocytes 
in this compartment as discussed below.
Adipose tissue dysfunction and inflammation
Not only the amount and distribution of body fat differs between South Asians and 
white Caucasians. It has been proposed that South Asians have abnormalities in adipo-
cyte function as well (Table 4). Adipocytes serve as buffer for the daily influx of fat. When 
adipocytes are overloaded, for example in case of obesity, they become dysfunctional; 
the ability to store lipids is decreased.111 Studies have shown that South Asians have 
significantly increased subcutaneous adipocyte size.34;109 Hypertrophic adipocytes are 
thought of as dysfunctional and appear to be associated with insulin resistance in 
non-diabetic individuals independent of BMI and to be an independent predictor for 
the development of type 2 diabetes.112;113 Furthermore, Balakrishnan et al. showed that 
South Asians not only have a higher fraction of very large adipocytes, but also exhibit a 
higher ratio of small-to-larger adipocytes, which is considered a defect in adipose tissue 
maturation, resulting in a decreased storage capacity of triglycerides.114 Also, in a recent 
study, normoglycemic young South Asian men were shown to have increased expres-
sion of col6a3 in SAT, which is known to reduce adipocyte maturation.36
Adipocyte dysfunction was also shown in a study of Abate et al., demonstrating that 
non-diabetic South Asians have higher fasting levels of free fatty acids (FFAs) compared 
to white Caucasians, even when adjusted for body fat content, and fail to completely 
suppress plasma FFA concentration during hyperinsulinemia induced by an OGTT.115 
Table 4. Differences in adipose tissue in South Asians vs. white Caucasians
South Asians vs. white Caucasians References
Increased adipocyte size 34;109;114
Increased FFA release 115
Increased leptin 18;22;115;117-119
Decreased adiponectin 36;119;124;125
Increased IL-6 and TNF-alpha release 22;131
Increased CRP production  132;133
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This suggests that in healthy South Asians insulin is unable to sufficiently inhibit lipoly-
sis, resulting in an excess efflux of FFA, which may play a role in the development of type 
2 diabetes.
White adipose tissue not only has a function in the storage and release of FFAs, but 
is more and more recognized as an endocrine organ secreting several proteins called 
adipocytokines. Of those, leptin and adiponectin are the most frequently studied in 
relation to insulin resistance and type 2 diabetes. Leptin has an important role in food in-
take, energy expenditure and glucose metabolism. Leptin seems to have a glucose- and 
insulin-lowering and insulin-sensitising effect on the whole body level. Plasma leptin 
levels are positively correlated with plasma insulin, BMI and body fat content, therefore 
obesity reflects a state of leptin-resistance.116 Plasma leptin levels were increased in 
South Asians as compared to Caucasian subjects in several studies18;22;115;117-119 indepen-
dent of overall or abdominal obesity. Leptin levels were found to be correlated with SAT 
and not with VAT.16;120 However, in some of these studies a difference in fat mass was 
present between the two groups, or data on fat mass were not reported. Furthermore, in 
a recent study, no correlation was shown between leptin and insulin resistance in South 
Asians.121
In contrast to leptin, adiponectin is decreased in obesity, insulin resistance and type 
2 diabetes.122 Adiponectin is thought to exert insulin-sensitizing, antiatherogenic and 
anti-inflammatory effects.123 South Asians exhibit lower levels of adiponectin compared 
to white Caucasians.36;119;124 This is already apparent in babies of 3-6 months old.125 
Furthermore, lower adiponectin levels have been found in South Asians with impaired 
glucose tolerance and type 2 diabetes as compared to normal glucose tolerant South 
Asian individuals.121;126 In addition, low adiponectin levels were found to be an indepen-
dent predictor for type 2 diabetes development in South Asians.127 However, another 
study showed no relation between adiponectin and insulin sensitivity in the South Asian 
group.128
Dysfunctional adipose tissue also produces pro-inflammatory cytokines, such as 
TNF-α and IL-6, leading to a chronic inflammatory state. Although not yet fully eluci-
dated, it is hypothesized that activation of proinflammatory pathways in for example 
muscle, liver, and adipose tissue, leads to insulin resistance by inhibiting the insulin 
signalling cascade.129;130 Middle-aged South Asian women were shown to exhibit sig-
nificantly higher IL-6 levels than Europeans, however no ethnic difference in IL-6 was 
detected among men.131 In young South Asian men however, Il-6 levels were found to 
be elevated as compared to white Caucasians.22 In this study, TNF-α was elevated as well, 
yet this difference disappeared when correcting for insulin sensitivity. In addition, in 
comparison to white Caucasians, studies showed higher C-reactive protein (CRP) levels 
in South Asians, also suggesting a state of low grade inflammation.132;133 The primary 
production site of CRP is the liver, and not adipose tissue. However, visceral fat is drained 
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by the portal vein to the liver and CRP production is induced by cytokines, such as IL-6.129 
In South Asians, visceral fat was positively associated with CRP levels, independent of 
total adiposity and was associated with fasting and 2-h insulin levels during an OGTT.133
In conclusion, dysfunctional adipose tissue and inflammation are likely to contribute 
to the South Asian phenotype of increased insulin resistance and type 2 diabetes. It 
is, however, difficult to determine the primary defect:  adipocyte dysfunction leads to 
abnormalities in the insulin signalling pathway, or vice versa: abnormal insulin signalling 
results in adipocyte dysfunction. Abate et al.115 proposed that it might be a vicious cycle 
starting with primary insulin resistance, leading to adipose tissue dysfunction, which 
is reflected by the increased secretion of FFAs and (adipo)cytokines. The high levels 
of circulating FFAs in turn can aggravate insulin resistance through the deposition of 
triglycerides in non-adipose tissues,134 also called ectopic fat.
Ectopic fat
Insulin resistance and type 2 diabetes are associated with ectopic fat accumulation, i.e. 
the storage of triglycerides in nonadipose tissues such as the liver, heart, and skeletal 
muscle. Intracellular lipid deposition in these tissues is a consequence of oversupply of 
FFAs due to increased caloric intake, obesity, adipocyte dysfunction, increase in fatty 
acid transporters and/or impairment in mitochondrial lipid oxidation. The subsequent 
accumulation of intermediates of lipid metabolism, such as long-chain acyl-CoA, diacyl-
glycerol, and ceramids, in these organs appears to disrupt normal metabolic processes, 
causing organ-specific dysfunction.134
Deposition of fat in the liver in the absence of excessive alcohol intake is referred to 
as nonalcoholic fatty liver disease (NAFLD), and is associated with hepatic insulin resis-
tance.135;136 This is due to a reduction in insulin-stimulated hepatic glucose uptake and 
decreased insulin suppressibility of hepatic glucose production, which both contribute 
to increased plasma glucose levels.134 In South Asians, limited data have reported higher 
hepatic triglyceride content in comparison to white Caucasians, as measured by 1H-
MRS.22;109 Petersen et al. showed that young healthy South Asian men (n=23) had a higher 
prevalence of insulin resistance, as assessed with an OGTT in combination with the insu-
lin sensitivity index, which was associated with a ~2-fold increase in hepatic triglyceride 
content compared with Caucasian men (n=73).22 Another study reported higher fat 
infiltration in the liver in adult South Asians (n=56) vs. white Caucasians (n=52).109 These 
data suggest that South Asians appear to be predisposed to develop hepatic steatosis, 
associated with hepatic insulin resistance.
In non-athletic white Caucasians, intramyocellular lipid (IMCL) accumulation is as-
sociated with insulin resistance and type 2 diabetes, due to its toxic effects on insulin 
signalling.137-139 In South Asians, IMCL content seems to be higher compared to white 
Caucasians.22;140 However, in contrast to white Caucasians, no correlation between IMCL 
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and insulin resistance has been found in South Asians so far. 22;109;140-143 This suggests 
that IMCL is of less significance to skeletal muscle insulin sensitivity in South Asians as 
compared to Caucasians.
Role of skeletal muscle
Muscle glucose uptake accounts for 75-80% of whole-body insulin-stimulated glucose 
disposal.144 Total body muscle mass (relative to body size) has been shown to exert 
an independent effect on insulin sensitivity and glucose disposal.145 Several studies 
reported that skeletal muscle mass, or lean body mass, is lower in South Asians than 
in white Caucasians.16;95;97;100;109;146 Furthermore, low muscle mass was associated with 
reduced insulin sensitivity in young, lean South Asian men.147 In studies conducted at 
our research centre, we also found lower lean body mass in healthy young South Asian 
men compared to BMI-matched Caucasians, as measured by dual-energy x-ray absorpti-
ometry (DEXA) scan (unpublished data).
In Caucasian type 2 diabetes patients the primary defect at the skeletal muscle level 
seems to reside in non-oxidative glucose disposal (NOGD), i.e. glycogen synthesis, due 
to impairments in insulin-stimulated GLUT-4 translocation leading to impaired glucose 
transport.148-150 These impairments in the insulin signalling pathway seem to be induced 
by defects in mitochondrial fatty acid oxidation and/or increased delivery of fatty 
acids, leading to IMCL. IMCL, in turn, can impair insulin signal transduction.134 Indeed, 
in type 2 diabetes patients a number of defects in the insulin signalling pathway have 
been found.151 Furthermore, reduced mitochondrial density with reduced oxidative 
phosphorylation have been described in insulin-resistant offspring of patients with type 
2 diabetes.152 Moreover, maximal oxygen uptake, or VO2max (a measure of whole-body 
oxidative capacity), is found to be a strong independent predictor of peripheral insulin 
sensitivity in white Caucasians,153-155 and low cardiorespiratory fitness is associated with 
low skeletal muscle lipid oxidative capacity.156 One might speculate, therefore, that the 
increased risk of insulin resistance and type 2 diabetes in South Asians might be, at least 
in part, explained by reduced skeletal muscle oxidative capacity.
In South Asians, several studies reported lower VO2max values in South Asians com-
pared to matched white Caucasians.89;146;157 A recent study of Ghouri et al. confirmed this 
finding in middle-aged South Asian men without type 2 diabetes (n=87) compared to 
age- and BMI-matched European men (n=99) and, importantly, found that the lower 
cardiorespiratory fitness explained 68% of the ethnic difference in HOMA-IR.97 Of note, 
the lower VO2max could not be explained by their lower levels of physical activity, indicat-
ing that low physical fitness is an innate feature of the South Asian phenotype. However, 
so far only two relatively small in-depth studies have been performed in South Asians, 
in which skeletal muscle biopsies were obtained to find out more about the molecular 
mechanisms of the increased risk of insulin resistance and type 2 diabetes in this eth-
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nicity. In a study of Nair et al. no impairment in mitochondrial function (measured as 
skeletal muscle mitochondrial capacity for oxidative phosphorylation (OXPHOS) as as-
sessed by mitochondrial DNA copy number (mtDNA), OXPHOS gene transcripts, citrate 
synthase activity, and maximal mitochondrial ATP production rate (MAPR)) was found in 
13 healthy, middle-aged South Asians living in the USA, even despite the finding that 
they were more insulin resistant than 13 age-, sex- and BMI-matched Northern European 
Americans. On the contrary: South Asians had even higher mitochondrial capacity for 
oxidative phosphorylation.21 Hall et al. also reported that healthy, young, lean male 
South Asians (n=20) compared to age- and BMI-matched white Caucasians (n=20) did 
not exhibit lower expression of skeletal muscle oxidative and lipid metabolism genes, 
and mitochondrial DNA to nuclear DNA ratio (index of mitochondrial biogenesis) did 
not differ between groups. Gene expression of carnitine palmitoyltransferase 1A (CPT1A) 
and fatty acid synthase (FASN), both involved in lipid metabolism, was even higher in 
South Asians.146 Consequently, both studies concluded that mitochondrial dysfunction 
did not account for the observed insulin resistance in South Asians. Importantly, Hall 
also showed that South Asians oxidized less fat during submaximal exercise, whereas 
the resting rate of fat oxidation did not differ between groups. This difference, however, 
was not reflected in reduced skeletal muscle expression of oxidative and lipid metabo-
lism genes.146 It should be noted, however, that these results are derived from only two 
relatively small studies in different age groups, and thus extrapolation of these results to 
the whole South Asian population should be done with caution.
The above-mentioned study of Hall et al. is the only study that compared skeletal 
muscle insulin signalling between both ethnicities.146 Interestingly, this study showed 
that South Asians had reduced skeletal muscle protein expression of key insulin signal-
ling proteins (phosphatidylinositol 3’-kinase p85 subunit (PI3K (p85)) and protein kinase 
B serine 473 phosphorylation (pPKB-Ser473)). Basal Ser473 phosphorylation of PKB 
was even 60% lower in South Asians, and was significantly correlated with whole-body 
insulin sensitivity. However, the expression of the insulin signalling proteins in hyperin-
sulinemic condition was assessed in response to maximal insulin stimulation via incuba-
tion for 10 minutes in the presence of 10 nM human soluble insulin, instead of using a 
hyperinsulinemic clamp. Hence, the meaning of this finding needs to be corroborated.
To summarize, South Asians have less skeletal muscle mass and seem to have lower 
cardiorespiratory fitness and reduced capacity for fat oxidation during submaximal 
exercise, all correlating with their reduced whole-body insulin sensitivity, which is not 
reflected in reduced expression of oxidative and lipid metabolism genes in skeletal 
muscle.146 However, so far only two relatively small in-depth studies have been per-
formed in South Asians, therefore these results should be interpreted with caution and 
more research is warranted.
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Nitric oxide bioavailability: endothelial and HDL-cholesterol dysfunction
Apart from the aforementioned metabolic functions, insulin also stimulates the re-
lease of nitric oxide (NO) from endothelium, which leads to peripheral vasodilatation, 
increased capillary recruitment and increased blood flow. Subsequently, these hemo-
dynamic actions increase the delivery of insulin to (underperfused) tissues and enhance 
the delivery of glucose and other substrates to skeletal muscle. It is thought that 25-40% 
of insulin-mediated glucose disposal is due to its hemodynamic effects.158;159
Several studies have demonstrated that South Asians have lower NO bioavailability 
compared to white Caucasians.160;161 NO is mainly produced by the endothelium as a 
consequence of an interaction with high density lipoprotein (HDL)-cholesterol.162;163 
Thus, a diminished NO bioavailability might be caused by dysfunction of the endothe-
lium and/or dysfunctional HDL. To what extent lower NO availability is present in South 
Asians as well as its cause, endothelial or HDL dysfunction or a combination of both, are 
yet unknown.
Endothelial dysfunction is defined as inadequate endothelial-mediated vasodi-
latation and is present in patients with obesity, dyslipidemia, diabetes and very early 
in individuals with (a high risk of ) atherosclerosis. Insulin resistance and endothelial 
dysfunction are closely related. It has been shown that gluco- and lipotoxicity decrease 
NO availability.158;159 In South Asians impairments in endothelial function have been 
demonstrated. Chambers et al. showed that endothelium-dependent dilatation (mea-
sured as brachial artery flow mediated dilatation) was reduced in South Asians living 
in the UK as compared to white Caucasians and this was confirmed by others.161;164 In 
yet another study, although no difference in vasodilatation was observed after reactive 
hyperemia or sublingual nitroglycerin administration between the two ethnic groups, 
the increase in vasodilatation during hyperinsulinemia as compared to basal conditions 
was significantly lower in South Asians.24 Signs of endothelial dysfunctions are already 
present early in life in South Asians. Din et al. showed that healthy, young South Asian 
men have increased arterial stiffness (reflected by an increased augmentation of radial 
artery pressure waveforms) compared to matched white Caucasians.165 Interestingly, in 
cord blood of South Asian neonates an elevated level of E-selectin, a marker of endo-
thelial dysfunction which has been shown to predict the occurrence of type 2 diabetes 
in adult women, was found, suggesting that endothelial dysfunction might already be 
present at birth.26 Furthermore, it was shown that South Asians have lower circulating 
numbers of endothelial progenitor cells (EPCs) and EPC colony forming units, which may 
result in a reduced capacity for endothelial repair.160;161 However, others did not find a 
difference in the EPC count between South Asian and Caucasian men with established 
atherosclerosis.166
Besides endothelial dysfunction, HDL dysfunction might also play a role in the 
decreased NO bioavailability observed in South Asians. Multiple studies have consis-
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tently shown lower HDL-cholesterol levels in South Asians compared to white Cauca-
sians.19;20;23;33;99;132;167 Not only do they have lower levels of HDL-cholesterol, they also 
seem to have more small-dense dysfunctional HDL particles, which are thought to be 
proinflammatory and less protective compared to normal HDL particles..168
A diminished NO bioavailability in South Asians might thus be caused by both endo-
thelial and HDL dysfunction, and might be a factor in the increased incidence of type 2 
diabetes and cardiovascular disease in this ethnic group.
CONCLUSION & FUTURE DIRECTIONS
The risk of developing type 2 diabetes is exceptionally high among both native and mi-
grant South Asians, comprising one fifth of the worlds’ population. The disease develops 
about a decade earlier than in white Caucasians and South Asians also have an increased 
incidence of retinopathy, nephropathy and coronary artery and cerebrovascular disease. 
Even non-diabetic individuals have higher insulin levels compared to other ethnic 
groups regardless of age, gender or BMI. This points to an impairment in insulin sensitiv-
ity. Indeed, several studies have shown that the predominant mechanism leading to the 
increased risk of type 2 diabetes in South Asians seems to be insulin resistance rather 
than decreased β-cell function.
We have tried to review several pathogenetic factors that might underlie the in-
creased and accelerated risk to develop insulin resistance and type 2 diabetes in South 
Asians, which is illustrated in Figure 2.
Given the strong familial clustering of type 2 diabetes in South Asians, one would 
assume distinctive genetic differences between white Caucasians and South Asians. 
However, the presence of polymorphisms associated with type 2 diabetes found thus 
far do not clearly differ between the two ethnicities. It might be that either the wrong 
loci have been investigated (i.e. South Asians have different polymorphisms), the sample 
sizes were too small, or that the increased risk is caused by epigenetic differences. We 
believe that genetics or epigenetics must play a role, despite the fact that this has not 
been confirmed yet.
South Asians unmistakably have a different body composition than white Cauca-
sians with relatively thin extremities and increased abdominal adiposity, both in the 
visceral as well as in the deep subcutaneous compartments. Increased visceral and deep 
subcutaneous fat mass are associated with insulin resistance. Up till now, however, stud-
ies in South Asians show contradictory results with either an association of VAT with 
insulin resistance or of SAT with insulin resistance. Furthermore, South Asians appear to 
have dysfunctional adipocytes, leading to a decreased storage capacity for triglycerides 
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and impaired release of FFA’s, adipokines and pro-inflammatory cytokines, which are 
thought to disrupt the insulin signalling pathway.
Remarkably, as of yet no convincing differences in intracellular signalling cascades 
and enzymatic process involved in insulin signalling have been found between South 
Asians and Caucasians. However, so far only two relatively small studies obtained muscle 
biopsies and investigated mitochondrial function, and only one investigated the insulin 
signalling pathway. Some studies show differences in endothelial function, suggesting 
that perhaps impaired insulin-mediated capillary recruitment plays a role in the devel-
opment of insulin resistance in South Asians. This would lead to diminished delivery of 
insulin to its site of action. Hence, perhaps the fact that no difference in insulin signalling 
was observed is a quantitative problem.
Differences in dietary habits do not seem to play an important role in the increased 
diabetes risk. The number of studies examining the effect of exercise are small but con-
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Figure 2. Potential pathophysiological mechanisms that may underlie or contribute to the increased 
risk of type 2 diabetes in South Asians as compared to white Caucasians.
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fitness (maximal oxygen uptake VO2max) in South Asians, which appears to contribute 
to the increased level of insulin resistance. Further research should not only focus on 
duration and intensity of physical activity and exercise (endurance vs. strength) but also 
on the underlying cellular mechanisms.
We think there are several other areas of interest that should be explored in South Asians 
to further investigate the increased risk for insulin resistance and type 2 diabetes. Firstly, 
brown adipose tissue. Brown adipose tissue burns triglycerides and glucose to generate 
heat through a process called mitochondrial uncoupling169. Since brown adipose tissue 
is involved in around 20% of total energy expenditure170 and clearance of serum triglyc-
erides and glucose, it could play a role in the disturbed metabolic phenotype of South 
Asians. Secondly, and in light with the interest in brown adipose tissue, is Irisin. Irisin is 
a recently discovered myokine that increases with exercise and is, at least in rodents, 
involved in browning of white adipose tissue.171 Given the fact that South Asians have 
lower muscle mass and lower physical activity levels the role of Irisin in insulin resistance 
and amount of brown adipose tissue should be further explored. Thirdly, the gut micro-
biota of South Asians might be quite different from white Caucasians. The gut microbiota 
of obese subjects appears to be different from that of lean subjects and is thought to 
be associated with insulin resistance.172 Fourthly, the thin-fat phenotype might suggest 
differences in the hypothalamic-pituitary-adrenal axis with (tissue-specific) impaired 
cortisol metabolism.
As for now, we conclude that the strong genetic predisposition for type 2 diabetes 
in South Asians should be explained by as of yet undiscovered polymorphisms that 
negatively interact with environmental factors such as Western-type diet and low physi-
cal activity level. In addition, genetic makeup accounts for the disadvantageous body 
composition with low muscle mass and increased visceral fat mass. The ensuing effects 
on release of pro-inflammatory adipocytokines, myokines and FFAs disrupt cellular 
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Objective: Higher insulin levels during an oral glucose test (OGTT) have consequently 
been shown in South Asians. We aimed to investigate if this increased insulin response 
causes reactive hypoglycemia later on, and if an increased glucagon-like-peptide-1 
(GLP-1) response, which could contribute to the hyperinsulinemia, is present in this 
ethnic group.
Methods: A prolonged, 6-hour, 75-g OGTT was performed in healthy, young white 
Caucasian (n = 10) and South Asian (n = 8) men. The glucose, insulin and GLP-1 response 
was measured and indices of insulin sensitivity and beta-cell activity were calculated.
Results: Age (Caucasians 21.5±0.7 years vs. South Asians 21.4±0.7 years (mean±SEM) 
and body mass index (Caucasians 22.7±0.7 kg/m2 vs. South Asians 22.1±0.8 kg/m2) were 
comparable between the two groups. South Asian men were more insulin resistant, as 
indicated by a comparable glucose but significantly higher insulin response, and a signifi-
cantly lower Matsuda index (Caucasians 8.7(8.6) vs. South Asians 3.2(19.2), median(IQR)). 
South Asians showed a higher GLP-1 response, as reflected by a higher area under the 
curve for GLP-1 (Caucasians 851 ± 100 mmol/L*h vs. South Asians 1235 ± 155 mmol/L*h). 
During the whole 6-hour period, no reactive hypoglycemia was observed.
Conclusion: Healthy, young South Asian men have higher insulin levels during an OGTT 
as compared to white Caucasians. This does not, however, lead to reactive hypoglyce-
mia. The hyperinsulinemia is accompanied by increased levels of GLP-1. Whether this is 
an adaptive response to facilitate hyperinsulinemia to overcome insulin resistance or 
reflects a GLP-1 resistant state has yet to be elucidated.
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INTRODUCTION
Among both native and migrant South Asians the risk of developing type 2 diabetes is 
exceptionally high. Furthermore, type 2 diabetes occurs at a younger age and lower BMI 
as compared to white Caucasians.1-3 Also, long-term complications start earlier and run a 
more serious course. The predominant mechanism involved in the pathogenesis of type 
2 diabetes in South Asians seems to be a decrease in insulin sensitivity.4-6
It has repeatedly been shown that South Asians, as compared to Caucasians, exhibit 
higher 2-hour insulin levels or a higher area under the curve (AUC) for insulin, with a normal 
glucose response, during an oral glucose or meal tolerance test (OGTT).7-9 These higher 
insulin levels are considered a compensatory mechanism to overcome insulin resistance 
and maintain glucose tolerance. The hyperinsulinemia might be caused by a decreased 
insulin clearance,5 but an increased β-cell response has been reported as well.10
Glucagon-like peptide-1 (GLP-1), an incretin secreted from the enteroendocrine 
L-cells in the gut in response to eating, is known to stimulate insulin secretion from pan-
creatic β-cells.11 An increased GLP-1 response could therefore contribute to the glucose-
stimulated hyperinsulinemia consequently seen in South Asians. However, whether 
GLP-1 levels are indeed higher in this ethnic group is currently unknown. Furthermore, 
not only the underlying mechanism, but also the consequences of the hyperinsulinemia 
in people of South Asian descent are not yet fully elucidated. It is, for instance, unknown 
if the increased insulin response in people of South Asian descent causes reactive hypo-
glycemia, a condition characterized by a drop in glucose levels 4-6 hours after a glucose 
load, which is considered a sign of early latent diabetes.12-14 In the present study we 
therefore studied the glucose and insulin response during a prolonged 6-hour OGTT in 
healthy, young South Asian and white Caucasian men. Furthermore, GLP-1 levels were 
assessed to investigate whether an increased GLP-1 response is present in South Asians.
SUBJECTS AND METHODS
Subjects
Eighteen healthy, young men were included in the study (10 white Caucasians, 8 South 
Asians). Male subjects aged 18-25 years, with a BMI between 18.5 and 25 kg/m2, and 
a positive family history of type 2 diabetes were eligible for enrolment. The South 
Asian subjects were all Hindustani Surinamese. In the Netherlands, almost all South 
Asians are Hindustani Surinamese, an ethnic group that has migrated from Surinam, 
a former Dutch colony in South America, and whose ancestors came from the Indian 
subcontinent. Seven of the South Asian subjects were born in the Netherlands. One was 
born in Surinam and migrated to the Netherlands at the age of eight. Exclusion criteria 
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were type 2 diabetes or any other chronic disease, smoking, use of medication known 
to influence glucose metabolism, and recent weight change. Subjects were recruited 
via advertisements placed online, in local media, and in public places. This study was 
approved by the Medical Ethical Committee of the Leiden University Medical Centre 
and performed in accordance with the Declaration of Helsinki. Informed consent was 
obtained from all subjects before participation.
Oral glucose tolerance test
Following an initial screening visit, each subject was studied once. Subjects arrived at the 
research centre at 8.00 AM after an overnight fast. Anthropometric measurements were 
obtained and fat mass was assessed by bioelectrical impedance analysis (Bodystat® 1500, 
Bodystat Ltd., Douglas, Isle of Man, UK). After insertion of an intravenous catheter, two 
baseline blood samples were drawn (t = -15 and t = 0). Thereafter, subjects underwent a 
prolonged 75-g OGTT, with measurements of glucose and insulin at t = 15, 30, 60, 90, 120, 
150, 180, 210, 240, 300, and 360 minutes. Samples for the measurement of GLP-1 were 
drawn at baseline and at t = 15, 30, 60, 90, 120, 150, and 180 minutes. Dipeptidyl peptidase 
IV (DPP-IV) inhibitor (10 µl/mL blood; Merck Millipore, Billerica, MA, USA) was added to 
these samples immediately. Blood samples were cooled on ice and centrifuged at 4 °C. 
Hereafter samples were distributed into aliquots and stored at −80 °C until analysis.
Assays
Serum glucose, total cholesterol, HDL-cholesterol and triglycerides were measured on a 
Modular P800 analyser (Roche, Almere, The Netherlands). LDL-cholesterol was calculated 
according to Friedewald’s formula.15 Serum insulin levels were analysed on an Immulite 
2500 (Siemens, The Netherlands). Active GLP-1 was measured using a standardized 
ELISA kit (Meso Scale Diagnostics, Gaithersburg, MD, USA).
Statistical analysis and calculations
Results are expressed as mean ± standard error (SEM) or median and interquartile range 
(IQR) in case of non-normally distributed data. Baseline values for glucose, insulin and 
GLP-1 were calculated as the average of the two baseline measurements (t = -15 and t = 
0). Reactive hypoglycemia was defined as a glucose level of 3 mmol/L or less between 3 
and 6 hours after the oral glucose load. For type 2 diabetes patients on glucose lowering 
therapy usually a cut-off value for hypoglycemia of < 3.9 mmol/L is used. We chose a 
lower cut-off value for hypoglycemia suggested by Marks et al. (Hypoglycemia, 1987) 
that 3.0 mmol/L is an appropriate cut-off point for evaluating hypoglycemia in healthy 
(non-diabetic) volunteers, since 95% of blood glucose levels in healthy volunteers are 
above this level. AUC values were determined using the trapezoidal rule.16 Incremental 
values are calculated by deducting the area below the baseline value from total AUCs. 
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Insulin sensitivity was estimated using the Matsuda index (glucose: mg/dL; insulin: 
mU/L).17 Recently it was shown that the Matsuda index correlates highly with insulin 
sensitivity measured with a hyperinsulinemic clamp in South Asians and Caucasians.18 
The insulinogenic index (IGI; ΔI0–30/ΔG0–30) was used as a measurement of early insulin 
secretion (glucose: mmol/l insulin: pmol/L).19 The oral disposition index (DIo; (ΔI0–30/
ΔG0–30)/fasting insulin) (glucose: mmol/L; insulin: mU/L) was used to provide an estimate 
of β-cell function relative to the prevailing level of insulin resistance.20,21
The independent Student’s t-test was used for comparisons between the groups. A 
non-parametric test (Mann-Whitney U test) was applied when appropriate. A p-value of 
< 0.05 was considered statistically significant. Statistical analyses were performed using 
SPSS for Windows (release 20.0, IBM, USA).
RESULTS
Anthropometric and laboratory measurements
Data on anthropometric and laboratory measurements are shown in Table 1. South 
Asians were significantly smaller and lighter compared to the Caucasian subjects. BMI, 
however, was comparable between the groups (Caucasians: 22.7 ± 0.7 vs. South Asians: 
22.1 ± 0.8 kg/m2). There were no significant differences in (percent of ) fat mass, waist 
circumference, or fasting levels of glucose, insulin and lipids.





age (years) 21.5 ± 0.7 21.4 ± 0.7
height (m) 1.82 ± 0.01 1.72 ± 0.02
weight (kg) 76.0 ± 2.7 65.7 ± 2.8*
BMI (kg/m2) 22.7 ± 0.7 22.1 ± 0.8
waist (cm) 81 ± 2.2 78 ± 2.1
fat mass (%) 14.9 ± 0.9 15.2 ± 1.5
fasting glucose (mmol/L) 4.9 ± 0.2 5.2 ± 0.1
fasting insulin (mU/L) 5.3 ± 1.5 9.5 ± 1.5
HOMA-IR 1.2 ± 0.4 2.2 ± 0.4
total cholesterol (mmol/L) 3.68 ± 0.26 3.90 ± 0.19
LDL-cholesterol (mmol/L) 2.10 ± 0.24 2.22 ± 0.12
triglycerides (mmol/L) 1.03 ± 0.13 0.92 ± 0.11
HDL-cholesterol (mmol/L) 1.10 ± 0.06 1.3 ± 0.06
Mean ± SEM. * p < 0.05 BMI: body mass index; HDL: high density lipoprotein; LDL: low density lipoprotein; 
HOMA-IR: homeostasis model of assessment insulin resistance
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Prolonged oral glucose tolerance test
Time courses for glucose and insulin during the prolonged 75-g OGTT are shown in 
Figure 1. Insulin levels were significantly higher in the South Asian group at several 
time points. During the whole 6-hour period there were no differences in glucose levels 
between the groups and reactive hypoglycemia did not occur. The AUCs for glucose and 
insulin are depicted in Figure 2. The AUC360 for insulin was significantly higher in the 
South Asian group (Caucasians: 6.6 ± 0.9*103 vs. South Asians: 16.7 ± 4.2*103 mU/L*h; 
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Figure 1. Time courses for plasma concentrations of glucose, insulin and glucagon-like peptide 
(GLP)-1 during an oral glucose tolerance test (OGTT) in healthy young white Caucasian and South 
Asian men. Data are mean ± SEM; * p<0.05.
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p<0.05). South Asians were less insulin sensitive as reflected by a lower Matsuda index 
(Table 2). A compensatory increase in insulin secretion was observed in this group as 
shown by an increased IGI, although this was only borderline significant (p=0.051). β-cell 
function in relation to the level of insulin sensitivity, as assessed by the oral disposition 






















































Figure 2. Area under the curve (AUC) for glucose, insulin and glucagon-like peptide (GLP)-1 during 
an oral glucose tolerance test (OGTT) in healthy, young white Caucasian and South Asian men. Data 




The time course and AUC for GLP-1 during the OGTT are shown in Figure 1 and 2. The 
AUC180 for GLP-1 was higher in South Asian subjects compared to Caucasian subjects 
(Caucasians: 851 ± 100 vs. South Asians: 1235 ± 155 mmol/L*h; p<0.05). The incremental 
AUC180 was higher in South Asians as well, although this did not reach statistical differ-
ence (Caucasians: 619 ± 94 vs. South Asians: 851 ± 142 mmol/L*h; p=0.18). In univariate 
analysis, fat percentage or waist circumference did not significantly predict the GLP-1 
AUC180 (p=0.852 and p=0.102). However when included in the model, they do alter 
the significance level of the between group difference in GLP-1 AUC180 (p=0.055 and 
p=0.103 instead of p=0.046). GLP-1 and insulin levels were highly correlated at several 
time points, especially GLP-1 at t = 15 min (with insulin at t = 15, 30, 90, 120, 150, 180, 
210, 240, 300 min; p<0.05). The GLP-1 AUC180 showed a significant correlation with the 
insulin AUC120 and the insulin AUC360 (0.607, p=0.008, and 0.599, p=0.009), but not with 
the AUCs for glucose. Due to the small sample size, correlations could not be calculated 
for South Asians and Caucasians separately.
Table 2. Glucose, insulin and GLP-1 indices during a 6-hour 75-g oral glucose tolerance test in young, 





peak glucose (mmol/L) 8.8 ± 0.30 9.1 ± 0.33
peak glucose time (min) (median, IQR) 30 (30) 30 (23)
peak insulin (mU/L) 59 ± 8.7 155 ± 39*
peak insulin time (min) (median, IQR) 60 (30) 60 (0)
peak GLP-1 (mmol/L) 9.4 ± 0.9 22.1 ± 6.2
peak GLP-1 time (min) (median, IQR) 30 (30) 30 (15)
AUC120 glucose (mmol/L * h) 818 ± 34 837 ± 32
AUC120 insulin (mU/L * h) 4.7 ± 0.6*103 12.0 ± 3.0*103*
AUC360 glucose (mmol/L * h) 1924 ± 47 1936 ± 48
AUC360 insulin (mU/L * h) 6.6 ± 0.9*103 16.7 ± 4.2*103*
AUC180 GLP-1 (mmol/L * h) 851 ± 100 1235 ± 155*
AUC180 incremental GLP-1 (mmol/L * h) 619 ± 94 851 ± 142
AUC120 glucose/AUC120 insulin (mmol/mU) 0.21 ± 0.33 0.13 ± 0.04
Matsuda index (median, IQR) 8.7 (8.6) 3.2 (19.2)*
IGI30 (pmol/mmol) (median, IQR) 83 (41) 175 (189)p=0.051
DIo (median, IQR) 3.1 (3.5) 2.4 (1.4)
Mean ± SEM, unless otherwise specified. * p < 0.05. GLP-1: glucagon-like peptide-1; AUC: area under the 
curve; IGI: insulinogenic index, DIo: oral disposition index
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DISCUSSION
In this study we investigated the glucose, insulin and GLP-1 response during a pro-
longed OGTT in young, healthy South Asian men. We confirmed that young, healthy 
South Asian men are more insulin resistant, as reflected by higher insulin levels during 
an OGTT, than their white Caucasian counterparts. A novel finding is that these higher 
insulin levels are accompanied by increased levels of GLP-1. Also we demonstrated that 
no reactive hypoglycemia occurred in the South Asians.
Whether the hyperinsulinemia in South Asians is caused by reduced clearance or 
increased secretion of insulin is unclear. A decreased insulin clearance has been found 
in South Asians during a euglycemic hyperinsulinemic clamp by our group (unpublished 
data) and by others.5 On the other hand, Petersen et al. showed an increase in β-cell re-
sponse (estimated using the oral C-peptide minimal model) in South Asians as compared 
to Caucasians during a 2-hour, 75-g OGTT.9 This increased β-cell response was, however, 
inadequate for their degree of insulin resistance as reflected by a lower disposition in-
dex. It is well known that to maintain glucose tolerance with declining insulin sensitivity, 
a proportionate increase in insulin output has to occur as a compensatory mechanism.22 
In our study the South Asian men were more insulin resistant, as shown by a comparable 
glucose but significantly higher insulin response and a decreased Matsuda index, and 
indeed showed an increased β-cell response, as reflected by a higher IGI. The oral dispo-
sition index did not differ between groups, suggesting that the increased insulin output 
was adequate for the level of insulin resistance.
In this study, we further explored a possible consequence of the glucose-stimulated 
hyperinsulinemia in South Asian men: reactive hypoglycemia. Despite the higher insulin 
levels, no reactive hypoglycemia was seen in this group. Reactive hypoglycemia 4-6 
hours after a glucose load has been observed in obese subjects and is considered an 
early sign of diabetes.12-14 Reactive hypoglycemia has also been found in  young, lean 
women with polycystic ovary syndrome (PCOS), a condition known to be associated 
with insulin resistance and increased risk of diabetes development.23 The fact that hypo-
glycemia did not occur in our study might be due to a high level of insulin resistance on 
a cellular level in the South Asian subjects, or by the induction of insulin resistance and 
increased hepatic glucose output by counter regulatory hormones, such as glucagon, 
catecholamines and cortisol, which were not measured in our study. Furthermore, be-
cause of the small sample size, it is possible that a difference was missed.
A novel finding is that the South Asians displayed a higher GLP-1 response to an oral 
glucose load, as reflected by an increased AUC for GLP-1. To our knowledge, this is the 
first study investigating the GLP-1 response in subjects of South Asian descent. GLP-1 is 
known to have several beneficial effects on glucose regulation. It stimulates endogenous 
insulin secretion in response to oral glucose or eating, suppresses glucagon secretion 
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resulting in a decreased hepatic glucose output, and is thought to exert extrapancreatic 
effects, since it improves glucose disposal and decreases endogenous glucose produc-
tion  independent of its release of islet hormones.24-26 Therefore, we hypothesized that 
an increased GLP-1 response could possibly explain, or at least contribute to the higher 
insulin levels in South Asians, which may initially help overcome the insulin resistance 
in this ethnic group.
The precise role of GLP-1 in the pathogenesis of type 2 diabetes is currently unknown. 
It is well known that the incretin effect (i.e. the augmented insulin secretion in response 
to oral compared with intravenous isoglycemic administration of glucose) is diminished 
in type 2 diabetes patients.27 It has been debated if this impaired incretin effect is caused 
by impaired GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) secretion or 
by a defective insulin secretory effect of these hormones (‘incretin resistance’). Several 
studies showed a lower postprandial GLP-1 release in subjects with type 2 diabetes and 
insulin resistance, but a recent meta-analysis found that patients with type 2 diabetes 
on the whole do not exhibit reduced GLP-1 secretion in response to oral glucose or meal 
tests and that type 2 diabetes patients may even have higher GLP-1 peak levels.28 Our 
data suggest that a state of insulin resistance leads to a higher GLP-1 response. Possibly, 
GLP-1 secretion changes during the progression from normal glucose tolerance to type 
2 diabetes, which was also suggested by the authors of the aforementioned meta-
analysis.28 Early stages of type 2 diabetes may lead to compensatory increased GLP-1 
secretion from intestinal L-cells, which is then followed by the exhaustion of these cells 
when the disease progresses. Indeed, a study by Theodorakis et al. in newly diagnosed 
type 2 diabetes patients showed an increase in late-phase (20-80 min) GLP-1 secretion 
after a 75-g OGTT, in parallel with rising plasma insulin levels. Furthermore, they found 
increased numbers of L-cells in the duodenum in this group.29 However, in a study of 
Knop et al. insulin resistant, but normal glucose tolerant, obese subjects did not show an 
increased GLP-1 response. In this study, however, an oral glucose load of 50-g was used, 
instead of the 75-g OGTT in our study. Furthermore, these subjects already displayed 
signs of β-cell dysfunction, as shown by a decreased disposition index, indicating a more 
progressed state of insulin resistance.30 In another study, insulin resistance induced in 
healthy, young men (using a 12 day intervention with prednisolone treatment, high-
energy diet, and relative physical inactivity) led to higher fasting GLP-1 levels, but no 
difference in the GLP-1 response to an oral glucose load was found when comparing the 
baseline and insulin resistant state.31 This might be due to the fact that the subjects in 
this study not only were insulin resistant, but also less glucose tolerant. Four of the 10 
subjects even displayed impaired glucose tolerance or diabetes after the intervention, 
whereas all our subjects were normal glucose tolerant. Hence, glucotoxicity might have 
attenuated the GLP-1 response.
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The increased GLP-1 response found in the South Asian subjects in our study on the 
other hand might also indicate a state of GLP-1 resistance. Although debated, evidence 
suggests that GLP-1 resistance is present in type 2 diabetes patients and their healthy 
offspring.32 Furthermore, in the aforementioned study in which insulin resistance was 
induced in healthy subjects, although no alterations in the GLP-1 response were seen, a 
reduction in the incretin effect was shown.31 In addition, the insulinotropic effect of GLP-
1 was impaired, suggesting that incretin resistance was present and is a consequence of 
insulin resistance. We also showed higher fasting GLP-1 levels in the South Asian group. 
However, since the incretin effect and the direct insulinotropic action of GLP-1 were 
not assessed in our study, it remains to be elucidated whether the higher fasting GLP-1 
levels and higher GLP-1 response in South Asians are due to a compensatory increased 
secretion or reflecting a GLP-1 resistant state. However, the peak GLP-1 levels preceded 
the peak insulin response and paralleled the increased β-cell activity (IGI), suggesting a 
direct relation between the increased GLP-1 response and the insulin secretion by the 
β-cell.
A limitation of our study is the small sample size. However, even with only 18 
subjects, a difference in GLP-1 response was found. Further research is required to see 
whether these findings can be reproduced in larger samples. In univariate analysis, fat 
percentage and waist circumference did influence the significance level of the between 
group difference in GLP-1 AUC180. It can therefore not be excluded that differences in 
body composition, although not significantly different between the two groups, has 
influenced our findings on GLP-1 levels. In addition, we do not have data on nutritional 
intake and exercise. It is possible that differences in intake and physical activity influ-
enced insulin resistance and GLP-1 secretion. However, it is unlikely that differences 
in behaviour solely explain the increased insulin sensitivity found in diverse groups of 
South Asians.6 Furthermore, in a previous study of our group in a similar study popula-
tion no differences were found in diet and exercise.33 Hence, it seems unlikely that these 
factors have influenced our findings.
In conclusion, we confirmed that young, healthy South Asian men are more insulin 
resistant and have higher insulin levels during an OGTT than their white Caucasian coun-
terparts. The higher insulin levels were accompanied by increased levels of GLP-1. No 
reactive hypoglycemia was observed in the South Asians despite the hyperinsulinemia. 
Whether this is an adaptive response to facilitate hyperinsulinemia to overcome insulin 
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South Asians develop type 2 diabetes at a younger age and lower BMI compared to 
white Caucasians. The underlying cause is still poorly understood but might result from 
an innate inability to adapt to the Westernized diet. This study aimed to compare the 
metabolic adaptation to a high fat high calorie diet (HFHCD) between both ethnicities. 
Twelve healthy young lean male South Asians and 12 matched white Caucasians un-
derwent a 2-step hyperinsulinemic-euglycemic clamp with skeletal muscle biopsies and 
indirect calorimetry before and after a 5-day HFHCD. Hepatic triglyceride content (HTG) 
and abdominal fat distribution were assessed using MRI/S. At baseline, South Asians had 
higher insulin clamp levels than Caucasians, indicating reduced insulin clearance rate. 
Despite the higher insulin levels, endogenous glucose production was comparable be-
tween groups, suggesting lower hepatic insulin sensitivity in South Asians. Furthermore, 
a 5-day HFHCD decreased insulin-stimulated (non-oxidative) glucose disposal rate only 
in South Asians. In skeletal muscle no significant differences were found between groups 
in insulin/mTOR-signalling, metabolic gene expression and mitochondrial respiratory-
chain content. Furthermore, no differences in (mobilization of ) HTG and abdominal fat 
were detected. We conclude that HFHC-feeding rapidly induces insulin resistance only 
in South Asians. Thus, distinct adaptation to “Western” food may partly explain their 
propensity to develop type 2 diabetes.
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INTRODUCTION
The incidence of type 2 diabetes is increasing rapidly worldwide, especially in people 
of South Asian descent.1 South Asians originate from the Indian subcontinent and 
represent one fifth of the world’s population. Both native and migrant South Asians 
are at high risk of developing type 2 diabetes compared to Caucasians.2-4 Not only is 
the prevalence of type 2 diabetes four to six times higher, it also occurs at a younger 
age and lower BMI.4-6 Moreover, the risk of cardiovascular and renal complications is 
higher.7-10 The underlying cause of this excess risk is still not completely understood, and 
only few in-depth studies have been conducted to investigate the pathogenesis of type 
2 diabetes in South Asians.11;12
The observation that South Asians have high hepatic and intramyocellular lipid con-
tent compared to people of Caucasian descent13;14 might suggest that South Asians have 
an impaired mitochondrial fatty acid beta-oxidation in either skeletal muscle and/or adi-
pose tissue, resulting in ectopic fat deposition in peripheral tissues, eventually leading 
to insulin resistance and other metabolic dysfunctions.15 South Asians may therefore be 
less capable to handle the Western-type high fat (HF)-diet as compared to Caucasians.
Interesting in this context are recent findings on the nutrient and energy-sensing 
mammalian target of rapamycin (mTOR)-pathway. The mTOR-pathway regulates cell 
growth according to cellular energy status and nutrient availability.16 Activated mTOR 
complex 1 (mTORC1) controls key cellular processes, e.g. it inhibits insulin signalling17 
and plays a crucial role in the regulation of oxidative metabolism and mitochondrial 
biogenesis.18-21 Importantly, mTORC1 also appears to promote lipid synthesis and stor-
age, while inhibiting processes leading to lipid consumption.22 Indeed, there is grow-
ing evidence that mTORC1 suppresses fatty acid beta-oxidation.21;23;24 Therefore, we 
hypothesize that differences in mTOR activity between the two ethnicities may underlie 
or contribute to the increased risk of type 2 diabetes in South Asians.
The aim of this study was to investigate whether the metabolic adaptation to a 5-day 
high fat high calorie diet (HFHCD) is different between young healthy lean South Asian 
males and matched Caucasians. In particular, we were interested whether differences 
in the activity of mTOR in skeletal muscle exist between the two ethnicities, both at 
baseline and in response to the HFHCD. Furthermore, hepatic and peripheral insulin 
sensitivity, substrate oxidation, abdominal fat distribution and skeletal muscle insulin 
signalling and mitochondrial respiratory-chain content were assessed.
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RESEARCH DESIGN AND METHODS
Subjects
Twelve Dutch South Asian and twelve Dutch Caucasian, lean (BMI < 25 kg/m2) and healthy 
men, aged 19-25 years with a positive family history of type 2 diabetes were enrolled via 
local advertisements. Subjects underwent a medical screening including their medical 
history, a physical examination, blood chemistry tests and an oral glucose tolerance test 
to exclude individuals with type 2 diabetes according to the American Diabetes Associa-
tion 2010 criteria. Other exclusion criteria were rigorous exercise, smoking and recent body 
weight change. The study was approved by the Medical Ethical Committee of the Leiden 
University Medical Centre and performed in accordance with the principles of the revised 
Declaration of Helsinki. All volunteers gave written informed consent before participation.
Study design
Subjects were studied before and after a 5-day HFHCD, consisting of the subject’s regu-
lar diet supplemented with 375 mL of cream per day (=1275 kcal/day, 94% fat). At the 
end of the first study day, subjects received 15 125 mL cups of cream to take home. They 
were instructed to continue their regular diet and, on top of that, to consume three cups 
of cream per day, directly following a meal in order to make sure they could adhere to 
their regular dietary habits. In addition, they kept a food diary before and during the 
HFHCD to estimate normal dietary intake, to maximize compliance with the diet, and to 
check for compliance and compensation behaviour. Diaries were entered and analysed 
using a specialized internet application (http://www.dieetinzicht.nl, Dutch). Compliance 
was measured by asking to bring leftover cups, inquiring, analysing the food diaries and 
laboratory parameters. Subjects were instructed not to alter life style habits, and not to 
perform physical activity in the last 48 hours before the study days. Magnetic resonance 
(MR) studies were performed shortly before and on the fifth day of the HFHCD. Metabolic 
studies were performed one day before and one day after the diet.
MR studies
Abdominal fat depots were quantified with turbo spin echo MR-imaging using a 1.5 
Tesla whole body MR-scanner (Gyroscan ACS-NT15; Philips, The Netherlands) four hours 
after the last meal.25 During one breath hold, three transverse images were obtained at 
the level of L5. Volumes of visceral and subcutaneous fat depots were quantified using 
MASS analytical software (Medis, The Netherlands). The number of pixels were converted 
to cm2 and multiplied by the slice thickness (10mm). Hepatic triglyceride content (HTG) 
was assessed by proton MR-spectroscopy (1H-MRS)26 A spectrum without water suppres-
sion, four averages, as internal standard was obtained, and 64 averages were collected 
with water suppression. The spectra were fitted using Java-based MR user interface soft-
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ware (jMRUI version 2.2).26 The percentage of hepatic triglyceride signals was calculated 
as: (signal amplitude hepatic triglycerides / signal amplitude water) x 100.
Metabolic studies
Anthropometric measurements, a 2-step hyperinsulinemic-euglycemic clamp with stable 
isotopes and indirect calorimetry were performed after an overnight fast. In addition, 
skeletal muscle biopsies were obtained. Fat and lean body mass (LBM) were assessed by 
bioelectrical impedance analysis (BIA; Bodystat® 1500, Bodystat Ltd., Douglas, UK).
Hyperinsulinemic-euglycemic clamp A 6-h 2-step hyperinsulinemic-euglycemic 
clamp was performed as described previously.27 In short, a primed constant infusion 
of glucose tracer ([6,6-2H2]-glucose; 0.22 μmol/kg/min) was used to determine rates of 
glucose appearance (Ra) and disposal (Rd). At t=120 min (step 1) and t=240 min (step 2), 
a primed constant infusion of insulin (step 1: 10 mU/m2/min, step 2: 40 mU/m2/min) was 
started and glucose-20% enriched with 3% [6,6-2H2]-glucose was infused at a variable 
rate to maintain glucose level at 5.0 mmol/L. In basal state (t=0 min), at the end of the 
non-insulin stimulated period (t=95-115 min) and at the end of each step (t=210-240 
min and t=330-360 min), blood samples were taken for determination of glucose, insu-
lin, C-peptide, free fatty acids (FFAs), and [6,6-2H2]-glucose specific activity.
Indirect calorimetry Indirect calorimetry was performed with a ventilated hood 
(Oxycon Pro™, CareFusion, Germany) in basal condition and during both steps of the 
clamp.
Skeletal muscle biopsies Muscle biopsies from the m. vastus lateralis (~75-100 mg) 
were collected in basal and hyperinsulinemic condition (at 30 minutes of step 2) under 
localized anesthesia, using a modified Bergström needle.28 Muscle samples were divided 
into two parts, snap-frozen in liquid nitrogen and stored at -80°C until further analysis.
Calculations
Glucose Ra and Rd were calculated as the tracer infusion rate divided by the tracer-to-
tracee ratio.29 Endogenous glucose production (EGP) was calculated as the difference 
between the rates of Ra and glucose infusion. Rd and EGP were adjusted for kilograms 
LBM. The metabolic clearance rate of insulin (MCRi) was computed according to Elahi et 
al.30 Resting energy expenditure (REE), respiratory quotient (RQ) and substrate oxidation 
rates were determined as described by Simonson and DeFronzo.31 Non-oxidative glu-
cose disposal (NOGD) was calculated by subtracting the glucose oxidation rate from Rd. 
The hepatic insulin resistance index (HIR) was calculated as the product of non-insulin 
stimulated EGP and fasting serum insulin concentration.32 Glucose metabolic clearance 
rate (MCRg) was calculated as the rate of disappearance of glucose (Rd) divided by the 




Fasting serum glucose and triglycerides were measured on a Modular P800 analyser 
(Roche, The Netherlands), serum insulin and C-peptide levels on an Immulite 2500 (Sie-
mens, The Netherlands), HbA1c on an HPLC machine Primus Ultra 2 (Kordia, The Nether-
lands), and plasma FFAs were determined by a colorimetric method (Wako Chemicals, 
Germany). Arterialized whole blood glucose levels during the clamp were measured 
by glucose dehydrogenase-NAD technique (Precision Xtra Blood Glucose Monitoring 
System, Abbott USA). [6,6-2H2]-glucose enrichment was measured in a single analytical 
run using gas chromatography-mass spectrometry as described previously.34
DNA/RNA isolation and real-time RT-PCR
Total RNA was isolated from skeletal muscle biopsies (~25-30 mg) using the phenol-
chloroform extraction method (Tripure RNA Isolation reagent, Roche, Germany), 
treated with a DNAse kit according to the manufacturer instruction (TURBO DNAse, Life 
Technologies, The Netherlands), and quantified by NanoDrop. First-strand cDNA were 
synthesized from 1 µg total RNA using a Superscript first strand synthesis kit (Invitrogen, 
The Netherlands). Real-time PCR assays were performed using specific primers sets (se-
quences provided on request) and SYBR Green on a StepOne Plus Real-time PCR system 
(Applied Biosystems, USA). mRNA expression was normalized to ribosomal protein S18 
(Rps18) and expressed as arbitrary units. Genomic DNA was extracted using the Qiagen 
Tissue and Blood Kit (Qiagen, Germany) and concentrations were measured spectropho-
tometrically (GeneQuant, GE Healthcare, Germany). Mitochondrial (mtDNA) and nuclear 
(nDNA) DNA copy numbers were quantified as described before35 and the mtDNA-to-
nDNA-ratio was used as an index of mitochondrial density. A complete overview of all 
analysed genes can be found in Supplemental Table 1.
Western Blot
Skeletal muscle biopsies (~30-45mg) were homogenized by Ultra-Turrax (22.000 rpm; 
2x5sec) in a 6:1 (v/w) ratio of ice-cold buffer containing: 50mM HEPES (pH 7.6), 50mM 
NaF, 50mM KCl, 5mM NaPPi, 1mM EDTA, 1mM EGTA, 5mM β-GP, 1mM Na3VO4, 1mM DTT, 
1% NP40 and protease inhibitors cocktail (Complete, Roche, The Netherlands). Western 
blots were performed using phospho-specific (Ser473-PKB, phospho-Akt substrate, 
Ser2448-mTOR, and Thr389-S6K from Cell Signalling; Thr246-PRAS40 from Biosource) or 
total primary antibodies (Tubulin, Akt1+2, Akt substrate of 160kDa, mTOR and S6K from 
Cell Signalling; PRAS40 from Biosource; MitoProfile OXPHOS from AbCam; IRβ from Santa 
Cruz).36 Blots were quantified by densitometric analysis using Image J software (NIH USA).
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Statistical analysis
Data are presented as mean±SEM when normally distributed or as median (IQR) when 
not normally distributed. A mixed effects model was applied to assess mean differ-
ences before and after the intervention within and between groups, and to determine 
differences in diet effect. Groups and intervention were modelled as fixed effects and 
the subject specific deviances from the group mean were modelled as random effects. 
Nonparametric tests (Wilcoxon signed-rank test within group, Mann-Whitney between 
groups) were performed when appropriate. Significance level was set at p<0.05. Statisti-
cal analyses were performed using SPSS for Windows version 20.0 (IBM, USA).
RESULTS
Clinical characteristics
BMI did not differ between groups (South Asians: 20.9±0.6 vs. Caucasians: 22.2±0.6 kg/
m2, p=0.11), but South Asian subjects were significantly shorter and lighter (Table 1). 
The percentage of fat mass was significantly higher in South Asians on both study days, 
and, consequently, the percentage of LBM was lower. Waist circumference did not differ 
between groups. Fasting glucose and insulin levels were similar at baseline, but were 
significantly higher in South Asians after the HFHCD. Fasting C-peptide levels increased 
significantly to a similar degree in both groups. HbA1c was higher in South Asians, as was 
LDL-cholesterol (2.77 (1.69) vs. 1.84 (0.91) mmol/L, p=0.03).
Diet and exercise
The physical activity level was comparable between both ethnicities (Supplemental 
Table 2). The South Asian diet consisted of fewer calories per day (South Asians: 
2170±102 vs. Caucasians: 2593±100 kcal, p=0.008), but corrected for bodyweight the 
amount of calories was similar (South Asians: 34±2 vs. Caucasians: 35±1 kcal/day/kg, 
p=0.91). Both ethnicities ate the same percentage of fat (~30%), carbohydrates (~50%) 
and proteins (~16%). Both groups complied well with the diet. Mean daily calorie intake 
was ~55% higher compared to their normal diet, and ~54% of energy was derived from 
fat (Supplemental Table 2).
Fat distribution
No differences were found between groups for visceral and subcutaneous fat volumes 
both at baseline and after the HFHCD. Furthermore, no diet effect was observed. HTG 
increased significantly after the diet in both groups, but no differences between groups 
were observed (Table 1).
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Endogenous glucose production and rate of glucose disposal
During the hyperinsulinemic-euglycemic clamp glucose concentrations were similar 
within and between groups for both steps (Table 2). Clamp insulin levels were signifi-
cantly higher in South Asians compared to Caucasians before and after the HFHCD; no 
diet effect was observed. The MCRi was significantly lower in South Asians on both study 
days. EGP in basal and insulin-stimulated conditions was similar for both groups, despite 
higher insulin levels in insulin-stimulated conditions in South Asians. Furthermore, no 
diet effect was observed. However, the calculated HIR index was higher in South Asians 
compared to Caucasians (p=0.065 before diet, p=0.002 after diet), and showed a signifi-
cant increase after the diet only in South Asians (p diet effect = 0.008). Suppression of 
EGP by insulin was comparable between groups and was around 24% in step 1 and 42% 
in step 2. Insulin-stimulated Rd in step 1 was similar for both groups on both occasions. 
In step 2 Rd was higher in South Asians compared to Caucasians before the diet (South 
Table 1. Clinical characteristics, body composition, and fasting plasma and serum levels before and after a 
5-day HFHCD in healthy, young South Asian men and matched white Caucasians.
 
 
white Caucasians South Asians
before HFHCD after HFHCD before HFHCD after HFHCD
Clinical characteristics
age (years) 22.1 ± 0.6 22.2 ± 0.7
length (m) 1.84 ± 0.01 1.74 ± 0.02**
weight (kg) 75.1 ± 1.8 75.6 ± 1.8 63.2 ± 2.3** 63.7 ± 2.3† **
BMI (kg/m2) 22.2 ± 0.6 22.4 ± 0.6 20.9 ± 0.6 21.0 ± 0.6†
waist (cm) 81.3 ± 2.2 82.0 ± 2.3 78.9 ± 2.2 79.5 ± 2.6
Body composition
fat mass (%) 11.3 ± 0.9 11.3 ± 0.8 15.1 ± 0.9* 14.7 ± 0.8*
visceral fat (mL) 104 ± 14 111 ± 12 120 ± 19 125 ± 18
subcutaneous fat (mL) 348 ± 54 363 ± 59 442 ± 61 432 ± 54
hepatic TG content (%) 1.7 ± 0.4 4.5 ± 0.8†† 1.3 ± 0.4 3.0 ± 0.5††
Fasting plasma and serum levels
HbA1c (%) 5.0 ± 0.1 5.2 ± 0.1*
HbA1c (mmol/mol) 31.2 ± 0.5 33.8 ± 0.6*
glucose (mmol/L) 5.1 ± 0.1 5.2 ± 0.1 5.3 ± 0.1 5.5 ± 0.1†† *
insulin (pmol/L) 34 (32) 49 (46) 49 (29) 73 (34)†† ** ‡‡
C-peptide (nmol/L) 0.47 (0.15) 0.57 (0.28)† 0.48 (0.11) 0.61 (0.18)††
FFA (g/L) 0.131 ± 0.01 0.121 ± 0.01 0.144 ± 0.01 0.151 ± 0.01
TG (mmol/L) 0.79 (0.26) 0.75 (0.67) 1.01 (0.65) 1.12 (0.77)
Data are presented as mean ± SEM or median (IQR). BMI, body mass index. TG, triglyceride. FFA, free fatty 
acid. † p<0.05, †† p<0.005 within group vs. before diet. * p<0.05, ** p<0.005 vs. Caucasians. ‡ p<0.05, ‡‡ 
p<0.005 diet effect vs. Caucasians.
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Asians: 48.7±2.9 vs. Caucasians: 41.7±2.9 μmol/kgLBM/min; p=0.003). However, when cor-
rected for insulin level, this difference disappeared and was almost reversed (p=0.052). 
After the diet Rd decreased significantly in South Asians despite similar insulin levels, 
Table 2. Metabolic parameters of a 2-step hyperinsulinemic-euglycemic clamp with stable isotopes before 
and after a 5-day HFHCD in healthy, young South Asian men and matched white Caucasians.
 
 
white Caucasians South Asians
before HFHCD after HFHCD before HFHCD after HFHCD
Basal steady state
average glucose (mmol/L) 5.1 ± 0.1 5.1 ± 0.1 5.2 ± 0.1 5.4 ± 0.1†
average insulin (pmol/L) 41 (26) 41 (27) 49 (36) 68 (45)† *
EGP = Rd (μmol kgLBM-1 min-1) 16.3 ± 0.4 17.0 ± 0.3 17.5 ± 0.5 17.5 ± 0.4
HIR (μmol pmol-1 kgLBM-1 min-1 L-1) 562 (600) 760 (778) 763 (512) 1269 (520)†† ** ‡
MCRg (mL kgLBM-1 min-1) 3.2 ± 0.1 3.3 ± 0.1 3.4 ± 0.1 3.3 ± 0.1
Step 1
average glucose (mmol/L) 5.1 ± 0.1 5.2 ± 0.1 5.0 ± 0.1 5.2 ± 0.1
average insulin (pmol/L) 83 ± 12 89 ± 11 116 ± 6** 126 ± 11**
average C-peptide (nmol/L) 0.26 (0.13) 0.27 (0.13) 0.22 (0.14) 0.29 (0.15)†
EGP (μmol kgLBM-1 min-1) 12.6 ± 0.5 13.4 ± 0.4 12.8 ± 0.4 12.8 ± 0.4
suppression EGP (%) -22.6 ± 1.8 -21.6 ± 1.6 -26.8 ± 1.3 -27.2 ± 1.0
Rd (μmol kgLBM-1 min-1) 15.3 ± 0.8 17.4 ± 1.2 16.2 ± 0.9 15.3 ± 1.1
MCRg (mL kgLBM-1 min-1) 3.0 ± 0.2 3.4 ± 0.2 3.2 ± 0.2 3.0 ± 0.2
Step 2
average glucose (mmol/L) 4.8 ± 0.1 4.8 ± 0.1 4.6 ± 0.1 4.6 ± 0.1
average insulin (pmol/L) 276 ± 19 285 ± 19 396 ± 15** 386 ± 21**
average C-peptide (nmol/L) 0.07 (0.12) 0.07 (0.09) 0.06 (0.12) 0.08 (0.08)†
EGP (μmol kgLBM-1 min-1) 10.0 ± 0.7 10.2 ± 0.5 9.7 ± 0.7 9.6 ± 0.5
suppression EGP (%) -38.9 ± 3.5 -39.8 ± 2.7 -43.9 ± 3.0 -45.7 ± 2.3
Rd (μmol kgLBM-1 min-1) 41.7 ± 2.9 41.0 ± 2.8 48.7 ± 2.9** 39.0 ± 2.1†† ‡‡
Rd / insulin (μmol L-1 kgLBM-1 min-1 mU-1) 1.14 ± 0.13 1.07 ± 0.12 0.87 ± 0.07 0.72 ± 0.05† *
MCRi (mL m-2 min-1) 1076 (397) 1054 (270) 735 (70)** 771 (164)† ** ‡
MCRg (mL kgLBM-1 min-1) 8.8 ± 0.7 8.7 ± 0.6 10.7 ± 0.8** 8.6 ± 0.5†† ‡‡
Data are presented as mean ± SEM or median (IQR). Due to hypoglycemia in the last part of step 2 of the 
clamp, two South Asian subjects on occasion 1 and one Caucasian subject on occasion 2 were excluded 
in the analysis of step 2. EGP=endogenous glucose production. Rd=rate of glucose disposal. HIR=hepatic 
insulin resistance. MCRg=metabolic clearance rate of glucose. MCRi=metabolic clearance rate of insulin. † 
p<0.05, †† p < 0.005 within group vs. before diet. * p<0.05, ** p<0.005 vs. Caucasians. ‡ p<0.05, ‡‡ p<0.005 
diet effect vs. Caucasians.
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whereas no diet effect was found in Caucasians (South Asians: 39.0±2.1 μmol/kgLBM/min 
(p<0.001) vs. Caucasians: 41.0±2.8 μmol/kgLBM/min (p=0.78); p diet effect = 0.002).
Glucose and lipid oxidation rates
REE, corrected for LBM, RQ, substrate oxidation rates and NOGD in basal condition 
and step 1 of the clamp were comparable for both groups before and after the HFHCD 
(Table 3). In step 2, however, glucose oxidation increased significantly in South Asians, 
whereas no diet effect was observed in Caucasians. Interestingly, NOGD in step 2 was 
significantly higher in South Asians compared to Caucasians at baseline (p<0.001), but 
decreased significantly after the HFHCD only in South Asians (South Asians: 34.4±4.0 vs. 
19.3±2.0 μmol/kgLBM/min (p<0.001), Caucasians: 24.1±2.1 vs. 23.8±1.6 μmol/kgLBM/min 
(p=0.87); p diet effect < 0.001).
Table 3. Parameters for indirect calorimetry before and after a 5-day HFHCD in healthy, young South Asian 
men and matched Caucasians.
 
 
white Caucasians South Asians
before HFHCD after HFHCD before HFHCD after HFHCD
Basal
REE (kcal/day) 1469 ± 50 1523 ± 38 1220 ± 31** 1224 ± 22**
REE (kcal day-1 kgLBM-1) 22.4 ± 0.7 22.7 ± 0.5 23.0 ± 0.9 22.8 ± 0.9
RQ 0.88 ± 0.01 0.87 ± 0.01 0.87 ± 0.02 0.89 ± 0.02
glucose oxidation (μmol kgLBM-1 min-1) 14.3 ± 1.0 13.6 ± 1.1 13.9 ± 1.3 14.7 ± 1.5
lipid oxidation (μmol kgLBM-1 min-1) 2.4 ± 0.3 2.7 ± 0.3 2.7 ± 0.4 2.4 ± 0.5
NOGD (μmol kgLBM-1 min-1) 2.3 ± 0.7 3.7 ± 0.8 4.2 ± 1.2 3.5 ± 1.4
Step 1
RQ 0.90 ± 0.02 0.91 ± 0.02 0.88 ± 0.02 0.90 ± 0.03
glucose oxidation (μmol kgLBM-1 min-1) 16.2 ± 1.6 16.4 ± 1.6 14.3 ± 1.7 14.8 ± 1.5
lipid oxidation (μmol kgLBM-1 min-1) 2.2 ± 0.5 1.9 ± 0.4 2.6 ± 0.5 2.3 ± 0.5
NOGD (μmol kgLBM-1 min-1) 1.8 ± 0.9 2.8 ± 0.9 3.1 ± 1.2 2.5 ± 1.2
Step 2
RQ 0.92 ± 0.02 0.93 ± 0.02 0.88 ± 0.02 0.95 ± 0.02†
glucose oxidation (μmol kgLBM-1 min-1) 17.7 ± 1.5 18.2 ± 1.8 14.4 ± 1.2 19.2 ± 1.5†
lipid oxidation (μmol kgLBM-1 min-1) 1.8 ± 0.4 1.6 ± 0.4 2.5 ± 0.4 1.4 ± 0.4
NOGD (μmol kgLBM-1 min-1) 24.1 ± 2.1 23.8 ± 1.6 34.4 ± 4.0** 19.3 ± 2.0†† ‡‡
Data are presented as mean ± SEM. REE=resting energy expenditure. RQ=respiratory quotient. NOGD=non-
oxidative glucose disposal rate. † p<0.05, †† p<0.005 within group vs. before diet. ** p<0.005 vs. Caucasians. 
‡‡ p<0.005 diet effect vs. Caucasians.
85
Effect of high fat feeding in young South Asians
Skeletal muscle signalling
The protein expression and phosphorylation state of key molecules involved in the in-
sulin and mTOR signalling pathways were determined in basal condition and during the 
hyperinsulinemic-euglycemic clamp in skeletal muscle (Figure 1). A trend for a reduced 
IRβ expression was observed in South Asians. During hyperinsulinemia, the phosphory-
lation state of key proteins involved in the insulin/mTOR pathway (PKB, AS160, PRAS40, 
mTOR and S6K1) was significantly increased when compared to basal, as expected (Fig-
ure 1). No obvious differences were observed between groups whatever the conditions.
Skeletal muscle metabolic gene expression
The skeletal muscle expression of key metabolic genes involved in the regulation of 
glucose and fatty acid metabolism was determined (Supplemental Table 1).
At baseline, no significant differences between groups were observed in the tran-
script levels of all analysed genes. The HFHCD induced significant downregulation of 
SLC2A4, GSK3A, GYS1, AGL, PPP1R3A, PDK2, ACACA, PPARA and PPARD mRNA expres-
sion in Caucasian subjects, with a comparable response in South Asians. Only PKM2 was 
differentially affected in South Asians in response to the HFHCD.
Skeletal muscle mitochondrial respiratory-chain content
The protein expression of several mitochondrial respiratory chain complex subunits was 
determined (Figure 2A). Although at baseline no differences were observed between 
groups, the expression of respiratory chain complex 1 and 2 was significantly increased 
after the HFHCD only in Caucasians (Figure 2B). However, the complex 2-on-complex 
1 ratio, as a measure of change in fat vs. glucose oxidation, was not significantly differ-
ent between both ethnicities (Figure 2C). The mtDNA-on-nDNA-ratio was significantly 
lower in South Asians compared to Caucasians, but was not affected in response to the 
diet (Figure 2D). Of note, the mRNA expression of key genes involved in mitochondrial 
biogenesis and tricarboxylic acid cycle was not different between groups, whatever the 
conditions (Supplemental Table 1).
DISCUSSION
This is the first study in South Asians in which a 2-step hyperinsulinemic-euglycemic 
clamp with stable isotopes was performed to measure peripheral and hepatic insulin 
sensitivity, and the first one in this ethnicity which assessed the effect of HF-feeding 
on both insulin sensitivity and skeletal muscle insulin and mTOR signalling. Strikingly, a 
5-day HFHCD was already sufficient to impair insulin-stimulated (non-oxidative) glucose 
disposal in South Asians, while such an effect was not observed in Caucasians.
Chapter 4
86
Figure 1. Insulin and mTOR signalling in skeletal muscle from healthy, young South Asian men and 
matched white Caucasians before (black bars) and after (white bars) a 5-day HFHCD. The protein ex-
pression of A. IRβ, B. Ser473-PKB, C. PKB, D. phospho-AS160, E. AS160, F. Thr246-PRAS40, G. PRAS40, H. 
Ser2448-mTOR, I. mTOR, J. Thr389-S6K, and K. S6K, were assessed by Western Blot. The phosphorylation 
state in basal and hyperinsulinemic (step 2) conditions (B, D, F, H, J), or the protein expression in basal 
conditions (A, C, E, G, I, K) are shown. Representative blots for one subject per group are shown. Results 
are normalized to Caucasian subjects (before diet, basal condition) and expressed as mean ± SEM. Due to 
a small amount of tissue two Caucasian subjects were excluded for Western Blot analysis. † p<0.05 within 
group vs. before diet. § p<0.05, §§ p<0.005 within groups vs. basal condition. * p<0.05 vs. Caucasians. IRβ, 
insulin receptor isoform β. PKB, protein kinase B. AS160, Akt substrate of 160 kDa. PRAS40, Proline rich Akt 
substrate of 40 kDa. mTOR, mammalian target of rapamycin. S6K1, ribosomal protein S6 kinase β1.
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Baseline comparisons
In contrast to other studies, waist fat distribution and HTG did not significantly differ 
between both ethnicities.13;14;37;38 In addition, we did not find higher fasting serum in-
sulin levels,14;37-41 nor lower peripheral insulin sensitivity in South Asians compared to 
Caucasians at baseline in both basal and insulin-stimulated conditions.12;38;40-42 Instead, 
South Asians seemed to have even higher insulin-stimulated peripheral insulin sensitiv-
Figure 2. Protein expression of mitochondrial respiratory-chain subunits in skeletal muscle from 
healthy, young South Asian (striped bars) men and matched white Caucasians (closed bars) before 
(black bars) and after (white bars) a 5-day HFHCD. A. Representative blots for one subject per group. B. 
The expression of various mitochondrial-respiratory chain subunits (CI: NDUFB8, CII: SDHB, CIII: UQCRC2, 
CIV: MTCO1, CV: ATP5A) were assessed by Western Blot in basal condition. C. The respiratory-chain complex 
2-on-complex 1 ratios were calculated. D. The mtDNA on nDNA ratio as assessed by qPCR in basal condition 
(n=7/12 (Caucasian/South Asian)). Results are normalized to Caucasian subjects (before diet) and expressed 
as mean ± SEM. Due to a small amount of tissue two Caucasian subjects were excluded for Western Blot 




ity. However, insulin levels during the clamp were higher in South Asians on both study 
days, which is in line with other studies.40-42 After correction for insulin levels, the differ-
ence in Rd between groups disappeared and was almost reversed. The higher insulin 
levels were presumably due to a lower MCRi in South Asians, which has been shown 
before.40 The lower MCRi together with the higher HIR index in South Asians indicates 
lower hepatic insulin sensitivity both at baseline and after the diet.
The difference in above-mentioned findings compared to literature might be 
explained by the relatively young age, low BMI and sex (no females were included) of 
our subjects, geographical differences as reflected by dietary and/or other acculturation 
changes, and/or the small sample size (despite power calculation beforehand).
Response to a 5-day HFHCD
The mean daily calorie intake during the HFHCD was ~55% higher compared to their 
normal diet, and both groups reached ~54% of energy derived from fat compared to 
~30% of their normal daily energy intake. HTG increased significantly after the diet in 
both groups, indicating good compliance to the diet, and consistent with a previous 
study in which young, healthy Caucasian males were subjected to a 3-day HF-diet.26 In 
contrast, fasting glucose and insulin levels increased significantly only in South Asians. 
No effect of the diet on basal EGP or on the capacity of insulin to suppress EGP was 
observed in either group, although the HIR index, which corrects EGP for insulin level,32 
was significantly increased in South Asians only. Strikingly, insulin-stimulated Rd was 
significantly impaired after the diet in South Asians, whereas no diet effect was observed 
in Caucasians.
The response to a HF-diet on (skeletal muscle) insulin sensitivity in people of Cau-
casian descent is variable in the literature, depending on the percentage of fat and 
carbohydrates, duration of the diet, amount of calories (eucaloric or hypercaloric), effect 
on bodyweight, and method used to assess insulin sensitivity. In general, HF-diets of 
several hours up to 3 days induce whole-body insulin resistance,43;44 whereas after HF-
diets of several days up to 3 weeks usually no effect is seen on insulin sensitivity.45-48 This 
difference in effect on insulin sensitivity might be attributed to a greater intramuscular 
lipid storage and/or use after several days, compensating for the increase in FFA avail-
ability induced by the HF-diet.47
The impairment in insulin-stimulated Rd after the diet in South Asians appears 
to be due to a decrease in NOGD, suggesting a defect in glycogen storage. Impaired 
non-oxidative glucose disposal is the main defect observed in patients with type 2 
diabetes.49 Interestingly, at baseline insulin-stimulated NOGD was significantly higher 
in South Asians compared to Caucasians, but this was possibly due to the higher insulin 
levels in South Asians. Because of the impairment in NOGD in South Asians after the 
diet, we also analysed proteins (Supplemental figure 1) and genes involved in glycolysis 
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and glycogen synthesis. However, no obvious differences were found between groups. 
The mRNA expression of GYS was significantly reduced in both groups after the diet 
(Supplemental table 1). Of note, in contrast to what was observed in South Asians in 
the present study, in several short-term HF-diet studies in Caucasians an increase in 
NOGD and a decrease in glucose oxidation was observed,45;47;48;50 accompanied by an 
increase in skeletal muscle mRNA level of pyruvate dehydrogenase kinase 4 (PDK4) and 
a corresponding decrease in pyruvate dehydrogenase enzyme complex (PDH) in basal 
and insulin-stimulated conditions.44;47;48 In the present study, PDK4 was not affected by 
the diet, and PDH was reduced only in South Asians (Supplemental Table 1). Therefore, 
it would have been interesting to determine skeletal muscle glycogen content. Further 
research is required to clarify the pathophysiological relevance of these apparent para-
doxical findings in glycogen metabolism in South Asians.
The nutrient-sensing mTOR-pathway is mostly known for its regulating role in cellular 
proliferation and growth but it was also recently shown to be involved in key metabolic 
processes.16 Therefore, it constitutes an interesting and relevant pathway to be inves-
tigated in the context of increased insulin resistance together with increased ectopic 
fat deposition in South Asians vs. Caucasians. Interestingly, mTORC1 appears to have 
negative effects on insulin signalling.17 There are various mechanisms through which 
this negative feedback loop of mTORC1 on insulin signalling is initiated. When activated 
by mTORC1, downstream target S6K1 can suppress IRS-1 via direct phosphorylation of 
IRS1 on multiple serine residues, and via transcription repression of IRS1 gene expres-
sion. Additionally, mTORC1 directly interacts with IRS1 via raptor and phosphorylates 
IRS1 at Ser636/639. Furthermore, several biochemical and genetic studies have shown 
that mTORC1 plays a crucial role in the regulation of oxidative metabolism and mito-
chondrial biogenesis18-21 as well as in lipid metabolism.22 In particular, mTORC1 seems to 
suppress FA beta-oxidation.21;23;24 Therefore, we hypothesized that differences in mTOR 
activity between the two ethnicities might underlie or contribute to the increased risk 
of insulin resistance and type 2 diabetes in South Asians. However, we did not find 
obvious differences in the mTOR-pathway between or within groups, neither at baseline 
nor after a 5-day HFHCD. Additionally, apart from a small difference in diet effect on 
respiratory chain complex subunits 1 and 2, we did not observe relevant differences in 
diet effect on skeletal muscle insulin signalling, mitochondrial density and expression of 
genes involved in oxidative phosphorylation and mitochondrial biogenesis that could 
explain the diet-induced impairment in insulin-stimulated Rd in South Asians, which is in 
line with a previous study in which young, healthy Caucasian males were subjected to a 
5-day HFHCD.46 The fact that we did not find obvious differences between groups might 
be explained by the relatively good health of our subjects and/or the small sample size. 
Of note, to confirm our findings on mitochondrial function other mitochondrial markers, 
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such as ex vivo determination of activities of mitochondrial respiratory-chain complexes 
and citrate synthase activity should be measured in future studies.
Only two other studies have been performed before in South Asians in which skeletal 
muscle biopsies were obtained to assess insulin signalling and/or mitochondrial function, 
and none assessed the mTOR-pathway. Nair et al. found no impairment in mitochondrial 
function in healthy, middle-aged South Asians, even despite the finding that they were 
more insulin resistant than matched Caucasians.12 Correspondingly, Hall and colleagues 
reported that healthy, young, lean South Asian males did not exhibit lower expression 
of skeletal muscle oxidative and lipid metabolism genes compared to matched white 
Caucasians, and that mtDNA-to-nDNA-ratio, an index of mitochondrial content, did not 
significantly differ between groups, although a trend for a lower ratio in South Asians 
was observed.11 Thus, both studies concluded that mitochondrial dysfunction did not 
account for the observed insulin resistance in South Asians, which is in line with our 
present findings concerning the effect of a HFHCD. Additionally, Hall’s study showed 
that South Asians had reduced skeletal muscle protein expression of key insulin signal-
ling proteins in the fasted state.11 In that study, insulin sensitivity, as measured from the 
Matsuda insulin sensitivity index, was however significantly lower in South Asians. Thus, 
these subjects might have been more insulin resistant, explaining the reduced expres-
sion of insulin signalling proteins as compared to our study. Other possibilities for the 
different findings on insulin signalling are the larger group size in the study of Hall, and/
or geographical differences as reflected by dietary and/or other acculturation changes.
Finally, we cannot exclude the possibility that white adipose tissue might have 
contributed to the diet-induced impairment in insulin-stimulated Rd in South Asians. 
Indeed, about 10-20% of whole-body glucose uptake occurs in white adipose tissue, 
which corresponds to the observed reduction in Rd in South Asians (mean percentage 
decrease: 20±5%).
In conclusion, we showed that a 5-day HFHCD is already sufficient to affect insulin-
stimulated (non-oxidative) glucose disposal in healthy, young, lean South Asian males, 
whereas no diet effect was found in age- and BMI-matched Caucasians, suggesting that 
the propensity of South Asians to develop type 2 diabetes may be partly explained by the 
way they adapt to HF western food. The mTOR-pathway does not seem to be involved, at 
least in skeletal muscle. These findings might provide new leads for further investigation 
aimed to elucidate the pathogenesis of insulin resistance and type 2 diabetes in South 
Asians.
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Supplemental Table 2. Activity level, normal dietary intake and intake during a 5-day HFHCD of healthy, 
young South Asian men and matched white Caucasians.
  white Caucasians South Asians
Activity level
exercise (min/week) 150 (203) 125 (210)
exercise (category) 2.5 (4) 2.5 (4)
activity factor 1.375 (0.22) 1.375 (0.26)
Normal diet
total kcal per day 2593 ± 100 2170 ± 102 *
kcal per day per kg 34.6 ± 1.2 34.3 ± 2.0
fat (kcal/day) 835 ± 63 674 ± 60
carbohydrates (kcal/day) 1217 ± 47 1079 ± 48
protein (kcal/day) 404 ± 19 363 ± 35
fat (%) 31.6 ± 1.6 29.8 ± 1.9
carbohydrates (%) 47.6 ± 1.6 51.6 ± 2.1
protein (%) 15.8 ± 0.7 16.5 ± 1.0
Intake during a 5-day HFHCD
total kcal per day 3824 ± 177 3453 ± 149
kcal per day per kg 51.1 ± 2.5 54.5 ± 2.9
fat (kcal/day) 2041 ± 92 1839 ± 62
carbohydrates (kcal/day) 1220 ± 81 1128 ± 65
protein (kcal/day) 439 ± 27 434 ± 31
fat (%) 54.0 ± 1.2 53.9 ± 1.2
carbohydrates (%) 31.6 ± 1.3 32.4 ± 0.9
protein (%) 11.4 ± 0.3 12.4 ± 0.6
Data are presented as mean ± SEM or median (IQR), n=12-11. Exercise categories: 0 = 0 minutes, 1 = 1-60 
minutes, 2 = 61-120 minutes, 3 = 121-180 minutes, 4 = 181-240 minutes, 5 = 241-300 minutes. Activity fac-





















































Supplemental Figure 1. Phosphorylation state of glycogen synthase kinase 3 and protein expres-
sion and phosphorylation state of glycogen synthase in skeletal muscle from healthy, young South 
Asian men and matched white Caucasians before (black bars) and after (white bars) a 5-day HFHCD. 
The protein expression of A. Ser21/9-GSK3, B. Ser641-GS, and C. GS were assessed by Western Blot. The 
phosphorylation state in basal and hyperinsulinemic (step 2) conditions (A, B), or the protein expression in 
basal conditions (C) are shown. Results are normalized to Caucasian subjects (before diet, basal condition) 
and expressed as mean ± SEM. Due to a small amount of tissue two Caucasian subjects were excluded for 
Western Blot analysis. § p<0.05, §§ p<0.005 within groups vs. basal condition. GS, glycogen synthase. GSK3, 
glycogen synthase kinase 3.
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Aims. South Asians have a higher risk of developing type 2 diabetes than white Cauca-
sians. The underlying cause is still poorly understood but might be related to differences 
in the regulation of energy/nutrient-sensing pathways in metabolic tissues and subse-
quent changes in whole-body substrate metabolism. In this study we investigated the 
whole-body and skeletal muscle metabolic adaptations to short-term caloric restriction 
in South Asian and white Caucasian volunteers.
Methods. 24 middle-aged overweight male South Asians and white Caucasians un-
derwent a 2-step hyperinsulinemic-euglycemic clamp with skeletal muscle biopsies 
and indirect calorimetry before and after an 8-day very-low-calorie-diet. Abdominal fat 
distribution and hepatic triglyceride content (HTG) were assessed using MR-imaging/
spectroscopy.
Results. South Asians had higher HTG than Caucasians, and exhibited elevated clamp 
insulin levels that likely reflect a lower insulin clearance rate. Despite higher insulin 
levels, endogenous glucose production rate was similar and (non-oxidative) glucose 
disposal rate (NOGD, Rd) was significantly lower in South Asians when compared to Cau-
casians, indicating impaired whole-body insulin sensitivity. Caloric restriction decreased 
abdominal fat mass and HTG in both groups. However, the caloric restriction induced 
shift from glucose towards lipid oxidation observed in Caucasians was impaired in South 
Asians, indicating whole-body metabolic inflexibility. Remarkably, although caloric re-
striction improved hepatic insulin sensitivity in both groups, Rd improved only in South 
Asians due to higher NOGD. At the molecular level, an increase in insulin-induced activa-
tion of the ERK-mTOR-S6K1 axis was found in South Asians, showing that skeletal muscle 
energy/nutrient-sensing pathways were differentially affected by caloric restriction.
Conclusions. We conclude that South Asians exhibit a different metabolic adaptation to 
short-term caloric restriction than white Caucasians.
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INTRODUCTION
The rapid increase in type 2 diabetes prevalence worldwide has been associated with a 
Western, obesogenic lifestyle.1 South Asians originating from the Indian sub-continent 
(India, Pakistan, Bangladesh, Nepal and Sri Lanka), who represent one fifth of the world’s 
population, seem to have an exceptionally high susceptibility to develop the metabolic 
syndrome and type 2 diabetes in the context of the same environmental pressure when 
compared to other ethnicities.2-5 A possible explanation for this excess risk might be re-
lated to differences in the regulation of energy/nutrient-sensing pathways in metabolic 
tissues thereby affecting whole-body substrate homeostasis.
Among these pathways, the nutrient and energy-sensing protein kinase mammalian 
target of rapamycin (mTOR), which regulates cell growth according to nutrient availabil-
ity and cellular energy status,6 is of major importance. The mTOR kinase interacts with 
several proteins to form two distinct complexes named mTOR complex 1 (mTORC1) and 
mTOR complex 2, which differ in their molecular composition, regulation, sensitivity to 
rapamycin, and downstream targets.6 mTORC1 responds to insulin and other growth fac-
tors, stress, oxygen and nutrient levels and controls key cellular processes.6 When active, 
mTORC1 promotes protein synthesis, cell growth and differentiation, and may inhibit in-
sulin signalling by feedback regulation of the insulin receptor substrate 1 (IRS1). mTORC1 
was also recently shown to play a crucial role in mitochondrial biogenesis and oxidative 
metabolism.7-10 Caloric restriction reduces mTORC1 activity,11 at least partly through activa-
tion of the AMP-activated protein kinase (AMPK), a key sensor of cellular energy status.12;13
We hypothesized that differences in the regulation of energy/nutrient-sensing path-
ways between people of South Asian and white Caucasian descent may affect whole-body 
glucose/lipid metabolism, and ultimately contribute to the increased risk of type 2 diabetes 
in South Asians. This study, therefore, assessed the effect of caloric restriction through an 
8-day very low calorie diet (VLCD) on skeletal muscle energy/nutrient-sensing pathways, 
with a special focus on canonical insulin signalling and mTORC1 pathways, in both middle-
aged overweight South Asian men and age- and BMI-matched white Caucasians.
METHODS
Participants
Twelve Dutch South Asian and twelve Dutch white Caucasian, overweight (BMI 25-30 kg/
m2) men, aged 40-50 years, with a waist circumference of >90 cm (South Asians) or >94 
cm (Caucasians), and a positive family history for type 2 diabetes were enrolled via local 
advertisements. South Asian participants were all Dutch Hindostani, an ethnic group of 
South Asian origin composed of people who were all born in Surinam before moving to the 
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Netherlands. Participants underwent a medical screening including their medical history, a 
physical examination, blood chemistry tests and an oral glucose tolerance test (OGTT) to ex-
clude individuals with type 2 diabetes according to the American Diabetes Association 2010 
criteria. Other exclusion criteria were rigorous exercise, smoking and recent body weight 
change. The study was approved by the Medical Ethical Committee of the Leiden University 
Medical Centre and performed in accordance with the principles of the revised Declaration 
of Helsinki. Written informed consent was obtained from all volunteers prior to participation.
Study design
Participants were studied before and after an 8-day VLCD, consisting of three sachets of Modi-
fast (Nutrition & Santé Benelux, Breda, The Netherlands) per day (~450 kcal/day, ~50g protein, 
50-60g carbohydrates, 7g lipids and 15g dietary fibres). They were instructed not to alter life 
style habits, and not to perform physical activity in the last 48 hours before the study days. 
Magnetic resonance (MR) and metabolic studies were performed shortly before the start and 
on the eighth day of the diet, and one day before and one day after the VLCD, respectively.
MR studies
Abdominal fat depots were quantified with turbo spin echo MR-imaging using a 1.5 
Tesla whole body MR-scanner (Gyroscan ACS-NT15, Philips, Best, The Netherlands) in 
postprandial state,14 and hepatic triglyceride content (HTG) was assessed by proton MR-
spectroscopy,15, as described previously.16
Metabolic Studies
Participants underwent anthropometric measurements, a 7-h 2-step hyperinsulinemic-
euglycemic clamp with stable isotopes, skeletal muscle biopsies and indirect calorim-
etry after an overnight fast, as described previously.16 Body fat mass and lean body mass 
(LBM) were assessed by bioelectrical impedance analysis (BIA; Bodystat® 1500, Bodystat 
Ltd., UK). Laboratory analysis was done as described before.16 Glucose appearance (Ra) 
and disposal (Rd), endogenous glucose production (EGP), metabolic clearance rate of 
insulin (MCRi), hepatic insulin resistance index (HIR), resting energy expenditure (REE), 
respiratory quotient (RQ), substrate oxidation rates, and non-oxidative glucose disposal 
(NOGD) were calculated as described previously.16 Metabolic flexibility was defined as 
the ability to increase lipid oxidation upon caloric restriction (change in fasting RQ in 
response to VLCD) and to switch from lipid to glucose oxidation upon insulin stimulation 
(change in RQ from the fasted to the insulin-stimulated state).17
DNA/RNA isolation and real-time RT-PCR
DNA/RNA isolation and real-time RT-PCR were done as previously described.16 In short, 
total RNA was isolated from skeletal muscle biopsies. First-strand cDNA were synthe-
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sized from 1 μg total RNA. Real-time PCR assays were performed using specific primers 
sets (sequences provided on request). mRNA expression was normalized to ribosomal 
protein S18 (Rps18) and expressed as arbitrary units. Genomic DNA was extracted for 
determination of mitochondrial (mtDNA) and nuclear (nDNA) DNA copy numbers.18
Western Blot
Skeletal muscle biopsies were homogenized as described previously.16 Western blots 
were performed using phospho-specific (Ser473-PKB, phospho-Akt substrate, Thr202/
Tyr204-ERK1/2, Thr1462-TSC2, Ser2448-mTOR, Thr389-S6K, Thr37/46-4EBP1, Ser21/9-
GSK3, Ser641-GS, Thr172-AMPK, and Ser79-ACC from Cell Signaling; Thr246-PRAS40 
from Biosource) or total primary antibodies (Tubulin, PKB, AS160, mTOR, S6K, AMPK, 
and ACC from Cell Signaling; IRβ and ERK1 from Santa Cruz; PRAS40 from Biosource; 
MitoProfile OXPHOS from AbCam).19 Blots were quantified by densitometric analysis 
using Image J software (NIH, USA).
Statistical analysis
Data are presented as mean±SEM or as median (IQR) depending on normality distribu-
tion. A mixed effects model was applied to assess mean differences before and after the 
intervention within and between groups, and to determine differences in diet effect. 
Groups and intervention were modelled as fixed effects and the individual specific 
deviances from the group mean were modelled as random effects. Nonparametric tests 
(Wilcoxon signed-rank test within group, Mann-Whitney between groups) were per-
formed when appropriate. P<0.05 was considered significant. Statistical analyses were 
performed using SPSS for Windows version 20.0 (IBM, USA).
RESULTS
Clinical characteristics
Mean age was 44.6±0.8 years. BMI did not differ between groups (South Asians: 28.4±0.4 
vs. Caucasians: 28.1±0.5 kg/m2, p=0.65), but South Asians tended to be lighter (p=0.055) 
and were significantly shorter (Table 1). The decreases in body weight (South Asians: 
-4.2±0.4% vs. Caucasians: -4.8±0.3%, p=0.14) and fat mass (South Asians: -3.7 (3.2)% vs. 
Caucasians: -5.3 (4.8)%, p=0.17) induced by caloric restriction were from the same extent 
in both groups. Fasting glucose, non-esterified fatty acids (NEFA) and triacylglycerol 
levels were comparable between groups, whereas HbA1c and fasting and OGTT insulin 
levels were significantly higher in South Asians (Table 1). Caloric restriction induced a 
significant similar decrease in fasting serum glucose, insulin and triacylglycerol levels. 




No differences between groups were observed for visceral and subcutaneous fat 
volumes (Table 1). However, HTG was significantly higher in South Asians at baseline. 
Caloric restriction led to a significant decrease in visceral and subcutaneous fat volumes 
and HTG in both South Asians and Caucasians (Table 1).
Table 1. Clinical and metabolic characteristics before and after an 8-day VLCD in middle-aged overweight 
South Asian men and matched white Caucasians.
 
 
white Caucasians South Asians
before VLCD after VLCD before VLCD after VLCD
Clinical characteristics
age (years) 44.3 ± 1.1 44.9 ± 0.9
length (m) 1.81 ± 0.02 1.75 ± 0.01**
weight (kg) 92.6 ± 2.5 88.2 ± 2.5†† 86.7 ± 1.4 83.2 ± 1.6†† ‡
body mass index (kg/m2) 28.1 ± 0.5 26.8 ± 0.5†† 28.4 ± 0.4 27.3 ± 0.4††
waist (cm) 103 ± 1.8 100 ± 1.6†† 101 ± 1.6 98 ± 1.5††
Body composition
fat mass (%) 23.1 ± 0.6 21.8 ± 0.6†† 23.8 ± 0.6 23.0 ± 0.6
lean body mass (kg) 71.1 ± 1.6 68.8 ± 1.6†† 66.1 ± 1.2* 64.0 ± 1.3†† *
visceral fat (mL) 360 ± 37 301 ± 27†† 359 ± 40 307 ± 33†
subcutaneous fat (mL) 791 (213) 779 (223)† 802 (321) 776 (261)
hepatic triglyceride content (%) 5.2 (3.0) 2.9 (1.2)† 9.3 (8.7)* 4.4 (9.1) †† ‡
Fasting plasma and serum levels
HbA1c (%, mmol/mol) 5.2 (0.5), 33.0 (6) 5.5 (0.1)*, 36.5 (1)*
glucose (mmol/L) 5.3 ± 0.2 4.5 ± 0.2†† 5.3 ± 0.1 4.5 ± 0.1††
insulin (mU/L) 12.8 (6.4) 5.5 (4.9) †† 16.6 (8.1)* 6.5 (7.2)††
C-peptide (nmol/L) 0.61 (0.28) 0.34 (0.30)†† 0.75 (0.19) 0.40 (0.42)††
non-esterified fatty acids (mmol/L) 0.53 ± 0.03 1.36 ± 0.13†† 0.58 ± 0.04 0.85 ± 0.06† ** ‡‡
triacylglycerol (mmol/L) 1.29 (2.48) 0.89 (0.18)†† 1.78 (2.91) 0.91 (0.25)††
Oral glucose tolerance test
2 hour insulin (mU/L) 45 ± 5.5 101 ± 17*
glucose AUC (mmol/L  * h) 959 ± 32 1027 ± 58
insulin AUC (mU/L * h) 5.8 ± 0.5*103 11.4 ± 0.8*103**
Data are presented as mean±SEM or median (IQR). AUC, area under the curve. † p<0.05, †† p<0.005 within 
group vs. before diet. * p<0.05, ** p<0.005 vs. Caucasians. ‡ p<0.05, ‡‡ p<0.005 diet effect vs. Caucasians.
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EGP and glucose disposal
During hyperinsulinemic-euglycemic clamp, glucose concentrations were comparable 
between groups whereas insulin levels were significantly higher in South Asians and 
were accompanied by a lower MCRi when compared to Caucasians (Table 2). Despite 
these higher insulin levels, EGP was similar between groups, indicating higher hepatic 
insulin resistance in South Asians. Furthermore, the insulin-stimulated Rd in step 2 was 
lower in South Asians, indicating reduced peripheral insulin sensitivity compared to 
Caucasians. In response to caloric restriction, hepatic insulin sensitivity was improved 
Table 2. Metabolic parameters of a 2-step hyperinsulinemic-euglycemic clamp with [6,6-2H2]-glucose be-
fore and after an 8-day VLCD in middle-aged overweight South Asian men and matched white Caucasians.
 
 
white Caucasians South Asians
before VLCD after VLCD before VLCD after VLCD
Basal steady state
average glucose (mmol/L) 5.4 ± 0.2 4.3 ± 0.2†† 5.2 ± 0.1 4.6 ± 0.1†† ‡
average insulin (mU/L) 8.3 (5.3) 2.2 (2.3)†† 13.0 (6.5)* 4.0 (4.9)††
EGP = Rd (μmol kgLBM-1 min-1) 16.1 ± 0.5 12.4 ± 0.4†† 15.4 ± 0.6 12.1 ± 0.3††
HIR (μmol pmol-1 kgLBM-1 min-1 L-1) 1359 ± 139 504 ± 74†† 1809 ± 151* 699 ± 131††
Step 1
average glucose (mmol/L) 5.7 ± 0.1 5.5 ± 0.1 5.4 ± 0.1 5.3 ± 0.1
average insulin (mU/L) 15.7 ± 1.3 14.0 ± 1.3 21.8 ± 1.5* 18.0 ± 1.0
average C-peptide (nmol/L) 0.41 (0.25) 0.27 (0.12)†† 0.61 (0.28)* 0.22 (0.30)††
average free fatty acids (mmol/L) 0.21 ± 0.02 0.45 ± 0.04†† 0.23 ± 0.02 0.41 ± 0.05††
EGP (μmol kgLBM-1 min-1) 11.1 ± 0.5 7.7 ± 0.3†† 10.4 ± 0.3 7.5 ± 0.4††
Rd (μmol kgLBM-1 min-1) 11.9 ± 0.4 12.7 ± 1.0 11.5 ± 0.3 11.8 ± 0.6
Step 2
average glucose (mmol/L) 5.0 ± 0.1 5.0 ± 0.1 5.1 ± 0.1 5.0 ± 0.1
average insulin (mU/L) 53.1 ± 2.9 50.8 ± 2.1 66.1 ± 3.0** 60.5 ± 1.9† **
average C-peptide (nmol/L) 0.14 (0.19) 0.08 (0.04)† 0.24 (0.25)* 0.12 (0.08)††
average free fatty acids (mmol/L) 0.09 ± 0.01 0.26 ± 0.05†† 0.10 ± 0.01 0.18 ± 0.03
EGP (μmol kgLBM-1 min-1) 7.9 ± 0.5 6.0 ± 0.3†† 6.8 ± 0.6 5.5 ± 0.5††
Rd (μmol kgLBM-1 min-1) 37.7 ± 2.3 34.9 ± 2.1 30.0 ± 3.4** 34.5 ± 2.9† ‡
Rd / insulin (μmol L-1 kgLBM-1 min-1 mU-1) 0.75 ± 0.08 0.71 ± 0.06 0.46 ± 0.05** 0.56 ± 0.04
MCRi (mL m-2 min-1) 840 ± 47 827 ± 34 697 ± 32* 694 ± 24*
Data are presented as mean±SEM or median (IQR). EGP=endogenous glucose production. Rd=rate of glu-
cose disposal. HIR=hepatic insulin resistance. MCRi=metabolic clearance rate of insulin. † p<0.05, †† p < 




to a similar extent in both groups. However, while no diet effect was observed in Cau-
casians, Rd in step 2 was significantly increased after caloric restriction in South Asians 
despite a slight decrease in insulin levels. When corrected for steady state insulin levels, 
this effect in South Asians was only borderline significant (p=0.08).
REE, substrate oxidation and NOGD
At baseline, both REE (corrected for LBM) and substrate oxidation rates were compa-
rable between groups (Table 3). During hyperinsulinemic-euglycemic clamp, insulin 
suppressed fat oxidation and stimulated glucose oxidation to a similar degree in both 
groups. NOGD in step 2 was significantly lower in South Asians, despite higher insulin 
levels. Caloric restriction led to a reduction in REE and a shift in substrate metabolism 
from glucose towards lipid oxidation. However, this shift was significantly blunted in 
South Asians compared to Caucasians. The effect of insulin on substrate oxidation rates 
Table 3. Indirect calorimetry parameters before and after an 8-day VLCD in middle-aged overweight South 
Asian men and matched white Caucasians.
 
 
white Caucasians South Asians
before VLCD after VLCD before VLCD after VLCD
Basal
REE (kcal/day) 1592 ± 35 1435 ± 39†† 1422 ± 30** 1291 ± 35†† *
REE (kcal day-1 kgLBM-1) 22.5 ± 0.5 21.0 ± 0.7†† 21.6 ± 0.6 20.2 ± 0.5††
RQ 0.83 ± 0.01 0.74 ± 0.01†† 0.84 ± 0.01 0.81 ± 0.01† ** ‡
glucose oxidation (μmol kgLBM-1 min-1) 10.1 ± 1.1 3.1 ± 0.8†† 10.9 ± 0.7 7.7 ± 0.8† ** ‡
lipid oxidation (μmol kgLBM-1 min-1) 3.3 ± 0.2 5.2 ± 0.5†† 3.1 ± 0.2 3.6 ± 0.2** ‡
NOGD (μmol kgLBM-1 min-1) 5.1 ± 0.6 10.1 ± 1.2† 4.5 ± 0.9 4.9 ± 0.6*
Step 1
RQ 0.83 ± 0.01 0.76 ± 0.01†† 0.85 ± 0.01 0.80 ± 0.01†† **
glucose oxidation (μmol kgLBM-1 min-1) 11.0 ± 0.6 3.8 ± 0.6†† 11.7 ± 1.0 7.5 ± 0.8†† **
lipid oxidation (μmol kgLBM-1 min-1) 3.3 ± 0.3 4.7 ± 0.3†† 3.0 ± 0.3 3.8 ± 0.2† *
NOGD (μmol kgLBM-1 min-1) 1.3 ± 0.4 8.7 ± 1.4†† 1.3 ± 0.4 4.1 ± 0.9
Step 2
RQ 0.86 ± 0.01 0.79 ± 0.01†† 0.89 ± 0.01 0.82 ± 0.01††
glucose oxidation (μmol kgLBM-1 min-1) 12.9 ± 0.6 6.5 ± 1.0†† 15.2 ± 1.2 9.1 ± 1.0†† *
lipid oxidation (μmol kgLBM-1 min-1) 2.6 ± 0.1 4.3 ± 0.4†† 2.1 ± 0.2 3.5 ± 0.3††
NOGD (μmol kgLBM-1 min-1) 23.6 ± 2.3 28.0 ± 2.6 14.8 ± 3.0** 25.3 ± 3.0††
Data are presented as mean±SEM. REE=resting energy expenditure. RQ=respiratory quotient. NOGD=non- 
oxidative glucose disposal rate. † p<0.05, †† p<0.005 within group vs. before diet. ** p<0.005 vs. Caucasians. 
‡‡ p<0.005 diet effect vs. Caucasians.
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was attenuated in South Asians after the diet compared to baseline, whereas it tended 
to improve in Caucasians (p diet effect vs. Caucasians =0.057 for both glucose and lipid 
oxidation). Caloric restriction induced a significant increase in NOGD in step 2 only in 


















































































































































































Figure 1. Effect of VLCD on insulin signalling pathways in skeletal muscle from South Asian and 
white Caucasian men in basal state and during a hyperinsulinemic-euglycemic clamp. The protein 
expression of tubulin (a), insulin receptor β (b) and the phosphorylation states of Ser473-PKB (c), Thr202/
Tyr204-ERK (d), Thr256-PRAS40 (e), phospho-AS160 (f ), Ser21/9-GSK3 (g) and Ser641-GS (h) were assessed 
by Western Blot in skeletal muscle from South Asian and white Caucasian volunteers before (black bars) 
and after (open bars) an 8-day VLCD in both basal and hyperinsulinemic states (step 2 of hyperinsulinemic-
euglycemic clamp). Representative blots for one individual per group are shown. Results are normalized 
to Caucasian participants in basal state before VLCD and expressed as mean±SEM. † p<0.05, †† p<0.005 
within group vs. before diet. § p<0.05, §§ p<0.005 within groups vs. basal condition. * p<0.05 vs. Caucasians. 
‡ p<0.05 diet effect vs. Caucasians. IRβ, insulin receptor isoform β. PKB, protein kinase B. ERK, extracellular 
signal-regulated kinase. PRAS40, Proline rich Akt substrate of 40 kDa.AS160, Akt substrate of 160 kDa. GSK3, 
glycogen synthase kinase-3. GS, glycogen synthase.
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Energy/nutrient-sensing signalling pathways in skeletal muscle
Insulin canonical pathway. Before diet, no significant differences between groups 
were observed in protein expression of IRβ and in both basal and insulin-induced phos-
phorylation of key proteins involved in the insulin canonical pathway (Figure 1). Caloric 
restriction induced a significant increase in protein expression of IRβ in South Asians and 
Caucasians (Figure 1a), whereas other proteins involved in insulin signalling were not 
affected (data not shown). The insulin-induced phosphorylation of PKB-Ser473, PRAS40-
Thr246 and AS160 were slightly but significantly increased after caloric restriction in 
Caucasians but not in South Asians (Figure 1c,e,f). By contrast, insulin-induced phos-
phorylation of ERK-Thr202/Tyr204 was increased in South Asians, whereas it tended to 
decrease in Caucasians (Figure 1d). Finally, phosphorylation of GS-Ser641 was reduced 
in response to caloric restriction at both baseline and during clamp in both groups, 
suggesting enhanced insulin sensitivity that might promote skeletal muscle glycogen 
synthesis (Figure 1g-h).
mTOR signalling. At baseline, no significant differences between groups were 
observed in protein expression of mTOR and S6K1 (Supplementary Figure 1), nor in 
phosphorylation states of key upstream and downstream proteins involved in mTORC1 
signalling, such as TSC2, S6K1 and 4EBP1 (Figure 2). Caloric restriction did not affect pro-
tein expression and phosphorylation states of TSC2, mTOR and S6K1 in basal condition, 
whereas 4E-BP1-Thr37/46 was slightly but significantly increased but only in Caucasians. 
Furthermore, except for 4E-BP1-Thr37/46 which was again significantly increased, the 



































































































Figure 2. Effect of VLCD on mTOR signalling in skeletal muscle from South Asian and white Caucasian 
men in basal state and during a hyperinsulinemic-euglycemic clamp. The phosphorylation states of 
Thr1462-TSC2 (a), Ser2448-mTOR (b), Thr389-S6K1 (c) and Thr37/46-4EBP1 (d) were assessed by Western 
Blot in the same conditions as described in legend Figure 1. TSC2, tuberous sclerosis complex 2. mTOR, 
mammalian target of rapamycin. S6K1, ribosomal protein S6 kinase β1. 4EBP1, eukaryotic translation initia-
tion factor 4E-binding protein 1.
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was also not affected by caloric restriction in Caucasians. By contrast, the phosphoryla-
tion of mTOR -Ser2448, S6K1-Thr389 and 4E-BP1-Thr37/46 was significantly increased 
during hyperinsulinemia in South Asians, suggesting enhanced skeletal muscle mTORC1 
activity in this condition.
AMPK pathway. Before diet, no differences were observed between groups in pro-
tein expression and phosphorylation states of AMPK and of its downstream target ACC 
in basal condition (Supplementary Figure 1; Figure 3). The phosphorylation state of 
AMPK-Thr172 was not affected by insulin in both groups, whereas a decrease in ACC-
Ser79 phosphorylation was observed, but only in Caucasians. Caloric restriction did not 
affect protein expression of AMPKα and ACC while phosphorylation of AMPK-Thr172 
Asians, but not in Caucasians. Phosphorylation of ACC-Ser79 was increased in both 
groups at basal state, whereas a higher degree of phosphorylation was only observed in 
Caucasians during hyperinsulinemic-euglycemic clamp.
Skeletal muscle mitochondrial respiratory-chain content
At baseline, the expression of mitochondrial respiratory-chain complex 2 was significantly 
cantly higher in South Asians. However, neither the complex-2-on-complex-1-ratio (Fig-
ure 4b) nor the mtDNA-to-nDNA-ratio (Figure 4c) was different between groups. Caloric 
restriction led to a significant increase in the expression of respiratory-chain complex 2 
in Caucasians but not in South Asians. In both groups, the complex 2-on-complex 1 ratio 
was significantly higher after caloric restriction, suggesting a mitochondrial adaptation 
towards fat oxidation (Figure 4b). The mtDNA-on-nDNA-ratio was not affected by the 
diet (Figure 4c).
Skeletal muscle metabolic gene expression
The skeletal muscle expression of key metabolic genes involved in the regulation of 
glucose and FA metabolism in basal condition was assessed (Supplementary Table 













































Figure 3. Effect of VLCD on AMPK signalling in skeletal muscle from South Asian and white Caucasian 
men in basal state and during a hyperinsulinemic-euglycemic clamp. The phosphorylation states of 
Thr172-AMPK (a) and Ser79-ACC (b) were assessed by Western Blot in the same conditions as described in 
legend Figure 1. AMPK, AMP-activated protein kinase. ACC, acetyl-CoA carboxylase.
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South Asians no major differences were observed between groups. Caloric restriction 
induced downregulation of several genes involved in glycolysis (PFKM, PKM2), glycogen 
synthesis (UGP2, GBE1) and glycogen breakdown (PYGM) in both groups. Of note, no 
obvious differences were found in mRNA levels of key genes involved in mitochondrial 
biogenesis and tricarboxylic acid cycle whatever the conditions. Interestingly, PPARA was 
differentially affected by the diet, with a significant downregulation induced by caloric 
restriction in South Asians but no effect in Caucasians. In line with this, several PPARA 
target genes, such as CPT1a, ACAA2 and TXNIP, showed a similar pattern, although not 
always reaching a significant threshold. Furthermore, FABP3 and HMGCS2 were found to 
be significantly upregulated by caloric restriction only in Caucasians.
DISCUSSION
South Asians have an exceptionally high risk to develop type 2 diabetes in the context 
of the same environmental pressure when compared to other ethnicities. A possible ex-
planation for this excess risk might be related to differences in the regulation of energy/
nutrient-sensing pathways. Intriguingly, the current study showed that middle-aged 
overweight South Asian men exhibited a different metabolic adaptation to an 8-day 
VLCD compared to age- and BMI-matched white Caucasians.
At baseline, South Asians were more insulin resistant compared to Caucasians, as 
indicated by higher insulin levels (both in fasted state and during OGTT), and lower 
hepatic and peripheral insulin sensitivity. In addition, HTG was significantly higher in 




























































Figure 4. Effect of VLCD on protein expression of mitochondrial respiratory-chain subunits and mt-
DNA-to-nDNA ratio in skeletal muscle from South Asian and white Caucasian men in basal state and 
during a hyperinsulinemic-euglycemic clamp. The protein expression of various mitochondrial respira-
tory-chain subunits (a; CI: NDUFB8, CII: SDHB, CIII: UQCRC2, CIV: MTCO1, CV: ATP5A) were assessed by West-
ern Blot in skeletal muscle from South Asian and white Caucasian volunteers in basal state before (black 
bars) and after (open bars) an 8-day VLCD. Representative blots for one individual per group are shown 
in (a). The respiratory-chain CII-on-CI ratio was calculated (b). The mtDNA-on-nDNA ratio was assessed in 
basal condition by qPCR (c). Results are normalised to Caucasian participants before VLCD and expressed 
as mean±SEM. † p<0.05 within group vs. before diet. CI–V, mitochondrial respiratory-chain subunits I–V.
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South Asians. Deposition of fat in the liver is often associated with hepatic insulin resis-
tance20 and previous studies also reported higher HTG and lower hepatic insulin resis-
tance in South Asians when compared to Caucasians.21;22 The reduced peripheral insulin 
sensitivity in South Asians appears to be due to a reduced rate of NOGD, suggesting 
an impairment in glycogen storage, one of the main defects also observed in patients 
with type 2 diabetes.23 To analyse this further, we assessed the expression of key genes 
involved in glycolysis and glycogen synthesis in skeletal muscle but did not find relevant 
differences between ethnicities. As expected,24 insulin promoted skeletal muscle GSK3-
Ser21/9 phosphorylation and GS-Ser641 dephosphorylation, but no differences were 
observed between groups. Furthermore, caloric restriction similarly potentiated the 
insulin-induced dephosphorylation of GS-Ser641 in both South Asians and Caucasians, 
suggesting that skeletal muscle glycogen synthesis might be improved secondary to 
enhanced insulin sensitivity in this condition. However, the canonical insulin signalling 
pathway assessed by phosphorylation of PKB and its downstream targets PRAS40, 
which is partly involved in the control of glycogen synthesis through the GSK3-GS axis, 
was not found to be differently affected by caloric restriction. Of note, other upstream 
kinases than GSK3 were shown to phosphorylate GS on this specific residue,25;26 and may 
therefore explain this apparent discrepancy.
In response to the 8-day VLCD, fasting glucose, insulin and triacylglycerol levels, 
and abdominal fat depots were reduced in both groups, with a concomitant increase in 
plasma NEFAs, reflecting increased lipolysis in adipose tissue. Furthermore, in line with 
previous studies HTG decreased in both groups,27 with an accompanying improvement 
in hepatic insulin sensitivity.28-30 Although, surprisingly, the changes in HTG were not 
correlated with the improvement in hepatic insulin sensitivity. In addition, Caucasians 
showed a classical switch from carbohydrate to lipid oxidation in response to caloric 
restriction together with an improved insulin effect on substrate oxidation rates, reflect-
ing a clear improvement in metabolic flexibility.28-30 Peripheral insulin sensitivity was not 
affected by the diet in Caucasians, in line with other short-term caloric restriction studies 
leading to minimal weight loss.28-30 By contrast, peripheral insulin sensitivity was in-
creased by caloric restriction in South Asians whereas the shift in whole-body substrate 
oxidation rates was found to be impaired, reflecting metabolic inflexibility. Although 
we do not have definitive explanation for this apparent dissociation, it is plausible that 
the metabolic inflexibility still present after caloric restriction in South Asians might 
result from impaired peripheral lipid metabolism despite better glucose Rd. Indeed, fatty 
acid oxidation rates, which are positively associated with plasma fatty acid levels, were 
reported to be an important determinant of metabolic flexibility.31;32
Remarkably, the skeletal muscle mTOR pathway was found to be differentially regulated 
in response to caloric restriction, with a higher activation of the mTORC1/S6K1 axis 
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upon insulin stimulation in South Asians when compared to Caucasians. Insulin, like 
many growth factors, induces activation of mTORC1 secondary to PKB and/or ERK1/2-
mediated phosphorylation and inactivation of TSC1/2, the major upstream regulator of 
mTORC1.33-35 Conversely, energy restriction leads to mTORC1 inhibition, partly due to 
TSC2 phosphorylation by AMPK on different regulatory residues than the ones targeted 
by PKB and ERK.13 Finally, some of these kinases can also modulate mTORC1 activity 
independently of TSC2 by directly phosphorylating the mTOR catalytic subunit and/or 
some regulatory proteins of the mTORC1 complex, like Raptor and PRAS40.12;36;37 In the 
present study, no diet effect was observed on PKB phosphorylation and its targeted 
residue on TSC2, and the AMPK activity was rather increased in South Asians after caloric 
restriction. Therefore, mTORC1 activation upon insulin-stimulation in South Asians most 
likely occurred via ERK, since phosphorylation of this kinase was significantly increased 
after caloric restriction when compared to Caucasians. Interestingly, insulin resistance 
was reported to be associated with defective insulin regulation of ERK signalling in 
skeletal muscle from women with polycystic ovary syndrome.38 Thus, it is tempting to 
speculate that caloric restriction can restore an insulin-sensitive pathway involved in 
ERK regulation that was specifically impaired in South Asians. However, the exact under-
lying mechanism(s) still need to be clarified and we cannot rule out that other signalling 
pathways are also involved.
Besides its established role in regulating cell proliferation and growth, mTORC1 also 
promotes lipid synthesis and storage, while inhibiting fatty acid β-oxidation.8 In the 
liver, this mTORC1-induced lipid partitioning has been shown to be mediated, at least 
partly, by inhibition of the transcription factor PPARa,39 which is also a key regulator of 
skeletal muscle fatty acid oxidation.40 Specifically, PPARa controls the transcription of 
genes involved in fatty acid uptake and mitochondrial import, as well as in β-oxidation 
and ketogenesis.40 Interestingly, in the present study we observed a significant decrease 
in skeletal muscle PPARA gene expression in South Asians, but not in Caucasians af-
ter caloric restriction. In line with this, several PPARA target genes were also similarly 
downregulated in South Asians, including the fatty acid binding protein FABP3, which 
was previously reported to be positively associated with enhanced skeletal muscle 
oxidative capacity after caloric restriction.41 Taken together, we might suggest that the 
higher insulin-stimulated mTORC1 activity observed after caloric restriction in South 
Asians may underlie a decrease in fatty acid oxidation secondary to inhibition of PPARa, 
ultimately resulting in impaired metabolic flexibility (Figure 5). Of note, mTORC1 was 
shown to control lipid metabolism in various other metabolic tissues.8 Thus, it is conceiv-
able that mTOR signalling can also be differently regulated in the adipose tissue from 
South Asians, thereby promoting the storage of NEFAs by inhibiting lipolysis.8 This may 
be another explanation for the attenuated increase in plasma NEFAs in South Asians 
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compared to Caucasians, apart from suppressed fatty acid oxidation in skeletal muscle. 
Among other possible explanations, a lower proportion of slow-twitch type 1 oxidative 
muscle fi bres in South Asians, rendering them less effi  cient for fatty acid oxidation,42 or 
the fact that NEFAs are not directed towards oxidation but preferentially to storage into 
complex lipids, i.e. intramyocellular lipid content (IMCL), might be suggested. It would 
therefore be interesting to address these points by measuring skeletal muscle IMCL and 








































Figure 5. Proposed mechanism(s) underlying the diff erent metabolic adaptations to short-term ca-
loric restriction in South Asian compared to white Caucasian men. The diff erences in skeletal muscle 
response to caloric restriction between South Asians and white Caucasians during step 2 of the hyperinsu-
linemic-euglycemic clamp are shown on the various signalling pathways assessed. South Asians showed 
an increase in mTORC1 signalling upon insulin stimulation, which most likely occurred via ERK rather than 
PKB activation. This higher mTORC1 activation, by inhibiting PPARa and the transcriptional regulation of 
its target genes, may decrease fatty acid β-oxidation and contribute to the impaired metabolic fl exibility 
observed in South Asians. Whole-body glucose disposal rate (Rd) was improved in South Asians, but not 
in Caucasians, after caloric restriction. This was associated with AMPK activation, which is known to pro-
mote skeletal muscle glucose uptake by an insulin-independent, but potentially additive, mechanism that 
remain to be clarifi ed. FA, fatty acid; G6P, glucose 6-phosphate; Raptor, regulatory-associated protein of 
mTOR; TBC1D1, TBC1 domain family member 1. Dark grey phosphorylation (P) sites: inhibitory; light grey 
phosphorylation (P) sites: activating; down arrows: expression is decreased in South Asians; up arrows: ex-
pression (or level for insulin, rate for Rd) is increased in South Asians; = similar eff ect to energy restriction in 
South Asians and Caucasians.
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Finally, in addition to its role in lipid metabolism, mTORC1 is also known to modulate 
insulin sensitivity by phosphorylating IRS-1 on specific serine residues, resulting in a 
negative-feedback loop on the canonical insulin pathway. Enhanced mTORC1 activity 
in livers from obese insulin-resistant mice was indeed shown to promote S6K-mediated 
phosphorylation of IRS1, presumably on Ser636/639 10 and/or Ser307.43 Furthermore, 
S6K-mediated phosphorylation of IRS1 on Ser1101 was also reported to mediate hepatic 
and skeletal muscle insulin resistance in high-fat diet fed mice.44 However, despite appar-
ent enhanced mTORC1 activation upon insulin stimulation, Rd was paradoxically found 
to be improved after caloric restriction in South Asians in our condition. Unfortunately, 
we were not able to detect significant phosphorylation of IRS1 on both Ser636/639 and 
Ser307 using commercial antibodies (data not shown), although it is worth mentioning 
that the existence of this regulatory feedback loop and the exact IRS1 residue(s) involved 
are still a matter of debate, especially in human skeletal muscle (see 45 for review).
The improvement in Rd after caloric restriction in South Asians is apparently primarily 
accounted for by increased NOGD, suggesting that glycogen storage might be improved, 
although no change in the insulin-induced dephosphorylation of Ser641-GS was found. 
AMPK activation, which is known to promote skeletal muscle glucose uptake by an 
insulin-independent but additive mechanism increasing translocation of GLUT4 to the 
plasma membrane,46 was significantly higher in South Asians than in Caucasians, sug-
gesting that this kinase might be involved in the improved Rd in South Asians. Although 
the exact mechanism by which AMPK increases glucose uptake remains incompletely 
understood (see 47 for recent review), it apparently involves phosphorylation of the 
Rab GTPase-activating proteins AS160 (TBC1D4) and/or on TBC1D1 by the kinase, on 
residues different than the ones targeted by PKB.48 However, activation of AMPK was 
also shown to decrease the rate of GLUT4 endocytosis both in human and rat muscle in 
vitro,49 whereas insulin had opposite effects, showing that multiple steps in the control 
of glucose uptake can be differently regulated by insulin and AMPK-dependent path-
ways. Interestingly, a recent study has also reported that elevated glucose transport 
promoted by increased AMPK activity causes an accumulation of intracellular G6P lead-
ing to allosteric activation of GS and glycogen storage in skeletal muscle, independently 
of changes in GS phosphorylation, notably on Ser641.50 Altogether, we might speculate 
that the higher AMPK activity observed during hyperinsulinemic-euglycemic clamp can 
underlie the improved NOGD in South Asians after caloric restriction, at least partly sec-
ondary to insulin-independent increase in glucose uptake. Further studies are required 
for clarifying this point, notably for measuring skeletal muscle glycogen content after 
caloric restriction in both South Asians and Caucasians.
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Taken together, the signalling pathway analysis performed in skeletal muscle in the 
present study does not allow us to draw definitive conclusions on the mechanism(s) un-
derlying the improvement in Rd observed after caloric restriction in South Asians, but not 
Caucasians. Additional in depth molecular investigations are therefore clearly required, 
not only in skeletal muscle but also in other organs involved in whole-body Rd, such 
as adipose tissue. In addition, as chronic mTORC1 activation is believed to contribute 
to the development of insulin resistance and type 2 diabetes,8 it would be interesting 
to investigate the response to long-term caloric restriction on mTORC1 signalling and 
insulin sensitivity in South Asians compared to Caucasians. Of note, we have recently 
studied the effect of high fat feeding on energy/nutrient-sensing pathways in young, 
healthy lean South Asian and white Caucasian men and showed that this diet rapidly 
induced insulin resistance in South Asians, but had no effect on Caucasians.16 However, 
in contrast to the present study, we did not observe differences in mTOR, AMPK or other 
energy/nutrient-sensing pathways, suggesting that differences in the regulation of these 
pathways may develop with age and in a more disadvantageous metabolic phenotype, 
e.g. in overweight individuals.
In conclusion, we showed that middle-aged overweight South Asian men exhibit a 
different metabolic adaptation to short-term caloric restriction compared to age- and 
BMI-matched Caucasians. Although metabolic flexibility was impaired after an 8-day 
VLCD, Rd was improved in South Asians in contrast to Caucasians, and was associated 
with an increase in insulin-induced activation of the skeletal muscle ERK-mTOR-S6K1 
axis. Additional studies are required to expand these findings, which might provide new 
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Supplemental Figure 1. Effect of VLCD on mTOR signalling in skeletal muscle from South Asian and 
white Caucasian men in basal state. The protein expression of PKB (a), AS160 (b), PRAS40 (c), ERK (d), 
mTOR (e), S6K (f ), AMPK (g), and ACC (h), were assessed by Western Blot in skeletal muscle from South 
Asian and white Caucasian subjects before (black bars) and after an 8-day VLCD (open bars) in basal state. 
Representative blots for one subject per group are shown. Results are normalized to Caucasian subjects in 
basal state before VLCD and expressed as mean±SEM. † p<0.05 within group vs. before diet. * p<0.05 vs. 
Caucasians. AS160, Akt substrate of 160 kDa. mTOR, mammalian target of rapamycin. AMPK, AMP-activated 
protein kinase. ERK, extracellular signal-regulated kinase. PKB, protein kinase B protein kinase B. PRAS40, 
Proline rich Akt substrate of 40 kDa. S6K1, ribosomal protein S6 kinase β1. ACC, acetyl-CoA carboxylase.
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Brown adipose tissue (BAT) dissipates energy stored in triglycerides as heat via the 
uncoupling protein UCP-1. It has recently been discovered that BAT is present and ac-
tive in adults. BAT is situated predominantly around the aorta and in the supraclavicular 
area. BAT volume and activity are lower in individuals who are obese, suggesting that 
BAT significantly contributes to energy expenditure. Several pathological conditions 
that lead to activation of BAT, such as hyperthyroidism and pheochromocytoma, result 
in increased energy expenditure and in weight loss. Various ways in which BAT can be 
manipulated to increase expenditure of energy have been identified, e.g. exposure to 
cold, the use of so-called uncoupling agents or the administration of the hormone irisin. 




Adipose tissue can be subdivided into ‘white adipose tissue’ and ‘brown adipose tissue’ 
(BAT). Until recently, it was thought that BAT disappears in adult life. However, modern 
techniques as 18F-FDG-PET-CT-scans have proven otherwise. Interestingly, it has been 
discovered not long ago that BAT can be manipulated to increase energy expenditure.
The function of white adipose tissue is to store triglycerides and to produce a large 
number of factors, the so called adipo(cyto)kines.1 In contrast, BAT continuously burns 
triglycerides and glucose, thereby releasing energy as heat. This process is called thermo-
genesis. In neonates, thermogenesis contributes importantly to the maintenance of body 
temperature.
In this article we will give an overview of the anatomy, physiology and function of 
BAT and describe how BAT can be manipulated in order to increase energy expenditure 
and possibly induce weight loss.
Anatomy and origin of brown adipose tissue
BAT differs strongly from white adipose tissue in both volume and structure (Table 1). 
The total amount of BAT in an adult human is estimated to be 50-100 grams, while the 
amount of white adipose tissue is roughly 20% of total body weight. A white adipocyte 
consists of a big vacuole filled with triglycerides, surrounded by a thin rim of cytoplasm. 
The cytoplasm contains the nucleus and cell organelles, including a few mitochondria 
Table 1 Differences between white and brown adipose tissue.
Characteristic White adipose tissue Brown adipose tissue
Microscopic image
Amount in human body 12 – 35 kg circa 50 – 100 g
Morphology large cells filled with triglycerides
few mitochondria
cells filled with small lipid droplets
large number of mitochondria
Location present throughout the whole body in brown fat pads, predominantly in 
the subscapular area (neonates), and in 
the supra-clavicular region and along 
the aorta (adults); scattered as groups 
of cells in white adipose tissue and 
skeletal muscle




that provide for the formation of ATP, the main energy supplier of cells. In contrast, a 
brown adipocyte contains several small lipid droplets that are surrounded by a large 
number of mitochondria. The iron-containing proteins that are part of the respiratory 
chain inside the mitochondria give BAT its brownish colour.
Brown fat cells are present in two forms. On the one hand, they form brown fat pads, 
which are located in the subscapular area in neonates and along the aorta and in the 
supraclavicular region in adults.2 In addition, individual brown fat cells lie scattered 
in other tissues, such as white adipose tissue and muscle, where they form a pool of 
´peripheral brown adipocytes´. These cells are also called ‘beige adipocytes´, since their 
phenotype lies between a white and brown fat cell.
The two types of brown fat cells have different origins (Figure 1). Brown adipocytes 
present in the brown fat pads originate from a Myf5 (myogenic factor 5)-positive precur-
Myf5 negative precursor cell 
Myf5 positive precursor cell 
white adipocyte 
transdifferentiation 

















Figure 1. Differentiation of mesenchymal stem cells into brown adipocytes. Myf5-positive precursor 
cells can differentiate into skeletal muscle cells or brown fat cells, depending on the presence of BMP7. The 
skeletal muscle cells express myogenin, the brown fat cells PRDM16. This type of brown fat cell is present in 
fat pads. Myf5-negative precursor cells differentiate into peripheral brown fat cells (‘beige fat cells’) under 
influence of several stimuli, such as BMP7, β-adrenergics and PPAR-γ agonists. Peripheral brown fat cells can 
also originate from transdifferentiation of a white fat cell. (Myf5 = myogenic factor 5; BMP7 = ‘bone mor-
phogenetic protein-7’; PRDM16 = ‘PR domain containing 16’; PPAR-γ = peroxisome proliferator-activated 
receptor-γ) (adaptation of a previously published figure).3
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sor cell; this precursor cell can differentiate into both a brown fat cell and a skeletal 
muscle cell, depending on the presence of stimuli such as Bone Morphogenetic Protein 
7 (BMP7). The peripheral brown fat cell – or beige fat cell – originates from a Myf5-
negative precursor cell, as well as from transdifferentation of a white fat cell into a brown 
fat cell.3;4 Several stimuli (such as BMP7, β-adrenergics and peroxisome proliferator-
activated receptor-γ (PPAR-γ)-agonists) can activate the differentiation of Myf5-negative 
precursor cells into peripheral brown fat cells.3 These stimuli are therefore considered 
interesting therapeutic targets.
Physiology of brown adipose tissue
In mitochondria ATP synthesis takes place. This process starts with the conversion of 
fatty acids and glucose into acetyl coenzyme A, that participates in the citric acid cycle 



















Figure 2. Activation of brown adipose tissue. In resting condition, the energy-rich compounds NADH 
en FADH2 donate their energy in the form of electrons to the electron transport chain, thereby creating a 
gradient of H+-ions across the inner mitochondrial membrane (see inset right). The energy stored in this 
gradient is used by the enzyme ATP synthetase to convert ADP into ATP.  However, in BAT the protein UCP-1 
uncouples the H+-gradient of ATP-synthetase. This happens when a sympathetic nerve cell activates the 
β3-receptor of brown adipocytes by secretion of noradrenalin (left drawing), leading to the formation of 
cAMP and eventually to the production of UCP-1. Transport of H+ across the inner membrane via UCP-1 
results in the production of heat instead of ATP. The active thyroid hormone T3 also leads to production of 
UCP-1 (cAMP = cyclisch AMP; UCP-1 = ‘uncoupling protein 1’; T3 = tri-iodothyronine; T4 = thyroxine; D2 = 
type 2-deiodinase) (derived from a figure published elsewhere).26
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NADH and FADH2, which donate their electrons during oxidative phosphorylation to 
the electron transport chain, thereby creating a gradient of H+-ions across the inner 
mitochondrial membrane (Figure 2). The energy stored in this gradient is used by the 
enzyme ATP synthetase to convert ADP into ATP.
The brown adipocyte is able to burn triglycerides and glucose via the process of 
´uncoupling´, in which energy is released as heat instead of ATP, resulting in increased 
energy expenditure in the cell. A detailed description of the physiology of a brown fat 
cell is shown in Figure 2.
Every brown adipocyte is innervated by a sympathetic nerve. The most important 
stimulus of the sympathetic nervous system is cold; the sympathetic nerve is activated 
by the temperature centre in the brain, which receives input from sensory nerve fibres in 
the skin. Upon stimulation, the sympathetic nerve locally releases noradrenalin, which 
binds to β3-adrenergic receptors on the brown adipocyte. Activation of these receptors 
results in a cascade of intracellular reactions.
Uncoupling protein (UCP) First, the expression of the gene encoding for the uncou-
pling protein UCP-1 is induced via elevation of intracellular cyclic AMP. UCP-1 is unique 
for BAT. UCP-1 proteins are then incorporated into the inner membrane of mitochondria, 
forming pores. However, in the presence of UCP-1 the proton gradient is disturbed and 
the accumulated energy dissipates as heat rather than being converted into ATP. The 
greater the density of mitochondria (or the amount of UCP-1) in BAT, the more glucose 
and triglycerides will be burned and released as heat when BAT is activated.
Increased influx of substrate At the same time, sympathetic activation of BAT re-
sults in an increased amount and activity of the enzyme lipoprotein lipase (LPL), which 
cleaves fatty acids from triglycerides for uptake by BAT, and of GLUT-1, the glucose trans-
porter that increases the uptake of glucose by BAT.5 In this way sympathetic activation 
of BAT increases not only thermogenesis, but also the influx of the necessary substrate.
Thyroid hormone Remarkably, thyroid hormone is also involved in the activation of 
brown fat. After uptake into the brown fat cell and translocation to the nucleus, T3, the 
active thyroid hormone, binds to thyroid hormone responsive elements located on the 
promoter of the UCP-1 gene.6 This leads to increased transcription of UCP-1 and conse-
quently to increased conversion of triglycerides and glucose into heat.5 Furthermore, 
T3 is able to stabilize the UCP-1-mRNA, thereby reducing its degradation in the cell.5 
During cold-induction, the activity of the enzyme type-2-deiodinase (D2) is increased 
in BAT, leading to locally increased amounts of T3. This is an additional and necessary 
mechanism to stimulate thermogenesis by BAT.
Presence of brown adipose tissue in adult humans
The primary function of BAT is the production of heat – nonshivering thermogenesis – 
to prevent a decrease in body temperature. In neonates this is particularly important, 
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since they have a relatively large body surface area and little capacity to shiver due to 
underdevelopment of their muscles.5
Although BAT remains present in large quantities in rodents and other mammals, in 
humans the amount of BAT declines fast after infancy. Until recently, it was even assumed 
that in adults BAT is almost completely absent; indeed, it is hardly necessary as in adults 
skeletal muscle contributes primarily to heat production. However, 18F-FDG-PET-CT scans 
performed in wintertime in adults in the context of visualization of malignancy showed 
increased glucose uptake in locations corresponding to BAT. Like malignant cells, brown 
fat cells take up glucose at an increased rate due to their high metabolism. Biopsies from 
these areas indeed showed a very high expression of UCP-1, the unique marker for BAT.
Further research by Van Marken Lichtenbelt and others with 18F-FDG-PET-CT scans 
showed that – following cold-induction – BAT is present in almost 100% of young adults 
(Figure 3).2 However, recent genotyping of human brown fat biopsies showed that this 
brown fat resembles more the beige fat found in white fat depots in mice rather than the 
classical brown fat.7 Whether beige fat in humans has the same physiological properties 
as the classical brown fat in mice remains to be determined in the coming years.
Figure 3. 18F-fluordeoxyglucose (FDG)-PET-CT-uptake of brown adipose tissue (BAT) in adults. BAT 
can be visualized with a FDG-PET-CT-scan. To do this, a patient is exposed to cold (circa 16°C) during 2 hours 
to activate BAT. After 1 hour of cold-induction the radioactive tracer 18F-FDG is injected intravenously. 18F-
FDG, a glucose analog, is taken up by organs that have a high glucose usage, especially the brain, heart and 
BAT. After 2 hours of cold-induction, and 1 hour after administration of the tracer, the uptake of 18F-FDG is 
measured in circa 30 minutes using a low-dose CT-scan, immediately followed by a PET-scan. The CT-scan 
is used for localization of the FDG uptake sites. The activity and volume of BAT can be quantified by auto-
contouring the areas in which FDG-uptake has taken place with a set threshold. Remarkable in this figure is 
the increased presence of BAT in a lean subject (left) compared to an obese subject (right) (figure is derived 
from a previous publication).2
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Involvement of brown adipose tissue in pathology
Hibernomas and pheochromocytomas
In adults, the presence of BAT was already noticed in two clinical conditions: hiberno-
mas and pheochromocytomas. Hibernomas are rare, benign tumours, named for their 
resemblance to BAT in animals that go into hibernation. They are clearly visible on 18F-
FDG-PET-CT scans, indicating that the tumour is metabolically active.8 Pheochromocy-
tomas, which are neuroendocrine tumours, secrete excessive amounts of noradrenalin, 
an important activator of BAT. Indeed, on 18F-FDG-PET-CT scans in patients with this 
tumour, an increased volume and activity of BAT is seen. Moreover, after resection of 
the tumour FDG uptake decreases dramatically. The increased activity of BAT probably 
contributes significantly to the increased energy expenditure typical for this condition.9
Hyperthyroidism and hypothyroidism
In people with hyperthyroidism energy expenditure is increased, while this is decreased 
in hypothyroidism. In mice, thyroid hormone has been shown to be both directly – via 
the T3-receptor – and indirectly – via the sympathetic nervous system – involved in the 
activation of BAT.10;11 The weight loss and excessive transpiration in hyperthyroidism, 
and the weight gain and reduced cold tolerance in hypothyroidism can therefore be 
(partly) attributed to an increased, respectively decreased activity of BAT.5
Obesity and type 2 diabetes mellitus
An interesting finding is that in adults the amount of BAT is inversely related to BMI and 
percentage of body fat.2 More specifically: the volume and activity of BAT are inversely 
correlated with parameters of central obesity, such as visceral fat volume on CT-scan and 
waist circumference.9 These findings suggest that obesity is associated with a low level 
of BAT activity. On the one hand, a reduced activity of BAT may predispose to obesity 
and obesity-related diseases such as type 2 diabetes mellitus by accumulation of triglyc-
erides in the blood and subsequent storage in white adipose tissue, including ectopic 
fat depots such as skeletal muscle and the liver. Indeed, it has been shown in mice that 
excision of BAT results in hypertriglyceridemia and obesity.12 Alternatively, insulation, 
due to the thick subcutaneous white fat layer in obese individuals, may be sufficient for 
the maintenance of body temperature, making active BAT redundant; low activity of BAT 
could then be the consequence of obesity.13
BAT burns both triglycerides and glucose. Therefore, BAT could also contribute to 
glucose homeostasis, particularly in resting conditions when glucose utilization by 
skeletal muscle is minimal. A low activity of BAT might, thus, not only predispose to 




Manipulating volume and activity of brown adipose tissue
The above-mentioned findings underscore that increasing the volume and activity of 
BAT is a promising target to increase total energy expenditure and consequently induce 
weight loss. Theoretically, BAT volume and activity can be increased in several ways. 
Generally, a distinction is made between methods that activate already present brown 
fat cells, and methods that stimulate the recruitment of new brown fat.
Activation of existing brown adipose tissue
BAT is strongly innervated by the sympathetic nervous system (Figure 2). This offers 
potential targets for intervention. Furthermore, the uncoupling phenomenon is a pos-
sible target.
Cold The most important activator of BAT via the sympathetic nervous system is 
cold. Several studies have shown a relation between the volume and activity of BAT 
and the outdoor temperature, with the highest activity during the coldest month of the 
year.15 Therefore, the simplest method to activate BAT seems to be cold induction, for 
instance via creating a colder living or working environment. Whether this will actually 
affect BAT activity, and thus may induce weight loss, remains to be investigated.
Sympathicomimetics In addition to indirect activation of β3-adrenergic receptors 
by cold, sympathicomimetics could also be used. In mouse models these seemed to be 
very successful.16 Unfortunately, the expected weight-reducing effect failed to occur in 
humans. In addition, side effects – sometimes life threatening – were experienced.17;18 So 
far, these agents are therefore not used for clinical purposes.
Uncouplers Increasing the uncoupling of ATP synthesis towards heat in BAT or other 
tissues, such as white adipose tissue or skeletal muscle (ectopic expression), might be 
an effective method to increase energy expenditure. Already in the thirties of the last 
century, the chemical uncoupler 2,4-dinitrophenol (DNP) was successfully used as an 
ingredient in diet pills. However, chemical uncouplers influence oxidative processes in 
all tissues, and not specifically in BAT. Due to serious side effects, like hyperthermia, this 
agent was therefore withdrawn from the market in 1938.19 Current research now focuses 
on increasing (ectopic) expression of naturally occurring uncouplers, such as UCP-1.20;21
Recruitment of new brown adipose tissue
New BAT could be recruited by stimulating the differentiation of precursor cells of white 
adipocytes into brown adipocytes.
PPAR-γ agonists One of the key regulators in the differentiation of adipocytes is 
PPAR-γ. Animal studies have shown that PPAR-γ-agonists can recruit precursor cells of 
BAT and, in addition, can “brown” white adipocytes that thereby obtain UCP-1.22 PPAR-
γ-agonists are already used in the treatment of type 2 diabetes: the thiazolinediones 
(TZDs). Research has shown that the improvement in insulin sensitivity with TZDs is 
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partly due to an accelerated clearance of glucose in BAT.23 Remarkably, though, use of 
TZDs leads to weight gain – partly due to fluid retention – and a different fat distribu-
tion, making their use as a weight loss agent less likely. Moreover, prescription of these 
agents is limited due to side effects such as heart failure and osteoporotic fractures.
BMP7 Another important regulator in the differentiation of BAT is BMP7. Recent 
studies in mice have shown that BMP7 is an effective agent to increase the amount of 
BAT – both in fat pads as peripherally – leading to an increase in energy expenditure and 
weight loss (Boon et al., unpublished data).3;24
Irisin Irisin is a recently discovered hormone that, in both mice and humans, is 
secreted by skeletal muscle during exercise. A recent study in mice demonstrated that 
exogenous administration of irisin induced ‘browning’ of subcutaneous white adipose 
tissue. This resulted in an increase in energy expenditure, a decrease in weight and an 
improvement in glucose tolerance.25
CONCLUSION
BAT burns triglycerides and glucose towards heat via the uncoupling protein UCP-1, and 
thus has a significant share in total energy expenditure. The recent observation of active 
BAT in adult humans might therefore offer new possibilities in the fight against obesity. 
Currently, various studies focus on activating BAT as a treatment strategy against obesity. 
In mouse models we seem to be close to success; the coming years will tell us whether 
BAT may be a novel therapeutic target organ in humans to combat obesity and related 
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Background. South Asians have an exceptionally high risk of developing type 2 diabe-
tes mellitus compared to white Caucasians. Though the underlying cause is still poorly 
understood, it is assumed that an ethnic susceptibility towards a disturbed energy me-
tabolism might be present. Brown adipose tissue (BAT) has emerged as an important 
player in energy metabolism by combusting fatty acids and glucose towards heat. We, 
therefore, hypothesized that a low total BAT activity might underlie the susceptibility for 
type 2 diabetes in South Asians.
Methods. BAT volume and activity were measured in healthy lean young adults (mean 
age 24.1±0.8 years) from South Asian (n=12) and white Caucasian (n=12) origin, matched 
for BMI, using cold-induced 18F-FDG-PET-CT scans. Furthermore, resting energy expen-
diture (REE), non-shivering thermogenesis (NST) and serum parameters were assessed.
Findings. Thermoneutral REE was lower in South Asian compared to white Caucasian 
subjects (-32%, P=0.001). Upon cold exposure, the shiver temperature of South Asians 
was higher (+2.0°C, P=0.007). Furthermore, cold exposure significantly increased NST 
in white Caucasians (+20%, P<0.0001), but not in South Asians. Though the SUVmax and 
SUVmean of 18F-FDG in BAT did not differ, total BAT volume was markedly lower in South 
Asians (-34%, P=0.04). Taken the subjects together, BAT volume correlated positively 
with basal REE (β=0.44; P=0.04).
Interpretation. Healthy South Asian young adults have lower REE, NST, as well as lower 
BAT volume compared to matched white Caucasians. This might underlie their high 
susceptibility to develop metabolic disturbances, such as obesity and type 2 diabetes. 
Future studies should focus on developing novel strategies to increase BAT volume and 
activity.
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INTRODUCTION
South Asians originate from the Indian sub-continent and represent one fifth of the 
world’s population. The risk of developing type 2 diabetes and its related complications 
is exceptionally high among both native and migrant South Asians compared to people 
of white Caucasian descent, and is still rising.1 Moreover, type 2 diabetes occurs at a 
younger age and lower BMI,2,3 and the risk of diabetes related complications is higher.4,5 
 The underlying cause of this excess risk is not completely understood, but might, involve 
their frequently present disadvantageous metabolic phenotype, consisting of central 
obesity, insulin resistance, and dyslipidemia.6,7 It is commonly assumed that an ethnic 
susceptibility towards a disturbed energy homeostasis (e.g. lower oxidation of glucose 
and fatty acids by mitochondria) might underlie this phenotype.8
Recently, brown adipose tissue (BAT) has emerged as a novel player in energy 
homeostasis in humans.9–12 In contrast to white adipose tissue, BAT burns triglycerides 
and glucose to generate heat through a process called mitochondrial uncoupling.13 
Interestingly, BAT volume and activity, as assessed after exposure to cold by 18F-fluoro-
deoxy-glucose (18F-FDG) positron emission tomography and computed tomography 
(PET-CT) scans, are inversely related to BMI and percentage of body fat in adult humans, 
indicating an inverse relationship between BAT and obesity.11,14,15 Besides a clear role 
for BAT in triglyceride metabolism16 BAT is also thought to contribute to glucose ho-
meostasis, particularly in resting conditions when glucose utilization by skeletal muscle 
is minimal.17 Importantly, BAT appears to contribute to non-shivering thermogenesis 
(NST)12,15 and it has been estimated that fully activated BAT in humans can contribute up 
to 15-20% of total energy expenditure.13
Thus, since BAT is involved in total energy expenditure and clearance of serum triglyc-
erides and glucose thereby protecting against metabolic disturbances, we hypothesized 
that a low BAT volume or activity might underlie the disadvantageous metabolic phe-
notype and susceptibility for type 2 diabetes in South Asians. Therefore, we investigated 
resting energy expenditure (REE) as well as BAT volume and activity in young healthy 
lean South Asian males and matched white Caucasians (hereafter referred to as Cauca-
sians), using ventilated hoods and cold-induced 18F-FDG-PET-CT-scans. In addition, we 
examined the effect of cold exposure on NST, thermoregulation, and plasma lipid levels.
METHODS
Subjects
Twelve Dutch South Asian (subjects with two South Asian parents born in The Neth-
erlands) and twelve Dutch Caucasian, lean (BMI <25 kg/m2) and healthy males [age: 
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24.1±2.8 years] were enrolled via local advertisements. Subjects underwent a medical 
screening including their medical history, a physical examination, blood chemistry tests, 
and an OGTT to exclude individuals with type 2 diabetes according to the American 
Diabetes Association  (ADA) 2010 criteria. Other exclusion criteria were rigorous exer-
cise (>10 hours of exercise per week), smoking, and recent body weight change (>3 
kg weight gain or loss within 3 months prior to the study). Subjects were matched for 
BMI by pairwise matching. The present study was approved by the Medical Ethical Com-
mittee of the Leiden University Medical Centre and performed in accordance with the 
principles of the revised Declaration of Helsinki. All volunteers gave written informed 
consent before participation.
Study design
The study was conducted in The Rijnland Hospital, Leiderdorp (The Netherlands). Sub-
jects were studied in the morning after a 10-hour overnight fast and subjects were not 
allowed to exercise 24 hours prior to the study. Subjects wore standardized clothing, 
consisting of a T-shirt and boxer short. Body composition was determined by means 
of dual-energy x-ray absorptiometry (DEXA) (iDXA, GE Healthcare, UK). A cannula was 
inserted in the left antecubital vein for blood sampling and 18F-FDG injection.
Details on the techniques used in the study are described in the supplementary 
technical appendix.
Cooling protocol. To activate BAT an individualized cooling protocol was applied, 
using two water perfused cooling mattresses (Blanketrol® III, Cincinatti Sub-Zero (CSZ) 
Products, Inc).15 During the procedure subjects stayed in a clinical examination room. 
The protocol started with a baseline period of one hour in thermoneutral condition, af-
ter which subjects were exposed to mild cold. Since the onset temperature of shivering 
shows high interindividual variation (e.g. due to differences in body composition),13 an 
individualized cooling protocol was used to ensure maximal NST, and thus a maximum 
level of BAT activity for each subject. Cooling started at 32°C and temperature was gradu-
ally decreased until shivering occurred. Temperature was then raised with 3-4°C and the 
cooling period of two hours was started (tcold=0min). In case of shivering, temperature 
was raised with 1°C until shivering just stopped. Shivering was detected visually and 
by asking the subject. At the end of the first hour (tcold=60min) of cooling 18F-FDG was 
injected intravenously (2 MBq/kg). To exclude artefacts of muscle activity, subjects were 
instructed to lie still. Both in thermoneutral and cold-induced condition (tcold=110min) 
venous blood was collected and indirect calorimetry was performed with a ventilated 
hood (Oxycon Pro™, CareFusion, Germany) (tcold=80-110min). After the second hour 
(tcold=120min) of cooling 18F-FDG-PET-CT imaging was performed to quantify BAT.
18F-FDG-PET-CT-scan. Imaging was performed on a PET-CT-scanner (Gemini TF PET-
CT, Philips, The Netherlands) as described previously.11 Imaging started with a low dose 
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CT-scan (effective dose 2 mSv), immediately followed by a PET-scan. The CT-scan was 
used for attenuation correction and localization of the 18F-FDG uptake sites. Both image 
sets were reconstructed in transaxial, coronal, and sagittal images with a slice thickness 
of 4 mm. PET-CT images were interpreted blinded by both a nuclear medicine physician 
and a researcher using dedicated software (Hermes Hybrid Viewer™, Hermes Medical 
Solutions AB, Sweden). BAT activity and detectable BAT volume were quantified in the 
region of interest by autocontouring the BAT areas with a set threshold (SUV of 2.0 g/
mL). One (Caucasian) subject developed hyperventilation following 18F-FDG administra-
tion, and was therefore excluded from all cold-induced and BAT measurements.
Temperature registration. Core body temperature was measured continuously in 
the small intestine with the use of an ingestible telemetric capsule (Jonah™, BMedical, 
Australia). Core temperature measurement failed in two subjects (one South Asian and 
one Caucasian). Skin temperature was measured continually by wireless iButtons (iBut-
tons®, Maxim, USA) placed at different positions on the skin.18
Calculations
Total detectable BAT volume is expressed in mL. BAT activity is expressed in standardized 
uptake values (SUV, the ratio of activity [kBq per mL] within the region of interest (ROI), 
and the injected activity [kBq] per bodyweight [g]). Both the maximum standardized 
uptake value (SUVmax) [g/mL] and the average standardized uptake value (SUVmean) [g/
mL] within the volume of interest (VOI) were determined. Energy expenditure, respira-
tory quotient (RQ) and substrate oxidation rates were sampled on a 1-minute basis and 
were determined as previously described.19,20 Skin temperatures were measured accord-
ing to the 14-point ISO method.18 See supplementary technical appendix for detailed 
description.
Laboratory analysis
Serum triglyceride levels were determined using a commercially available kit (Roche 
Diagnostics, The Netherlands). Serum glucose and FFA levels were measured via enzy-
matic kits obtained via Instruchemie (Delfzijl, The Netherlands) and Wako Chemicals 
(Germany), respectively.
Statistical analysis
Data are presented as mean±SD when normally distributed or as median (IQR) when 
not normally distributed. A mixed effects model was applied to assess mean differ-
ences before and after cold exposure within and between groups, and to determine 
differences in the effect of cold exposure. Groups and intervention were modelled as 
fixed effects and the subject specific deviances from the group mean were modelled as 
random effects. Unpaired t-tests were used to compare baseline characteristics and BAT 
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parameters between groups. Nonparametric tests (Wilcoxon signed-rank test within 
group, Mann-Whitney between groups) were performed when appropriate. Correction 
of parameters for lean body mass (LBM) was performed by ANCOVA. To identify correla-
tions between variables, linear regression analyses were performed. Significance level 




Mean age was 24.1±2.8 years (Table 1). BMI did not differ between groups (South 
Asians: 21.5±2.0 vs. Caucasians: 22.0±1.6 kg/m2, p=0.50), but South Asians were shorter 
and lighter. The percentage of fat mass was higher in South Asians and, consequently, 
the percentage of LBM was lower. Additionally, the waist hip ratio was higher in South 
Asians.









age (years) 24.6 ± 2.8 23.6 ± 2.8 0.390
length (m) 1.85 ± 0.04 1.74 ± 0.06 <0.0001
weight (kg) 75.1 ± 7.2 65.0 ± 8.5 0.005
body mass index (kg/m2) 22.0 ± 1.6 21.5 ± 2.0 0.496
waist (cm) 84 ± 5.1 83 ± 7.7 0.804
hip (cm) 96 ± 3.5 89 ± 5.7 0.004
waist hip ratio 0.88 ± 0.04 0.93 ± 0.04 0.005
Body composition
fat mass (%) 18.3 ± 5.0 23.9 ± 5.0 0.012
fat mass (kg) 13.9 ± 4.3 15.8 ± 4.6 0.306
lean body mass (%) 77.6 ± 4.8 72.1 ± 4.7 0.011
lean body mass (kg) 58.5 ± 6.0 46.8 ± 5.1 <0.0001
bone mineral content (%) 4.1 ± 0.2 4.0 ± 0.4 0.489
bone mineral mass (kg) 3.1 ± 0.3 2.6 ± 0.3 0.001
Data are presented as mean ± SD. P value vs. Caucasians based on an unpaired T-test
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Cold exposure increased diastolic blood pressure and decreased heart rate in both groups 
(Table 2). Cold exposure tended to increase systolic blood pressure in Caucasians (+6%, 
135±11 vs. 143±13 mmHg, p=0.08), but not in South Asians (+0%, 126±18 vs. 125±13 
mmHg, p=0.76). Of note, cold-induced systolic blood pressure was significantly lower 
in South Asian compared to Caucasian subjects (125±13 vs. 143±13 mmHg, p=0.005).
Glucose and lipid levels
Fasting thermoneutral glucose and lipid levels were comparable between groups (Table 
2). Cooling did not affect serum glucose levels, but markedly increased serum triglycer-
ide levels in both groups. Of note, a significant cold-induced increase in serum FFA levels 
was present in Caucasian subjects (+50%, 0.66±0.30 vs. 0.99±0.29 mmol/L, p<0.0001), 
but not in South Asian subjects (+10%, 0.88±0.39 vs. 0.97±0.37 mmol/L, p=0.10). The 
ethnic difference in cold-induced FFA release was even more pronounced after dividing 
serum FFA levels by total fat mass, being the main source of serum FFA (Table 2).
Cold-induced thermogenesis
REE was 32% lower in South Asians compared to Caucasians (1279±123 vs. 1689±193 
kcal/day, p=0.001) (Table 3). This difference was still apparent after correction for LBM, 
which was performed via ANCOVA (intercept 177±173 vs. 290±215 kcal/day, p=0.03, 
Supplementary Figure 1). During cold exposure, NST increased significantly in Cauca-








TN Cold-induced p value† TN Cold-induced p value† p value*
REE (kcal/day)
Mean (SD) 1689 ± 193 2027 ± 471 0.001 1297 ± 123‡ 1462 ± 127‡‡ 0.072 0.186
vs. TN (95% CI) +20% (9% to 31%) +13% (-1% to 27%)
Lipid ox (g/min)
Mean (SD) 0.063 ±0.024 0.092 ±0.040 <0.0001 0.049 ±0.009 0.062 ±0.014$ 0.072 0.119
vs. TN (95% CI) +46% (24% to 70%) +26% (-7% to 46%)
Glucose ox (g/min)
Mean (SD) 0.151 ± 0.057 0.141 ± 0.037 0.277 0.114 ±0.014$$ 0.111 ±0.036 0.804 0.538
vs. TN (95% CI) -6% (-23% to 12%) -0·3% (-25% to 24%)
Respiratory quotient
Mean (SD) 0.85 ± 0.06 0.82 ± 0.04 0.030 0.84 ± 0.02 0.82 ± 0.04 0.128 0.577
vs. TN (95% CI) -4% (-6% to -1%) -2% (-6% to 1%)
† P value within group vs. thermoneutral condition. * P value cooling effect vs. Caucasians. ‡ P value of thermoneutral 
REE = 0.001 vs. Caucasians. ‡‡ P value of cold-induced REE<0.0001 vs. Caucasians. $ P value of cold-induced lipid ox = 
0.006 vs. Caucasians. $$ P value of thermoneutral glucose ox = 0.028 vs. Caucasians. All p values are based on a mixed 
model. ox, oxidation; REE, resting energy expenditure; TN, thermoneutral.
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sians (+20%; 1689±193 vs. 2027±471 kcal/day, p<0.0001), but not in South Asians (+13%; 
1297±123 vs. 1462±127 kcal/day, p=0.09) (Supplementary Figure 2). Furthermore, cold 
exposure significantly increased fat oxidation in Caucasians only (+46%, 0.063±0.024 
vs. 0.092±0.040 g/min, p<0.0001), while glucose oxidation was not affected. In line with 
this, cold exposure significantly decreased RQ in Caucasians only (-0.03±0.01, p=0.03 vs. 
-0.02±0.01, p=0.13).
Core and skin temperature
Despite their increased fat mass percentage, the temperature at which shivering started 
was higher in South Asians than in Caucasians (10.9±1.8 vs. 8.9±1.5°C, p=0.007) (Table 
4). Due to individual fine-tuning of the environmental temperature during NST, mean 
environmental temperature did not differ during the second half of cooling (19.8±2.5 vs. 
18.7±2.2°C, p=0.27). Core temperature was not affected by cold exposure. Mean total, 
proximal and distal skin temperature markedly decreased to a similar extent in both 
groups. Consequently, core distal and core mean skin temperature gradients were sig-
nificantly higher during cooling, indicating an insulative response in both South Asian 
and Caucasian subjects.
Brown adipose tissue volume and activity
In 96% (22/23) of the subjects active BAT was detected, as evidenced by 18F-FDG uptake 
in the classical BAT regions (Figure 1).14 The only (Caucasian) subject that lacked cold-
induced BAT activity also exhibited the lowest REE when compared to all Caucasian 
subjects. SUVmax and SUVmean in the VOI with metabolically active BAT did not differ 
Table 4. Thermoregulation in thermoneutral and cold-induced condition in healthy, young South Asian men 





  TN Cold-induced p value† TN Cold-induced p value† p value*
shiver temp (°C) 8.9 ±1.5 10.9 ±1.8 0.007
cooling temp (°C) 19.8± 2.5 18.7±2.2 0.271
core temp (°C) 36.8 ±0.2 36.6 ±0.3 0.130 36.6 ±0.3 36.8 ±0.2 0.128 0.034
mean skin temp (°C) 33.1 ±0.5 28.6 ±1.0 <0.0001 33.4 ±0.7 28.8 ±1.0 <0.0001 0.836
mean prox skin temp (°C) 34.4 ±0.4 30.8 ±1.0 <0.0001 34.4 ±0.4 31.0 ±1.1 <0.0001 0.535
mean dist skin temp (°C) 31.8 ±0.9 26.3 ±1.4 <0.0001 32.5 ±1.3 26.6 ±1.5 <0.0001 0.482
core mean skin temp gradient (°C) 3.6 ±0.4 7.9 ±0.9 <0.0001 3.2 ±1.0 8.1 ±1.1 <0.0001 0.643
core distal skin temp gradient (°C) 4.8 ±0.7 10.0 ±1.4 <0.0001 4.1 ±1.5 10.2 ±1.5 <0.0001 0.236
† P value within group vs. thermoneutral condition. * P value cooling effect vs. Caucasians or difference in 
shiver temp and cooling temp based on an unpaired T-test. All p values are based on a mixed model, except 




between South Asian and Caucasian subjects (Figure 2). Intriguingly, detectable BAT 
volume was markedly lower in South Asians (-34%, 188±81 vs. 287±169 mL, p=0.04), 
which is also evident from Figure 1, depicting 18F-FDG uptake in the upper body from 
three representative Caucasian and South Asian subjects.
Linear regression analysis showed a clear positive correlation between SUVmax and 
BAT volume (R2=0.64, β=0.80, p<0.0001) (Figure 3A). Furthermore, thermoneutral serum 
FFA concentration correlated with BAT volume in Caucasian (R2=0.49, β=0.70, p=0.02), 
but not in South Asian subjects (R2=0.0009, β=0.03, p=0.97). Thermoneutral REE tended 
to correlate positively with BAT volume in both groups, although this correlation did 
not reach statistical significance per group. After pooling of all subjects, a clear positive 
correlation was evident between thermoneutral REE and BAT volume (R2=0.19, β=0.44, 
p=0.04; Figure 3B), also after correction of REE for LBM (R2=0.27, β=0.52, p=0.01; Supple-
mentary Figure 2), strongly suggesting that BAT is involved in total energy metabolism.
Caucasians 
South Asians 
Figure 1. Brown adipose tissue activity in healthy young South Asian males and matched white Cau-
casians as assessed by PET-CT scan with 18F-FDG. The images in the top row are from three representa-
tive Caucasian subjects, and the images in the bottom row from three representative South Asian subjects. 
FDG, 18F-fluoro-deoxy-glucose. PET-CT, positron emission tomography and computed tomography.
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DISCUSSION
In the present study, we demonstrate that healthy South Asian young adults have a lower 
REE compared to white Caucasians. Strikingly, we show that the detectable volume of 
metabolically active BAT, which has previously been shown to significantly contribute 
to energy metabolism,11,14 is markedly lower in healthy South Asian subjects. These find-
ings were corroborated by the higher shiver temperature and smaller cold-induced NST 
in South Asians compared to Caucasians.
We detected BAT in 96% (22/23) of the subjects, which corresponds to the numbers 
found in previous studies.11,21 Moreover, as reported previously (reviewed in reference 
13),13,21 in Caucasian subjects cold exposure resulted in increased serum FFA levels, 













































A B C 
Figure 2. Brown adipose tissue (BAT) activity and volume in healthy young South Asian men and 
matched white Caucasians as assessed by quantifying 18F-FDG-uptake on PET-CT scans. (A) SUVmax, 
the maximum standardized uptake value (B) SUVmean [g/mL], the average standardized uptake value, and (C) 
total detectable BAT volume (mL). Results are expressed as mean± SD. * p<0·05 vs. Caucasians. BAT, brown 
adipose tissue. FDG, 18F-fluoro-deoxy-glucose. PET-CT, positron emission tomography and computed to-
mography. SUV, standard uptake value.








































Figure 3. Correlations with brown adipose tissue (BAT). BAT volume in relation to SUVmax (A) and ther-
moneutral REE (B) in healthy young South Asian men (black circles) and matched white Caucasians (white 
circles). Correlations were determined by linear regression analysis. BAT, brown adipose tissue. REE, resting 
energy expenditure. SUV, standard uptake value.
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in core body temperature. In South Asians, all of these responses were reduced. Our 
previous study indicated that BAT, and not muscle, is responsible for NST via the process 
of mitochondrial uncoupling.22 Intriguingly, lean subjects with detectable BAT activity 
have significantly higher NST than those without detectable BAT activity.12 It is therefore 
tempting to speculate that the lower BAT volume might underlie the smaller increase in 
NST in South Asians, although we could not find a significant correlation between BAT 
volume and NST, as has been shown previously12,15,23, albeit not consistently.11,24
Since cold-induced increases in lipolysis and systolic blood pressure are mediated 
by sympathetic activation, the lower response in South Asians may be due to a lower 
cold-induced sympathetic activation. We cannot rule out the possibility that this is due 
to the fact that South Asians were initially cooled at a somewhat higher initial environ-
mental temperature, resulting in less sympathetic outflow. However, SUVmax and SUVmean 
did not differ, suggesting that BAT could be equally stimulated in both groups by cold 
exposure. Thus, signs of lower sympathetic activation were only present in the white 
adipose tissue depot and the vasculature, and not in BAT. This can be explained given 
that sympathetic outflow neurons towards various organs derive from different brain 
regions.25 A lower sympathetic response in South Asians may, at least in part, underlie 
their lower REE, as the reduced liberation of FFAs from white adipose tissue in plasma 
may have lowered the availability of FFAs for combustion by BAT, resulting in lower fat 
oxidation. Future studies would be needed to investigate a potentially different (organ-
specific) sympathetic response in South Asians and the potential link with REE.
Strikingly, South Asians had a significantly higher shivering temperature upon cold 
exposure, despite their higher total percentage of fat mass. It has previously been shown 
that obese subjects have lower shivering temperatures compared to lean subjects due 
to better insulation.15 However, the opposite occurred in South Asians. An impaired 
capacity of BAT to contribute to total heat production might underlie the accelerated 
action of the muscles to produce heat by shivering. Indeed, this is supported by a study 
of Ouellet et al10 in which subjects with higher BAT volume experienced less shivering 
during cooling. However, we cannot exclude the possibility that the higher shivering 
temperature in South Asians could, at least in part, be influenced by their smaller body 
size and lean body mass.
It could be argued that the lower energy metabolism in South Asians may not be 
solely due to decreased BAT volume but also due to diminished oxidative metabolism 
in muscle. Of note, we recently obtained muscle biopsies from the same subjects before 
and after a short-term high-fat diet challenge, and did not observe differences in skeletal 
muscle insulin signalling and expression of genes involved in oxidative phosphorylation 
and mitochondrial biogenesis.26 Furthermore, food intake and physical activity levels 
did not differ between South Asians and Caucasians.
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It is interesting to speculate on possible mechanisms that could underlie the de-
creased BAT volume in South Asians. The fact that this is found already in healthy young 
adults without differences in the degree of 18F-FDG uptake, as evidenced by equal SUVmax 
and SUVmean, could point to a defect in BAT differentiation. However, 18F-FDG uptake only 
represents glucose uptake by the tissue and not metabolism per se. Therefore, a poten-
tial dysfunction in oxidative metabolism in the tissue cannot be excluded and should 
be further investigated, for example with an 11C-acetate tracer as previously described10 
or by studying BAT biopsies. The underlying cause of the lower BAT volume in South 
Asians may be genetic (i.e. blunted expression of signalling molecules involved in BAT 
differentiation), environmental (i.e. clothing behaviour or central heating setting), or a 
combination of the two, and is an interesting subject for future studies.
Our study is not without limitations. Although our group size is an accepted number 
conform several landmark BAT studies,9,11 yielding sufficient power to identify differ-
ences in detectable BAT volume between South Asians and Caucasians, the numbers 
may be limited for interpreting certain correlations. Strengths of our study are the 
large number of measurements we performed next to 18F-FDG PET-CT scans, such as 
indirect calorimetry and temperature records, and the use of a personalized cooling 
protocol with water perfused cooling mattresses, which results in maximal BAT activ-
ity and detectable BAT volume under non-shivering conditions.13 The latter may well 
explain why in a recent study by Admiraal et al27, in which all subjects were cooled in 
an air-cooled chamber with a stable temperature of 17°C, no difference in BAT volume 
could be identified in South Asian compared to Caucasian subjects. Since water has a 
higher heat transfer coefficient than air, water cooling results in more intense cooling 
of subjects and, likely, higher detectable BAT volume. Indeed, when comparing detect-
able BAT volume of Caucasian subjects between the two studies, BAT volume in the 
Admiraal study was markedly lower compared to the current study (16 vs. 287 mL). 
Thus, the less intense cooling protocol may have underestimated the BAT volume in 
their study subjects. Moreover, exposure of all subjects to a stable room temperature 
of 17°C instead of using a personalized cooling protocol might have led to relatively 
higher underestimation of BAT volume in Caucasian vs. South Asian subjects, as they 
have, according to our study, a markedly lower shiver temperature. A possible drawback 
of the use of a personalized cooling protocol may be that differences in environmental 
temperature may induce differences in BAT activity, since a steep relation exists between 
environmental temperature and thermogenesis.28 This was, however, likely not the case 
in our study, since SUVmax and SUVmean did not differ between the ethnic groups pointing 
to equal BAT activation.
This study may have major clinical impact. Untill now, little is known about the under-
lying mechanisms of the disadvantageous metabolic phenotype and the consequently 
high risk of type 2 diabetes in South Asians. Therefore, treatment options and, more 
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importantly, preventive strategies are unfocused and of limited efficacy in South Asians. 
Thus, increasing the volume or activity of BAT might be of great therapeutic potential in 
South Asians, resulting in increased clearance of glucose and fatty acids and increased 
total energy expenditure. We have recently shown that BAT can be recruited in humans 
following 10 days of cold intervention.22 Future studies should be directed towards the 
efficacy of this strategy, as well as other options, such as medication, to increase BAT 
activity. These strategies might finally be used to improve the metabolic phenotype in 
South Asians.
In conclusion, this study shows that healthy, young South Asian subjects have lower 
BAT volume and lower REE compared to matched white Caucasians, possibly underlying 
their high susceptibility to develop metabolic disturbances, such as obesity and type 
2 diabetes. Future studies should, therefore, be directed towards the development of 
novel strategies to increase BAT volume and activity.
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SUPPLEMENTARY TECHNICAL APPENDIX
Cooling protocol
To activate BAT an individualized cooling protocol was applied.1,2 Cooling was per-
formed using two water perfused cooling mattresses (Blanketrol® III, Cincinatti Sub-Zero 
(CSZ) Products, Inc) to cool both the dorsal and ventral side of the body. During the 
procedure subjects stayed in a clinical examination room (temperature approx. 24°C) 
in a semi-supine position. The protocol started with a baseline period of one hour in 
thermoneutral condition (water temperature cooling mattresses 32°C), after which sub-
jects were exposed to mild cold. Since the onset temperature of shivering shows a high 
interindividual variation (e.g. due to differences in body composition),3,4 an individual-
ized cooling protocol was used to ensure maximal non-shivering thermogenesis (NST), 
and thus a maximum level of BAT activity for each subject. Cooling started at a mattress 
temperature of 32°C and water temperature was gradually decreased until shivering 
occurred. In short, we first decreased the temperature with steps of 5°C every 5 minutes. 
After we reached a water temperature of 17°C, we decreased the temperature with 2°C 
every 10 minutes. When a water temperature of 11°C was reached (but not all subjects 
reached this temperature), we decreased temperature with 1°C every 10 minutes. This 
was continued until shivering occurred. Shivering was detected visually and by asking 
the subject if he experienced shivering. When the shivering temperature had been 
reached, the subject was warmed for 3 minutes with a warm blanket so that shivering 
stopped and then the subject was cooled with a water temperature that lay 3°C higher 
than the temperature at which shivering occurred. From that moment, the cooling pe-
riod of two hours was started (tcold=0min). In case of shivering, temperature was raised 
by steps of 1°C until shivering just stopped. In this manner NST was maximized for each 
individual without shivering. Also, just before administration of the FDG, we raised the 
temperature by 1°C to prevent occurrence of shivering during the FDG uptake period. 
At the end of the first hour (tcold=60min) of cooling 18F-FDG was injected intravenously 
(2 MBq/kg). To exclude the artefact of muscle activity, subjects were instructed to lay 
still. Both in thermoneutral and cold-induced condition (tcold=110min) venous blood was 
collected, blood pressure was measured and indirect calorimetry was performed with a 
ventilated hood (Oxycon Pro™, CareFusion, Germany) (tcold=80-110min). After the second 
hour (tcold=120min) of cooling 18F-FDG-PET-CT imaging was performed to quantify BAT.
18F-FDG-PET-CT scan
Imaging was performed on a PET-CT-scanner (Gemini TF PET-CT, Philips, The Netherlands) 
after confirmation of the serum glucose level and the intravenous injection of 2 MBq/
kg 18F-FDG. Imaging was performed in three dimensional mode, with emission scans of 
3 minutes per bed position in the upper part of the body where brown adipose tissue 
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is usually found (first seven bed positions) and scans of 30 seconds per bed position in 
the body area below. Imaging started with a low dose CT-scan (effective dose 2 mSv), 
immediately followed by a PET-scan. The CT-scan was used for attenuation correction 
and localization of the 18F-FDG uptake sites. The resulting total radiation dose from the 
low-dose CT scan and the injected radioactive tracer was approximately 4.6 mSv, which 
is comparable to a standard CT-thorax. Both image sets were reconstructed in transaxial, 
coronal, and sagittal images with a slice thickness of 4 mm. PET-CT images were inter-
preted blinded by both a nuclear medicine physician and a researcher using dedicated 
software (Hermes Hybrid Viewer™, Hermes Medical Solutions AB, Sweden). BAT activity 
(measured in g/mL) and detectable BAT volume (measured in cubic centimetres) were 
quantified in anatomical regions of interest (i.e. the cervical, supraclavicular and superior 
mediastinal depots) using the auto contouring and region growing tool of the Hybrid 
Viewer. In these areas a SUV cut-off value for 18F-FDG uptake indicating BAT was defined 
to be at least 2.0 g/mL.
Temperature registration
Core body temperature was measured continuously in the small intestine with the use 
of an ingestible telemetric capsule (Jonah™, BMedical, Australia) that recorded core tem-
perature at 1-minute intervals. Skin temperature was measured continually by wireless 
iButtons (iButtons®, Maxim, USA).5 An iButton contains a semiconductor temperature 
sensor, a computer chip with a real time clock and memory, and a battery. In total four-
teen iButtons were attached to the skin with adhesive tape at the following ISO-defined 
locations: forehead, clavicular (left and right), sternal (left and right), supra umbilical, 
anterior thigh (left and right), lateral thigh (left and right), flat of the hand (left and right) 
and bow of the foot (left and right). The iButtons recorded skin temperature at 1-minute 
intervals.
Calculations
Total detectable BAT volume: In every slice, BAT size (measured in square centimetres) 
was quantified in the anatomical regions of interest (ROIs) using the auto contouring 
and region growing tool of the Hybrid Viewer. Detectable BAT volume (measured in 
cubic centimetres) was calculated by summing up the ROIs from the individual slices, 
establishing a volume of interest (VOI).
BAT activity: Within every region of interest, the Hybrid Viewer provides two measures of 
18F-FDG uptake, the maximal and mean standardized uptake value (SUVmax and SUVmean 
respectively). The standardized uptake value (SUV) is defined as the ratio of activity [kBq 
per mL] within the region of interest (ROI) and the injected activity [kBq] per bodyweight 
[g] and is expressed in g/mL. For SUVmax, the highest value in the VOI was taken. For 
SUVmean the mean value within the VOI was determined.
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Indirect calorimetry: Respiratory quotient (RQ) and substrate oxidation rates were 
sampled on a 1-minute basis and were determined as described by Simonson and 
DeFronzo.6 Energy expenditure was calculated according to the Weir equation7. We used 
the following formula:
(1) Respiratory quotient (RQ) = VCO2 / VO2
(2) Lipid oxidation = 1.69*VO2 – 1.69*VCO2
(3) Glucose oxidation = 4.57*VO2 – 3.23*VCO2
(4) Resting energy expenditure = (3.9*VO2 + 1.1*VCO2)*1.44
In these equations, VCO2 is the carbon dioxide production and VO2 the oxygen con-
sumption.
Skin temperature measurements: Distal skin temperature was calculated as the average 
temperature of hands and feet and proximal skin temperature as the weighted aver-
age temperature of claviculae, anterior thigh and umbilicus (Tprox=0.383*Tavg_thighs 
+ 0.293*Tavg_clav + 0.324*Tavg_umbilicus) according to the equation of Van Marken 
Lichtenbelt et al5, based on the formulas by Kräuchi et al8 and Hardy et al9. Mean skin 
temperature was calculated as the average of distal and proximal skin temperature. 
Core mean skin temperature gradient was calculated as the difference between core 
and mean skin temperature, and core distal skin temperature gradient as the difference 
between core and distal skin temperature.
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Supplemental figure 1. Resting energy ex-
penditure (REE) after correction for lean 
body mass. REE in healthy young South Asian 
men (black circles) and matched white Cau-
casians (white circles) was corrected for lean 
body mass by ANCOVA. REE, resting energy 
expendtiure. *p = 0.03.
Supplemental figure 2. Individual responses of 
non-shivering thermogenesis in healthy young 
South Asian males and matched white Caucasians 
as assessed by indirect calorimetry. Non-shivering 
thermogenesis (NST) in healthy young South 
Asian males (black circles) and matched Cauca-
sians (white circles). p = 0.186.
Supplemental figures
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Cardiovascular disease is the leading cause of death in modern society. Interestingly, the 
risk of developing cardiovascular disease varies between different ethnical groups. A 
particularly high risk is faced by South Asians, representing over one fifth of the world’s 
population. Here, we review potential factors contributing to the increased cardiovascu-
lar risk of the South Asian population and discuss novel therapeutic strategies based on 
recent insights. In South Asians, classical (‘metabolic’) risk factors associated with cardio-
vascular disease are highly prevalent and include central obesity, insulin resistance, type 
2 diabetes and dyslipidemia. A contributing factor that may underlie the development of 
this disadvantageous metabolic phenotype is the presence of a lower amount of brown 
adipose tissue in South Asian subjects, resulting in lower energy expenditure and lower 
lipid oxidation and glucose uptake. As it has been established that the increased preva-
lence of classical risk factors in South Asians cannot fully explain their increased risk for 
cardiovascular disease, other non-classical risk factors must underlie this residual risk. 
In South Asians, the prevalence of ‘inflammatory’ risk factors including visceral adipose 
tissue inflammation, endothelial dysfunction and HDL dysfunction is higher compared 
to white Caucasians. We conclude that a potential novel therapy to lower cardiovascular 
disease risk in the South Asian population is to enhance brown adipose tissue volume 
or its activity in order to diminish classical risk factors. Furthermore, anti-inflammatory 
therapy may lower non-classical risk factors in this population and the combination of 
both strategies may be especially effective.
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INTRODUCTION
The South Asian population originally descends from the Indian subcontinent (India, 
Pakistan, Bangladesh, Nepal and Sri Lanka) and comprises approximately 20% of the 
total world population. The burden and mortality of cardiovascular disease are signifi-
cantly higher among both native and migrant South Asians in comparison to subjects of 
white Caucasian descent.1-3 In addition, South Asian individuals are affected at a younger 
age and as a result India suffers the highest loss in potentially productive years of life 
due to cardiovascular deaths.2;4;5 The exceptionally high cardiovascular disease risk in 
South Asians poses a major health and socioeconomic burden and gaining more insight 
in the pathogenesis of cardiovascular disease in this population is of great importance. 
Several studies show that in South Asians classical cardiovascular risk factors, including 
dyslipidemia, obesity, insulin resistance and type 2 diabetes are more prevalent. How-
ever, after correction for these classical risk factors, ethnicity remains an independent 
determinant of cardiovascular events.1;4;6 Thus, residual risk is present suggesting that 
additional, non-classical, cardiovascular risk factors may play a role.
In this review, we discuss classical and non-classical risk factors for cardiovascular 
disease in subjects of South Asian origin and focus on potential pathophysiological 
pathways that might clarify the unexplained ‘excess’ risk for cardiovascular disease in 
this population. Furthermore, we discuss novel therapeutic strategies based on recent 
insights.
Epidemiology of cardiovascular disease in South Asians
The epidemiology of cardiovascular disease in South Asians has been studied exten-
sively in countries with large South Asian immigrant populations. These studies consis-
tently show that the risk of cardiovascular disease among South Asian immigrants is at 
least two-fold increased compared to native populations as well as to other immigrant 
groups. In Canada, the prevalence of cardiovascular disease among South Asian im-
migrants is 10.7%, compared to 5.4% and 2.4% for people from European and Chinese 
descent, respectively.4 In the UK, South Asians show a 40-60% higher mortality rate from 
coronary heart disease compared to white Europeans.1;6;7 Furthermore, in all of these 
studies South Asian immigrants were affected at a younger age than control groups. 
Importantly, cardiovascular disease risk is not solely increased in South Asian immi-
grants but also in native South Asian subjects as the age standardized mortality rate for 
cardiovascular disease is around 50% higher in South Asian countries as compared to 
Western countries.3
The higher risk of cardiovascular disease in South Asians most likely reflects inter-
actions between genetic susceptibility and environmental factors, such as changes 
secondary to urbanization and migration. Indeed, the risk of cardiovascular disease 
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appears to increase as South Asians move from rural India to urban India to immigrant 
populations.8 With urbanization and migration to Western environments the consump-
tion of energy-rich diets markedly increases. In addition, energy expenditure decreases 
due to less physical activity, and exposure to stress increases. Acculturation is positively 
associated with coronary artery disease and type 2 diabetes in South Asian immigrants 
in the US.9 Thus, migration itself could be an aggravating factor in the high cardiovascu-
lar disease risk of migrant South Asians. Most studies however, have not examined such 
variables, nor did they differentiate between first and second generation migration. We 
propose that future studies should include a more detailed migration history to examine 
what factors associated with migration may contribute to the increased cardiovascular 
disease risk of South Asians.
PATHOGENESIS OF CARDIOVASCULAR DISEASE
Initiation of atherosclerosis development
The major cause of cardiovascular disease is atherosclerosis, which is present many 
years before any clinical symptoms of cardiovascular disease become manifest, includ-
ing ischemic heart disease, cerebrovascular accident and peripheral arterial occlusive 
disease. Atherosclerosis development starts with endothelial damage and dysfunction, 
often promoted by inflammatory mediators or shear stress induced by nonlaminar blood 
flow.10 Endothelial activation is characterized by a proadhesion, proinflammatory, and 
procoagulatory milieu that favours all stages of atherogenesis. This results in enhanced 
recruitment of inflammatory leukocytes such as monocytes and T-lymphocytes towards 
the damaged site, and migration of monocytes into the subendothelial intima followed 
by transformation into macrophages. At the same time, low-density lipoprotein (LDL) 
particles may become oxidized (e.g. due to release of reactive oxygen species or cigarette 
smoke), resulting in accumulation of oxidized LDL within the vessel wall. Macrophages 
within the vessel wall engulf this oxidized LDL, and become lipid-laden foam cells.11 What 
follows is an inflammatory status in which leukocytes and local endothelial cells excrete 
pro-inflammatory cytokines, including interferon γ (IFN-γ), tumour necrosis factor-α 
(TNF-α) and growth factors, further stimulating leukocyte recruitment, accumulation of 
macrophages as well as proliferation of smooth muscle cells in the vascular intima, which 
produce elastin and collagen.12 This all sequentially leads to plaque formation, plaque 
expansion and formation of a fibrous cap. High-density lipoprotein (HDL) has been at-
tributed several atheroprotective properties. Firstly, HDL stimulates cholesterol efflux 
from foam cells present in atherosclerotic plaques by acting as cholesterol acceptor and 
transporting cholesterol back to the liver for excretion into the bile.13 Secondly, HDL 
prevents LDL from oxidation.14-16 Thirdly, HDL has anti-inflammatory properties; during 
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the early phase of atherosclerosis development, HDL prevents leukocyte adhesion to 
endothelial cells by lowering expression of monocyte chemotactic protein 1 (MCP-1) 
and vascular cell adhesion molecule (VCAM-1) and by counteracting platelet-activating 
factor (PAF) induced adhesion of leukocytes.13-15;17 Fourthly, HDL induces vasodilation 
through stimulation of nitric oxide (NO) release by endothelial cells.18 This results in 
lower endothelial shear stress (i.e. improved endothelial function) and thereby lower 
initiation of atherosclerosis development. The vasodilating effect also increases delivery 
of insulin to tissues that take up glucose.
Classical and non-classical cardiovascular disease risk factors
From the above-mentioned pathophysiology it becomes clear that the development 
of atherosclerosis may be promoted by metabolic as well as inflammatory risk factors. 
Metabolic or ‘classical’ risk factors include dyslipidemia (marked by elevated LDL-choles-
terol and triglycerides, and decreased HDL-cholesterol levels), hypertension (resulting in 
nonlaminar oscillatory blood flow), and smoking (resulting in endothelial dysfunction).19 
Furthermore, central obesity and insulin resistance are metabolic risk factors that are as-
sociated with increased cardiovascular disease risk.20-22 In addition, although the precise 
mechanism is still under debate, inflammatory or ‘non-classical’ risk factors may contrib-
ute to development of cardiovascular disease. Among these are systemic inflammation 
(marked by elevated C-reactive protein and/or TNF-α levels), as well as HDL dysfunction 
and endothelial dysfunction which can both give rise to inflammation.23
Role of brown adipose tissue in whole-body metabolism
Interestingly, brown adipose tissue (BAT) recently emerged as a novel player in energy 
metabolism in humans. In contrast to white adipose tissue that stores excess triglycer-
ides as fat, BAT takes up glucose and triglyceride-derived fatty acids (FA) from the plasma 
and subsequently burns FA to generate heat by means of mitochondrial uncoupling, a 
process called thermogenesis.24 BAT is physiologically distinct from white adipose tissue 
as it contains high numbers of mitochondria in order to provide high oxidative capacity 
and is densely innervated by the sympathetic nervous system. The latter makes sure 
that BAT is rapidly activated in case of a cold environment, resulting in generation of 
heat. BAT was long thought to be present only in neonates, as they have minimal shiver 
capacity due to their underdeveloped muscles, and that with increasing age BAT would 
gradually disappear. Only in 2009 it has been discovered by means of cold-induced 
18F-fluorodeoxyglucose (FDG) PET-CT scans that BAT is still present and functional in 
adults,25-27 and that it is mainly located in the supraclavicular and paravertebral regions.28 
The major involvement of BAT in whole-body metabolism appeared from pre-clinical 
studies in rodents. Decreasing BAT activity or removal of BAT in mice markedly increased 
plasma glucose and triglyceride levels as well as the development of obesity and insulin 
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resistance.29;30 Furthermore, in humans, BAT activity was found to be inversely related 
with BMI and fat mass.26 Hence, a low BAT volume or activity may aggravate develop-
ment of dyslipidemia, obesity and type 2 diabetes, i.e. classical metabolic risk factors.
Next, we will discuss the classical (metabolic) and non-classical (inflammatory) risk 
factors for cardiovascular disease in South Asian subjects, and speculate on underlying 
mechanisms.
Classical cardiovascular disease risk factors in South Asians
Dyslipidemia
Dyslipidemia often is one of the main risk factors of cardiovascular disease. South Asians 
have consistently been shown to have higher triglyceride levels.7;31;32 Some studies also 
reported higher LDL-cholesterol levels in South Asian subjects compared to Cauca-
sians.4;33 Furthermore, multiple studies have consistently shown lower HDL-cholesterol 
levels in South Asians compared to Caucasians, even in South Asian neonates,7;32;34-39 and 
the low levels of HDL-cholesterol are inversely related to cardiovascular risk.40-45
Obesity
South Asians have a disadvantageous fat distribution pattern with relatively thin ex-
tremities and increased abdominal adiposity.46;47 Furthermore, at a similar level of BMI, 
body fat percentage is higher in South Asians compared to Caucasians.46;48 South Asians 
also have a tendency for deposition of fat within cells of non-adipose tissues such as 
muscle and liver, so called “ectopic” sites. Petersen et al49 showed that in young healthy 
lean South Asians hepatic triglyceride content was two-fold higher than in healthy lean 
Caucasians. This higher triglyceride content was associated with insulin resistance and 
increased levels of pro-inflammatory cytokines. We and others also reported higher fat 
infiltration in the liver in adult South Asians compared to white Caucasians (Bakker et al, 
submitted data, and others50). Storage of fat in these ectopic sites has a disruptive effect 
on glucose metabolism and it is now increasingly recognized that hepatic steatosis, 
besides abdominal obesity, may be causally related with hepatic insulin resistance, the 
metabolic syndrome, systemic inflammation and even cardiovascular disease.49;51-53
Insulin resistance
Insulin resistance and elevated fasting glucose levels are more prevalent in non-diabetic 
South Asians compared to non-diabetic white Caucasians,6;31 possibly as a consequence 
of increased obesity and ectopic fat deposition. Most striking is the high rate of type 2 
diabetes in South Asians. In 35-60 year old South Asian males living in the UK, diabetes 
prevalence was 16% compared with only 4% among European whites.32 Other studies 
have reported an even higher prevalence of up to 25.4% for both South Asian men and 
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women.54 Furthermore, the onset of diabetes is over 10 years earlier in South Asians,54 
and diabetes occurs at a lower BMI compared to Caucasians: the risk of developing type 
2 diabetes for a South Asian with a BMI of 21 kg/m2 is comparable to the risk of a white 
Caucasian with a BMI of 30 kg/m2.3;33 Finally, South Asians develop diabetes-related 
complications, such as diabetic nephropathy and retinopathy, more often.55
Thus, in South Asians a disadvantageous metabolic profile, including dyslipidemia, 
obesity insulin resistance, and type 2 diabetes is highly prevalent. Up to recently, little 
was known about the pathophysiological mechanism that underlies this metabolic 
phenotype, but it was hypothesized that this may be explained by a disturbed energy 
homeostasis (i.e. lower oxidation of glucose and fatty acids by mitochondria) in South 
Asians as they have recently been shown to exhibit reduced fat oxidation during sub-
maximal exercise as compared to Caucasians.56
Brown adipose tissue: central role in classical cardiovascular disease risk factors?
Recently, we demonstrated that Dutch South Asians adolescents have a markedly lower 
resting energy expenditure (-32%) than BMI-matched Dutch white Caucasians as well 
as less cold-induced non-shivering thermogenesis, both of which are consistent with 
lower BAT function. Indeed, cold-induced 18F-FDG PET-CT scans revealed that South 
Asian adolescents have a markedly lower BAT volume (-34%) in comparison to white 
Caucasians.57 Interestingly, the BAT volume correlated positively with thermoneutral 
resting energy expenditure, indicating that BAT contributes to energy expenditure even 
under non-cold-induced conditions. Therefore, it is likely that the reduced BAT activity 
causally contributes to the adverse metabolic phenotype of South Asians including 
dyslipidemia, obesity, insulin resistance and type 2 diabetes.
It is interesting to speculate on possible mechanisms that underlie the decreased 
BAT volume in South Asians. The underlying cause may be genetic, i.e. blunted expres-
sion of signalling molecules involved in BAT differentiation, environmental, i.e. clothing 
behaviour, central heating setting or eating pattern, or a combination of the two. Several 
key molecules have been shown to be importantly involved in BAT differentiation in ro-
dents, including bone morphogenetic protein 7 (BMP7)58 and NO59. We have previously 
measured BMP7 levels in several cohorts of South Asian subjects including neonates, 
and we consistently found increased rather than decreased BMP7 levels compared to 
Caucasians (unpublished data). Thus, decreased BAT differentiation in South Asians does 
not seem to be caused by impaired BMP7 availability. NO has been recently linked to 
BAT, as mice that lack the enzyme NO synthase, crucial for catalysing the conversion of 
L-arginine to NO, have fewer and smaller mitochondria in BAT and lower energy expen-
diture leading to obesity.59 Interestingly, South Asians have reduced bioavailability of 
NO in comparison to white Caucasians.60 Thus, an inborn reduction in NO bioavailability 
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might underlie the lower BAT volume in South Asians and is an interesting subject for 
future studies.
Taken together, as BAT is an important player in triglyceride and glucose clearance 
as well as in total energy expenditure, a low BAT volume may well contribute to the 
high prevalence of classical cardiovascular disease risk factors in South Asians, including 
dyslipidemia, obesity, insulin resistance and type 2 diabetes.
Non-classical cardiovascular disease risk factors in South Asians
Visceral adipose tissue inflammation
As mentioned above, inflammation is a well-recognized key player in the pathogenesis 
of atherosclerosis and may, therefore, be considered a risk factor for cardiovascular dis-
ease.61 Besides promoting initiation of atherosclerosis development through monocyte 
attraction, inflammation may lead to instability of the fibrous cap of the atherosclerotic 
plaque, resulting in rupture of the plaque and a subsequent cardiovascular event. C-
reactive protein (CRP), which is synthesized by the liver in response to inflammatory 
factors released by macrophages and adipocytes,62;63 is a sensitive marker of inflamma-
tion.64 In a study of Chambers et al,32 CRP levels were found to be significantly increased 
in South Asians compared with Caucasians even after adjustment for factors such as age, 
smoking and body mass index, suggesting a chronic state of low grade inflammation in 
this population. The difference in CRP levels was predominantly explained by greater 
central obesity and insulin resistance in South Asians. Visceral adipose tissue has been 
found to be a major source of cytokine release into the circulation.32;65 Not only do South 
Asians have more visceral adipose tissue, their adipocytes appear to be more inflam-
matory as well. Several studies reported that South Asian visceral adipocytes release 
higher levels of pro-inflammatory cytokines, such as TNF-α and interleukin 6 (IL-6) in 
comparison to Caucasians,49;66 which may contribute to increased cardiovascular disease 
risk. Indeed, a larger amount of visceral adipose tissue associates with the increased risk 
of cardiovascular disease in South Asians.67 Of note, enhanced visceral adipose tissue 
inflammation may also be linked to the lower BAT volume in South Asian subjects, as 
TNF-α has been shown to induce brown adipocyte apoptosis and hamper BAT differen-
tiation in pre-clinical models.68
HDL dysfunction
As described above, HDL has several anti-atherogenic properties and dysfunction of 
HDL may not only directly aggravate atherosclerosis development as a consequence of 
lower cholesterol uptake from the vascular wall, but also indirectly through induction of 
inflammation as well as endothelial dysfunction.
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Recent evidence suggests that HDL functionality may be more importantly linked to 
cardiovascular disease than plasma HDL-cholesterol levels per se.69;70 In trials that aimed 
at raising HDL-cholesterol levels with dalcetrapib or niacin on top of statin, no decrease 
in the occurrence of cardiovascular endpoints was observed compared to treatment 
with statins only.71;72 In line with this, several studies showed that HDL is dysfunctional 
in patients with coronary atherosclerosis, in patients with an acute phase response after 
surgery, and in men with cardiovascular risk factors.73-76
Remarkably, little is known about HDL functionality in South Asians. To date only 
one cross-sectional, uncontrolled pilot study assessed the anti-oxidative capacity of HDL 
in South Asian immigrants living in the USA. Dysfunctional HDL was found in 50% of 
the participants, which was significantly correlated with carotid intima media thickness 
, a surrogate marker of atherosclerosis.77 However, another ethnic control group was 
lacking in the study, so no statements could be made on the implication of this percent-
age for the South Asian population specifically. Future studies are needed to investigate 
whether the prevalence of HDL dysfunction is higher in South Asian compared to white 
Caucasian subjects, as this may contribute to the excess risk of cardiovascular disease in 
people of South Asian origin.
Endothelial activation
A hallmark of endothelial activation is a reduction in the bioavailability of endothelium-
derived NO. An impaired NO-mediated vasodilatory response has been demonstrated 
in patients with cardiac risk factors or established atherosclerosis.78;79 Furthermore, the 
degree of impairment is related to the severity and extent of coronary artery disease.80 
NO not only has vasodilating properties, but also anti-platelet, anti-proliferative, and 
anti-inflammatory properties.81;82 Thus, there is a close link between inflammation, HDL 
function, and endothelial function; HDL dysfunction may result in inflammation and en-
dothelial activation and furthermore, endothelial activation could induce inflammation, 
resulting in a negative feedback loop. In addition, the vasodilating effect of NO is related 
to insulin resistance and type 2 diabetes: vasodilatation increases delivery of insulin to 
tissues that take up glucose, and, vice versa, insulin stimulates the release of NO from 
the endothelium.83;84 Moreover, as NO is important for BAT development, a link between 
diminished NO availability and BAT function and thus energy metabolism may also exist.
Interestingly, signs of endothelial activation in South Asians are already present upon 
birth. We previously found that levels of E-selectin, a marker of endothelial activation, 
are elevated in South Asian neonates compared with Caucasian neonates.35 In line with 
this, several studies demonstrated reduced endothelium-dependent vasodilatation in 
South Asians compared to white Caucasians, pointing to lower NO bioavailability.85;86 
Of note, NO is mainly produced by the endothelium as a consequence of an interaction 
with HDL.81;87 The reduced NO bioavailability in South Asians may thus be a consequence 
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of endothelial activation per se or of dysfunctional HDL. Since release of NO from endo-
thelium is also stimulated by insulin, the highly prevalent insulin resistance in South 
Asians may also contribute to lower NO availability.83;84
Circulating endothelial progenitor cells (EPCs), mobilized from the bone marrow, 
have an important role in the repair and regeneration of the endothelium.88-90 The 
number of circulating EPCs is lower in patients with established coronary artery disease, 
is predictive of future cardiovascular events, and is positively correlated with measures 
of endothelial function.91;92 Intriguingly, South Asians have lower circulating numbers 
of EPCs compared to Caucasians, which may lead to a reduced capacity for endothelial 
repair.60;85 Furthermore, exercise-induced EPC mobilization was reduced in South Asian 
men.60 Interestingly, NO appears to be critical for EPC mobilization in response to 
exercise.60 Hence, the reduced exercise mediated EPC mobilization in South Asians is 
likely secondary to their reduced NO bioavailability. Future studies should be directed at 
developing strategies that enhance EPC mobilization by augmenting NO bioavailability.
CONCLUSIONS AND FUTURE DIRECTIONS
South Asians are more liable to develop cardiovascular disease at an early age, and 
classical risk factors associated with cardiovascular disease, including dyslipidemia, 
central obesity and insulin resistance, are more prevalent in this population. However, 
these ‘metabolic’ risk factors seem to account for only part of the increased risk in South 
Asians. We propose that non-classical ‘inflammatory’ risk factors, i.e. higher levels of 
(visceral adipose tissue) inflammation, HDL dysfunction, and endothelial activation are 
involved in the residual cardiovascular disease risk in South Asians (see Figure 1).
The pathophysiological mechanism for the high prevalence of classical cardiovas-
cular disease risk factors has not been fully established, but may be due to a lower BAT 
volume in South Asians. This offers a promising new target for preventive and therapeu-
tic interventions as increasing BAT volume or activity will enhance energy expenditure 
and subsequent clearance of lipids and glucose from the circulation, resulting in im-
provement of the disadvantageous metabolic phenotype of South Asians and possibly 
reducing cardiovascular disease risk. Indeed, we recently showed that activation of BAT 
by ß3-adrenergic stimulation, in a human-like mouse model of lipoprotein metabolism 
and atherosclerosis, markedly diminished atherosclerosis development (Berbée et al, 
unpublished). Possible options for increasing BAT volume or activity are cold exposure 
or medication. BAT can be recruited in human subjects following cold exposure resulting 
in lowering of fat mass.93;94 Furthermore, we recently showed in a pre-clinical setting that 
the commonly used anti-diabetic drug metformin activates BAT, which is responsible 
for its lipid-lowering effect.95 Moreover, since South Asians have been shown to exhibit 
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lower NO bioavailability, BAT function may be improved by targeting the NO pathway. 
As NO also has anti-inflammatory properties and is involved in EPC mobilization, this 
strategy may also lower inflammation and improve endothelial function and thereby 
lower the ‘residual’ cardiovascular disease risk in South Asians.
Thus, future studies should investigate the efficacy of treatment strategies that 
target both classical as well as non-classical risk factors in the South Asian population to 
lower cardiovascular disease risk. A combination of therapies that increases BAT activity 


















cytokines ↑ NO ↓ 
endothelial activation 
Figure 1. Proposed underlying mechanisms in the high cardiovascular risk in the South Asian popu-
lation. Classical (metabolic) risk factors, i.e. dyslipidemia, obesity, insulin resistance (IR) and type 2 diabe-
tes (T2D), are highly prevalent in the South Asian population. A low brown adipose tissue (BAT) volume 
might underlie this disadvantageous metabolic phenotype. In addition, non-classical (inflammatory) risk 
factors may contribute to the high cardiovascular disease risk in South Asians, such as HDL dysfunction, 
enhanced pro-inflammatory cytokine release and low nitric oxide (NO) availability, as well as endothelial 
cell activation. Visceral adipose tissue inflammation may link obesity and inflammation. The classical and 
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Background. South Asians have a higher risk of developing cardiovascular disease than 
white Caucasians. Since the mortality risk of cardiovascular disease associated with 
type 2 diabetes is higher in South Asians, the excess cardiovascular disease risk in this 
group might be due to inherent ethnicity-associated structural cardiac diseases and/
or a higher cardiac susceptibility to metabolic disorders. Therefore, this study assessed 
whether cardiac dimensions and cardiovascular function differ between young South 
Asians and white Caucasians and whether there is a differential response to a high fat 
diet.
Methods. Cardiac dimensions and cardiovascular function were assessed using a 
1.5T-MRI-scanner in 12 young, healthy South Asian and 12 matched white Caucasian 
men. Both groups were subjected to a 5-day high fat high calorie diet (HFHCD) to study 
cardiac response to metabolic stress.
Results. At baseline South Asians had lower left ventricular mass (p<0.001) and end-di-
astolic volume (p<0.001), indexed for body surface area, than Caucasians. Furthermore, 
differences in cardiac function profile were observed. E acceleration peak (p=0.010) and 
E deceleration peak (p=0.005) were lower in South Asians. Additionally, South Asians 
had lower acceleration (p=0.001) and deceleration peak flows (p<0.001) over the aorta. 
A 5-day HFHCD did not increase these differences. Finally, pulse wave velocity at base-
line was higher in South Asians (p=0.022), which normalized after the diet.
Conclusions. Young, healthy South Asians have smaller cardiac dimensions and a dif-
ferent cardiovascular function profile than white Caucasians. A 5-day HFHCD did not 
increase these differences, suggesting these findings cannot be explained by a different 
metabolic response to dietary fat.
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INTRODUCTION
People of South Asian descent, originating from the Indian subcontinent, represent 
one fifth of the world’s population. South Asians are at an increased risk of developing 
cardiovascular disease compared to white Caucasians.1 The age-standardized mortality 
rate from cardiovascular disease is around 50% higher for South Asians than for white 
Caucasians.2-5 Furthermore, the mean age of first acute myocardial infarction is approxi-
mately five years earlier in South Asians than in Caucasians.6;7 Moreover, cardiovascular 
disease in this population is more aggressive and has higher mortality rates at younger 
ages.1-3;7
The differences in cardiovascular disease prevalence and severity between both eth-
nicities cannot be explained by traditional risk factors, such as smoking, hypertension 
and cholesterol levels.4 Since insulin resistance and type 2 diabetes mellitus are highly 
prevalent in South Asians8;9 and the mortality risk of cardiovascular disease associated 
with type 2 diabetes is higher in this ethnicity compared to Caucasians,4;10 the increased 
cardiovascular disease risk might be related to inherent ethnicity-associated structural 
cardiac features and/or a higher susceptibility to detrimental metabolic changes as re-
flected by ectopic fat deposition in organs such as the heart, liver and skeletal muscle.11
Little is known about differences in cardiovascular function between South Asians 
and Caucasians at a relatively young age. In a previous study, in which cardiac func-
tion was assessed with echocardiography, middle-aged South Asians had attenuated 
longitudinal left ventricular (LV) function, higher LV filling pressure and a greater degree 
of concentric remodelling compared to Caucasians.12 Whether these findings are related 
to the increased cardiovascular disease risk, however, remains to be determined.
The aim of the present study was to assess whether differences in cardiac dimensions, 
cardiovascular function, and myocardial triglyceride (TG) content are present between 
young, healthy South Asians and matched Caucasians using Magnetic Resonance (MR) 
Imaging (MRI) and Spectroscopic (MRS) techniques. In addition, we measured abdomi-
nal fat distribution and hepatic TG content. We hypothesized that possible differences 
in cardiovascular function between South Asians and Caucasians can be attributed to a 
higher cardiac susceptibility to metabolic disorders in South Asians. In a previous study, 
short-term high fat feeding decreased diastolic function.13 If the differences in cardio-
vascular function and dimensions in South Asians can indeed be attributed to a higher 
susceptibility to metabolic stress, a high fat high calorie diet (HFHCD) may have more 
profound effects on cardiovascular function in this ethnicity then in white Caucasians. 





Twelve Dutch South Asian and twelve Dutch Caucasian healthy men matched for age 
(19-25 years) and BMI (<25 kg/m2), with a positive family history for type 2 diabetes were 
enrolled. Exclusion criteria were: any significant chronic disease (including type 2 diabe-
tes), use of medication known to influence glucose and/or lipid metabolism, smoking, 
recent weight change and general contraindications to MR-scanning. Subjects were 
recruited via advertisements in newspapers. The study was approved by the local ethics 
committee and performed in accordance with the principles of the revised Declaration 
of Helsinki. Written informed consent was obtained from all subjects.
Study design
The study consisted of 2 occasions separated by a 5-day HFHCD. The HFHCD consisted 
of the subject’s regular diet, supplemented with 375 mL of cream per day (=1275 kcal/
day, 94% fat), yielding to around 3775 kcal/day and 54% of fat. Subjects underwent MRI/
MRS shortly before the start of the HFHCD and at the end of the 5th day of the diet. 
Participants were instructed not to alter lifestyle habits. Anthropometric measurements 
and blood samples were obtained on both occasions after a 10-hour overnight fast.
MR protocol
All measurements were performed on a 1.5-Tesla MR-scanner (Gyroscan ACS-NT15; 
Philips Medical Systems, The Netherlands) in supine position, and were made in post-
prandial state (four hours after the last meal).
Left ventricular dimensions and function
Data were analysed blinded for ethnicity and study occasion.
The heart was imaged in short-axis orientation, using electrocardiographically gated 
breath-hold cine steady-state free-precession sequences as previously described.14 
Imaging parameters were: repetition time (TR) 3.4ms, echo time (TE) 1.7ms, flip angle 
(FA) 35º, field of view (FOV) 400×320mm, and slice thickness 10mm, no slice gap was 
used. Epicardial and endocardial left ventricular (LV) contours were manually drawn in 
the end-systolic and end-diastolic phases of the short-axis data, using validated MASS® 
software (Medis, Leiden, The Netherlands). LV end-diastolic volume (EDV), end-systolic 
volume (ESV), ejection fraction (EF), stroke volume (SV) and end-diastolic mass (EDM) 
were assessed. We divided LVEDM by LVEDV to obtain the LVEDM/LVEDV ratio (also 
known as concentricity). Volumes and mass were indexed (I) for body surface area (BSA).
We calculated LV end systolic wall stress (LVESWS) with the formula 0.133*systolic 
blood pressure*((3xESV/wall volume)+1).15
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For assessment of LV diastolic function, transmitral flow was measured, using elec-
trocardiographically gated gradient echo sequence with a velocity sensitivity of 100 
cm/sec (TR 9.1ms, TE 1.0ms, FA 20º, slice thickness 8mm, FOV 350mm2, matrix 256x256 
pixels). Flow velocities in early diastole (E) and at atrial contraction (A) were measured 















































Figure 1. Panel A: Mitral valve flow curve. Panel B and C: Aortic flow curve.
Panel A shows an example of the flow through the mitral valve, representing diastolic cardiac function. The 
black line represents a South Asian subject, the dotted line a Caucasian subject. These curves suggest that 
cardiac relaxation is prolonged in South Asians.
Panel B shows how aortic flow parameters are assessed. * is the AO peak flow rate. Acceleration duration is 
the time between the beginning of the flow curve and the peak flow rate. The deceleration duration is the 
time between the peak flow rate and the end of the deceleration period. The acceleration peak is the peak 
slope (dy/dx) of the acceleration phase, the deceleration peak the peak slope (dy/dx) of the deceleration 
phase.
Panel C shows an example of flow velocity curve through the ascending aorta. The black line represents 
a typical curve of a South Asian subject, the dotted line of a Caucasian subject: the cardiac contraction is 
somewhat prolonged in South Asians.
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and their peak flow ratio was calculated (E/A ratio) using FLOW® software (Medis, Leiden, 
The Netherlands). Furthermore the peak deceleration gradient of E, the E/A peak ratio 
and LV filling pressures E/Ea were determined.15;16 Heart rate was monitored and stored 
during the transmitral flow measurements.
As a measurement of more subtle changes in systolic function of the heart, aortic 
flow curves were acquired, using electrocardiographically gated gradient echo sequence 
with a velocity sensitivity of 150 cm/sec (TR 5.0ms, TE 1.0ms, FA 20º, slice thickness 8mm, 
FOV 300mm2, matrix 128x128 pixels). Flow velocities in the ascending aorta at the level 
of the pulmonary trunk were measured and calculated using FLOW® software (Medis, 
Leiden, The Netherlands). The peak slope of the acceleration (aortic (AO) acceleration 
peak) and deceleration (AO deceleration peak) of the aortic flow curve were calculated. 
Furthermore, AO duration, AO peak filling rate and AO deceleration duration were de-
termined (Figure 1B).
Pulse Wave Velocity
Aortic PWV was determined for the evaluation of aortic stiffness, using a previously 
described protocol.17 In short, a scout view of the aorta was performed. Next, a veloc-
ity encoded image perpendicular to the ascending aorta at the level of the pulmonary 
trunk, and at the level of the aortic bifurcation was assessed. This resulted in through-
plane flow measurements of the ascending and descending aorta. Scan parameters 
were: TR 5.0ms, TE 1.0ms, flip angle 20º, FOV 300mm, 128×128 acquisition matrix, slice 
thickness 8mm, with maximal number of phases reconstructed ensuring high (6-10ms) 
effective temporal resolution. True temporal resolution is defined as 2 times TR = 10ms. 
PWV was calculated using the formula: Δx/Δt, where Δx describes the aortic path length 
between two measurement sites and Δt describes the transit time between the arrival 
of the PWV at three respective sites. The distance between the measurement sites was 
manually determined by drawing a poly-line in the centre of the aorta as defined in a 
double-oblique parasagittal aortic scout view, using the software package MASS®. Data 
were analysed using MASS® and FLOW® (Medis, Leiden, The Netherlands).
Myocardial and liver triglyceride content
MR spectroscopy (1H-MRS) was used to quantify myocardial and hepatic TG content. 
Details on 1H-MRS acquisition and post processing were published before.18;19 In short, 
myocardial and hepatic 1H-MR single voxel MR spectroscopic data were acquired using 
a point resolved spectroscopy sequence. For the heart an 8-mL voxel was positioned 
in the interventricular septum on four-chamber and short-axis images in end-systole, 
avoiding contamination from epicardial fat. Electrocardiographically triggering (only 
for myocardial spectra) and respiratory pencil beam navigator were used during 
acquisition.18 For the liver, voxel sites were matched at both study occasions, avoiding 
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blood vessels and bile ducts. Main acquisition parameters for water suppressed spectra 
were: TE 26ms, TR 3000ms, 1,024 data points, spectral bandwidth 1,000-Hz, 128 aver-
ages. Acquisitions were performed with and without (TE 10000ms, 4 averages) water 
suppression, with myocardial TG expressed as percentage of the unsuppressed water 
signal. Hepatic 1H-MRS was performed using the same acquisition parameters, except 
for 64 averages for the suppressed spectrum. Java-based MR user interface software 
(jMRUI v2.2, Leuven, Belgium) was used for fitting of the spectra.19 The TG content was 
calculated as the amplitude of the (TG signal/amplitude of water signal)*100.
Visceral and subcutaneous fat
Abdominal visceral and subcutaneous fat volumes were imaged using a turbo spin 
echo imaging sequence.20 During one breath-hold, three consecutive transversal slices 
of 10mm thickness were scanned at level of L5 (TR 168ms, TE 11ms, FA 90º). Volumes 
of visceral and subcutaneous fat depots were quantified using MASS® software (Medis, 
Leiden, The Netherlands). Visceral and subcutaneous fat areas of each individual slice 
were multiplied by the slice thickness to acquire a volume and the volumes of all three 
slices were summed.
Assays
Serum concentrations of glucose, total cholesterol, HDL and triglycerides were mea-
sured on a  Modular P800 analyser (Roche, Netherlands), and serum insulin levels on 
an Immulite 2500 (Siemens, The Netherlands). HbA1c was measured on an HPLC system 
(Kordia, The Netherlands). Plasma free fatty acids (FFAs) concentrations were measured 
by a commercial kit (Wako Chemicals, Germany).
Statistical analysis
Data are presented as mean ± SEM or median (interquartile range (IQR)). A mixed model 
was applied to assess mean differences before and after the intervention within and 
between groups, and to assess differences in diet effect. Nonparametric tests (Wilcoxon 
signed-rank test within group, Mann-Whitney between groups) were performed when 
appropriate. Significance level was set at p < 0.05. Statistical analyses were performed 
using SPSS for Windows version 20.0 (IBM, USA).
RESULTS
Clinical and metabolic characteristics
Mean age was 22.1 ± 0.4 years. BSA was lower in South Asians. As expected, BMI did 
not differ between groups (South Asians: 20.9 ± 0.6 kg/m2 vs. Caucasians: 22.2 ± 0.6 
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kg/m2 (p=0.11)), but South Asians were shorter and weighed less. After the HFHCD a 
very small increase in BMI and weight to a similar extent in both groups was observed. 
Waist circumference did not differ between groups. Blood pressure and heart rate were 
comparable between groups and did not change after the HFHCD (Table 1).
HbA1c was higher in South Asians. Fasting glucose, insulin levels and HOMA-B, a 
measure for pancreas function, were comparable at baseline, but were significantly 
higher in South Asians after the diet. FFAs were comparable between groups and no 
diet effect was found. LDL-cholesterol was slightly higher in South Asians, whereas other 
lipid levels did not differ significantly (Table 1).
Table 1. Clinical and metabolic characteristics
 
white Caucasians South Asians
before HFHCD after HFHCD before HFHCD after HFHCD
Clinical characteristics
age (years) 22.1 ± 0.6 22.2 ± 0.7
height (m) 1.84 ± 0.01 1.74 ± 0.02**
weight (kg) 75.1 ± 1.8 75.6 ± 1.8 63.2 ± 2.3** 63.7 ± 2.3† **
BSA (m2) 1.97 ± 0.02 1.98 ± 0.02 1.76 ± 0.04** 1.76 ± 0.04† **
BMI (kg/m2) 22.2 ± 0.6 22.4 ± 0.6 20.9 ± 0.6 21.0 ± 0.6†
waist (cm) 81 ± 2 82 ± 2 79 ± 2 80 ± 3
systolic BP (mmHg) 135 ± 3 133 ± 3 129 ± 3 129 ± 3
diastolic BP (mmHg) 79 ± 3 80 ± 2 76.8 ± 2.3 76 ± 2
heart rate (bpm) 65 ± 2 64 ± 2 61 ± 2 66 ± 3
Metabolic characteristics
HbA1c (%) 5.02 ± 0.06 5.24 ± 0.05*
HbA1c (mmol/mol) 31.2 ± 0.5 33.8 ± 0.6*
glucose (mmol/L) 5.09 ± 0.09 5.22 ± 0.07 5.26 ± 0.09 5.53 ± 0.08†† *
insulin (pmol/L) 16 (24) 30 (37) 30 (26) 52 (31)†† ** §§
HOMA-B% 52 ± 11 55 ± 10 65 ± 14 90 ± 11†† * §
free fatty acids (mmol/L) 0.46 ± 0.05 0.43 ± 0.04 0.51 ± 0.04 0.54 ± 0.05
triglycerides (mmol/L) 0.79 (0.26) 0.75 (0.67) 1.01 (0.65) 1.12 (0.77)
total cholesterol (mmol/L) 3.10 (1.80) 4.34 (2.21)
HDL-cholesterol (mmol/L) 1.05 (0.35) 1.02 (0.38)
LDL-cholesterol (mmol/L) 1.84 (0.91) 2.77 (1.69)*
total cholesterol/HDL ratio 3.00 (0.80) 4.05 (2.48)
Data are presented as mean ± SEM or median (IQR). BSA, body surface area; BMI, body mass index; BP, blood 
pressure. † p<0.05, †† p<0.05 within groups. * p<0.05, ** p<0.005 between groups. § p<0.05, §§ p<0.005 
diet effect between groups.
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Left ventricular dimensions and function
At baseline all cardiac left ventricular dimensions indexed for BSA, i.e. EDVI, ESVI, SVI, CI and 
EDMI, were lower in South Asians than in Caucasians (Table 2). EF did not differ between 
groups at baseline. In addition, LVESWS and LVEDM/LVEDV were comparable (Table 2).
Table 2. Cardiac dimensions and parameters of cardiovascular function assessed with MRI before and after 
a 5-day HFHCD.
 
white Caucasians South Asians
before HFHCD after HFHCD before HFHCD after HFHCD
Cardiac dimensions and basic function
LVEDMI (g/m2) 62.2 ± 1.2 62.0 ± 1.5 50.7 ± 1.4** 50.0 ± 1.3**
EDVI (mL/m2) 102.2 ± 3.0 102.7 ± 2.8 83.3 ± 3.4** 81.5 ± 2.9**
ESVI (mL/m2) 42.8 ± 2.1 42.3 ± 2.4 33.9 ± 2.0* 33.1 ± 1.7**
SVI (mL/m2) 59.4 ± 2.2 60.4 ± 1.3 49.3 ± 2.1** 48.3 ± 1.7**
CI (mL/min/m2) 3.8 ± 0.3*103 3.8 ± 0.2*103 3.0 ± 0.1*103** 3.2 ± 0.2*103*
EF (%) 58.2 ± 1.5 59.1 ± 1.4 59.4 ± 1.4 59.4 ± 1.1
LVESWS (kN/m2) 56.3 ± 1.4 55.4 ± 2.1 53.0 ± 1.8 52.4 ± 1.2
LVEDM/EDV (g/mL) 0.61 ± 0.02 0.61 ± 0.02 0.62 ± 0.02 0.62 ± 0.02
Systolic cardiac function
AO peak filling rate (mL/s) 538 ± 17 549 ± 18 404 ± 17** 429 ± 14**
AO acceleration peak (mL/s2·10-3) 13.1 ± 0.5 13.6 ± 0.7 10.6 ± 0.4** 12.6 ± 0.5†
AO acceleration duration (ms) 101 ± 3 99 ± 4 91 ± 2* 88 ± 3*
AO deceleration peak (mL/s2·10-3) -5.9 ± 0.3 -5.9 ± 0.4 -3.7 ± 0.2** -3.9 ± 0.2**
AO deceleration duration (ms) 227 ± 6 231 ± 4 252 ± 4** 240 ± 5† §
AO duration (ms) 328 ± 6 330 ± 5 343 ± 5 328 ± 6†
Diastolic cardiac function
E peak filling rate (mL/s) 570 ± 20 571 ± 13 431 ± 18** 447 ± 14**
E acceleration peak (mL/s²x10-³) 7.5 ± 0.5 7.3 ± 0.4 5.9 ± 0.3** 6.4 ± 0.3
E deceleration peak  (mL/s²x10-³) -5.0 ± 0.3 -4.9 ± 0.4 -3.8 ± 0.2* -4.1 ± 0.2
A peak filling rate (mL/s) 262 ± 10 266 ± 13 201 ± 9** 205 ± 10**
A acceleration peak (mL/s²x10-³) 4.4 ± 0.3 4.8 ± 0.4 3.3 ± 0.2* 3.7 ± 0.3*
A deceleration peak (mL/s²x10-³) -4.6 ± 0.3 -4.7 ± 0.3 -3.7 ± 0.3* -4.2 ± 0.5
E/A-peak ratio 2.2 ± 0.1 2.2 ± 0.1 2.2 ± 0.1 2.2 ± 0.1
E/Ea 8.8 ± 1.0 8.6 ± 0.6 11.0 ± 1.3 10.4 ± 1.1
Pulse wave velocity
PWV total aorta (m/s) 4.3 ± 0.1 4.4 ± 0.1 4.7 ± 0.1* 4.4 ± 0.1†
Data are mean ± SEM. HFHCD, high fat high calorie diet; LV, left ventricular; EDM, end diastolic mass; EDV, 
end-diastolic volume; ESV, end-systolic volume; SV, stroke volume; CI, cardiac index; EF, ejection fraction; 
ESWS, end-systolic wall stress. I, indexed for body surface area; AO, Aortic; E, early diastolic wave; A, atrial 
diastolic wave; E/Ea, estimated left ventricular filling pressure; PWV, pulse wave velocity. † p<0.05 within 
groups. * p<0.05, ** p<0.005 between groups. § p<0.05 diet effect between groups.
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Flow velocities through the ascending aorta were measured. Typical aortic flow 
curves of a South Asian versus a Caucasian subject are depicted in Figure 1C. The ac-
celeration peak and duration were significantly lower in South Asians. Furthermore, the 
aortic peak flow rate, deceleration peak and duration were significantly lower in South 
Asians. After the HFHCD the acceleration peak and deceleration duration over the aorta 
significantly changed in South Asians, but not in Caucasians (Table 2).
Several parameters of diastolic cardiac function differed at baseline between both 
groups: E peak filling rate, E acceleration peak and E deceleration peak were significantly 
lower in South Asians as compared with Caucasians. In addition, the A peak filling rate, 
the A acceleration peak and A deceleration peak were significantly lower in South Asians 
(Table 2). E/A ratio and the estimated filling pressure E/Ea were the same in both groups 
and did not change after the HFHCD. Examples of mitral valve flow curves of a South 
Asian versus a Caucasian subject are depicted in Figure 1A.
Pulse Wave Velocity
The aortic PWV was significantly higher in South Asians than in Caucasians at baseline, 
4.7±0.1 m/s vs. 4.3±0.1 m/s, p=0.022. After the HFHCD, PWV decreased significantly only 
in South Asians, and was no longer different from Caucasians
Fat distribution
Although South Asians tended to have more visceral and subcutaneous adipose tissue, 
differences were not significant between groups (Table 3). Also, the visceral/subcutane-
ous fat ratio did not differ between groups. Furthermore, no diet effect was observed. 
Additionally, there was no significant difference between groups in hepatic and myocar-
dial TG content at baseline (Table 3). After the HFHCD hepatic TG content increased in 
both groups, whereas myocardial TG content did not change.
Table 3. Waist fat distribution and myocardial and hepatic triglyceride content assessed with MRI and MRS 
before and after a 5-day HFHCD.
 
 
white Caucasians South Asians
before HFHCD after HFHCD before HFHCD after HFHCD
Visceral fat (mL) 104 ± 14 111 ± 12 120 ± 19 125 ± 18
Subcutaneous fat (mL) 348 ± 54 363 ± 59 442 ± 61 432 ± 54
Visceral / subcutaneous ratio 0.33 ± 0.04 0.36 ± 0.05 0.28 ± 0.03 0.29 ± 0.03
Total fat (mL) 453 ± 65 474 ± 70 563 ± 76 558 ± 71
Myocardial TG content (%) 0.34 ± 0.06 0.32 ± 0.03 0.33 ± 0.04 0.34 ± 0.08
Hepatic TG content (%) 1.7 ± 0.4 4.5 ± 0.8†† 1.3 ± 0.4 3.0 ± 0.5††
Data are mean ± SEM. HFHCD, high fat high calorie diet; TG, triglyceride. †† p<0.005 within groups.
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DISCUSSION
This study shows that young, healthy South Asians have smaller cardiac dimensions 
compared to age- and BMI-matched white Caucasians, even after correction for BSA. 
Furthermore, diastolic cardiac function in South Asians is different. In addition, although 
the EF, a gross parameter of systolic function, was comparable between both groups, 
more subtle parameters of systolic function were different. A 5-day HFHCD did not 
increase these differences. Finally, South Asians had a higher aortic PWV on baseline.
Cardiac dimensions
Little is known about differences in cardiac dimensions and cardiovascular function at a 
young age between South Asians and Caucasians. Previous studies showed smaller left 
heart volumes, i.e. LVEDV, LVESV, and LV mass in South Asians, which is in line with our 
results.12;21 However, these studies were performed in older subjects (mean age ~50yr) 
using echocardiography, while in the current study young adults (mean age ~22yr) were 
included and MRI was used. One might suggest that the smaller cardiac dimensions 
observed in South Asians are a consequence of their overall smaller body size. However, 
adjustment for different parameters of body size such as BMI, BSA and lean body mass 
did not attenuate the observed differences in the present and other studies.
Left ventricular function
Besides smaller cardiac dimensions, we found a different diastolic and systolic functional 
profile between both ethnicities. Although the traditional parameters of diastolic func-
tion (E/A) and systolic function (EF) did not differ between both groups, more sensitive 
parameters were significantly different. E and A peak filling rate, and E and A acceleration 
peak were lower and E and A deceleration peak were higher in South Asians, suggesting 
that cardiac relaxation is prolonged in South Asians compared to Caucasians (Figure 
1A). The E/Ea ratio, an estimation of LV filling pressure, was the same for both ethnici-
ties, which is expected in two groups with comparable blood pressures. In concordance 
with the present study, Chahal et al. also found that E/A ratio did not differ between 
South Asians and Caucasians.12 However, in contrast to the present study, they did find a 
higher E/Ea ratio in South Asians. This discrepancy could be due to differences in age of 
subjects and/or to different methods of cardiac assessment between the studies. In this 
study we assessed flow through the aorta ascendens at the level of the pulmonary trunk. 
This showed a flow profile difference between groups. The difference is similar to what 
we observed in the diastolic flow profile as described above: the cardiac contraction is 
somewhat prolonged in South Asians (Figure 1C).
LVESWS, which is considered to be an important determinant of cardiac function 
and myocardial oxygen demand, did not differ between South Asians and Caucasians. 
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This finding indicates that no pressure overload was present in either of the groups, 
which is compatible with the normal LV mass in both groups. Additionally, LVEDM/EDV, 
a measure for concentricity, was the same between both groups, suggesting there was 
no difference in LV concentric remodelling either.
Effect of HFHC diet
With respect to the increased risk of cardiovascular disease, an important notion is that 
insulin resistance and type 2 diabetes are also highly prevalent in South Asians.8;9 More-
over, South Asians develop type 2 diabetes at a younger age and lower BMI compared to 
Caucasians,22;23 suggesting South Asians are metabolically at a higher risk. The increased 
risk of cardiovascular disease might be related to the metabolic changes that occur with 
insulin resistance. Therefore, we hypothesized that alterations in energy metabolism 
between South Asians and Caucasians, including differential fat distribution, might be 
responsible for the higher risk of cardiovascular disease in South Asians. In this study, 
South Asians were already more insulin resistant at baseline compared to Caucasians, 
as reflected by a comparable glucose but higher insulin curve and area under the curve 
measured by an OGTT (data not shown). Since people with insulin resistance are known 
to have abnormal cardiac relaxation,24 the prolonged cardiac relaxation observed in 
South Asians in this study might be due to their underlying insulin resistance.
To test whether possible differences in cardiovascular function between South 
Asians and Caucasians can be attributed to alterations in energy metabolism the ef-
fect of a 5-day HFHCD, inducing fat overload, on cardiovascular function was assessed. 
Previous studies showed that short-term dietary interventions can induce changes in 
cardiac function.13;25 A short-term HFHCD, consisting of 800 mL cream per day, in 15 
Caucasian healthy males (age 25.0±6.6yr), already decreased diastolic function after 3 
days.13 Therefore, we expected that if metabolic variations were the cause of differences 
in cardiovascular function, these differences would become more pronounced after a 
HFHCD.
However, although both insulin levels and HOMA-B% increased significantly only 
in South Asians, indicating they became even more insulin resistant, cardiovascular 
function did not deteriorate after the diet. Therefore, we did not find support for our hy-
pothesis. It might be that the observed differences in cardiovascular function are innate 
and that these findings are simply representative of differing normal reference values in 
these two ethnic groups. Whether these findings are related to increased cardiovascular 
disease risk in South Asians is unclear.
After the HFHCD hepatic TG content significantly increased in both groups, indicat-
ing good dietary compliance of the volunteers. In contrast to accumulation of hepatic 
TG content, myocardial TGs did not increase after the diet in both groups. A possible 
explanation is that the liver acts as a buffer for excessive postprandial flux of FFAs and 
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TGs resulting in no net change in myocardial TG content. This is in line with results of the 
above mentioned study in Caucasian males who received a 3-day HFHCD.13 However, in 
contrast to other studies, which observed higher hepatic TG in (young) healthy South 
Asians compared to Caucasians,26;27 in the present study no differences were found 
between groups before and after the diet. Surprisingly, we did not find a significant 
difference in abdominal fat distribution between groups either, although South Asians 
tended to have more visceral and subcutaneous fat mass. Other studies did find signifi-
cantly more abdominal fat mass in South Asians compared to Caucasians,27-29 though not 
all studies reached significance.30 These differences in (ectopic) fat distribution might 
be attributed to the relatively young age and low BMI of subjects in the present study 
compared to other studies. Possibly, the differences in body fat distribution become 
stronger with increasing age. Other explanations might be that we included only males, 
or that the group sizes were too small to reach significance.
Vascular function
PWV is a surrogate marker for arterial stiffness and is a powerful independent predic-
tor of cardiovascular events.31 The aortic PWV in this study was significantly higher in 
South Asians at baseline, indicating a stiffer aorta. Previous studies in older subjects also 
reported a higher PWV in South Asians than in Caucasians.32;33 After the HFHCD the PWV 
decreased significantly in South Asians, but not in Caucasians. This difference in diet 
effect might be explained by the significant increase in insulin levels after the diet occur-
ring only in South Asians. Insulin is known to acutely act as a vasodilator via stimulation 
of the vasculature to produce endothelial-derived vasodilator nitric oxide.34;35 In contrast, 
long-term increased insulin levels, as present in insulin resistance and type 2 diabetes, 
can contribute to increased arterial wall thickness by direct and indirect trophic effects 
on smooth muscle cells.36
The strength of this study is that this is the first time that the response to a HFHCD 
on cardiovascular function was assessed in South Asians. Furthermore, cardiovascular 
function was extensively analysed. A possible limitation of this study is the small sample 
size, which might limit generalization potential. In addition, a 5-day HFHCD might not 
necessarily be of sufficient duration to already observe differences in cardiovascular 
function. However, previous studies showed that short-term dietary interventions can 
induce changes in cardiac function in young, healthy people.13;25
In conclusion, already at a young age, South Asians have smaller cardiac dimensions and 
different diastolic and systolic cardiac function profiles as compared to white Cauca-
sians. To our knowledge, these differences in cardiac dimensions and function between 
healthy, lean South Asians and Caucasians of young age have not been described before. 
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Additionally, South Asians have higher aortic PWV, indicating increased arterial stiffness. 
Reduced insulin sensitivity and increased LDL-cholesterol might be causally related to 
the different cardiac function profiles in South Asians.24;37 Whether these differences 
contribute to the higher incidence of cardiovascular disease in South Asians, however, 
remains to be determined. A 5-day HFHCD did not increase the observed functional 
cardiovascular differences between both groups, despite distinct metabolic effects 
of the diet. This might suggest that these findings cannot be explained by a different 
metabolic response to short-term dietary fat consumption between both ethnicities at 
young age. It is possible, however, that a longer HF-diet is needed to induce changes.
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Background. South Asians have a higher risk of developing cardiovascular disease than 
white Caucasians. The underlying cause is unknown, but might be related to higher 
cardiac susceptibility to metabolic disorders. Short-term caloric restriction can be used 
as a metabolic stress test to study cardiac flexibility. We assessed whether metabolic and 
functional cardiovascular flexibility to caloric restriction differs between South Asians 
and white Caucasians.
Methods. Cardiovascular function and myocardial triglycerides were assessed using a 
1.5T-MRI/S-scanner in 12 middle-aged overweight male South Asians and 12 matched 
white Caucasians before and after an 8-day very low calorie diet (VLCD).
Results. At baseline South Asians were more insulin resistant than Caucasians. Cardiac 
dimensions were smaller, despite correction for body surface area, and PWV in the distal 
aorta was higher in South Asians. Systolic and diastolic function, myocardial triglyc-
erides and pericardial fat did not differ significantly between groups. After the VLCD 
body weight reduced on average with 4.0±0.2 kg. Myocardial triglycerides increased in 
both ethnicities with 69±18%, and diastolic function decreased although this was not 
significant in South Asians. However, pericardial fat and PWV in the proximal and total 
aorta were reduced in Caucasians only.
Conclusions. Myocardial triglyceride stores in middle-aged overweight and insulin re-
sistant South Asians are as flexible and amenable to therapeutic intervention by caloric 
restriction as age-, sex- and BMI-matched but less insulin resistant white Caucasians. 
However, paracardial fat volume and PWV showed a differential effect in response to an 
8-day VLCD in favour of Caucasians.
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INTRODUCTION
People of South Asian descent are at an increased risk of developing cardiovascular 
disease compared to white Caucasians. The age-standardized mortality rate from 
cardiovascular disease is approximately 50% higher for South Asians.1-3 Furthermore, 
cardiovascular disease in South Asians is more aggressive and has higher mortality rates 
at younger ages.1;2;4 The mean age of first acute myocardial infarction is around five years 
earlier than in Caucasians.5
Traditional risk factors, such as smoking, hypertension and cholesterol levels, do not 
seem to account for the excess risk for cardiovascular disease in South Asians.3 Major 
contributing factors to the high prevalence of cardiovascular disease in South Asians are 
insulin resistance and type 2 diabetes, also highly prevalent in this group. Mortality risk 
of cardiovascular disease associated with diabetes is higher in South Asians compared to 
Caucasians,3 which might suggest that South Asians have a higher cardiac susceptibility 
to metabolic disorders. Since South Asians represent one fifth of the world’s population, 
the increased risk for cardiovascular disease and type 2 diabetes in this ethnicity poses a 
major burden on the health care system. Therefore, we aimed to gain more insight in the 
underlying cause of the increased susceptibility of South Asians to develop cardiovascu-
lar disease compared to white Caucasians, and, more specifically, in the interrelationship 
between metabolic disorders and cardiac function.
We have shown previously that short-term caloric restriction can be used as a 
metabolic stress test to induce a short-term physiological increase of plasma free fatty 
acid (FFA) levels, which enables us to study the flexibility of myocardial triglyceride (TG) 
content and cardiac function, as assessed by magnetic resonance (MR) techniques.6-9 
Surprisingly, so far no studies have been published on the effect of caloric restriction on 
cardiovascular function in South Asians.
Given the high risk of cardiovascular disease in South Asians, we hypothesize that 
cardiovascular function in middle-aged overweight South Asians is impaired compared 
to Caucasians. Furthermore, we hypothesize that the metabolic and functional cardio-
vascular flexibility in response to caloric restriction is compromised in people of South 
Asian descent. Therefore, we subjected middle-aged, overweight South Asians and age-, 
sex- and BMI-matched white Caucasians to an 8-day very low calorie diet (VLCD) and 
studied cardiac function and myocardial TG content using MR techniques. In addition, 





Eligible participants were men of Dutch South Asian origin (n=12) or Dutch white Cauca-
sian origin (n=12), aged 40-50 year, with BMI between 25 and 30 kg/m2, waist circumfer-
ence >90 cm (South Asians) or >94 cm (Caucasians), and a positive family history for type 
2 diabetes (at least 1 (grand)parent and 1 other family member with type 2 diabetes). 
Subjects were recruited between October 2010 and May 2012 via local advertisements, 
and underwent a medical screening including a physical examination, blood chemistry 
tests and an oral glucose tolerance test (OGTT) to exclude type 2 diabetes. Other exclusion 
criteria were: cardiovascular disease, any significant chronic disease, use of medication 
known to influence glucose and/or lipid metabolism, smoking, recent weight change, 
and general contraindications to MR scanning. The study was approved by the local ethics 
committee and performed in accordance with the principles of the revised Declaration of 
Helsinki. Subjects gave written informed consent prior to participation.
Study design
In this prospective, non-randomized clinical intervention study, participants were stud-
ied on 2 study days after a 10-hour fast, separated by an 8-day VLCD. The VLCD consisted 
of three sachets of Modifast® (Nutrition & Santé Benelux, Breda, The Netherlands) per 
day (~450 kcal/day; ~50 g protein, 50-60 g carbohydrates, ~7 g lipids and ~15 g dietary 
fibres). MR studies were performed shortly before the start and at the end of the 8th 
day of the diet. Subjects were instructed not to alter life style habits. Anthropometric 
measurements were performed according to WHO recommendations. Body fat was 
assessed by bioelectrical impedance analysis (Bodystat® 1500). Blood pressure was 
measured with a vital function monitor (Philips Sure Signs VS3). A 75-gram 2-hour OGTT 
was performed on the screening day. Total areas under the curve (AUC) for glucose and 
insulin were determined using the linear trapezoidal rule. The Matsuda index was used 
as a measure for insulin sensitivity.10
MR protocol
Measurements were performed using a 1.5-Tesla whole-body MR-scanner (Gyroscan 
ACS-NT15; Philips Medical Systems, The Netherlands) in postprandial state (four hours 
after last meal).
Myocardial triglyceride content
MR spectroscopy (1H-MRS) was used to quantify myocardial TG content as described 
before.11 In summary, an 8-mL voxel was placed in the interventricular septum on four-
chamber and short-axis images at end-systole. Electrocardiographic triggering (for myo-
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cardial spectra) and respiratory pencil beam navigator were used during acquisition.11 
Acquisitions were performed with and without water suppression, with myocardial TG 
expressed as percentage of the unsuppressed water signal.
Pericardial fat quantification
As described before,12 to quantify the pericardial fat volume, the heart was imaged using 
electrocardiographically-gated breath-holds with a multi shot turbo spin echo sequence 
in a four-chamber view orientation. Water was suppressed using Spectral Inversion Re-
covery (SPIR). Contours were drawn around both pericardial fat layers surrounding the 
ventricles and atria using MASS® software (Medis, Leiden, The Netherlands) (Figure 1). 
The number of pixels were converted to square centimetres and multiplied by the slice 
thickness to obtain volume.
Left ventricular dimensions and function
Data were analysed blinded for ethnicity and study occasion. As previously described, 
the entire heart was imaged in short-axis orientation, using electrocardiographically-
gated breath-hold cine steady-state free-precession sequences.13 Left ventricular (LV) 
epicardial and endocardial contours were manually drawn in the end-systolic and 
end-diastolic phases of the short-axis images, using validated MASS® software. LV end-
diastolic volume (EDV), end-systolic volume (ESV), ejection fraction (EF), stroke volume 
(SV) and end-diastolic mass (EDM) were calculated.
Furthermore, an electrocardiographically-gated gradient-echo sequence with 
velocity encoding (100 cm/sec) was performed to measure transmitral blood, for the 
determination of LV diastolic function. Analysis was performed by using FLOW® software 
(Medis, Leiden, The Netherlands). The early filling phase (E) and the atrial contraction (A) 
were analysed and their peak flow ratio was calculated (E/A ratio). Additionally, the peak 
deceleration gradient of E and LV filling pressures (E/Ea) were assessed.14;15 Heart rate 
was monitored and stored during the transmitral flow measurements.
Figure 1. Quantification of the pericardial fat layer. This figure shows the quantification of the pericar-




To evaluate the aortic stiff ness, aortic PWV was determined, using a previously described 
protocol.16 Shortly, a scout view of the aorta was performed. Subsequently, a velocity en-
coded image perpendicular to the ascending aorta at the level of the pulmonary trunk, 
at the level of the aorta crossing the diaphragm and at the level of the aortic bifurca-
tion was assessed (Figure 2). This resulted in through-plane fl ow measurements of the 
ascending and descending aorta. PWV was calculated using the formula: Δx/Δt, where 
Δx  is the aortic path length between two measurement sites and Δt  is the time delay 
between the arrivals of the foot of the pulse wave at the respective measurements site. 
The distance between the measurement sites was determined manually using MASS®. 
Data were analysed using MASS® and FLOW®.
Assays
Serum concentrations of glucose, total cholesterol, HDL and TG were measured on 
a Modular P800 analyser (Roche, The Netherlands), serum insulin levels on an Immulite 
2500 (Siemens, The Netherlands), HbA1c on an HPLC system (Kordia, The Netherlands), 
and plasma FFAs by a commercial kit (Wako Chemicals, Germany).





























3PWV aortic arch (m/s) PWV distal descending aorta (m/s)
PWV proximal descending aorta (m/s)
Figure 2. Aortic PWV determination with MRI. The left panel shows a double-oblique parasagittal im-
age of the aorta. The coloured lines represent the acquisition planes for velocity-encoded MRI which are 
positioned perpendicular to the aorta. 1 is the path length of the aortic arch, 2 of the proximal descending 
aorta and 3 of the distal descending aorta, determined along the centreline of the aorta. The right panel 
shows the velocity-time curves for the four diff erent measurement sites in the aorta.
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Statistical analysis
Data are presented as mean±SEM or median (interquartile range (IQR)). A mixed effects 
model was applied to assess mean differences within and between groups, and to 
determine differences in diet effect. Groups and intervention were modelled as fixed 
effects and the subject specific deviances from the group mean were modelled as ran-
dom effects. Nonparametric tests were performed when appropriate (related-samples 
Wilcoxon Signed Rank Test (within group), independent-samples Mann-Whitney U Test 
(between-group)). Significance level was set at p<0.05 (two-sided). Statistical analyses 
were performed using SPSS for Windows version 20.0 (IBM, USA).
RESULTS
Clinical and metabolic characteristics
Baseline Mean age was 44.6±0.8 year. Body surface area (BSA) was significantly lower 
in South Asians compared to Caucasians. However, BMI (28.3±0.3 kg/m2), waist and hip 
circumference and percentage of fat mass were comparable between groups. The same 
was true for blood pressure and heart rate. Both ethnicities had similar fasting glucose 
levels, but insulin levels (both fasting and during OGTT) were higher and Matsuda index 
was lower in South Asians. Fasting FFAs, TGs and cholesterol levels did not significantly 
differ between groups (Table 1).
Effect of VLCD Anthropometric measurements were significantly reduced after the diet 
in both groups. The mean reduction in body weight for both groups was 4.0±0.2 kg, of 
which approximately 50% was fat mass. BMI decreased on average with 1.28±0.07 kg/
m2. Systolic and diastolic blood pressure were reduced in both ethnicities. The heart rate 
was not affected. In both groups, fasting glucose, insulin, TG and total cholesterol levels 
decreased significantly, while FFAs increased in response to the VLCD (Table 1).
Myocardial TG content
Baseline No differences in myocardial TG content were found between both groups at 
baseline (Table 2, Figure 3).
Effect of VLCD Myocardial TG content increased in both ethnicities, although in Cauca-
sians this did not reach significance (p=0.067). The percentage of myocardial TG increase, 
however, was comparable between groups (69±18%, p=0.868) (Table 2, Figure 3 and 
4).
Pericardial fat distribution
Baseline There were no differences in pericardial, epicardial or paracardial fat volumes 
between groups at baseline (Table 2, Figure 3).
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Table 1. Clinical and metabolic characteristics.
 
white Caucasians South Asians
before VLCD after VLCD before VLCD after VLCD
Clinical characteristics
age (years) 44.3 ± 1.1 44.9 ± 0.9
height (m) 1.81 ± 0.02 1.75 ± 0.01**
weight (kg) 92.6 ± 2.5 88.2 ± 2.5†† 86.7 ± 1.4 83.2 ± 1.6†† ‡
BSA (m2) 2.14 ± 0.04 2.09 ± 0.04†† 2.02 ± 0.02* 1.99 ± 0.02††*‡
BMI (kg/m2) 28.1 ± 0.5 26.8 ± 0.5†† 28.4 ± 0.4 27.3 ± 0.4††
waist (cm) 103 ± 2 100 ± 2†† 99 ± 2 97 ± 1††
hip (cm) 102 ± 1 100 ± 1 99 ± 2 97 ± 1†
WHR 1.01 ± 0.01 0.99 ± 0.01† 1.02 ± 0.01 1.01 ± 0.01
fat mass (%) 23.1 ± 0.6 21.8 ± 0.6†† 23.8 ± 0.6 23.0 ± 0.6††
systolic BP (mmHg) 130 ± 3 118 ± 2†† 136 ± 3 124 ± 3††
diastolic BP (mmHg) 85 ± 3 77 ± 3†† 90 ± 4 85 ± 3††
heart rate (bpm) 64 ± 3 61 ± 2 70 ± 3 65 ± 3
Metabolic characteristics
free fatty acids (mmol/L) 0.53 ± 0.03 1.36 ± 0.13† 0.58 ± 0.04 0.85 ± 0.06†*‡
triglycerides (mmol/L) 1.29 (2.48) 0.89 (0.18) † 1.78 (2.91) 0.91 (0.25)†
total cholesterol (mmol/L) 5.56 ± 0.24 4.72 ± 0.33† 5.74 ± 0.28 5.13 ± 0.26†
HDL-cholesterol (mmol/L) 1.09 ± 0.08 0.99 ± 0.06 1.00 ± 0.07 0.95 ± 0.05
LDL-cholesterol (mmol/L) 3.54 ± 0.28 3.42 ± 0.37 3.58 ± 0.25 3.77 ± 0.24
total cholesterol/HDL ratio 5.57 ± 0.59 5.02 ± 0.54 6.05 ± 0.48 5.49 ± 0.35
HbA1c (mmol/mol, %) 33.0 (6), 5.20 (0.5) 36.5 (1)*, 5.45 (0.1) *
glucose (mmol/L) 5.33 ± 0.20 4.45 ± 0.22†† 5.30 ± 0.11 4.51 ± 0.14††
insulin (mU/L) 6.0 (3.0) 1.7 (3.7)†† 8.5 (2.5)** 2.3 (4.7)††
Oral glucose tolerance test
2 hour insulin (mU/L) 31 (29) 77 (76)*
glucose AUC (mmol/L * h) 959 ± 32 1027 ± 58
insulin AUC (mU/L * h) 4477 ± 586 8790 ± 711**
Matsuda index 7.1 ± 1.3 3.9 ± 0.6*
Data are presented as mean ± SEM or median (IQR). VLCD, very low calorie diet. BSA, body surface area; BMI, 
body mass index; WHR, waist hip ratio; BP, blood pressure; AUC, total area under the curve.  † p<0.05, †† 
p<0.005 within group vs. before diet. * p<0.05, ** p<0.005 vs. Caucasians. ‡ p<0.05, ‡‡ p<0.005 diet effect 
vs. Caucasians.
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Table 2. Cardiac dimensions, parameters of cardiovascular function, pericardial fat distribution and myo-
cardial triglyceride content assessed with MRI and MRS before and after an 8-day VLCD.
 
white Caucasians South Asians
before VLCD after VLCD before VLCD after VLCD
Cardiac dimensions and basic function
LVEDMI (g/m2) 51 ± 2 48 ± 2†† 52 ± 1 50 ± 1†
EDVI (mL/m2) 87 ± 3 83 ± 2† 74 ± 3** 72 ± 3*
ESVI (mL/m2) 34 ± 1 32 ± 1 29 ± 1* 27 ± 1*
SVI (mL/m2) 53 ± 2 51 ± 2 46 ± 2* 45 ± 2*
CI (mL/min/m2) 3.3 ± 0.1*103 3.1 ± 0.1*103† 3.2 ± 0.2*103* 2.9 ± 0.1*103†*
EF (%) 61 ± 2 62 ± 1 62 ± 1 63 ± 1
Diastolic cardiac function
E peak filling rate (mL/s) 549 ± 28 477 ± 26†† 493 ± 26 445 ± 22†
E acceleration peak (mL/s²x10-³) 8.4 ± 0.6 7.0 ± 0.5†† 7.5 ± 0.5 6.4 ± 0.3
E deceleration peak  (mL/s²x10-³) -4.7 ± 0.3 -3.7 ± 0.2†† -4.9 ± 0.3 -4.1 ± 0.3†
E deceleration mean  (mL/s²x10-³) -3.2 ± 0.2 -2.5 ± 0.2†† -3.4 ± 0.3 -2.8 ± 0.3†
A peak filling rate (mL/s) 392 ± 18 364 ± 20 365 ± 17 360 ± 10
E/A-peak ratio 1.43 ± 0.10 1.34 ± 0.09† 1.37 ± 0.08 1.24 ± 0.07
E/Ea 9.4 ± 0.7 8.3 ± 1.0 9.8 ± 0.8 7.2 ± 0.8†
Pulse wave velocity
PWV aortic arch (m/s) 5.6 (0.9) 5.3 (1.1) 5.7 (1.3) 5.7 (0.9)
PWV proximal aorta (m/s) 6.7 (2.4) 5.2 (1.4)† 7.2 (3.7) 7.1 (2.6)**
PWV distal aorta (m/s) 5.0 (0.5) 4.9 (1.7) 5.5 (1.2)* 5.2 (1.0)
PWV total aorta (m/s) 5.5 (1.0) 5.2 (0.4)† 6.1 (0.9) 5.8 (0.9)*
Fat distribution
Epicardial fat (mL) 3.1 (1.8) 3.6 (1.4) 3.3 (1.4) 3.0 (1.0)
Paracardial fat (mL) 4.8 (3.7) 3.7 (3.0)†† 3.5 (2.1) 2.7 (2.6)‡
Pericardial fat (mL) 7.6 (4.0) 6.6 (3.5)† 6.7 (3.0) 6.0 (4.0)
Myocardial TG content (%) 0.56 ± 0.08 0.74 ± 0.08 0.59 ± 0.08 0.98 ± 0.13††
Data are mean ± SEM or median (IQR). VLCD, very low calorie diet; LV, left ventricular; EDM, end diastolic 
mass; EDV, end-diastolic volume; ESV, end-systolic volume; SV, stroke volume; CI, cardiac index; EF, ejection 
fraction; ESWS, end-systolic wall stress. I, indexed for body surface area; E, early diastolic wave; A, atrial 
diastolic wave; E/Ea, estimated left ventricular filling pressure; PWV, pulse wave velocity; TG, triglyceride. † 
p<0.05, †† p<0.005 within group vs. before diet. * p<0.05, ** p<0.005 vs. Caucasians. ‡ p<0.05, ‡‡ p<0.005 
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Figure 3. Overview of main results in middle-aged overweight South Asian and white Caucasian men 
before (dark bars) and after (open bars) an 8-day VLCD. A: Myocardial triglyceride content. B-D: peri-
cardial fat. E-H: variables of diastolic cardiac function. I-L: pulse wave velocity (PWV). Data are expressed as 
mean ± SEM (A, E-H) or as median (IQR) in a box-whiskerplot (B-D, I-L). † p<0.05 within group vs. before diet. 
* p<0.05 vs. Caucasians. ‡ p<0.05 diet effect vs. Caucasians.
Effect of VLCD The pericardial and paracardial fat volumes decreased significantly in 
Caucasians in response to the VLCD (p=0.003 and p=0.050, respectively), whereas no 
significant changes occurred in South Asians (Table 2, Figure 3).
Left ventricular dimensions and function
Baseline Despite correction for BSA EDV, ESV and SV were significantly lower in South 
Asians. EF was on average 61±4%, and was comparable between ethnicities (p=0.808). 
There were no significant differences in diastolic cardiac function, as reflected in the E/A 
ratio (p=0.168) and the E/Ea ratio (p=0.088) (Table 2, Figure 3).
Effect of VLCD LV mass, indexed for BSA, decreased slightly in both groups after the 
diet. EDV reduced in Caucasians, however no significant change occurred in South 
Asians. The cardiac index reduced equally in both ethnicities. The E/A ratio reduced sig-
nificantly in Caucasians, whereas no significant diet effect was observed in South Asians. 
In contrast, the VLCD did not induce significant changes in the E/Ea ratio in Caucasians, 
while in South Asians E/Ea decreased significantly. The early peak filling rate (EPFR) and 
early deceleration mean showed a significant decrease in both groups in response to the 
VLCD (Table 2, Figure 3).
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Pulse wave velocity
Baseline PWV in the distal segment of the aorta was significantly higher in South Asians 
compared to Caucasians. Furthermore, PWV in the total aorta tended to be higher in 
South Asians, however this did not reach statistical significance (p=0.068) (Table 2, 
Figure 3).
Effect of VLCD After the VLCD, PWV in the proximal descending part of the aorta and 
PWV of the total aorta were significantly reduced in Caucasians. In contrast, no diet ef-
fect on PWV in any of the segments of the aorta was observed in South Asians (Table 2, 
Figure 3).
DISCUSSION
South Asians have a higher risk of developing cardiovascular disease than white Cauca-

































and type 2 diabetes is higher in this population, indicating they are metabolically more 
at risk. Previous studies in healthy subjects and obese patients with type 2 diabetes 
with and without cardiovascular disease of Caucasian descent demonstrated metabolic 
and functional flexibility of the heart in response to both short- and long-term caloric 
restriction. To date, however, it was unknown if caloric restriction in South Asians has 
comparable effects. This study showed that an 8-day VLCD increased myocardial TG 
content to a similar degree in middle-age overweight South Asians as compared to 
age-, sex- and BMI-matched but less insulin resistant Caucasians, indicating comparable 
flexibility of the heart. Paracardial fat volume and PWV, however, showed a differential 
effect in response to caloric restriction in favour of Caucasians.
Myocardial TG content
At baseline, South Asians were more insulin resistant, indicated by higher insulin levels 
(both in fasted condition and during OGTT) and lower Matsuda index (Table 1). Stud-
ies in animals and humans have demonstrated that increased myocardial TG content 
in insulin resistance is associated with impaired myocardial function.17-19 Paradoxically, 
however, the increase in myocardial TG observed after a short-term VLCD is a sign of pre-
served metabolic flexibility of the heart. Given the high risk on cardiovascular disease 
and diabetes in South Asians, we hypothesized, therefore, that the flexibility of the heart 
to adjust myocardial TG content in response to caloric restriction was diminished in 
South Asians compared to Caucasians. Surprisingly, however, an 8-day VLCD increased 
myocardial TG similarly in both groups. Thus, South Asians showed a similar physiologi-
cal flexibility of myocardial lipid metabolism as Caucasians.
Previous short-term VLCD studies have shown that the increase in myocardial TG 
is the net result of increased uptake of FFAs in cardiomyocytes in relation to oxidative 
FFA requirements. This increased uptake is due to an increased release of FFAs from 
the adipose tissue into the circulation, which is caused by increased lipolysis of TG in 
adipose tissue in response to caloric restriction.7;9 Indeed, in the present study FFAs were 
significantly increased after the diet in both ethnicities, and waist fat was significantly 
reduced (data not shown), indicating increased lipolysis in the adipose tissue.
Pericardial fat
Pericardial fat, the layer of fat surrounding the heart, can be divided in an epicardial and 
paracardial layer. Both fat layers are metabolically different. Whereas epicardial fat has 
been shown to be a source of several inflammatory mediators, paracardial fat seems 
to have a greater importance in mechanical restriction, which exerts an unfavourable 
effect on the coronary vasculature.20 In the present study, pericardial fat distribution 
was similar between groups at baseline. However, pericardial fat decreased significantly 
in Caucasians in response to the dietary intervention, mainly due to a reduction in the 
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paracardial fat layer, whereas in South Asians no significant diet effect was observed. 
Since the paracardial fat layer has been found to be a predictor of cardiovascular disease, 
the decrease in this specific fat compartment in Caucasians probably conveys reduced 
cardiovascular risk.21
Cardiac dimensions and function
Cardiac dimensions were smaller in South Asians compared to Caucasians, despite cor-
rection for BSA. This is in line with other studies, which showed smaller left heart volumes 
in middle-aged South Asians,22;23 using echocardiography. In a recent study in healthy 
young adults, we showed that these smaller cardiac dimensions are already present at a 
young age.24 No major effects of the diet on cardiac dimensions were observed.
Cardiac systolic function, reflected as the LV ejection fraction, was normal (~62%) 
and comparable in both groups. Systolic function was not affected by the diet, which is 
in line with previous VLCD studies.7;9;25
Diastolic cardiac function, reflected as the E/A ratio, decreased after the diet as 
expected from previous studies.7;9;26 The reduction, however, was only significant in 
Caucasians. This difference in diet effect might be attributed to a decrease in filling 
pressure (E/Ea ratio) in South Asians. In addition, other parameters for diastolic func-
tion did decrease in both groups. The decrease in diastolic function can probably be 
explained by changes in elastic properties of the LV. In animal models, TG accumulation 
in cardiomyocytes is directly related to impaired cardiac function via complex mecha-
nisms involving fatty acid derivatives.17 An alternative explanation may be that changes 
in plasma FFAs, induced by caloric restriction, change the calcium homeostasis in the 
myocardium, thereby influencing LV diastolic function.27
Pulse wave velocity
The PWV is a powerful independent predictor of cardiovascular events.28 In the pres-
ent study, PWV in the distal aorta was significantly higher in South Asians compared to 
Caucasians at baseline, indicating a stiffer aorta. This is in line with other studies that 
showed a higher PWV in middle-aged South Asians compared to Caucasians.29;30 In 
addition, we have shown recently that PWV is already higher in healthy young South 
Asians.24 It is known that insulin resistance and diabetes compromise aortic elastic 
function. Although the precise underlying mechanisms remain unclear, it is known that 
long-term increased insulin levels can contribute to increased arterial wall thickness, 
and thereby to increased arterial stiffening, by direct and indirect trophic effects on 
smooth muscle cells.31 In the present study, South Asians were more insulin resistant 
than Caucasian subjects – as reflected in higher insulin levels (both fasting and during 
OGTT) – which might explain the higher PWV observed in South Asians.
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The PWV responded differentially to an 8-day VLCD, consisting of a reduction in 
proximal and total PWV in Caucasians, whereas no diet effect was observed in South 
Asians, suggesting that large arteries are less flexible in South Asians in response to 
caloric restriction. This might be due to the, probably long-term existing, higher insulin 
resistance observed in South Asians which may have induced irreversible changes in the 
arterial wall according to the aforementioned mechanism.
Strengths of this study are that this is the first time the response to a VLCD on cardio-
vascular function was assessed and the first time myocardial and pericardial TG content 
were measured in South Asians. We used an extreme intervention (8-day VLCD) to be 
able to detect differences between ethnicities. Furthermore, we matched on BMI in 
order to gain more insight in the pathophysiological mechanism behind the increased 
risk of South Asians to develop insulin resistance and type 2 diabetes at lower ranges 
of BMI than Caucasians. A possible limitation is the relatively small sample size, which 
might limit generalization potential. However, subjects were their own controls, which 
increases power to detect relevant differences.
In conclusion, this study proves that myocardial TG stores in middle-aged overweight 
and insulin resistant South Asians are as flexible and amenable to therapeutic inter-
vention by caloric restriction as age-, sex- and BMI-matched but less insulin resistant 
Caucasians. However, paracardial fat volume and PWV showed a differential effect in 
response to an 8-day VLCD in favour of Caucasians.
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Objective. South Asians have an exceptionally high risk of developing cardiovascular 
disease compared to white Caucasians. A contributing factor might be dysfunction of 
high density lipoprotein (HDL). This study aimed to compare HDL function in neonates, 
adolescents and adults of both ethnicities.
Methods. HDL functionality with respect to cholesterol efflux, anti-oxidation and 
anti-inflammation was determined using fasting plasma samples from South Asian and 
white Caucasian neonates (n=14 each), young adult healthy men (n=12 each, 18-25y), 
and adult, overweight men (n=12 each, 40-50y). Young adults were subjected to a 5-day 
high fat high calorie diet (HFHCD) and adults to an 8-day very low calorie diet (VLCD).
Results. Anti-oxidative capacity was lower in South Asian adults before VLCD (18.1±2.6 
vs. 24.2±2.2%, p=0.077) and after VLCD (16.4±2.4 vs. 27.6±2.7%, p=0.003). Anti-
inflammatory capacity was reduced in South Asian neonates (22.9±0.7 vs. 35.9±1.9%, 
p<0.00001), and was negatively affected by an 8-day VLCD only in South Asian adults 
(-12.2±4.3%, p=0.005). Cholesterol efflux capacity was increased in response to HFHCD 
in the young adult groups (South Asians: +6.3±2.9%, p=0.073, Caucasians: +11.8±3.4%, 
p=0.002) and decreased after VLCD in the adult groups (South Asians: -10.3±2.4%, 
p<0.001, Caucasians: -13.7±1.9%, p<0.0001)).
Conclusions. South Asians exhibit disturbed age-dependent function of HDL compared 
to white Caucasians, which may conceivably contribute to their excess risk of cardiovas-
cular disease.
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INTRODUCTION
The burden and mortality of cardiovascular disease are significantly increased among 
both native and migrant South Asians compared to people of white Caucasian descent. 
The age-standardized mortality rate from cardiovascular disease is around 50% higher 
for South Asians.1-4 In addition, cardiovascular disease is more aggressive and has higher 
mortality rates at younger ages in South Asians.2;5-8 The underlying mechanism of this ex-
cess risk is still poorly understood. Traditional risk factors such as smoking, hypertension, 
and type 2 diabetes seem to account for only part of the excess risk in South Asians.3;9-11 
Thus, additional factors likely play a role. One of these factors may be dysfunction of 
high density lipoprotein (HDL).
Numerous clinical and epidemiological studies have consistently shown a strong 
inverse association between the level of HDL-cholesterol and cardiovascular risk.12-16 The 
cardiovascular protective effects of HDL have been attributed to several anti-atherogenic 
functional properties, including: HDL (i) prevents LDL oxidation, (ii) is anti-inflammatory, 
and (iii) stimulates cholesterol efflux from macrophage foam cells.17-19 Of note, recent 
evidence suggests that HDL functionality might be affected independent of changes 
in plasma HDL-cholesterol level.20;21 In trials that aimed at raising HDL-cholesterol levels 
with niacin or dalcetrapib on top of LDL lowering, no decrease in the occurrence of 
cardiovascular endpoints was observed compared to LDL lowering therapy only.22;23 This 
suggests that simply raising HDL-cholesterol levels is not sufficient to lower cardiovas-
cular disease risk and that HDL functionality may thus be more importantly linked to 
cardiovascular disease than plasma HDL-cholesterol concentrations. Indeed, previous 
studies showed that HDL is dysfunctional in people with (increased risk of ) coronary 
atherosclerosis.24-26
HDL functionality is not only related to the cardiovascular health status. A 3-week 
high-fibre-low-fat diet and exercise intervention converted HDL from pro- to anti-inflam-
matory.27 Furthermore, data from our study group demonstrated a decrease in cholesterol 
efflux capacity of HDL after very low calorie diet (VLCD)-induced weight loss.28
Interestingly, multiple studies have found lower HDL-cholesterol levels in South 
Asians compared to white Caucasians, even in South Asian neonates.29-32 In addition, 
South Asians seem to have relatively more small sized HDL particles, which are associ-
ated with decreased cardiac protection compared to normal sized HDL particles.33-35 
Remarkably, little is known about HDL functionality in South Asians. Therefore, this 
study aimed to compare HDL function in South Asian and white Caucasian subjects. In 
particular, we were interested in the following questions: (i) is HDL function impaired in 
middle-aged overweight South Asians compared to matched white Caucasians?, (ii) if so, 
is this dysfunction already present in young healthy subjects or even at birth?, and (iii) is 
the effect of short-term dietary intervention on HDL function different between South 
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Asians and Caucasians? To address these questions, we determined three key biological 
functions of HDL, namely its ability to induce cholesterol efflux, anti-oxidative and anti-
inflammatory properties, in three groups of South Asian and white Caucasian neonates, 
young healthy men (young adults) and middle-aged overweight men (adults). The 
young adults and adults were subjected to a 5-day high-fat-high-calorie diet (HFHCD) 
and an 8-day VLCD, respectively.
MATERIAL AND METHODS
Subjects
Neonates. Umbilical venous cord blood was collected from 28 neonates (14 South Asian 
and 14 Caucasian neonates) as described previously.36 All neonates were born between 
January 1st, 2006, and January 1st, 2009, and were examined after their mothers had 
given informed consent and approval had been obtained by the local ethics committee. 
Live-born singleton babies with 4 South Asian grandparents or 4 Caucasian grandpar-
ents were included. Pregnancies complicated by pre-eclampsia were excluded. Gesta-
tional age was based on last menstrual period or ultrasound scanning (before 12 weeks). 
Birth weights were taken from the medical records. Immediately after delivery, 20 mL of 
cord blood was collected from the umbilical vein according to standard protocols. South 
Asian and Caucasian neonates were matched for HDL-cholesterol level.
Young adults and adults. 24 young healthy Dutch males (young adults; age 18-25y, 
BMI <25 kg/m2) and 24 middle-aged overweight Dutch males (adults; age 40-50y, BMI 
25-30 kg/m2) were enrolled via local advertisements. Subjects were of South Asian (n=12 
for each group) or Caucasian (n=12 for each group) origin. They underwent a medical 
screening including their medical history, a physical examination, blood chemistry tests 
and an oral glucose tolerance test to exclude individuals with type 2 diabetes. Other 
exclusion criteria were cardiovascular disease, any significant chronic disease, use of 
medication known to influence lipid metabolism, rigorous exercise, smoking and recent 
body weight change. The study was approved by the Medical Ethical Committee of the 
Leiden University Medical Centre and performed in accordance with the principles of 
the revised Declaration of Helsinki. Written informed consent was obtained from all 
subjects prior to participation.
Dietary interventions in young adults and adults
The young adults were subjected to a 5-day HFHCD, consisting of the subject’s regular 
diet, supplemented with 375 mL of cream per day (1275 kcal/day, 94% fat), yielding to 
approx. 3775 kcal/day and 54% of fat. The adults received an 8-day VLCD, consisting of 
three sachets of Modifast per day (approx. 450 kcal/day, 50 g protein, 50-60 g carbohy-
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drates, 7 g lipids and 15 g dietary fibres). Subjects were instructed not to alter life style 
habits, and not to perform physical activity in the last 48 h before the study days. One 
day before and one day after the dietary interventions blood samples were obtained 
from all subjects after a 10h overnight fast.
Laboratory analyses
Fasting plasma total cholesterol, triglycerides and glucose were measured on a 
Modular P800 analyser (Roche, Almere, The Netherlands) using commercially available 
enzymatic kits from Roche Molecular Biochemicals (total cholesterol, triglycerides) and 
Instruchemie, Delfzijl, The Netherlands (glucose). HDL-cholesterol levels were deter-
mined after precipitating the apoB-containing lipoproteins as described previously.37 
LDL-cholesterol was calculated according to Friedewald’s formula.38 Serum insulin levels 
were analysed using a commercially available chemiluminescence immunometric assay 
on an Immulite 2500 analyser (Siemens Healthcare Medical Diagnostics, Germany).
HDL function measurements
ApoB-containing lipoproteins were precipitated by adding 100 μL 36% polyethylene 
glycol (PEG 6000, Sigma, St. Louis, MO, USA) in 10 mM HEPES (pH = 8.0) to 200 μL plasma. 
Subsequently, samples were incubated for 30 min on ice and centrifuged for 30 min at 
2200 g.39 The HDL-containing supernatant was collected, kept on ice, and used within 
the same week for HDL function assays.
Cholesterol efflux capacity. To determine HDL-mediated cholesterol efflux, THP-1 
human monocytes (ATCC via LGC Promochem, Teddington, UK) were differentiated into 
macrophages in the presence of 100 nM phorbol myristate acetate.40 Differentiated THP-
1 macrophages were then loaded with 50 μg/mL acetylated LDL and 1 μCi/mL [3H]cho-
lesterol (Perkin Elmer, Boston, MA, USA) for 24 h. Next, macrophages were equilibrated 
for 18 h in RPMI 1640 medium containing 2% bovine serum albumin.40 Thereafter, 2% 
apoB-depleted plasma was added to the macrophages. After 5 h, effluxed radioactiv-
ity was determined by liquid scintillation counting (Packard 1600CA Tri-Carb, Packard, 
Meriden, CT, USA). Then the plates were washed two times with PBS and cells were lysed 
with 0.1 M NaOH (30 min incubation at room temperature). Subsequently, the radio-
activity within the cells was counted. Efflux per well is expressed as the percentage of 
radioactivity released into the medium related to the total initial dose of radioactivity. To 
correct for nonspecific efflux, we subtracted values obtained from control cells without 
added apoB-depleted plasma.
Anti-oxidative capacity. The anti-oxidative properties of HDL were assessed by 
measuring the capacity of HDL from the respective groups to inhibit the oxidation of 
native LDL using a previously published method.41 LDL was isolated from plasma of a 
fasted healthy male donor by density gradient ultracentrifugation (1.019 < d < 1.063 
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g/mL).42 LDL (100 mg/dL cholesterol) was then oxidized with 5 mM 2,2’-azobis(2-
methylpropionamidine) dihydrochloride (AAPH) for 24 h at 37°C either in the presence 
of 2% apoB-depleted plasma or an equal volume of precipitation reagent in PBS as a 
control. Protein was precipitated with 10% trichloroacetic acid. Then, the accumulation 
of thiobarbituric acid reactive substances (TBARS) as a measure of oxidative modifica-
tion was determined by incubating the samples for 10 min at 99°C and measuring the 
fluorescence at 485 nm excitation and 545 nm emission using 1,1,3,3-tetramethoxypro-
pane as a standard as published previously.42 The anti-oxidative capacity of HDL was 
expressed as the amount of TBARS accumulating in the samples relative to control LDL 
oxidized in the absence of HDL.
Anti-inflammatory capacity. Anti-inflammatory properties of HDL were assessed 
using human umbilical vein endothelial cells (HUVECs, provided by the Endothelial 
Cell Core Facility of the UMCG) isolated and cultured as described previously.43 HUVECs 
were pre-incubated with 2% apoB-depleted plasma or an equal volume of precipitation 
reagent in PBS as a control for 1 h. Then, 10 ng/mL tumor necrosis factor α (TNF-α; R&D 
systems, Abingdon, UK) was added. After an additional incubation for 8 h, total RNA was 
isolated using Trizol (Invitrogen, Carlsbad, CA, USA) and quantified with a NanoDrop 
ND-100 UV-Vis spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). One 
μg of total RNA was reverse transcribed into cDNA (Invitrogen). Real-time quantitative 
PCR was performed on an ABI-Prism 7700 (Applied Biosystems) sequence detector.44 
Vascular cell adhesion molecule-1 (VCAM-1) mRNA expression was calculated relative to 
the expression of the housekeeping gene cyclophilin.
Statistical analysis
Data are presented as mean ± SEM when normally distributed or as median (IQR) when 
not normally distributed. A mixed effects model was applied to assess mean differ-
ences before and after the intervention within and between groups, and to determine 
differences in diet effect. Groups and intervention were modelled as fixed effects and 
the subject specific deviances from the group mean were modelled as random effects. 
Nonparametric tests (Wilcoxon signed-rank test within group, Mann-Whitney between 
groups) were performed when appropriate. Significance level was set at p<0.05. Statisti-
cal analyses were performed using SPSS for Windows version 20.0 (IBM, USA).
RESULTS
Clinical characteristics
Clinical characteristics are shown in Table 1. In all groups, HDL-cholesterol levels were 
comparable between South Asian and Caucasian subjects.
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Neonates. Mean gestational age was 278 ± 2 days and did not differ between groups. 
Birth weight tended to be lower in South Asian neonates (p=0.078). Glucose levels were 
comparable between groups, but insulin levels were significantly higher in South Asian 
neonates (p=0.044). No significant differences were observed in lipid levels.
Young adults. Mean age was 22.1 ± 0.4 years. BMI did not differ between groups 
(p=0.11 (baseline)). Fasting glucose, insulin, triglyceride, HDL-cholesterol and phospho-
lipid levels were comparable at baseline, while total cholesterol levels were significantly 
higher (p=0.021) and LDL-cholesterol tended (p=0.055) to be higher in South Asians. 
After the HFHCD, anthropometric parameters were unchanged. Fasting glucose and 
insulin levels were significantly increased only in South Asians. The HFHCD induced a 
significant increase in total cholesterol, HDL-cholesterol and LDL-cholesterol levels 
in Caucasians. In South Asians only HDL-cholesterol showed a tendency towards an 
increase (p=0.060). Phospholipids increased significantly to a similar degree in both 
groups (data not shown).
Adults. Mean age was 44.6 ± 0.8 years. BMI did not differ between groups (p=0.65 
(baseline)). Fasting glucose and lipid levels were comparable between groups, whereas 
insulin levels were significantly higher in South Asians (p=0.002). After the VLCD, anthro-
pometric parameters were significantly reduced in both groups. The mean reduction 
in body weight was 4.0±0.2 kg. Furthermore, caloric restriction induced a comparable, 
significant decrease in fasting plasma glucose, insulin, triglyceride, total cholesterol and 
phospholipid levels in both South Asians and Caucasians. HDL-cholesterol and LDL-
cholesterol levels were not affected by the diet.
Of note, HDL-cholesterol levels were significantly lower in adult South Asians vs. 
young adult South Asians (p=0.027). Furthermore, HDL-cholesterol was significantly 
lower at neonatal age compared to young adult age for both South Asian (p=0.001 and 
p=0.040) and Caucasian (p=0.005 and p=0.017) subjects.
HDL functionality
The functionalities of HDL in Caucasians and South Asians with respect to inducing cho-
lesterol efflux and anti-oxidative and anti-inflammatory activity are depicted in Figure 1.
Cholesterol efflux capacity is affected by dietary intervention. The ability of HDL 
to elicit cholesterol efflux from macrophages did not differ between ethnicities for all 
ages, both at baseline and after the dietary interventions. However, the HFHCD led to a 
significant increase in cholesterol efflux ability in Caucasian young adults (+11.8 ± 3.4%, 
p=0.002), while in South Asian young adults there was a tendency towards an increase 
(+6.3 ± 2.9%, p=0.073). On the other hand, the VLCD in the adult group resulted in a 
significantly lower cholesterol efflux capacity for both ethnicities (South Asians: -10.3 ± 
2.4% (p<0.001) vs. Caucasians: -13.7 ± 1.9% (p<0.0001)). Cholesterol efflux capacity was 
comparable for all three age groups for both ethnicities.
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Anti-oxidative capacity is impaired in adult South Asians. The ability of HDL to 
prevent oxidation of LDL was comparable between groups at neonatal and young 
adult age. However, this ability was markedly impaired in adult South Asian subjects 
compared to Caucasians (before VLCD: 18.1 ± 2.6 vs. 24.2 ± 2.2%, p=0.077; after VLCD: 
16.4 ± 2.4 vs. 27.6 ± 2.7%, p=0.003). Anti-oxidative capacity was not affected by dietary 
intervention. Of note, anti-oxidative capacity was significantly lower in adult South 
Asians compared to young adult South Asians (p<0.005), while for Caucasian subjects 
anti-oxidative capacity was comparable between both age groups (p=0.160). Further-
more, anti-oxidative capacity was markedly lower at neonatal age compared to young 
adult and adult age for both South Asian (vs. young adults: p<0.001, vs. adults: p=0.048) 
and Caucasian (vs. young adults: p<0.001; vs. adults: p<0.001) subjects.
Anti-inflammatory capacity is impaired in South Asian neonates and is negatively 
affected by an 8-day VLCD in South Asian adults only. The anti-inflammatory capacity 
of HDL was significantly lower in South Asian compared to Caucasian neonates (22.9 ± 
0.7 vs. 35.9 ± 1.9%, p<0.00001), a difference that was not present at young adult and 
adult age, at least at baseline. A 5-day HFHCD had no impact on anti-inflammatory 
capacity. Remarkably, though, anti-inflammatory capacity was negatively affected by an 
8-day VLCD in adult South Asians only (-12.2 ± 4.3% (p=0.005) vs. +0.2 ± 4.2% (p=0.984)), 
resulting in a significantly lower anti-inflammatory capacity compared to adult Cauca-
sians after the diet (23.0 ± 1.6% vs. 29.8 ± 2.3%, p=0.024). Anti-inflammatory capacity 
was significantly higher in Caucasian neonates compared to Caucasian adults (p=0.044). 
No other significant differences were observed for anti-inflammatory capacity at differ-
ent ages.
Cholesterol efflux capacity positively correlates with HDL-cholesterol and 
phospholipid levels.
Linear regression analysis showed a clear positive correlation between cholesterol efflux 
capacity and HDL-cholesterol levels for all ages at baseline (neonates: R2=0.451, β=0.672, 
p<0.0001; young adults: R2=0.286, β=0.534, p=0.009; adults: R2=0.201, β=0.448, p=0.032; 
Figure 2). The same was true for cholesterol efflux capacity and HDL-phospholipid lev-
els (neonates: R2=0.277, β=0.527, p=0.004; young adults: R2=0.293, β=0.541, p=0.008; 
adults: R2=0.176, β=0.419, p=0.047; data not shown). In addition, cholesterol efflux 
capacity was positively correlated with HDL-cholesterol after the diet (young adults: 
R2=0.456, β=0.676, p=0.0004; adults: R2=0.307, β=0.554, p=0.006) and for diet effect 
(delta HDL-cholesterol; young adults: R2=0.395, β=0.629, p=0.001; adults: R2=0.240, 
β=0.489, p=0.018). Of note, correlations were pooled for South Asians and Caucasians. 
Similar correlations were observed per group, although these did not always reach 
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Figure 2. Correlations of cholesterol efflux capacity with HDL-cholesterol. Cholesterol efflux capacity 
in relation to HDL-cholesterol levels in (A) South Asian and white Caucasian neonates, and in (B) young 
adult healthy and (C) adult overweight South Asian and white Caucasian men, respectively. Correlations 
were determined by linear regression analysis. South Asian subjects are depicted in black circles and Cau-














































































































































Figure 1. HDL functionality in South Asian (striped black) and white Caucasian (solid black) neo-
nates, and in young adult healthy and adult overweight South Asian and white Caucasian men be-
fore (striped black and solid black, respectively) and after (striped white and solid white, respec-
tively) a 5-day HFHCD and 8-day VLCD, respectively. HDL function was determined as A/D/G) inducing 
cholesterol efflux from cholesterol-laden THP-1 cells, B/E/H) protection against oxidation of LDL, and C/F/I) 
protection of HUVECs against TNFα-induced inflammation as determined by VCAM-1 expression. Assays 
were performed as detailed in methods. Data are presented as mean ± SEM. † p<0.05, †† p<0.005 within 
group vs. before diet. * p<0.05, ** p<0.005 vs. Caucasians. ‡ p<0.05 diet effect vs. Caucasians.
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Anti-oxidative and anti-inflammatory capacity did not correlate with HDL-cholesterol 
levels nor with HDL-phospholipid levels for all age groups (data not shown). As expected, 
HDL-cholesterol and HDL-phospholipid levels were positively correlated for all ages and 
all conditions (data not shown).
DISCUSSION
South Asians have an exceptionally high risk to develop cardiovascular disease compared 
to white Caucasians. A contributing factor might be dysfunctionality of HDL, which has 
been shown to be associated with cardiovascular disease in human studies. The current 
study showed that the ability of HDL to prevent oxidation of LDL was impaired in adult 
overweight South Asian males compared to matched white Caucasians. At younger 
ages, the anti-oxidative function of HDL was comparable between both ethnicities. In 
contrast, the anti-inflammatory capacity of HDL was markedly lower in South Asian neo-
nates, a difference that was not present at young adult and adult age. However, short-
term caloric restriction at adult age significantly impaired anti-inflammatory capacity 
in South Asians only. Finally, the ability of HDL to induce cholesterol efflux was similar 
between South Asians and Caucasians, albeit that in both ethnic groups cholesterol ef-
flux was increased after a 5-day HFHCD and reduced after an 8-day VLCD.
HDL functionality between ethnic groups
Several recent studies have reported lower HDL-cholesterol levels in South Asians as 
compared to Caucasians.29;31;32;36 Surprisingly, little is known about HDL functionality in 
South Asians. To date only one cross-sectional, uncontrolled pilot study assessed the 
anti-oxidative capacity of HDL in 28 South Asian immigrants in the USA.45 They found 
dysfunctional HDL, as measured by a cell-free assay, in 50% of the participants, which 
was significantly correlated with carotid intima media thickness, a surrogate marker of 
atherosclerosis. However, no Caucasian control group was included, so no statements 
could be made on the ethnic implication of this percentage. In the present study, 
HDL-cholesterol levels were comparable between South Asians and Caucasians for all 
ages. For the neonates this was due to the fact that we matched the groups on HDL-
cholesterol levels. For the young adults and adults, this might be due to lack of power 
to detect differences on HDL levels. However, despite equal HDL-cholesterol levels, 
we still observed several differences in HDL functionality between both ethnicities, 
suggesting that the HDL-cholesterol level was not a confounder in the current set-up. 
Recent evidence indeed suggests that HDL functionality might be affected independent 
of changes in plasma HDL-cholesterol levels and may be more important than plasma 
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HDL-cholesterol concentrations with respect to prediction of the cardioprotective effect 
of HDL.20;21;24-26
The oxidative modification of LDL is an important step in the initiation and progres-
sion of atherosclerosis as it results in enhanced uptake of LDL by macrophages and 
subsequent foam cell formation. HDL is able to prevent the oxidation of LDL and hence 
its subsequent atherogenic actions by various mechanisms.19;46 In the present study, 
we observed that the ability of HDL to prevent oxidation of LDL was markedly lower in 
adult South Asian men compared to matched Caucasian men. Therefore, the reduced 
anti-oxidative capacity of HDL in South Asians may be involved in the increased risk of 
cardiovascular disease in this ethnic group. Interestingly, the anti-oxidative capacity of 
HDL was not impaired at young adult and neonatal age, suggesting that the ability of 
HDL to protect against LDL oxidation deteriorates with age. Indeed, for South Asians 
anti-oxidative capacity was significantly lower in adult compared to young adult sub-
jects (p=0.002), while for Caucasians this capacity was comparable between both age 
groups (p=0.160). On the underlying mechanism behind this deterioration we can only 
speculate, but this might be due to exogenous factors such as insulin resistance and 
type 2 diabetes, which are also known to be considerably more prevalent in people of 
South Asian origin especially at higher age.9;11 It has been shown that insulin resistance 
and type 2 diabetesare associated with a decrease in HDL-cholesterol levels, altered 
HDL composition and impaired HDL function.47 In the current study plasma insulin 
levels were significantly higher in the South Asian adults, pointing to insulin resistance. 
Interestingly, Mulder et al.39 showed that the anti-oxidative capacity of HDL from type 2 
diabetes patients is inversely related to skin autofluorescence, a non-invasive marker of 
tissue advanced glycation end products, suggesting that impaired anti-oxidative capac-
ity of HDL may contribute to tissue accumulation of advanced glycation end products 
and thereby to the development of long term diabetic complications. Thus, insulin 
resistance may affect the ability of HDL to prevent oxidation of LDL or, vice versa, HDL 
dysfunction may also be involved in the increased risk of type 2 diabetes and diabetes-
related complications observed in South Asians.
HDL has several anti-inflammatory effects, such as the ability to inhibit cytokine-
induced expression of adhesion molecules on endothelial cells, and to control the 
adaptive immune system.46;48 Since suppression of immunity in neonates is important 
during pregnancy to prevent miscarriage, this may explain why we found higher anti-
inflammatory capacity of HDL in neonates as compared to adults. Furthermore, the anti-
inflammatory capacity of HDL was significantly lower in South Asian neonates (-36%). 
Interestingly, we previously found higher levels of the adhesion molecule E-selectin in 
cord blood of the same cohort of South Asian neonates as compared to Caucasians.30 This 
is a marker of endothelial activation which may thus be the consequence of the lower 
anti-inflammatory capacity of HDL. We did not find a difference in anti-inflammatory 
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capacity of HDL at young adult and adult age. This could suggest that during develop-
ment the lower anti-inflammatory function in South Asians recovers. However, a basis 
for atherosclerosis and the concomitant risk of cardiovascular disease is then probably 
already formed.
Finally, cholesterol efflux capacity did not differ between groups for all ages. The abil-
ity of HDL to stimulate cholesterol efflux involves transport of cholesterol from peripheral 
cells, particularly macrophage foam cells within atherosclerotic plaques, to the liver for 
final excretion into bile and feces, i.e. the reverse cholesterol transport pathway.49 This 
ability of HDL therefore might reverse or prevent the formation of macrophage foam 
cells and is thus an important atheroprotective property, however, deterioration of this 
function is likely not involved in the high cardiovascular disease risk of the South Asian 
population.
Response of HDL functionality to short-term dietary intervention
HDL functionality was also assessed in response to short-term dietary intervention 
in order to investigate ethnic differences upon dietary stimuli. Previous studies have 
demonstrated that both HDL-cholesterol levels and HDL functionality can be influenced 
by dietary intervention.27;28;50-52
In the present study, a 5-day HFHCD increased HDL-cholesterol, whereas an 8-day 
VLCD did not affect HDL-cholesterol levels and decreased HDL-phospholipids. Choles-
terol efflux ability was enhanced in response to a 5-day HFHCD, and reduced after an 
8-day VLCD, which might be explained by the increase in HDL-cholesterol and phos-
pholipid levels and decrease in phospholipids, respectively. Indeed, in both the young 
adult group and adult group cholesterol efflux capacity was positively correlated with 
HDL-cholesterol (Figure 2) and phospholipid levels.
Interestingly, anti-inflammatory capacity was significantly impaired after an 8-day 
VLCD only in South Asians. Hence, instead of being beneficial, caloric restriction appears 
to be detrimental to South Asians with respect to anti-inflammatory function of HDL. 
Possibly, this worsening of HDL anti-inflammatory capacity may only be present in the 
calorie-restricted state, returning to normal or even improving after weight loss and 
re-introduction of a normal diet. Indeed, our group previously assessed the short- and 
long-term effects of a 4-month VLCD on low-grade inflammation in obese patients with 
type 2 diabetes and demonstrated that the beneficial effects on chronic inflammation 
become apparent only when patients are on a eucaloric diet, suggesting that severe 
caloric restriction at first increases cytokine production by adipose tissue macrophages 
and that the beneficial effects of weight loss become apparent only in the eucaloric 
state.53 Hence, perhaps the initial response to caloric restriction is worse in South Asians 
compared to Caucasians, but may normalize later on. This may, at least in part, be due 
to the fact that South Asians have higher release of pro-inflammatory cytokines, such as 
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interleukin-6 and tumour necrosis factor-α, by adipocytes, which may aggravate in case 
of caloric restriction.54;55 Taken together, further research is needed to elucidate why 
South Asians respond differently compared to Caucasians to caloric restriction concern-
ing HDL anti-inflammatory functionality.
This study is not without limitations. The sample sizes are relatively small, which 
might limit generalization potential. On the other hand, subjects were their own con-
trols (with respect to diet intervention), which increases the power to detect relevant 
differences. Strengths of this study are the assessment of several HDL functions in South 
Asians, in comparison to Caucasians, at three different age categories, and in response 
to dietary intervention.
In conclusion, we showed that adult, overweight South Asians have impaired anti-
oxidative capacity of HDL, which is not yet present at a young age and, therefore, pos-
sibly at least partly the consequence of environmental factors. Furthermore, anti-inflam-
matory capacity was reduced in South Asian neonates, and was significantly impaired 
in response to short-term caloric restriction in South Asian adults. These impairments 
in HDL functionality may contribute to the excess risk of cardiovascular disease, and 
possibly of type 2 diabetes in people of South Asian origin. Therefore, future studies 
should be directed at developing treatment strategies that improve HDL functionality, 
and at investigating whether these strategies will lower cardiovascular risk in South 
Asian subjects.
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The risk of developing type 2 diabetes and cardiovascular disease is exceptionally high 
among both native and migrant South Asians, comprising one fifth of the total world’s 
population and consequently posing a major health and socioeconomic burden world-
wide. The underlying cause of this excess risk is still poorly understood. This thesis aimed 
to gain more insight in the pathogenesis of type 2 diabetes and cardiovascular disease 
in people of South Asian descent, and to provide new leads for preventive strategies and 
treatment options.
PART 1: TYPE 2 DIABETES MELLITUS
In PART 1 of this thesis we focused on the pathogenesis of type 2 diabetes in South 
Asians.
In Chapter 2 we reviewed potential pathophysiological mechanisms responsible for 
the increased risk of type 2 diabetes in South Asians compared to white Caucasians. The 
predominant mechanism in this ethnic group seems to be insulin resistance rather than 
impaired insulin secretion, given the consistently found higher insulin levels in South 
Asians compared to other ethnic groups regardless of age, gender or BMI. We described 
several possible mechanisms that may underlie or contribute to this increased preva-
lence of insulin resistance. A gene-environment interaction seems most likely: South 
Asians seem to have a high genetic susceptibility and enhanced interaction with envi-
ronmental triggers such as a high fat diet and low levels of physical activity. They have 
a remarkable disadvantageous metabolic phenotype. South Asians are born relatively 
small, and already at birth they have high insulin levels and exhibit a thin-fat-phenotype, 
which remains throughout life. They develop type 2 diabetes at lower ranges of BMI 
compared to white Caucasians. Furthermore, it has been shown that South Asians have 
dysfunctional adipose tissue and are in a continuous state of low grade inflammation. 
Additionally, South Asians seem to have higher hepatic and intramyocellular lipid 
content, but have less skeletal muscle mass and seem to have lower cardiorespiratory 
fitness and reduced capacity for fat oxidation during submaximal exercise. Remarkably, 
as of yet no convincing differences in intracellular signalling cascades and enzymatic 
process involved in insulin signalling have been found between South Asians and white 
Caucasians. However, so far only two studies obtained muscle biopsies and investigated 
mitochondrial function, and only one investigated the insulin signalling pathway. Finally, 
endothelial and HDL dysfunction have been observed in several studies in South Asians, 
possibly leading to a decreased NO bioavailability and affecting substrate delivery to 
skeletal muscle. Hence, so far, an overall biological explanation for their unfavourable 
phenotype remains to be elucidated. We proposed several other areas of interest that 
should be explored in South Asians to further investigate this phenotype.
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Chapter 3 describes a study investigating the high insulin levels in response to an oral 
glucose load consistently found in South Asians compared to white Caucasians. These 
higher insulin levels are considered a compensatory mechanism to overcome insulin 
resistance and maintain normal glucose tolerance, and might either be caused by a 
decreased insulin clearance, or an increased β-cell response. Therefore, we investigated 
if this increased insulin response is due to an increased response of GLP-1, an incretin 
secreted from the gut in response to eating that stimulates insulin secretion. In addition, 
we were interested whether this increased insulin response causes reactive hypogly-
cemia, which is characterized by a drop in glucose level 4-6 hours after a glucose load, 
and is considered a sign of latent diabetes.1-3 For this purpose, eight young, healthy 
South Asian men and ten white Caucasian men were subjected to a prolonged 6-hour 
75-g OGTT. This study confirms that young healthy South Asian men are more insulin 
resistant and have higher insulin levels during an OGTT than white Caucasian men. The 
high insulin levels were accompanied by increased levels of GLP-1, as reflected by an 
increased AUC for GLP-1. Since the incretin effect and the direct insulinotropic action 
of GLP-1 were not assessed in this study, it remains to be elucidated whether this is a 
compensatory response to facilitate hyperinsulinemia to overcome insulin resistance or 
reflects a GLP-1 resistant state. The finding that the peak GLP-1 levels preceded the peak 
insulin response and paralleled the increased β-cell activity suggests, however, a direct 
relation between the increased GLP-1 response and the insulin secretion by the β-cell. 
Finally, although insulin levels were higher in South Asians during the whole test, this 
did not lead to reactive hypoglycemia.
Given the high susceptibility of South Asians to develop type 2 diabetes despite a similar 
environmental pressure when compared to other ethnicities, a possible explanation for 
this excess risk might be related to differences in the regulation of energy/nutrient-
sensing pathways in metabolic tissues thereby affecting whole-body substrate homeo-
stasis. In Chapters 4 and 5 we investigated these pathways in young adult and adult 
subjects, respectively, with a special focus on canonical insulin signalling and mTORC1 
pathways. All subjects underwent a 2-step hyperinsulinemic-euglycemic clamp with 
skeletal muscle biopsies and indirect calorimetry before and after a short-term dietary 
intervention. In addition, HTG and abdominal fat distribution were assessed using MRI/S.
In Chapter 4 we compared the metabolic adaptation to a 5-day HFHCD in 12 young 
healthy South Asian and 12 white Caucasian men. Metabolic clearance rate of insulin 
and hepatic insulin sensitivity were reduced in South Asians compared to Caucasian 
subjects both before and after the diet. Strikingly, a 5-day HFHCD was already sufficient 
to impair insulin-stimulated glucose disposal in South Asians, while such an effect was 
not observed in Caucasians. The impairment in glucose disposal was primarily due to 
a decrease in NOGD, suggesting a defect in glycogen storage. However, no obvious 
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differences were found in expression of proteins and genes involved in glycolysis and 
glycogen synthesis between groups. At the skeletal muscle level no significant differ-
ences were found between groups in mTOR-signalling, nor in insulin signalling, meta-
bolic gene expression and mitochondrial respiratory-chain content, that could explain 
the diet-induced impairment in insulin-stimulated glucose disposal in South Asians. 
Furthermore, no differences in HTG and abdominal fat were detected. The fact that we 
did not find obvious differences between groups might be explained by the relatively 
good health of our subjects and/or the small sample size. Finally, we cannot exclude 
the possibility that white adipose tissue might have contributed to the diet-induced 
impairment in insulin-stimulated glucose disposal in South Asians. About 10-20% of 
whole-body glucose uptake occurs in white adipose tissue, which corresponds to the 
observed reduction in glucose disposal in South Asians. In conclusion, HFHC-feeding 
rapidly induced insulin resistance only in healthy, young, lean South Asian subjects, sug-
gesting that the propensity of South Asians to develop type 2 diabetes may be partly 
explained by the way they adapt to high fat western food. The mTOR-pathway does not 
seem to be involved, at least in skeletal muscle.
In Chapter 5 we assessed the effect of caloric restriction through an 8-day VLCD on 
skeletal muscle energy/nutrient-sensing pathways in 12 middle-aged overweight South 
Asian and 12 white Caucasian men. At baseline, South Asians were more insulin resistant 
compared to Caucasians, as indicated by higher insulin levels (both fasting and during 
OGTT), and lower hepatic and peripheral insulin sensitivity. In addition, metabolic clear-
ance rate of insulin was lower and hepatic triglyceride content was higher in South Asian 
subjects. Deposition of fat in the liver is associated with hepatic insulin resistance.4 The 
impairment in peripheral insulin sensitivity in South Asians appeared to be due to a 
reduced rate of NOGD, suggesting a defect in glycogen storage, one of the main defects 
observed in patients with type 2 diabetes.5 However, no between-group differences 
were found in expression of proteins and genes involved in glycolysis and glycogen 
synthesis, in line with our findings in the young adult group. In addition, no differences 
were observed before the diet in skeletal muscle insulin and mTOR signalling. Substrate 
oxidation rates and metabolic flexibility were comparable between groups. Intriguingly, 
South Asian subjects exhibited a different metabolic adaptation to an 8-day VLCD. In 
both groups, HTG and abdominal fat distribution were reduced, and hepatic insulin 
sensitivity was improved in response to the diet, as expected from previous studies.6-9 
However, whereas Caucasian subjects switched from carbohydrate to lipid oxidation in 
fasted condition and showed an improved insulin effect on substrate oxidation rates, 
indicating they were metabolically flexible, the shift in whole-body substrate oxidation 
rates in South Asians was impaired after the diet, both in fasted condition and during 
hyperinsulinemia, reflecting metabolic inflexibility. Furthermore, in Caucasians periph-
eral insulin sensitivity was not affected by the diet, in line with other short-term caloric 
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restriction studies leading to minimal weight loss,6-8 whereas in South Asians periph-
eral insulin sensitivity was slightly improved, primarily due to enhanced NOGD, despite 
lowered insulin levels. Interestingly, skeletal muscle energy/nutrient-sensing pathways 
were differentially affected, notably with an increase in insulin-induced activation of 
the ERK-mTOR-S6K1 axis in South Asians. Growing evidence suggests that mTORC1 can 
suppress fatty acid β-oxidation by inhibiting PPARα and the transcriptional regulation of 
its target genes.10-14 Intriguingly, mRNA-expression of PPARA was significantly decreased 
only in South Asian subjects. Hence, the hyperactive mTOR-pathway in South Asians in 
response to short-term caloric restriction may have repressed fatty acid β-oxidation by 
inhibiting PPARα, resulting in impaired metabolic flexibility. mTORC1 is also known to 
have negative effects on insulin sensitivity. Glucose disposal rate, however, improved in 
South Asians, apparently primarily accounted for by increased NOGD, although no dif-
ferences in glycogen metabolism were observed between groups. Interestingly, AMPK 
expression was significantly increased in South Asians, but not in Caucasians. AMPK 
activation promotes skeletal muscle glucose uptake and may underlie the improved 
NOGD in South Asians after caloric restriction, which might explain the improved glu-
cose disposal rate in South Asian subjects. In conclusion, middle-aged overweight South 
Asian men exhibited a different metabolic adaptation to short-term caloric restriction 
compared to age- and BMI-matched white Caucasians. Although glucose disposal rate 
was improved in South Asians in contrast to Caucasians, metabolic flexibility was im-
paired after an 8-day VLCD, which was accompanied by an increase in insulin-induced 
activation of the skeletal muscle ERK-mTOR-S6K1 axis.
Recently, brown adipose tissue (BAT) has emerged as a novel player in energy metabo-
lism in humans. In Chapter 6 we gave an overview of the anatomy, physiology and func-
tion of BAT and described how BAT could be manipulated in order to increase energy 
expenditure and possibly induce weight loss. In contrast to white adipose tissue, BAT 
takes up glucose and triglyceride-derived fatty acids from the plasma and subsequently 
burns fatty acids to generate heat through a process called mitochondrial uncoupling.15 
Interestingly, BAT volume and activity, as assessed after exposure to cold by 18F-FDG 
PET-CT-scans, are inversely related to BMI and percentage of body fat in adult humans, 
indicating an inverse relationship between BAT and obesity.16-18 Besides a clear role for 
BAT in triglyceride metabolism19 BAT is also thought to contribute to glucose homeo-
stasis, particularly in resting conditions when glucose utilization by skeletal muscle is 
minimal.20 Importantly, BAT appears to contribute to NST18;21 and it has been estimated 
that fully activated BAT in humans can contribute up to 15-20% of total energy expendi-
ture.15 Additionally, several pathological conditions that lead to activation of BAT, such as 
hyperthyroidism and pheochromocytoma, result in increased energy expenditure and 
in weight loss. Hence, increasing the activity of BAT is considered a promising method 
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to increase energy expenditure and subsequently induce weight loss. Various ways in 
which BAT can be manipulated have been identified, e.g. exposure to cold, the use of 
so-called uncoupling agents or the administration of the hormone irisin.
Since BAT is involved in total energy expenditure and clearance of serum triglycer-
ides and glucose thereby protecting against metabolic disturbances, we hypothesized 
that a low BAT volume or activity might underlie the disadvantageous metabolic phe-
notype and susceptibility for type 2 diabetes in South Asians. Therefore, in Chapter 7, 
we investigated REE as well as BAT volume and activity in 12 young healthy lean South 
Asian men and 12 white Caucasians, using ventilated hoods and cold-induced 18F-FDG-
PET-CT-scans. We demonstrated that thermoneutral REE was -32% lower in South Asian 
subjects compared to Caucasians. In addition, temperature at which shivering started 
was higher despite a higher total percentage of fat mass, and cold-induced NST was 
smaller in South Asians. Strikingly, the detectable volume of metabolically active BAT 
was markedly lower in South Asians (-34%). The fact that this is found already in healthy 
young adults without differences in the degree of 18F-FDG uptake, as evidenced by equal 
SUVmax and SUVmean, could point to a defect in BAT differentiation. The underlying cause 
of the lower BAT volume in South Asians may be genetic (i.e. blunted expression of sig-
nalling molecules involved in BAT differentiation, e.g. NO, environmental (i.e. clothing 
behaviour, central heating setting and/or eating pattern), or a combination of the two. 
These findings suggest that a low BAT volume may underlie the high susceptibility to 
develop metabolic disturbances, such as obesity and type 2 diabetes, in South Asians. 
Hence, increasing the volume or activity of BAT might be of great therapeutic potential 
in this ethnic group, possibly resulting in increased clearance of glucose and fatty acids 
and increased total energy expenditure.
PART 2: CARDIOVASCULAR DISEASE
In PART 2 of this thesis we focused on the pathogenesis of cardiovascular disease in 
South Asians.
In Chapter 8, we reviewed potential factors contributing to the increased car-
diovascular risk of South Asians and discussed novel therapeutic strategies based on 
recent insights. The major cause of cardiovascular disease is atherosclerosis, which is 
present many years before any clinical symptoms of cardiovascular disease become 
manifest. The development of atherosclerosis may be promoted by metabolic as well 
as inflammatory risk factors. Metabolic or ‘classical’ risk factors include dyslipidemia, 
central obesity and insulin resistance. In addition, although the precise mechanism is 
still under debate, inflammatory or ‘non-classical’ risk factors may contribute to devel-
opment of cardiovascular disease. Among these are systemic inflammation, as well as 
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HDL dysfunction and endothelial dysfunction which can both give rise to inflammation. 
In South Asians, classical risk factors associated with cardiovascular disease are highly 
prevalent. A contributing factor that may underlie the development of this disadvanta-
geous metabolic phenotype is the presence of a lower amount of BAT volume in South 
Asians, resulting in lower lipid oxidation and glucose uptake. These classical risk factors, 
however, cannot fully explain the increased South Asian risk for cardiovascular disease. 
Therefore, other non-classical risk factors must underlie this residual risk. Indeed, the 
prevalence of inflammatory risk factors including visceral adipose tissue inflammation, 
endothelial dysfunction, and HDL dysfunction, is higher in South Asians compared to 
white Caucasians. We concluded that a potential novel therapy to lower cardiovascular 
disease risk in the South Asian population is to enhance BAT volume or its activity in or-
der to diminish classical risk factors. Furthermore, anti-inflammatory therapy may lower 
non-classical risk factors in this population and the combination of both strategies may 
be especially effective.
Chapter 9 aimed to assess whether cardiac dimensions, cardiovascular function and 
myocardial triglyceride content differ between young, healthy South Asian and white 
Caucasian men, possibly contributing to the increased cardiovascular disease risk 
in South Asians. In addition, since insulin resistance and type 2 diabetes are highly 
prevalent in South Asians22 and the mortality risk of cardiovascular disease associated 
with type 2 diabetes is higher in South Asians compared to white Caucasians,23;24 we 
hypothesized that the excess cardiac risk in South Asians might be due to a higher 
cardiac susceptibility to metabolic disorders. Therefore, we assessed cardiac dimensions 
and cardiovascular function using a 1.5T-MRI/S-scanner in 12 young, healthy male South 
Asians and 12 white Caucasians, and subjected them to a 5-day HFHCD to study cardiac 
response to metabolic stress. At baseline, South Asians were more insulin resistant and 
had higher LDL-cholesterol levels. Cardiac dimensions were smaller in South Asians, as 
indicated by lower left ventricular mass and end-diastolic volume, indexed for body 
surface area. Furthermore, differences in diastolic and systolic cardiac function profiles 
were observed. Parameters of diastolic function, E acceleration and deceleration peak 
flows, were lower in South Asians, suggesting prolonged cardiac relaxation compared to 
white Caucasians. In addition, measures of systolic cardiac function, aortic acceleration 
and deceleration peak flows, were lower in South Asians, indicating prolonged cardiac 
contraction as well. A 5-day HFHCD did not increase these differences, despite a signifi-
cant increase in both insulin levels and HOMA-B% only in South Asians, indicating they 
became even more insulin resistant. Finally, aortic pulse wave velocity, a powerful in-
dependent predictor of cardiovascular events,25 was higher in South Asians at baseline, 
indicating increased arterial stiffness, which normalized after the diet. Hence, young, 
healthy South Asians have smaller cardiac dimensions, even when corrected for their 
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smaller stature, and a different cardiovascular function profile than white Caucasians. 
Reduced insulin sensitivity and increased LDL-cholesterol might be causally related 
to the different cardiac function profiles in South Asians.26;27 Another possibility is that 
the observed differences in cardiac dimensions and cardiovascular function are innate 
and are simply representative of differing normal reference values in these two ethnic 
groups. Whether the observed differences contribute to the higher incidence of cardio-
vascular disease in South Asians remains to be determined. They cannot be explained by 
a different metabolic response to short-term dietary fat consumption, as a 5-day HFHCD 
did not increase the observed differences, despite distinct metabolic effects. It is pos-
sible, however, that a longer HF-diet is needed to induce changes.
In Chapter 10 we assessed whether metabolic and functional cardiovascular flex-
ibility to caloric restriction differs between middle-aged, overweight South Asian and 
white Caucasian men. Mortality risk of cardiovascular disease associated with type 2 
diabetes is higher in South Asians compared to Caucasians,23 suggesting they have a 
higher cardiac susceptibility to metabolic disorders. Short-term caloric restriction can 
be used as a metabolic stress test to study cardiac flexibility. Previous studies in healthy 
subjects and obese patients with type 2 diabetes with and without cardiovascular 
disease of white Caucasian descent demonstrated similar metabolic and functional 
flexibility of the heart in response to both short- and long-term caloric restriction.9;28-30 
It is unknown, however, if caloric restriction has comparable effects in South Asians. 
Therefore, we assessed cardiovascular function and myocardial triglycerides using 
a 1.5T-MRI/S-scanner in 12 middle-aged overweight South Asian men and 12 white 
Caucasians before and after an 8-day VLCD. At baseline, South Asians were more insulin 
resistant than Caucasians as indicated by higher insulin levels both in fasted condition 
and during OGTT. Cardiac dimensions were smaller, despite correction for body surface 
area, and PWV in the distal aorta was higher in South Asians, similar to our findings in the 
young adult group. The higher PWV in South Asians might be attributed to the higher 
insulin levels observed in this group. Long-term increased insulin levels, as observed 
in insulin resistance and type 2 diabetes, are known to compromise aortic elastic func-
tion.31 Systolic and diastolic function, myocardial triglycerides and pericardial fat did not 
differ significantly between groups. After the VLCD, myocardial triglycerides increased 
in both ethnicities with 69±18%. Although increased myocardial triglyceride content 
in insulin resistance is associated with impaired myocardial function,32-34 the increase in 
myocardial triglycerides observed after a short-term VLCD is a sign of preserved meta-
bolic flexibility of the heart.9;28 Given the high risk on cardiovascular disease and type 
2 diabetes in South Asians, we hypothesized that the flexibility of the heart to adjust 
myocardial triglyceride content in response to caloric restriction would be diminished 
in South Asians. Surprisingly, however, an 8-day VLCD increased myocardial triglycerides 
similarly in both groups, suggesting a similar physiological flexibility of myocardial lipid 
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metabolism in both ethnicities. Diastolic cardiac function decreased after the diet in 
both South Asians and Caucasians, as expected from previous studies,9;28;30 and can 
probably be explained by changes in elastic properties of the LV. However, pericardial 
fat decreased significantly in Caucasians only in response to the dietary intervention, 
mainly due to a reduction in the paracardial fat layer. Since the paracardial fat layer has 
been found to be a predictor of cardiovascular disease, the decrease in this specific fat 
compartment in Caucasians probably conveys less cardiovascular risk.35 Furthermore, 
PWV in the proximal and total aorta was reduced after the VLCD in Caucasians only, 
suggesting that the large arteries are less flexible in South Asians in response to ca-
loric restriction. This might be due to the, probably long-term existing, higher insulin 
levels observed in South Asians which may have induced irreversible changes in the 
arterial wall. Hence, myocardial triglyceride stores and diastolic function in middle-aged 
overweight and insulin resistant South Asians are as flexible and amenable to thera-
peutic intervention by caloric restriction as age-, sex- and BMI-matched but less insulin 
resistant white Caucasians This suggests that caloric restriction as a preventive and/or 
therapeutic strategy against cardiovascular disease is as valuable in South Asians as in 
white Caucasians. However, paracardial fat volume and PWV showed a differential effect 
in response to an 8-day VLCD in favour of Caucasians.
Finally, in Chapter 11 we compared HDL function in neonates, young adults and adults 
of South Asian and white Caucasian origin. Dysfunction of HDL has been is associated 
with cardiovascular disease.36-41 The cardiovascular protective effects of HDL have been 
attributed to several anti-atherogenic properties, including prevention of LDL oxida-
tion, anti-inflammatory properties, stimulation of cholesterol efflux from foam cells, 
and inducing vasodilation by induction of NO release.42-46 Interestingly, multiple studies 
have repeatedly found lower HDL-cholesterol levels in South Asians compared to Cauca-
sians.47-54 Hence, a possible contributing factor to the excess high risk of cardiovascular 
disease in South Asians might be low levels and/or dysfunction of HDL. Therefore, this 
study determined HDL functionality with respect to cholesterol efflux, anti-oxidation 
and anti-inflammation in vitro using fasting plasma samples from South Asian and white 
Caucasian neonates (n=14 each), young adult healthy men (n=12 each, 18-25y), and 
adult overweight men (n=12 each, 40-50y). Furthermore, since HDL function can be 
influenced by dietary intervention,55;56 we assessed the effect of short-term dietary in-
tervention on HDL function: young adults were subjected to a 5-day HFHCD and adults 
to an 8-day VLCD. This study showed that the ability of HDL to prevent oxidation of LDL 
was impaired in adult overweight South Asian men compared to white Caucasians. At 
younger ages, the anti-oxidative function of HDL was still comparable between both 
ethnicities. The underlying mechanism behind this deterioration might be due to exog-
enous factors such as insulin resistance and type 2 diabetes, highly present in people 
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of South Asian origin, especially at higher age. Indeed, it has been shown that insulin 
resistance and type 2 diabetes are associated with a decrease in HDL-cholesterol levels, 
altered HDL composition and impaired HDL function.44 In the current study plasma 
insulin levels were significantly higher in the South Asian adults, pointing to insulin 
resistance. Interestingly, the anti-oxidative capacity of HDL from diabetic patients is 
inversely related to skin autofluorescence, a non-invasive marker of tissue AGEs, sug-
gesting that impaired anti-oxidative capacity of HDL may contribute to tissue accumula-
tion of AGEs and thereby to the development of long term diabetic complications.57 
Thus, insulin resistance may affect the ability of HDL to prevent oxidation of LDL or, vice 
versa, HDL dysfunction may also be involved in the increased risk of type 2 diabetes 
and diabetes-related complication in South Asians. In contrast, the anti-inflammatory 
capacity of HDL was markedly lower in South Asian neonates, a difference that was not 
present at young adult and adult age, suggesting that during development the lower 
anti-inflammatory function in South Asians recovers. However, a basis for atherosclero-
sis and the concomitant risk of cardiovascular disease is then probably already formed. 
Furthermore, short-term caloric restriction at adult age significantly impaired anti-
inflammatory capacity in South Asians only. Hence, instead of being beneficial, caloric 
restriction appears to be detrimental to South Asians with respect to anti-inflammatory 
function of HDL. Possibly, this worsening of HDL anti-inflammatory capacity may only 
be present in the calorie-restricted state, returning to normal or even improving after 
weight loss and re-introduction of a normal diet. This may, at least in part, be due to the 
fact that South Asians have higher release of pro-inflammatory cytokines by adipocytes, 
which may aggravate in case of caloric restriction.58;59 Finally, the ability of HDL to induce 
cholesterol efflux was similar between South Asians and Caucasians. In both ethnic 
groups cholesterol efflux was increased after a 5-day HFHCD and reduced after an 8-day 
VLCD. In conclusion, we showed that anti-inflammatory capacity of HDL was reduced 
in South Asian neonates, and was significantly impaired in response to short-term 
caloric restriction in South Asian adults. Furthermore, adult overweight South Asians 
had impaired anti-oxidative capacity of HDL, which was not yet present at a young age 
and, therefore, likely the consequence of exogenous factors. These impairments in HDL 
functionality may contribute to the excess risk of cardiovascular disease, and possibly of 
type 2 diabetes, in people of South Asian origin.
CONCLUDING REMARKS AND FUTURE RESEARCH
The ethnic disparity in diabetic and cardiovascular risk between South Asians and white 
Caucasians is most likely due to different gene frequencies or expression as well as 
diverse programming influences (either genetic or programmed by an adverse intra-
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uterine environment). This has led to the disadvantageous metabolic South Asian phe-
notype, which has evolved over generations promoting selective survival in response 
to certain environmental challenges – such as recurring famine-induced starvation, 
adverse climate conditions, and varying burdens of infectious diseases – but is now 
out of step with modern lifestyle and longer life expectancy. In addition, differences in 
demographic profiles and environmental factors secondary to urbanization will have 
contributed to the high susceptibility of South Asian people to develop type 2 diabetes 
and cardiovascular diseases.60 This thesis aimed to gain more insight in the pathogenesis 
of these diseases in South Asians. I propose that these various influences have affected 
not one, but multiple important metabolic mechanisms. Below I will discuss several top-
ics, some of which have been studied in this thesis and some of which still need to be 
investigated, and suggest ideas for future research.
Insulin signalling, mitochondrial function and GLP-1
Insulin signalling and mitochondrial function are involved in glucose metabolism. 
Skeletal muscle accounts for the major part of insulin-stimulated glucose disposal.61 
NOGD or glycogen synthesis and oxidative glucose metabolism through glycolysis are 
the major pathways for glucose disposal.5;62;63 Furthermore, GLP-1, secreted in the gut 
in response to eating, is known to have several beneficial effects on glucose regulation.
Compared with control subjects (white Caucasians) a 5-day HFHCD rapidly impaired 
insulin-stimulated glucose disposal in young, healthy South Asians. Furthermore, in adult 
overweight South Asians, peripheral insulin sensitivity was lower at baseline. In both 
age groups, this impairment in glucose disposal was primarily due to reduced NOGD, 
suggesting a defect in glycogen storage. However, no differences were found in skeletal 
muscle expression of proteins and genes involved in glycolysis and glycogen synthesis 
between controls and South Asians. In addition, no differences were observed in skeletal 
muscle insulin signalling, metabolic gene expression or mitochondrial respiratory-chain 
content. Another finding is that the higher insulin levels during an OGTT in South Asians 
were accompanied by increased levels of GLP-1, probably as an adaptive response to 
facilitate hyperinsulinemia to overcome insulin resistance.
Future research. The role of glycogen metabolism should be further explored by de-
termining skeletal muscle glycogen content and dynamics. The findings on mitochon-
drial function should be verified via measuring other, more sophisticated mitochondrial 
markers, such as ex vivo determination of activities of mitochondrial respiratory-chain 
complexes and citrate synthase activity. Furthermore, we cannot exclude the possibility 
that differences in white adipose tissue function might have contributed to our findings; 
hence, the role of white adipose tissue in the pathogenesis of type 2 diabetes in South 
Asians should be assessed, especially since it has been shown that South Asians have 
dysfunctional adipose tissue. Regarding GLP-1, it would be interesting to assess the 
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incretin effect and the direct insulinotropic action of GLP-1 to confirm that the increased 
GLP-1 response is a compensatory response rather than reflecting a GLP-1 resistant 
state. This can be studied by an OGTT and an isoglycemic intravenous glucose tolerance 
test to determine the incretin effect, and by hyperglycemic clamps to determine the 
direct action of GLP-1.
Energy/nutrient sensing pathways
A possible explanation for the South Asian predisposition for type 2 diabetes might be 
related to differences in the regulation of energy/nutrient-sensing pathways in skeletal 
muscle and other metabolic tissues affecting whole-body substrate homeostasis.
Indeed, adult overweight South Asian men exhibited a different metabolic adapta-
tion to short-term caloric restriction. Although glucose disposal rate was improved in 
contrast to Caucasian subjects, metabolic flexibility was impaired, which was accompa-
nied by an increase in insulin-induced activation of the ERK-mTOR-S6K1 axis. In addition, 
mRNA expression of PPARA was decreased in South Asians with a concomitant differ-
ential effect on several of its target genes, suggesting the hyperactive mTOR-pathway 
may have repressed fatty acid β-oxidation by inhibiting PPARα resulting in impaired 
metabolic flexibility. The increase in AMPK expression in South Asians may underlie their 
improved NOGD after caloric restriction, which might explain the enhanced glucose 
disposal rate in South Asians only. The fact that we did not observe differences in mTOR, 
AMPK or other energy/nutrient-sensing pathways in the young adult study might sug-
gest that differences in these pathways develop with age and in a more unfavourable 
metabolic phenotype.
Future research. To explore the underlying mechanisms in more detail, in depth stud-
ies should be performed on the role of mTOR and AMPK in glucose and FFA metabolism 
and metabolic flexibility using clamping techniques and skeletal muscle and white 
adipose tissue biopsies before and after a single exercise test and short-term exercise 
and dietary interventions. As chronic mTORC1 activation is believed to contribute to 
the development of insulin resistance and type 2 diabetes,11 the response to long-term 
caloric restriction on mTORC1 signalling and insulin sensitivity merits investigation. 
Interestingly, not only mTORC1 but also mTORC2 appears to be a central regulator of 
lipid metabolism, regulating for example lipolysis in white adipose tissue.64 mTORC2 is 
therefore another interesting research topic. In light of the impaired metabolic flexibility, 
other possible explanations apart from suppressed skeletal muscle lipid oxidation via 
mTORC1/PPARα, such as a lower portion of slow-twitch type 1 oxidative muscle fibres, 





Since BAT is involved in total energy expenditure and clearance of serum triglycerides 
and glucose,15 a low BAT volume or activity, leading to a disturbed energy homeostasis, 
might underlie the disadvantageous metabolic phenotype and susceptibility for type 2 
diabetes and cardiovascular disease in South Asians.
Indeed, the detectable volume of metabolically active BAT was lower in young, 
healthy South Asians compared to controls. The underlying cause of the lower BAT 
volume may be genetic (i.e. blunted expression of signalling molecules involved in BAT 
differentiation) and/or- environmental, i.e. clothing behaviour, central heating setting or 
eating pattern, or a combination of the two.
Future research. Future studies should investigate the underlying cause of lower BAT 
volume in South Asians. Several key molecules have been shown to be involved in BAT 
differentiation in rodents, including NO.65 Interestingly, South Asians appear to have re-
duced bioavailability of NO compared to white Caucasians.66 Thus, an inborn reduction 
in NO bioavailability might play a role in the diminished BAT volume in South Asians. 
Furthermore, studies should be directed towards the development of novel strategies 
(e.g. cold exposure or medication) to increase BAT volume and activity. For example, re-
garding the role of NO in BAT differentiation and the observed lower NO bioavailability 
in South Asians, it would be interesting to perform a randomized placebo controlled 
trial to determine the effect of oral supplementation of L-arginine, a semi-essential 
amino acid and the precursor of NO, on energy expenditure and insulin sensitivity, using 
cold-induced 18F-FDG PET-CT-scans, indirect calorimetry and clamping techniques. Also 
interesting is to study the effect of cold exposure on BAT recruitment in South Asians.
HDL function
HDL has several anti-atherogenic properties46;67-71 and dysfunction of HDL may not only 
directly aggravate atherosclerosis development as a consequence of lower cholesterol 
uptake from the vascular wall, but also indirectly through induction of inflammation 
as well as through reduced vasodilatation, due to less stimulation of NO release. The 
latter leads to increased endothelial shear stress and, hence, to endothelial activation. 
Reduced vasodilatation also leads to decreased delivery of insulin to tissues that take 
up glucose.
Anti-inflammatory capacity of HDL was reduced in South Asian neonates, and was 
significantly impaired in response to short-term caloric restriction in South Asian adults. 
This impairment is possibly only present in the calorie-restricted state and may be due 
to higher release of pro-inflammatory cytokines. Furthermore, adult overweight South 
Asians had impaired anti-oxidative capacity of HDL, which was not yet present at a 
young age and, therefore, likely the consequence of exogenous factors. Cholesterol ef-
flux capacity of HDL was similar between groups.
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Future research. Studies should be directed at developing treatment strategies that 
improve HDL functionality. The next step would be to investigate whether these strate-
gies will indeed lower cardiovascular and diabetic risk in South Asians. In this context 
it is worthwhile to investigate whether HDL-cholesterol of South Asians is functionally 
capable of stimulating NO release by the endothelium. This can be studied by isolating 
HDL from blood samples and incubate HDL with endothelial cells; the amount of NO 
release by the endothelium is a measure for the functionality of HDL.
Endothelial function
Endothelial activation is involved in the development of atherosclerosis.72 A hallmark of 
endothelial activation is a reduction in the bioavailability of endothelium-derived NO. 
NO not only has vasodilating properties, but also anti-platelet, anti-proliferative, and 
anti-inflammatory properties.73;74 The vasodilating effect of NO is related to insulin resis-
tance and type 2 diabetes: vasodilatation increases delivery of insulin to tissues that take 
up glucose, and, vice versa, insulin stimulates the release of NO from the endothelium 
thereby inducing capillary recruitment.75;76
Signs of endothelial dysfunction have been demonstrated in South Asians.48;77;78 
Furthermore, South Asians appear to have lower circulating EPCs compared to white 
Caucasians.66;78 This may lead to a reduced capacity for endothelial repair, and exercise-
induced EPC mobilization. In addition, EPC mobilization was reduced in South Asian 
men,66 presumably as a consequence of their reduced NO bioavailability.
Future research. It would be interesting to assess the role of endothelial function in 
insulin sensitivity, atherosclerosis and BAT metabolism in South Asians compared to 
white Caucasians. Endothelial function can be determined by isolating EPCs from blood 
samples and performing in vitro function tests e.g. NO production. The effect of hyper-
insulinemia on insulin-induced capillary recruitment and the response to infusion of NO 
precursor L-arginine on capillary density, EPC mobilization, degree of atherosclerosis 
and insulin-stimulated glucose disposal should be further explored. Furthermore, the 
effect of submaximal exercise on capillary recruitment is worth investigating in light of 
a possible defect in substrate delivery to muscle.79
Sympathetic nervous system activity
The sympathetic nervous system is involved in many homeostatic mechanisms by 
innervating tissues in virtually every organ system, and is recognized to play a role in 
energy expenditure. Interestingly, reduced muscle sympathetic nervous system activity 
has been found in Pima Indians, a population with a similar high prevalence of obesity, 
insulin resistance and type 2 diabetes as South Asians. Furthermore, sympathetic ner-
vous system activity was not related to body fat mass and energy expenditure in Pima 
Indians, whereas in Caucasians a significant correlation was observed.80
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Plasma FFAs increased less in response to short-term caloric restriction in adult 
overweight South Asians and in response to cold in young healthy South Asians. This 
was accompanied with a lower increase in whole-body lipid oxidation in adult South 
Asians, and a lower cold-induced increase in lipid oxidation and systolic blood pressure 
in adolescent South Asians. This may suggest that South Asians rather store than burn 
fat (or energy), and may point to differences in sympathetic activation and/or peripheral 
resistance to sympathetic outflow in white adipose tissue and the vasculature.
Future research. Future studies should investigate a potentially different, organ-
specific sympathetic response in South Asians compared to white Caucasians and the 
potential link with energy expenditure, in fasted resting condition and in response to 
glucose, insulin and exercise.
Finally, there are other areas that merit further exploration as well, including: 1) Adipo-
cyte function: South Asians appear to have dysfunctional adipocytes, leading to impaired 
release of FFA’s, adipokines and pro-inflammatory cytokines, which may contribute to 
their increased diabetic and cardiovascular risk. 2) Cortisol metabolism: the typical South 
Asian thin-fat phenotype might suggest differences in the hypothalamic-pituitary-
adrenal-target organ-axis with (tissue-specific) impaired cortisol metabolism. 3) Irisin: a 
recently discovered myokine that increases with exercise and is involved in browning of 
white adipose tissue.81 Considering the fact that South Asians have lower muscle mass 
and lower physical activity levels, irisin might have a role in insulin resistance and the 
amount of BAT. Given the findings of a recent study, though, it is not certain that irisin 
will have a similar beneficial effect in humans as in mice.82 4) Gut microbiota: the gut 
microbiota of obese subjects appears to be different from that of lean subjects and is 
thought to be associated with insulin resistance.83 Possibly, the gut microbiota also dif-
fer between various ethnicities. 5) Resveratrol: a natural polyphenol produced by plants 
and present in low concentrations in plant-based foods, which mediates some of its 
effects via activation of AMPK. Recent studies in rats showed that intrauterine growth 
restriction increased the susceptibility to HF-diet induced alterations of fat distribution, 
adipocyte size, lipid metabolism, and insulin signalling pathways,84 and that resveratrol 
reduced this susceptibility.85 It would be interesting to investigate the effect of resvera-
trol in South Asians compared to white Caucasians.
To conclude, there are still many promising areas to explore in order to find new strate-
gies for the prevention and treatment of type 2 diabetes and cardiovascular disease in 
people of South Asian origin thereby hopefully reducing the major health and socioeco-
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DEEL 1: TYPE 2 DIABETES MELLITUS IN ZUID AZIATEN
Bij diabetes (suikerziekte) kan het lichaam de bloedsuiker niet meer regelen. Normaal 
regelt het lichaam de bloedsuikerspiegel heel precies met het hormoon insuline. Insu-
line wordt gemaakt en uitgescheiden door de alvleesklier. Het zorgt ervoor dat glucose 
uit het bloed wordt opgenomen door onder meer de skeletspieren en het vetweefsel, 
en het remt de glucoseproductie door de lever. Tegelijkertijd remt insuline ook de 
afbraak van vet. Mensen met diabetes maken zelf geen insuline meer, of hun lichaam 
reageert niet meer op de insuline, afhankelijk van het type diabetes (type 1 of 2). Bij 
type 2 diabetes is het lichaam minder gevoelig voor insuline (insulineresistentie). Eerst 
maakt de alvleesklier nog extra insuline aan om te compenseren voor de verminderde 
insulinegevoeligheid, maar na verloop van tijd wordt dit steeds minder en stijgt de 
bloedsuikerspiegel; men spreekt dan van diabetes. Diabetes kan nadelige gevolgen 
hebben in het hele lichaam. Veel voorkomende complicaties van diabetes zijn hart- en 
vaatziekten, achteruitgang van de nierfunctie en ogen, en zenuwschade.
Diabetes is één van de meest voorkomende chronische aandoeningen wereldwijd en 
neemt nog steeds toe in aantal. Opvallend is dat er sterke geografische variatie is in het 
voorkomen van type 2 diabetes, waarschijnlijk ten gevolge van genetische, gedrags, en 
omgevingsfactoren. Dit geldt onder meer voor mensen van Zuid Aziatische afkomst, bij 
wie sprake is van een snelle toename in het voorkomen van type 2 diabetes. Zuid Aziaten 
komen oorspronkelijk van het Indiase subcontinent – India, Pakistan, Bangladesh, Nepal 
en Sri Lanka – en vertegenwoordigen één vijfde van de wereldbevolking. Het risico is 
verhoogd voor zowel Zuid Aziaten die zijn blijven wonen op het Indiase subcontinent 
als voor Zuid Aziaten die geëmigreerd zijn, zoals de Hindostaanse bevolkingsgroep 
in Nederland. In 2008 had 26.7% (age-standardized prevalence) van de Hindostanen 
diabetes in vergelijking tot 5.5% van de blanke autochtone Nederlanders en tot 10% 
wereldwijd. Niet alleen komt type 2 diabetes 4 tot 6 keer vaker voor in Zuid Aziaten, 
het treedt ook op jongere leeftijd (ongeveer 10 jaar eerder) op en bij een lagere body 
mass index (BMI) in vergelijking tot blanke mensen van Kaukasische afkomst. Bovendien 
ontwikkelen ze eerder en ernstiger complicaties.
De snelle toename van type 2 diabetes wereldwijd is geassocieerd met een Westerse 
levensstijl (calorierijk eten, weinig lichaamsbeweging). Zuid Aziaten lijken echter een 
uitzonderlijk hoog risico te hebben voor het ontwikkelen van diabetes bij eenzelfde le-
vensstijl in vergelijking tot andere bevolkingsgroepen. Hoewel bepaalde risicofactoren 
zoals een zittende levensstijl en ongezond dieet zeker van toepassing zijn voor Zuid 
Aziaten, mede het gevolg van de snelle ontwikkelingen in Zuid Aziatische landen in 
de afgelopen decennia, kunnen zij niet volledig het hoge risico verklaren en hebben 
genetische invloeden waarschijnlijk ook een belangrijke rol.
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De hoge prevalentie van diabetes in de Zuid Aziatische populatie vormt wereldwijd 
een belangrijk gezondheids- en sociaaleconomisch probleem. Een verklaring voor het 
hoge risico is echter nog onduidelijk. In dit proefschrift worden studies beschreven 
gericht op het verkrijgen van meer inzicht in de pathogenese van type 2 diabetes in 
Zuid Aziaten en om zo nieuwe aanknopingspunten te vinden voor het ontwikkelen van 
preventieve maatregelen en behandelopties van diabetes in deze populatie. Hiertoe 
werden jonge (18 tot 25 jaar) gezonde slanke mannen en oudere (40 tot 50 jaar) mannen 
met overgewicht (BMI 25 tot 30 kg/m2) onderzocht. De Zuid Aziatische proefpersonen 
die deel hebben genomen aan deze studies zijn Nederlandse Hindostanen. Deze groep 
komt oorspronkelijk uit Noord-India. Na het afschaffen van de slavernij in 1862 in de 
Nederlandse koloniën, zoals Suriname, mochten de Nederlanders van de Britten in 1873 
werknemers rekruteren in Noord-India voor Suriname. Vlak voor en vlak na de onafhan-
kelijkheid van Suriname in 1975 zijn veel Hindostanen gemigreerd naar Nederland. In 
2010 woonden er circa 123.000 – 147.000 Hindostanen in Nederland; de grootste groep 
woont in Den Haag (circa 45.000). Blanke autochtone Nederlanders vormen de controle-
groep van de studies beschreven in dit proefschrift.
Hoofdstuk 2 is een review over studies die onderzocht hebben waarom mensen van 
Zuid Aziatische afkomst een verhoogd risico hebben op het ontwikkelen van type 2 
diabetes in vergelijking tot mensen van blanke Kaukasische afkomst. Het voornaamste 
mechanisme in Zuid Aziaten lijkt insulineresistentie te zijn. Deze insulineresistentie is 
meest waarschijnlijk het gevolg van een interactie tussen genen en omgeving. Zuid 
Aziaten hebben een opmerkelijk ongunstig metabool fenotype: ze worden relatief 
klein geboren en hebben al bij de geboorte hoge insulinewaarden en een ongunstige 
lichaamsbouw (het zogenaamde ‘thin-fat-phenotype’: dunne armen en benen (dat wil 
zeggen weinig spiermassa), en relatief veel vet aan de romp, zowel rondom de organen, 
zogenaamd visceraal vet, als onderhuids). Dit uit zich ook in een hoger vetpercentage 
bij een vergelijkbare BMI. Bovendien is hun vetweefsel dysfunctioneel: er is minder 
opslagvermogen voor vetten en een gestoorde uitscheiding van vrije vetzuren, adipok-
inen en pro-inflammatoire (‘pro ontsteking’) cytokinen waardoor er continu sprake is 
van een laaggradige ontsteking. Dit leidt tot opslag van vet elders (in de lever, spier; 
ook wel ectopisch vet genoemd), verstoring van de insuline signaalroute en toename 
van insulineresistentie. Enkele studies tonen een gestoorde functie van het endotheel 
(de binnenbekleding van bloedvaten) leidend tot onvoldoende vaatverwijding en 
verminderde afgifte van insuline aan de weefsels. Dysfunctie van het HDL-cholesterol 
zou mogelijk ook een rol kunnen spelen. Verschillen in dieetgewoonten lijken geen be-
langrijke rol te spelen in het verhoogde risico. Wel lijken het dagelijks minder bewegen 




Dit literatuuroverzicht maakt echter ook duidelijk dat er maar weinig studies gedaan 
zijn bij Zuid Aziaten op weefselniveau, en dat een verklaring voor hun ongunstige meta-
bole fenotype nog niet opgehelderd is.
In Hoofdstuk 3 wordt een onderzoek beschreven dat ingaat op de bij herhaling gevon-
den hoge insulinewaarden na een orale glucosebelasting in Zuid Aziaten vergeleken 
met blanke Kaukasiërs. Deze hogere insulinewaarden worden gezien als een compen-
satoir mechanisme voor insulineresistentie om normale glucosewaarden te behouden. 
De hoge waarden kunnen het gevolg zijn van een verminderde klaring van insuline 
uit het bloed, of door een verhoogde uitscheiding van insuline door de alvleesklier. In 
deze studie is onderzocht of de verhoogde insulinewaarden het gevolg zijn van een 
verhoogde respons van GLP-1. GLP-1 is een hormoon dat door de darm uitgescheiden 
wordt in reactie op eten, en dat de uitscheiding van insuline stimuleert. Verder waren 
we geïnteresseerd of de hoge insulinewaarden een reactieve hypoglykemie (lage bloed-
suikerspiegel) veroorzaken, gekenmerkt door een daling in de bloedsuikerspiegel(<= 3 
mmol/L) 4 tot 6 uur na de glucosebelasting; dit wordt gezien als een teken van begin-
nende diabetes. Hiertoe ondergingen 8 jonge, gezonde Zuid Aziatische mannen en 10 
blanke Kaukasische mannen een 6-uur durende orale glucose belastingstest (OGTT). 
De Zuid Aziatische proefpersonen waren meer insulineresistent en hadden hogere 
insulinewaarden conform andere studies. De hoge insulinewaarden gingen vergezeld 
met verhoogde waarden van GLP-1. De piek GLP-1 waarden gingen vooraf aan de 
piek insulinewaarden, dit suggereert een direct verband tussen de verhoogde GLP-1 
respons en insuline afscheiding door de alvleesklier. Aanvullend onderzoek is echter 
nodig om te bepalen of de verhoogde GLP-1 concentraties inderdaad de oorzaak zijn 
van de verhoogde insulinewaarden, of dat deze hoge GLP-1 waarden een uiting zijn 
van ongevoeligheid voor GLP-1. Er was verder geen sprake van reactieve hypoglykemie.
Het belangrijkste orgaan dat glucose onder invloed van insuline opneemt uit het bloed 
is de skeletspier (75-80%). In de spier wordt de glucose vervolgens ofwel verbrand tot 
energie (oxidatieve glucose stofwisseling (Rd)) ofwel opgeslagen als glycogeen (niet-
oxidatieve glucose verwijdering (NOGD)). Deze processen lopen via de zogenaamde 
‘insuline signaalroute’ (insulin signaling pathway). Bij mensen met diabetes lijkt het 
belangrijkste probleem in de skeletspier de NOGD te zijn. Opvallend genoeg zijn bij Zuid 
Aziaten slechts twee onderzoeken gedaan op weefselniveau, waarvan in één de insuline 
signaalroute onderzocht is.
Gezien het hoge risico van Zuid Aziaten om diabetes te ontwikkelen bij eenzelfde 
levensstijl in vergelijking tot andere bevolkingsgroepen, zou een verklaring voor hun 
predispositie ook gelegen kunnen zijn in een verschillende regulatie van ‘energie/
nutriënt-gevoelige routes’ in metabole weefsels wat effect kan hebben op de gehele 
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stofwisseling. Een belangrijke signaalroute hierbij is de mTOR route. mTOR is een eiwit 
dat aan de hand van beschikbaarheid van voedingsstoffen en energieniveau van de 
cel de celgroei reguleert. mTOR reageert op insuline en andere groeifactoren, stress, 
zuurstof en niveau van voedingsstoffen. Het bevordert de eiwitaanmaak, celgroei en 
-differentiatie, en kan de insuline signaalroute remmen. Verder lijkt het ook een cruciale 
rol te spelen in de mitochrondriële biogenese en oxidatieve stofwisseling.
In de Hoofdstukken 4 en 5 zijn deze signaalroutes onderzocht in jong volwassen en 
volwassen proefpersonen voor en na een dieet.
INTERMEZZO: UITLEG ONDERZOEKSMETHODEN
In dit proefschrift is gebruik gemaakt van diverse onderzoekstechnieken.
2-staps hyperinsulinemische-euglycemische clamp. Met deze test kan de gevoeligheid van 
weefsels voor insuline worden bepaald. De proefpersoon krijgt zowel insuline als glucose 
toegediend. Onder invloed van insuline wordt glucose uit het bloed opgenomen door met name 
de spieren; hierdoor gaat de bloedglucosewaarde omLaag. Hoe meer glucose men iemand moet 
toedienen om de bloedglucosespiegel stabiel te houden hoe gevoeliger de spier is voor insuline 
(perifere insulinegevoeligheid, Rd). De lever produceert zelf ook glucose (endogene of hepatische 
glucoseproductie, EGP). Om onderscheid te kunnen maken tussen het door lever geproduceerde 
glucose en het toegediende glucose wordt gelabelde glucose toegediend (glucose gelabeld met 2 
waterstofatomen, de stabiele isotoop deuterium). Hiermee kun je de gevoeligheid van de lever voor 
insuline bepalen (hoe gevoeliger hoe minder glucoseproductie). De test bestaat uit 2 stappen, een 
lage insuline stap waarin met name de lever insulinegevoeligheid goed te meten is, en een hoge 
insuline stap waarin juist de perifere insulinegevoeligheid (met name spier; Rd) goed te meten is.
Spierbiopsie. Met een holle naald wordt onder lokale verdoving een biopt afgenomen uit 
skeletspierweefsel (uit het bovenbeen), zowel voor als na het dieet, en voor en tijdens de clamp; 
tijdens de clamp kan dan het effect van insuline op de insulinegevoelige signaalroutes in spier worden 
bestudeerd. In het spierweefsel wordt gekeken naar eiwitexpressie (door middel van Western Blot) 
en genexpressie (door middel van qPCR) van eiwitten betrokken in diverse signaalroutes.
Indirecte calorimetrie. Vlak voor en tijdens de clamp ondergingen de proefpersonen een 
geventileerde kapmeting (indirecte calorimetrie). Tijdens deze meting krijgt de proefpersoon een 
geventileerde doorzichtige kap over zijn hoofd waarin het zuurstofgehalte (O2) en koolzuurgasgehalte 
(CO2) in de in- en uitademingslucht wordt gemeten en met elkaar wordt vergeleken. Hieruit kan 
men bepalen wat iemands energiegebruik is in rust (resting energy expenditure, REE), en hoeveel 
koolhydraten, vetten en eiwitten iemand verbrandt. Insuline remt de vetverbranding en stimuleert 
de glucoseverbranding. Tijdens de clamp waarbij insuline wordt toegediend verwacht men dus 
een afname van de vetverbranding en een toename van de glucoseverbranding. Hoe resistenter 
iemand is voor insuline, hoe minder sterk dit effect zal zijn. Bij caloriebeperking gaat het lichaam 
over op vetverbranding om glucose te sparen voor de glucoseafhankelijke weefsels (de hersenen en 
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Hoofdstuk 4 vergelijkt de metabole aanpassing aan een 5-dagen hoog-vet-hoog-calo-
risch dieet (HFHCD, eigen dieet plus 375 mL slagroom per dag (= 1275 kcal per dag extra 
bestaande uit 94% vet)) in de jonge groep. Het bleek dat een 5-dagen HFHCD al vol-
doende is om de perifere insulinegevoeligheid te verminderen in Zuid Aziaten, terwijl er 
geen effect te zien was in de blanke controles. Deze afname in insulinegevoeligheid was 
voornamelijk het gevolg van een afname in NOGD wat een defect in de glycogeenopslag 
suggereert. Er werden echter geen duidelijke verschillen tussen de groepen gevonden 
in de expressie van eiwitten en genen betrokken in glycogeenafbraak en -opslag. Op 
het niveau van de skeletspier werden verder ook geen significante verschillen gezien 
tussen de groepen in mTOR en insuline signalering, en ook niet in de expressie van 
metabole genen en mitochondriële functie (mitochrondria zijn de energiecentrales van 
de cel). Verder waren levervet en buikvetverdeling niet verschillend tussen Zuid Aziaten 
en blanke controles. Wel was sprake van een lagere insuline klaringssnelheid en lever 
insulinegevoeligheid in Zuid Aziaten, zowel voor als na het dieet.
Redenen waarom geen duidelijke verschillen werden gevonden op weefselniveau 
kunnen de relatief goede gezondheid van de proefpersonen en/of de kleine groeps-
grootte zijn. Verder kan niet worden uitgesloten dat het witte vetweefsel bijgedragen 
heeft aan de afname in perifere insulinegevoeligheid in Zuid Aziaten. Ongeveer 10-20% 
van de insulinegestimuleerde glucoseopname treedt namelijk op in wit vetweefsel.
rode bloedcellen). Na het dieet verwacht men daarom in de niet-insuline-gestimuleerde toestand 
een toename van de vetverbranding en een afname van de glucoseverbranding. Het effect van 
insuline zal in principe sterker zijn door toegenomen insulinegevoeligheid. Het vermogen om de 
vetverbranding te verhogen na caloriebeperking en om te switchen van vet- naar glucoseverbranding 
tijdens insulinetoediening wordt metabole flexibiliteit genoemd.
MRI/MRS. Voorafgaand aan en 1 dag na het dieet werd een MRI (magnetic resonance imaging) 
en spectroscopie (MRS) verricht. Hiermee is gekeken naar de hartfunctie, het hartvet (myocardial 
triglyceride content), levervet (hepatic triglyceride content, HTG), buikvetverdeling en de stijfheid 
van de aorta (pulse wave velocity, PWV).
18F-FDG-PET-CT scan. Voor de bruin vet studie (Hoofdstuk 7) is  gebruik gemaakt van een 18F-FDG-
PET-CT scan. Een 18F-FDG PET-onderzoek (positron emissie tomografie) geeft informatie over de 
glucosestofwisseling in weefsels die glucose opnemen, zoals bruin vet. Een PET-camera kan glucose 
in beeld brengen wanneer het radioactief is gemerkt (18F-FDG). De PET-scan wordt gecombineerd 
met een CT-scan om de glucoseopname nauwkeurig te kunnen lokaliseren. Om de detectiekans 
van bruin vet te vergroten op de PET-CT scan wordt een koelprocedure toegepast; bruin vet wordt 
immers geactiveerd door kou. Tijdens het koelen met speciale koelmatten wordt de proefpersoon 
gedurende circa 3 uur blootgesteld aan milde kou (± 16 °C). Het doel is om het bruine vet maximaal 
te activeren zonder dat de proefpersoon gaat rillen.
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Concluderend gaf een HFHCD snel insulineresistentie in jonge gezonde slanke Zuid 
Aziatische proefpersonen. Dit suggereert dat de vatbaarheid van Zuid Aziaten voor het 
ontwikkelen van type 2 diabetes deels verklaard kan worden door de manier waarop ze 
zich aanpassen aan een Westers vetrijk dieet. De mTOR route in skeletspierweefsel lijkt 
daarbij nog geen rol te hebben.
Hoofdstuk 5 bestudeert het effect van caloriebeperking door middel van een 8-dagen 
zeer-laag-calorisch-dieet (VLCD, ~450 kcal per dag) op energie/nutriënt-gevoelige sig-
naalroutes in skeletspierweefsel in de oudere groep. Voorafgaand aan het dieet waren 
de Zuid Aziaten meer insulineresistent dan de blanke controles: ze hadden hogere insu-
linewaarden zowel in nuchtere toestand als tijdens orale glucosebelasting, en een lagere 
lever en perifere insulinegevoeligheid. Verder was de insuline klaringssnelheid lager en 
het levervet hoger in de Zuid Aziatische proefpersonen. Opslag van vet in de lever is ge-
associeerd met insulineresistentie van de lever. De lagere perifere insulinegevoeligheid 
in Zuid Aziaten leek het gevolg te zijn van een verminderde NOGD. Dit suggereert een 
defect in glycogeenopslag, één van de belangrijkste problemen in patiënten met type 2 
diabetes. Er werden echter geen verschillen tussen de groepen gevonden in de expres-
sie van eiwitten en genen betrokken bij glycogeenafbraak en -opslag, zoals eerder ook 
in de jonge groep was gezien (Hoofdstuk 4). Verder werden voorafgaand aan het dieet 
geen verschillen gevonden in insuline en mTOR signalering, en was de verbranding van 
koolhydraten en vetten en de metabole flexibiliteit vergelijkbaar.
De Zuid Aziatische proefpersonen reageerden echter metabool anders op het VLCD 
dan de blanke controles. In beide groepen namen lever- en buikvet af en verbeterde 
de insulinegevoeligheid van de lever. De blanke controles waren metabool flexibel: ze 
switchten van glucose naar vetverbranding in de nuchtere toestand en lieten een ver-
sterkt insuline effect zien op de glucose- en vetverbranding. In de Zuid Aziatische groep 
was deze switch echter gestoord na het dieet, zowel in de nuchtere toestand als tijdens 
de clamp, en was derhalve sprake van metabole inflexibiliteit. Verder werd in de blanke 
groep geen dieeteffect gezien op de perifere insulinegevoeligheid, overeenkomend met 
andere kortdurende studies met caloriebeperking en minimaal gewichtsverlies. In de 
Zuid Aziaten werd juist een lichte verbetering gezien in de perifere insulinegevoeligheid 
ondanks een afname in insulinewaarden, voornamelijk door een toename in NOGD. Op 
spierniveau bleken energie/nutriënt-gevoelige signaalroutes anders aangedaan, met 
een toename in insuline geïnduceerde activatie van de mTOR (ERK-mTOR-S6K1) signaal-
route in Zuid Aziaten.
Er is steeds meer bewijs dat mTOR de vetzuurverbranding kan onderdrukken door 
het remmen van PPARα, een transcriptiefactor. PPARα regelt de transcriptie van genen 
betrokken in onder meer de opname van vetzuren in de cel en mitochondria en vet-
zuurverbranding. Inderdaad bleek mRNA expressie van PPARA en enkele doelgenen van 
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PPARA alleen in Zuid Aziaten significant afgenomen te zijn. Het is dus mogelijk dat de 
activatie van de mTOR signaalroute in Zuid Aziaten in reactie op caloriebeperking de 
vetzuurverbranding heeft onderdrukt door het remmende effect van mTOR op PPARα, 
leidend tot metabole inflexibiliteit.
Een opvallende bevinding was de toegenomen perifere insulinegevoeligheid in 
Zuid Aziaten, terwijl mTOR hierop juist een remmend effect zou hebben. De toename in 
perifere insulinegevoeligheid lijkt met name verklaard te worden door een toegenomen 
NOGD, hoewel er wederom geen verschillen in het glycogeenmetabolisme gevonden 
werden. Interessant in dit opzicht is dat alleen in de Zuid Aziatische proefpersonen 
de expressie van AMPK significant toenam na het dieet. AMPK activatie bevordert de 
glucoseopname in de spier en zou daarom onderliggend kunnen zijn aan de verbeterde 
NOGD in Zuid Aziaten.
Concluderend reageerden volwassen Zuid Aziatische mannen met overgewicht me-
tabool anders op kortdurende caloriebeperking in vergelijking tot blanke mannen van 
Kaukasische afkomst. Hoewel de perifere insulinegevoeligheid toenam, was de meta-
bole flexibiliteit gestoord. Dit ging gepaard met een toename in insuline geïnduceerde 
activatie van de ERK-mTOR-S6K1 signaalroute op spierniveau.
Bruin vet is een recent ontdekte speler in de energie stofwisseling van mensen. Hoofd-
stuk 6 geeft een overzicht over de anatomie, fysiologie en functie van bruin vet en 
beschrijft hoe bruin vet gemanipuleerd zou kunnen worden om het energiegebruik 
te verhogen en daarmee mogelijk gewichtsverlies te induceren. In tegenstelling tot 
het witte vet neemt bruin vet glucose en vetten op uit het bloed en verbrandt deze 
vervolgens tot warmte. Dit mechanisme draagt in baby’s bij aan het handhaven van 
hun lichaamstemperatuur. De hoeveelheid bruin vet neemt in mensen echter snel af 
na de peutertijd. In 2009 is met een speciale scantechniek (18F-FDG PET-CT scan) echter 
ontdekt dat volwassen mensen nog functioneel bruin vet hebben. Kou activeert bruin 
vet; de beste detectiekans heb je daarom door voorafgaand aan het toedienen van het 
FDG de proefpersoon te koelen. Bruin vet kan in belangrijke mate bijdragen aan het 
energiegebruik (tot 15-20% van het totale dagelijkse energiegebruik). Een interessante 
bevinding is dat mensen met overgewicht minder bruin vet lijken te hebben. Verder re-
sulteren bepaalde aandoeningen die leiden tot activatie van bruin vet, zoals een snelle 
schildklierfunctie en een feochromocytoom (een neuroendocriene (bijnier)tumor dat 
teveel stresshormonen aanmaakt), tot een verhoogd energiegebruik en gewichtsverlies. 
Het stimuleren van bruin vet wordt daarom gezien als een mogelijk preventief en thera-
peutisch doel in onze strijd tegen overgewicht en aan overgewicht gerelateerde ziekten, 
zoals type 2 diabetes. Verschillende methoden waarop bruin vet gemanipuleerd kan 
worden zijn geïdentificeerd met wisselend succes, zoals het stimuleren van aanwezig 
bruin vet door stimulatie van het sympathisch zenuwstelsel, via blootstelling aan kou 
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en bepaalde medicamenten, en het rekruteren van bruin vet door het stimuleren van de 
differentiatie van vetcellen naar bruine vetcellen.
Aangezien bruin vet betrokken is in het totale energiegebruik en de klaring van 
vetten en glucose en daarmee beschermt tegen metabole verstoringen, was onze 
hypothese dat een laag bruin vet volume of activiteit onderliggend zou kunnen zijn 
aan het ongunstige metabole fenotype van Zuid Aziaten (overgewicht, gestoorde 
vetbalans, insulineresistentie) en aan hun vatbaarheid voor diabetes. In Hoofdstuk 7 is 
daarom zowel het rust energiegebruik (REE) als het volume en de activiteit van bruin vet 
onderzocht in de jonge groep met behulp van de geventileerde kapmeting en koude-
geïnduceerde 18F-FDG-PET-CT-scans. REE was 32% lager in de Zuid Aziatische proef-
personen. Bovendien lag de temperatuur waarop het rillen begon hoger in deze groep 
ondanks een hoger totaal vetpercentage, en de koude geïnduceerde ‘non-shivering’ 
thermogenese (warmteproductie niet door spieractiviteit (rillen)) was kleiner. Het bruin 
vet volume was aanzienlijk lager in de Zuid Aziatische groep (34%), terwijl er geen ver-
schil was in de activiteit. Een verklaring voor het lagere bruin vet volume in Zuid Aziaten 
zou genetisch kunnen zijn (verminderde expressie van signaalmoleculen betrokken bij 
de differentiatie van bruin vet), en/of omgeving gerelateerd (kleedgedrag, instelling 
centrale verwarming, en/of eetpatroon). Concluderend zou een laag bruin vet volume 
onderliggend kunnen zijn aan het hoge risico van Zuid Aziaten tot het ontwikkelen van 
metabole aandoeningen als obesitas en type 2 diabetes. Het vergroten van het volume 
of activiteit van bruin vet zou daarom een belangrijk therapeutisch aangrijpingspunt 
kunnen zijn, mogelijk leidend tot een verhoogde klaring van glucose en vetten en een 
verhoogd totaal energiegebruik.
DEEL 2: HART- EN VAATZIEKTEN IN ZUID AZIATEN
Hart- en vaatziekten komen veel voor in de algemene bevolking en zijn wereldwijd een 
belangrijke doodsoorzaak. Onder hart- en vaatziekten vallen hartinfarct, herseninfarct 
of beroerte, en perifeer vaatlijden (bijv. ‘etalagebenen’). De belangrijkste oorzaak is 
atherosclerose (aderverkalking), wat vaak al vele jaren aanwezig is voordat symptomen 
optreden. Belangrijke oorzaken van atherosclerose zijn leefstijlfactoren zoals roken, 
ongezonde voeding en te weinig beweging, stress, overgewicht, ongunstig vetprofiel 
(hoog LDL, laag HDL, hoog triglyceridengehalte), verhoogde bloeddruk (hypertensie) 
en diabetes. Daarnaast spelen ook erfelijke factoren een rol bij het ontstaan van hart- en 
vaatziekten.
Net als voor diabetes hebben mensen van Zuid Aziatische afkomst een verhoogd 
risico op het ontwikkelen van hart- en vaatziekten in vergelijking tot blanke Kaukasische 
mensen. Zuid Aziatische mensen krijgen eerder een hartinfarct (circa 5 jaar), kennen 
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een agressiever beloop en hoger overlijdensrisico op jongere leeftijd. Het hoge risico 
op hart- en vaatziekten in Zuid Aziaten komt waarschijnlijk door een wisselwerking tus-
sen genetische gevoeligheid en omgevingsfactoren. In dit proefschrift worden studies 
beschreven gericht op het verkrijgen van meer inzicht in de pathogenese van hart- en 
vaatziekten in Zuid Aziaten en om zo nieuwe aanknopingspunten te vinden voor het 
ontwikkelen van preventieve maatregelen en behandelopties in deze populatie. Hiertoe 
werden dezelfde proefpersonen onderzocht als eerder beschreven onder Type 2 diabe-
tes.
In Hoofdstuk 8 worden mogelijke factoren besproken die bij kunnen dragen aan het 
verhoogde cardiovasculaire risico van Zuid Aziaten evenals nieuwe therapeutische 
strategieën. De belangrijkste oorzaak van hart- en vaatziekten is atherosclerose 
(aderverkalking), wat al vele jaren aanwezig kan zijn voordat symptomen optreden. 
De ontwikkeling van atherosclerose wordt beïnvloed door zowel metabole als inflam-
matoire risicofactoren. Metabole of ‘klassieke’ risicofactoren zijn dyslipidemie (gestoord 
vetprofiel), abdominaal overgewicht (vet met name in de buik) en insulineresistentie. 
Inflammatoire of ‘niet klassieke’ risicofactoren zijn systemische ontsteking, HDL dys-
functie en endotheel dysfunctie. In Zuid Aziaten komen de klassieke risicofactoren veel 
voor. Een mogelijke bijdragende factor aan de ontwikkeling hiervan is een lager volume 
van bruin vet, resulterend in een afgenomen vetverbranding en glucoseopname. De 
klassieke factoren kunnen echter niet volledig het verhoogde risico verklaren. Andere, 
niet-klassieke risicofactoren moeten daarom aanwezig zijn. Inderdaad is de prevalentie 
van inflammatoire risicofactoren, waaronder ontsteking van het viscerale (orgaan) vet-
weefsel, endotheel dysfunctie en HDL dysfunctie hoger in de Zuid Aziatische populatie 
vergeleken met mensen van blanke Kaukasische afkomst. Concluderend zou het hoge 
risico op hart- en vaatziekten in Zuid Aziaten mogelijk verminderd kunnen worden door 
behandelmethoden gericht op het vergroten van het bruin vet volume of activiteit, 
daarmee de klassieke risicofactoren verminderend. Verder zou anti-inflammatoire 
therapie de niet-klassieke risicofactoren in deze bevolkingsgroep kunnen verlagen. Een 
combinatie van beide strategieën zal met name effectief zijn.
In de hoofdstukken 9 en 10 zijn de cardiale dimensies, cardiovasculaire functie en het 
vetgehalte van de hartspier onderzocht middels MRI en spectroscopie. De mortaliteit 
van hart- en vaatziekten bij diabetes is hoger in Zuid Aziaten in vergelijking tot blanke 
Kaukasiërs. Dit suggereert een hogere cardiale vatbaarheid voor metabole verstoringen. 
Kortdurende dieetinterventies, zoals hoog vet belasting en caloriebeperking, kunnen 




In Hoofdstuk 9 is onderzocht of de cardiale dimensies, cardiovasculaire functie en 
het vetgehalte van de hartspier op jonge leeftijd verschillen tussen Zuid Aziaten en 
blanke Nederlanders, met het idee dat dit bij zou kunnen dragen aan het verhoogde 
risico op hart- en vaatziekten in Zuid Aziaten. Verder is de respons op een 5-dagen 
HFHCD bekeken. Voorafgaand aan het dieet bleken de cardiale dimensies kleiner in Zuid 
Aziaten, ook na correctie voor hun kleinere lichaamspostuur. Verder werden er verschil-
len in diastolische en systolische cardiale functie gezien passend bij een langere cardiale 
relaxatie en contractie. Een 5-dagen HFHCD vergrootte deze verschillen niet, ondanks 
een significante toename in insulinewaarden in Zuid Aziaten aangevend dat ze meer 
insulineresistent waren geworden. Tot slot was de pulse wave velocity (PWV) van de 
aorta hoger (dat wil zeggen een stijvere aorta) in Zuid Aziaten voorafgaand aan het di-
eet; dit normaliseerde na het dieet. De PWV van de aorta is een krachtige onafhankelijke 
voorspeller van cardiovasculaire complicaties. Verminderde insulinegevoeligheid en 
verhoogd LDL-cholesterol zouden causaal gerelateerd kunnen zijn aan de verschillende 
cardiale functieprofielen. Een andere mogelijkheid is dat de geobserveerde verschillen 
in cardiale dimensies en cardiovasculaire functie aangeboren zijn en simpelweg repre-
sentatief zijn voor verschillende normale referentiewaarden in deze twee etnische groe-
pen. Of de waargenomen verschillen bijdragen aan de hogere incidentie van hart- en 
vaatziekten in Zuid Aziaten moet nog worden vastgesteld. Ze kunnen in ieder geval niet 
verklaard worden door een verschillende metabole respons op een kortdurend hoog 
vet dieet, aangezien een 5-dagen HFHCD de waargenomen verschillen niet vergrootte 
ondanks duidelijke metabole effecten. Het is echter mogelijk dat een langer durend 
HFHCD nodig is om veranderingen teweeg te brengen.
In Hoofdstuk 10 is onderzocht of de metabole en functionele cardiovasculaire 
flexibiliteit op caloriebeperking verschillend is tussen volwassen Zuid Aziaten en blanke 
Kaukasiërs. Eerdere studies in gezonde proefpersonen en mensen met overgewicht en 
diabetes met en zonder hart- en vaatziekten van blanke Kaukasische afkomst toonden 
een vergelijkbare metabole en functionele flexibiliteit van het hart aan in reactie op 
zowel kort- als langdurende caloriebeperking. Het is echter onbekend of caloriebeperk-
ing vergelijkbare effecten heeft in Zuid Aziaten. In deze studie werd daarom de volwas-
sen groep onderzocht voor en na een 8-dagen VLCD. Voorafgaand aan het dieet bleken 
de cardiale dimensies kleiner ondanks correctie voor hun kleinere postuur, en was de 
PWV in de aorta hoger in Zuid Aziaten, conform onze bevindingen in de jonge groep. 
De hogere PWV zou toegeschreven kunnen worden aan de hogere insulinewaarden. 
Langdurig verhoogde insulinewaarden, zoals bij insulineresistentie en diabetes, kunnen 
de elastische functie van de aorta verminderen. Systolische en diastolische functie, 
vetgehalte in de hartspier en rondom het hart waren niet significant verschillend. Na 
het VLCD, steeg het vetgehalte in de hartspier in beide groepen met 69%. Hoewel een 
verhoogd myocardiaal vetgehalte bij insulineresistentie geassocieerd is met een ges-
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toorde hartfunctie, is de toename van myocardiale vetopslag na een kortdurend VLCD 
een teken van behouden metabole flexibiliteit van het hart. Gezien het hoge risico op 
hart- en vaatziekten en diabetes in Zuid Aziaten was de hypothese dat de flexibiliteit 
van het hart afgenomen zou zijn in deze populatie. Het vetgehalte van het hart steeg 
echter in gelijke mate in beide groepen. Diastolische cardiale functie nam af na het dieet 
in beide groepen, conform eerdere studies, en kan waarschijnlijk verklaard worden door 
veranderingen in elastische eigenschappen van de linkerkamer. Daarentegen nam het 
pericardiale vet (vet rondom het hart) alleen in de Kaukasische groep significant af 
na het dieet, voornamelijk door een afname in de paracardiale vetlaag. Aangezien de 
paracardiale vetlaag een voorspeller is voor hart- en vaatziekten, geeft de afname in 
Kaukasiërs waarschijnlijk minder cardiovasculair risico. Verder nam alleen in de Kauka-
sische groep de PWV in een deel van de aorta af na het dieet. Dit suggereert dat de grote 
slagaderen minder flexibel zijn in Zuid Aziaten in respons op caloriebeperking. Dit kan 
het gevolg zijn van de, waarschijnlijk langdurig bestaande, hogere insulinewaarden met 
irreversibele veranderingen in de arteriewand tot gevolg. Concluderend zijn de myo-
cardiale vetopslag en diastolische hartfunctie van volwassen insulineresistente Zuid 
Aziaten net zo flexibel en ontvankelijk voor caloriebeperking als van gematchte, maar 
minder insulineresistente blanke Kaukasiërs. Daarentegen was sprake van een verschil-
lend dieeteffect op het paracardiale vetvolume en de PWV ten gunste van Kaukasiërs.
Tot slot werd in Hoofdstuk 11 de HDL functie vergeleken tussen Zuid Aziaten en blanke 
Kaukasiërs in pasgeborenen, de jonge groep en de volwassen groep.
De belangrijkste oorzaak van hart- en vaatziekten is atherosclerose (aderverkalking). 
Atherosclerose ontstaat door een continue afzetting van vetten en cholesterol in de 
binnenwand van slagaders (juist onder het endotheel). De ontwikkeling ervan start al 
vele jaren voordat er symptomen ontstaan en begint met schade en dysfunctie van de 
binnenwand van slagaders (het endotheel), bijvoorbeeld door een te hoge bloeddruk, 
waardoor er ontstekingscellen worden aangetrokken naar de plekken met endotheel-
schade. Een te hoog LDL-cholesterol (het ‘slechte’ cholesterol) is een belangrijke factor 
die het risico op aderverkalking verhoogt. LDL kan geoxideerd raken en op den duur 
door de vaatwand heen dringen en vervolgens ter plekke neerslaan. Deze geoxideerde 
LDL-deeltjes worden opgeruimd door macrofagen, een bepaald type ontstekingscel, 
met gevolg dat deze cellen gaan schuimen. De schuimcellen hopen zich op in de vaat-
wand en vormen uiteindelijk een vetophoping (een plaque). Dit trekt weer ontstekings-
cellen aan wat de ontwikkeling van atherosclerose verder in stand houdt. De plaque kan 
verder groeien en zo vernauwing van het bloedvat veroorzaken met belemmering van 
de bloedstroom tot gevolg. Ook kan er een hard kapje (fibreuze kap) over de plaque 
gevormd worden als een soort bescherming. Echter, als de plaque blijft groeien kan het 
kapje scheuren, waardoor er een bloedstolsel gevormd wordt met mogelijk complete 
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blokkade van het bloedvat tot gevolg. Hierdoor krijgt het weefsel achter de blokkade 
geen zuurstof meer met tot gevolg dat dit weefsel afsterft (infarct).
Dysfunctie van HDL (het ‘goede’ cholesterol) is geassocieerd met hart- en vaatziekten. 
De cardiovasculaire beschermende effecten van HDL worden toegeschreven aan enkele 
anti-atherogene eigenschappen, waaronder 1) het voorkomen van LDL oxidatie, een 
belangrijke stap in het begin en de progressie van atherosclerose, 2) anti-inflammatoire 
eigenschappen, 3) stimulatie van cholesterol efflux uit macrofaag schuimcellen in athe-
rosclerotische plaques naar de lever met uiteindelijk uitscheiding van cholesterol in gal, 
en 4) het induceren van vaatverwijding door stimulatie van NO (stikstof oxide) afgifte 
door endotheelcellen, waardoor er minder spanning staat op de vaatwand en daardoor 
minder ontwikkeling van atherosclerose.
Interessant is dat meerdere studies bij herhaling lagere HDL-cholesterol waarden 
hebben gevonden in Zuid Aziaten in vergelijking tot mensen van blanke Kaukasische 
afkomst. Een bijdragende factor aan het hoge risico op hart- en vaatziekten in Zuid 
Aziaten zou daarom een lage concentratie en/of dysfunctie van HDL kunnen zijn. 
Deze studie onderzocht de HDL functionaliteit met betrekking tot cholesterol efflux, 
anti-oxidatie en anti-inflammatie in bloedmonsters van de eerder genoemde groepen. 
Aangezien de HDL functie beïnvloed kan worden door dieetinterventie werd ook het 
effect van kortdurende dieetinterventie op de HDL functie onderzocht (5-dagen HFHCD 
in de jonge groep, 8-dagen VLCD in de volwassen groep).
Deze studie toont aan dat het vermogen van HDL om oxidatie van LDL te voorko-
men gestoord was in volwassen Zuid Aziaten. Op jongere leeftijd is deze functie nog 
vergelijkbaar. Een verklaring voor deze verslechtering zouden exogene factoren kunnen 
zijn, zoals insulineresistentie en diabetes. Beide zijn geassocieerd met een afname in 
HDL-cholesterol waarden, veranderde HDL samenstelling en gestoorde HDL functie. 
Interessant is dat een gestoord anti-oxidatief vermogen van HDL andersom ook lijkt bij 
te dragen aan het verhoogde risico op diabetes en diabetes gerelateerde complicaties 
in Zuid Aziaten.
Het anti-inflammatoire vermogen van HDL was aanzienlijk lager in pasgeboren Zuid 
Aziaten. Dit verschil was niet aanwezig in de jonge en volwassen groep, suggererend 
dat tijdens de ontwikkeling de verminderde anti-inflammatoire functie zich herstelt. 
Echter, er is dan waarschijnlijk al wel een basis voor atherosclerose en het daarmee 
gepaard gaande risico op hart- en vaatziekten gelegd. Kortdurende caloriebeperking 
op volwassen leeftijd verstoorde alleen in de Zuid-Aziatische proefpersonen de anti-
inflammatoire capaciteit. Dus in plaats van gunstig te zijn, lijkt caloriebeperking eerder 
schadelijk voor Zuid Aziaten wat betreft de anti-inflammatoire functie. Mogelijk is deze 
verslechtering alleen aanwezig in de caloriebeperkte toestand, en normaliseert deze 
zich weer na gewichtsverlies en herintroducering van een normaal dieet. Dit zou deels 
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het gevolg kunnen zijn van de hogere afgifte van pro-inflammatoire cytokinen door 
vetcellen in Zuid Aziaten, die verergerd kan worden in geval van caloriebeperking.
Tot slot was het vermogen van HDL om cholesterol efflux te induceren vergelijkbaar 
tussen de bevolkingsgroepen. In beide groepen nam de cholesterol efflux toe na een 
5-dagen HFHCD en af na een 8-dagen VLCD.
Concluderend hebben we aangetoond dat de anti-inflammatoire functie van HDL 
verminderd was in Zuid Aziatische pasgeborenen, en significant gestoord was na 
kortdurende caloriebeperking in volwassen Zuid Aziaten. Verder was de anti-oxidatieve 
capaciteit van HDL gestoord in volwassen Zuid Aziaten, wat nog niet het geval was op 
jonge leeftijd, en daarom mogelijk het gevolg is van exogene factoren. Deze versto-
ringen in HDL functionaliteit zouden bij kunnen dragen aan het overmatige risico op 
hart- en vaatziekten, en mogelijk ook diabetes, in mensen van Zuid Aziatische afkomst.
CONCLUSIE EN TOEKOMSTIG ONDERZOEK
De etnische ongelijkheid tussen Zuid Aziaten en blanke Kaukasiërs in het risico op dia-
betes en hart- en vaatziekten is waarschijnlijk te wijten aan verschillen in genen, maar 
ook aan andere programmeringsinvloeden (gedurende de afgelopen eeuwen maar bij-
voorbeeld ook door ongunstige omstandigheden in de baarmoeder zoals bij maternale 
ondervoeding of hyperglykemie), leidend tot het huidige ongunstige metabole Zuid 
Aziatische fenotype. Dit fenotype was oorspronkelijk gunstig voor de overleving onder 
bepaalde nadelige omstandigheden, zoals terugkerende hongersnood, ongunstige 
klimatologische omstandigheden en bepaalde infectieziekten, maar past nu niet meer 
bij de moderne Westerse levensstijl en langere levensverwachting. Daarnaast zullen ook 
demografische en omgevingsfactoren secundair aan verstedelijking hebben bijgedra-
gen aan de gevoeligheid van Zuid Aziatische mensen voor het ontwikkelen van dia-
betes en hart- en vaatziekten. Dit proefschrift had als doel meer inzicht te krijgen in de 
pathogenese van deze aandoeningen in Zuid Aziaten. Het lijkt erop dat bovenstaande 
factoren niet één, maar meerdere belangrijke metabole mechanismen beïnvloed heb-
ben. Een aantal van deze mechanismen zijn in dit proefschrift onderzocht.
Ten eerste de insuline signaalroute. Een kortdurende HFHCD verminderde al de 
perifere insulinegevoeligheid in de jonge Zuid Aziatische groep, en in de oudere groep 
was deze al in de uitgangssituatie lager. In beide leeftijdsgroepen leek dit het gevolg te 
zijn van een afgenomen NOGD wat een probleem in de glycogeenopslag suggereert. 
Op spierniveau werden echter geen verschillen gevonden in expressie van eiwitten 
en genen betrokken bij de afbraak en opslag van glycogeen. Daarnaast waren er geen 
verschillen in de insuline signaalroute, expressie van metabole genen of mitochondri-
ele elektronentransportketen (een indirecte maat voor de mitochondriële functie). Een 
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andere bevinding was dat hogere insulinewaarden tijdens een OGTT in Zuid Aziaten 
gepaard gingen met hogere waardes van GLP-1, waarschijnlijk als aanpassing aan de 
insulineresistentie. Verder onderzoek naar de rol van het glycogeenmetabolisme, mi-
tochondriële functie en GLP-1 is nodig. Ook zou het interessant zijn om de rol van wit 
vetweefsel te onderzoeken, aangezien ongeveer 10-20% van de insulinegestimuleerde 
glucoseopname optreedt in wit vetweefsel.
Ten tweede de energie/nutriënt-gevoelige signaalroutes. De oudere Zuid Aziatische 
groep liet een andere metabole aanpassing zien aan kortdurende caloriebeperking in 
vergelijking tot blanke mannen van Kaukasische afkomst met een toename in insuline 
geïnduceerde activatie van de ERK-mTOR-S6K1 signaalroute op spierniveau. Dit ging 
onder meer gepaard met een gestoorde metabole flexibiliteit. Verder onderzoek naar 
de rol van energie/nutriënt-gevoelige signaalroutes in de glucose- en vetstofwisseling 
en metabole flexibiliteit in spier en wit vet voor en na inspanning en langer durende 
dieetinterventies zou interessant zijn.
Ten derde bruin vet. Bruin vet is betrokken in het totale energiegebruik. Het volume 
van bruin vet bleek lager te zijn in de jonge groep Zuid Aziaten. Toekomstig onderzoek 
moet bekijken wat de onderliggende oorzaak hiervan is, zoals een verminderde ex-
pressie van signaalmoleculen betrokken in de differentiatie van bruin vet. Ook is het 
interessant om onderzoek te doen gericht op het ontwikkelen van nieuwe strategieën 
om bruin volume en/of activiteit te vergroten.
Ten vierde HDL functie. Er was sprake van een leeftijdsafhankelijke dysfunctie van 
HDL in de Zuid Aziatische proefpersonen wat mogelijk bij zou kunnen dragen aan hun 
hoge risico op hart- en vaatziekten. Toekomstige studies moeten bijvoorbeeld gericht 
zijn op het ontwikkelen van behandelstrategieën die de HDL functionaliteit kunnen ver-
beteren en of dit daadwerkelijk het cardiovasculaire risico vermindert in Zuid Aziaten.
Ook zijn er mechanismen die niet in dit proefschrift onderzocht zijn maar wel aandacht 
verdienen. Zoals de endotheel functie. Endotheel dysfunctie is betrokken in de ontwik-
keling van atherosclerose. Enkele studies hebben al tekenen van endotheel dysfunctie 
aangetoond in Zuid Aziaten. Het sympathische zenuwstelsel. Het sympathisch zenuw-
stelsel speelt onder meer een rol in het energiegebruik. De mindere toename in vrije 
vetzuren na caloriebeperking in volwassen Zuid Aziaten en na koude expositie in jonge 
Zuid Aziaten, samen met een mindere toename in vetverbranding in de volwassen 
groep en een lagere koude geïnduceerde toename in vetverbranding en bloeddruk in 
de jonge groep kan wijzen op verschillen in sympathische activatie en/of resistentie 
voor sympathische activatie. Andere interessante gebieden om nog te onderzoeken 
zijn bijvoorbeeld de functie van witte vetcellen, het cortisol metabolisme en het darm 
microbioom (bacteriën in het maag-darmkanaal).
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Concluderend zijn er nog tal van veelbelovende onderzoeksgebieden om nieuwe stra-
tegieën voor de preventie en behandeling van type 2 diabetes en hart- en vaatziekten 
in mensen van Zuid Aziatische afkomst te vinden en daarmee uiteindelijk het grote 
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